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INTRODUCTION AND OVERVIEW OF THIS 
THESIS 
The use of percutaneous translul1linal angioplasty was initiated by Dotter and 
Judkins, with the introduction of tapered dilating catheters of increasing diameters 
in 1964 [I]. Almosl a decade passed before Andreas GrLinlzig reporled Ihe use of 
cylindrical high pressure balloons for the dilatatinll of atherosclerotic arteries [2]. 
In 1976, he miniaturized his peripheral balloon catheter to perform coronary 
angioplasty in a canine model and later in human cadaver experiments [3], Then 
in 1977, in Ztirich, Andreas Grlintzig performed the first percutaneous 
transluminal coronary angioplasty in a human [4]. Ever since, coronary balloon 
angioplasty has become an accepted treatment modality, as it appears to be safe 
and effective. Typically, PTCA was performed in patients with single vessel 
disease with a discrete stenosis in the proximal part of the coronary artery. After 
the introduction of the steerable balloon catheters in the early 80's and with 
increasing operator experiences, a rapidly increasing number of procedures were 
performed in Europe and across the Atlantic Ocean [5], These improvements have 
resulted in a high primary sllccess rate (>90%) and low complication rate (4-5%) 
despite extension of the indication to include patients with unstable angina, 
l11ultivessel disease, bypass graft lesions, poor left ventricular function and totally 
occluded vessels [6]. In 1985, John Simpson [7] inlroduced a new Iranscalheler 
technique, directional coronary atherectomy, for the treatment of coronary lesions 
which removes obstructive tissue rather than dilates the lesion by a balloon. It was 
hypothesized that debulking of atherosclerotic tissue by atherectomy may reduce 
restcnosis by I) producing a large post-procedural lumen, 2) creating a smooth 
surface at the intervention site and 3) preventing elastic recoil. At September JlI 
1989, John Simpson came to the Thoraxcentre in Rotterdam to introduce this 
novel interventional technique in Europe. Since the start of the Rotterdam 
atherectorny program, the clinical, histological and angiographic data of all 
patients were prospectively collected in the database and lIsed for this thesis. 
The central topic of this thesis are the acute and long-term clinical and 
angiographic outcome of di rectional coronary athcrectomy and the response of the 
vessel wall after atherectomy. 
Part J describes the angiographic observations after directional athereclomy. In 
particular, the concept of matching for quantitative angiographic and clinical 
characteristics is introduced and validated. Indeed, it is shown that matching may 
serve as a surrogate for the prediction of the outcome randomized trials 
comparing atherectomy with halloon angiopiasty. 
In chapters 1-3, some methodologic aspects of performing quantitative coronary 
analysis following directional coronary atherectomy are presented. Although 
quantitative coronary angiography has become the gold standard, the optimal 
method for the assessment of immediate and long-term results of coronary 
interventions has not been determined. Although edge detection remains the main 
form of analysis, its use may be limited particularly after dissections disrupt the 
anatomy of the vessel wall. Densitometry has been proposed as an alternative 
method because it theoretically is independent of the geometric shape. In chapter 
2, we compared the results of minimal luminal cross-sectional area obtained by 
edge detection versus densitometry in 20 patients. In chapter 3, we integrated 
information obtained from edge detection, videocicnsitometry, lesion matching and 
pathology to assess the mecharlism of directional atherectomy. 
In chapters 4-7, the immediate and late results of directional atherectomy are 
reviewed and compared with the results of conventional balloon dilatation, 
stenting and rotating atherectomy. In chapter 4, the immediate angiographic 
results of atherectomy is compared with those of balloon angioplasly and stenling. 
In stead of the previously used historic controls. Ihis comparative study uses the 
concept of lesion matching to individually match 51 athereclorny patients with 
angioplasty and sterlt patients. Matching is performed according to lesion location 
and reference diameter. In chapter 5, we have attempted 10 assess the utility of 
directional atherectomy, through a new quantitative angiographic index. 
Therefore, the utility index, which is the ratio between the tinal gain in diameter 
at follow-up and that what theoretically could have been achieved, is assessed in 
the initial 30 consecutive lesions treated by directional atherectomy which are 
matched with 30 angioplasty lesions. In chapter 6, the matching technique is 
further refined to include clinical and angiographic patient characteristics. 
Subsequently, we have attempted to assess late luminal renarrowing following 
atherectomy and angioplasty in 87 matched lesions. Relative gain and relative 
loss, being the angiographic correlates of vessel wall injury and neo-intimal 
hyperplasia, are assessed in both groups. In chapter 7, we have examined whether 
restenosis is related to the extent or mechanism of luminal improvement and we 
have explored the determinants of optimal atherectomy. 
In chapter 8, the complimentary information of angiography, intravascular 
ultrasound and intracofOnary ultrasound before and after directional atherectomy 
is used to characterize the mechanism of luminal enlargement and the vessel wall 
contour. Intracoronary ultrasound and coronary angioscopy findings in 26 patients 
are described and compared with those of angiography. 
Part /I addresses the clinical application of directional coronary atherectomy. In 
particular, the safety and efficacy of this procedure is assessed. The composite 
clinical endpoint which is used in this study to demonstrate the efficacy of 
atherectomy is the occurrence of any of the following: death, myocardial 
infarction, coronary artery bypass grafting and repeat percutaneous intervention. 
The advantage of such an analysis is that it only considers objective criteria which 
are evaluable in all patients. 
In chapter 9-11, early and late follow-up of the first atherectomy procedures in 
two European centers are reviewed. The same quantitative angiographic analysis 
system, Coronary Artery Analysis System (CAAS), which has been extensively 
validated, was used for all quantitative analyses. In chapter 9, the acute clinical 
results of the first 113 procedures performed in Rotterdam and Brussel are 
described. In chapter 10, the long-term clinical follow-up of 150 patients is 
reported. In this analysis, the population was divided according to their clinical 
syndrome, i.e. stable or unstable angina, at the time of the index atherectomy 
procedure. In chapter II, we have identified the clinical, angiographic and 
histologic predictors for restenosis. A dual approach to data analysis is taken in 
order to gain insight into factors affecting the clinical outcome and biological 
process. Therefore, Illultivariate analysis was performed to determine the 
correlates of residual lumen diameter at follow-up (angiographic outcome) and to 
characterize the determinants of late luminal loss (renarrowing process). 
In chapter 12, the early and late resuIts of directional atherectomy performed 
for restenosis within the coronary stent of 9 patients are examined. In addition, 
the retrieved tissue was studied for cell identificaHon, proliferation rates and cell 
density lIsing light microscopy, electron microscopy and immunohistochemical 
staining techniques. The results were compared with a control group of patients 
who had atherectomy for restenosis after earlier angioplasty, atherectomy or laser 
therapy. 
Pan 1I1 highlights the function of directional coronary atherectomy as a bridge 
between clinical care and experimental research. Atherectomy is the first 
percutaneous technique which allows us to harvest fresh atherosclerotic tissue 
from diseased human coronary arteries. Subsequent (iml1luno)histologic 
examination of this freshly obtained de-novo or restenotic plaque material may 
provide further insights into the mechanism of restenosis. 
Chapter 13 provides an overview of the potential research applications. Some 
preliminary results of outgrowth of cultured smooth muscle cells arc provided and 
compared with cultured medial cells from normal human umbilical arteries. 
In chapter 14, the histopathologic characteristics of atherectomy specimens of 
stablc and unstable angina pectoris are reported. Tissue samples of 93 procedures 
were examined using Jightmicroscopy for the idelltification of specific landmarks 
of the vessel wall to gain further insight into the histopathological substrate of 
stable and unstable angina. 
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Part I 
ANGIOGRAPHIC OBSERVATIONS 

Chapter I 
EV ALUA TION OF THE CLINICAL USE OF 
DIRECTIONAL CORONARY ATHERECTOMY 
USING QUANTITATIVE CORONARY 
ANGIOGRAPHY 
VAWM Uillans, D Foley, A Robert, P QlIaedvlieg, W Wijns, PW SerrllYs. 
In: Clinical applicafirm q( quol/l;falive anxiograpJry &Is: PW Serruys, DF Foley, 
Pi de Fey/cr. Kllfwer Academic Puhlishers Dortlnxlill Bos/oll! Londoll 1993 pp 
537-561. 
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INTRODUCTION 
Quantitative Coronary Angiography (QCA has had a major impact in the field of 
interventional cardiology. Due to its superior accuracy and objectivity and 
improved interobserver and intraobserver variability, it has supplanted visual and 
hand-held calliper assessments of coronary arteriograms [1-3]. QCA is now the 
gold standard for the assessment of the coronary tree in the context of scientific 
research, although it has not yet gained widespread appeal for routine clinical usc, 
because of expense and time constraints. To dat~ there are two different 
techniques to quantitative angiographic stenosis measurement. The first one is 
based on the detection of luminal borders from orthogonal images to create a 
three-dimensional approximation of the diseased vessel while the second approach 
uses videodensitometry of the stenosis to extract three-dimensional information 
from a single angiographic view. Although this latter approach has particular 
advantages, we have favored the edge detection method because it provides 
absolute measurements, relatively insensitive to the image quality. 
From a clinical viewpoint, the objectives of quantitative angiography are to obtain 
information that (I contributes to the understanding of clinical syndromes, (2 
facilitates decision-making, (3 helps to forecast future events (e.g. subacute 
occlusion, restenosis and (4 guides invasive therapy. It has been particularly 
useful in interventional cardiology as the only reliable means of assessing the 
short- and Jong- term effects of coronary interventions. In particular, the 
phenomenon of restenosis has been primarily described and researched 1110st 
extensively on the basis of sequential QCA studies. At the Thoraxcenter in 
Rotterdam, we have been advocating the importance of QCA since the !irst 
publication of its use by our group in 1978 [4] and with subsequent and renewed 
vigour following our initial experience with QCA in the assessment of coronary 
interventions as reported in 1982 [5]. The system developed at the Thoraxcenter 
by lohan Reiber and colleagues, the Cardiovascular Angiographic Analysis 
System (CAAS, has been extensively and rigorously validated [6-8]. In our 
database, we have now collected information from 4,662 patients who have 
undergone several different forms of nonoperative coronary revascularization [1]. 
We have had to adapt the principles of QCA, which were initially designed for 
diagnostic studies to assess the extent of coronary artery disease, to more 
complicated and complex situations related to either the presence of a device, or 
the effect of an intervention, on the angiographic appearance of a damaged vessel. 
The introduction of several newer devices in the past 6 years, has presented a 
number of unique and unforeseen problems in image analysis and subsequent 
interpretation of important quantitative data. The emergence of digital subtraction 
angiography has allowed the uon-line ll performance of QCA measurements in the 
catheterization laboratory. so that a technique previollsly contined to research 
applications has been transformed -into a powerful analytical tool, directly 
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applicable to clinical decision making [9-12]. The immediate availability of QCA 
measurements during intervcntional procedures provides a unique opportunity for 
more accurate selection of appropriate interventional devices (eg. balloon or 
atherotomc dimension, and for continuolls monitoring and immediate evaluation 
of the resuit obtained. 
The purpose of this chapter is to highlight the basic features of and information 
which can be provided by these two automatic computer assisted angiographic 
analysis systems and also to discuss some of the benefits and limitations of QCA 
in the analysis of the angiographic short and long-term sequelae of the various 
"devices tl of intervcntionai cardiology. Only close scrutiny of the analytical 
results, combined with ongoing communication between the angiographer, the 
analyst and the programmer, eilsures that meaningful and useful data emerge from 
the use of QCA. 
Whal if!formalion call he ,,"tail/l'lt/hull Ihe lise itt automatic complIIer assisled 
allMioMraphic quantilafil'(' mudy.\'is .\)'slefll.\,? 
The prime aim of QCA is to provide precise and accurate measurements of 
coronary anatomy. The CAAS system can provide this information by two 
different methods: (I detection of luminal borders (so called "edge detection", 
preferably in two orthogonal projections (to provide a three~dimensional 
approximation of the diseased segment which can then be converted into absolute 
values after calibration with an object of known diameter, such as the shaft of the 
guiding catheter; and (2 videodensitometry, an approach which assesses the 
relative area stenosis by comparing the density of contrast in the diseased and 
"normal" segment. The method by which the relative area stenosis is converted 
to absolute area stenosis measurements will be explained later in the chapter. The 
advantage of the information acquired by the densitometric method is th~t 
meaningful data can be obtained in a single projection, even if the cross-sectional 
shape is highly asymmetrical or eccentric. In contrast, area measurements derived 
from edge detection data (and specifically from 111inimalluminal diameter values, 
by definition, require an assumption of a circular cross-sectional lumen in the 
diseased arterial segment, which is at odds with the observations of several 
pathologic studies [13,14]. The limitations of both techniques will subsequently 
be discussed, and discrepancies in the results of these two methods following 
coronary interventions, will be presented later. 
(I Ed!',,, del('clioll: 
In our laboratory, the quantitative analysis of the stenotic coronary segments are 
carried out using the computer assisted Cardiovascular Angiographic AnaJysis 
System (CAAS, which has been described in detail elsewhere [2-7]. To analyse 
a coronary arterial segment a 35 mill cineframe is selected. Electronically a region 
of interest (512 x 512 pixels encompassing the arterial segment to be analyzed, 
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is digitized with a high fidelity videocamera. Contours of the arterial segments are 
detected automatically un the basis of the weighted sum of the first and second 
derivative fUllctions applied to the digitized brightness prof1ie. From these 
contours, the vessel diameter functions are determined by computing the shortest 
distance between the left and right contour positions. A computer-derived 
estimation of the original arterial dimension at the site of the obstruction is used 
to deline the interpolated reference diameter. This technique is based on a 
computer-derived estimation of the original diameter val lies over the analyzed 
region (assuming there was no disease present according to the diameter function. 
Conversion of the diameter measurements of the vessel to absolute values was 
achieved by lIsing the contrast catheter as a scaling devise, after correction for 
pincushion distortion. The minimal cross-sectional area of the narrowed segment 
and the interpolated percentage area stenosis are then derived by assuming a 
circular vessel cross-section and comparing the observed stenosis dimensions to 
the reference values. 
The plaque area is a measure of the atherosclerotic plaque in this angiographic 
view, expressed in mm2• This area is calculated as the SUIll of pixels between the 
computer-estimated predisease reference contours and the actual detected luminal 
contours of the obstructive lesion. Since measurement of area plaque is highly 
dependent on the length of the stenosis (which is subject to considerable variation 
and the determination of the reference contours of the artery in the presumed 
prediseased state, the usefulness of this parameter is debatable. 
The symmetry value is a measure of the eccentricity of a particular lesion. A 
symmetry measure of I denotes a concentric obstruction; the number decreases 
(down to 0 with increasing asymmetry or eccentricity of the obstruction. 
Unfortunately, this parameter has not yet been validated against pathology and 
thus the pathologist and angiographer may not be referring to the same feature. 
The curvature value is measured to assess the bend of the coronary segment 
analyzed. The view in which the vessel appears to be the least foreshortened (ie. 
the segment length is longest is chosen for the curvature analysis. The inflow and 
outflow angles are derived from the slope of the diameter function at the 
descending and ascending limb of the diameter function curve at the defined site 
of the obstruction. 
The CAAS and the Philips digital cardiac imaging system (DCI have also 
attempted to convert information 011 angiographic parameters into functional data 
based on well-known tluid-dynamic equations [7]. 
The Hngiographic analysis is performed whenever possible using the average of 
multiple matched views with orthogonal projections. 
(2 Vit/e()(/eIlSil(mU'fl)': 
To determine the changes in cross-sectional area of a coronary segment from the 
density profile within the artery, the calibration of the brightness levels in terms 
of the alllount of X-ray absorption (Lambert Beer's Law is required. The 
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videodensitometric method used with our system, corrects for spatially variant 
responses in the imaging chain and for daily variations in the cine-mill 
processing. Details of this technique have been described elsewhere [2-7J. 
Contours of the artery are detected by automated contour detection with the 
CAAS system as previollsly described. From the measured diameters along the 
analyzed segment, the diameter data described above are derived. On each scan 
line perpendicular to the centerline of the vessel, a profile of brightness is 
measured. This profile is transformed into an absorption profile by means of a 
simple logarithmic transfer function. The background contribution is estimated by 
computing the linear regression line through the background points directly left 
and right of the detected contours. Subtraction of this background portion from 
the absorbed profile within the arterial contours yields the net cross-sectional 
absorption profile. Integration of this fUllction gives a measure for the cross-
sectional area at the particular scan line. By repeating this procedure for all 
scanlines, the cross-sectional area function is obtained. A reference densitometric 
area is obtained following the same principles as described above for the diameter 
functions. Calibration of the densitometric area values is accomplished by 
comparing the reference area calculated from the diameter measurements 
(assuming a circular cross-section with the corresponding densitometric area 
value. By this method, no assumption is made about the cross-sectional shape of 
the lesion in the most severely diseased segment of the vessel. Although 
densitometry is extremely attractive on a theoretical basis, numerous technical 
problems have limited its use. The major limitation is the strict requirement of an 
angiographic projection which is perpendicular to the long axis of the vessel (to 
prevent oblique "cuts" which would lead to overestimation of the luminal area, 
and the absence of overlapping, or closely parallel, sidebranches or other vessels, 
in the segment to be analyzed (which would illterfere with the density of the 
lesion, due to background subtraction. Densitometry is also more sensitive than 
edge detection to densitometric nonlinearities (x-ray scatter, veiling glare and 
beam hardening and to inaccurate contrast filling of vessels. 
Despite these limitations the results of a recent in vivo validation study suggest 
that videodensitometry can reliably measure vascular dimensions provided a 
sufficient care is taken to obtain a perpendicular incidence of the x-ray beam onto 
the examined coronary segment and b a homogeneolls contrast I1lling of the vessel 
is obtained. The method was thoroughly validated in a porcine model where 
precision-dri lied circular coronary stenosis phantoms (with diameters ranging from 
0.5 to 1.9 mm and angiograms were analyzed lIsing the edge detection and the 
densitometric technique of the CAAS system [5-8]. In this experimental 
application simulating a diagnostic coronary angiography, both analysis techniques 
showed a high accuracy and precision in the automatic measurement of the 
stenosis phantoms. In particular, the mean difference between minimal cross-
sectional area, measured with videodcnsitometry, and true stenosis cross-sectional 
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area, was -O.12±O.31 1111n 2. A limitation of vidcodensitometry, however, was its 
inability to distinguish accurately the very low density of some of the stenosis 
phantoms with the smallest diameter stenosis, from the background density. 
Comparison (!( d!fIl'rent (filIital and cillC'frame QCA mC'asllrcmelll systcms: 
Recent developments in digital cardiac imaging systems have been directed 
towards on-line stenosis measurements during the procedure from video digitized 
images. By this approach the system will guide the operator in selecting the 
appropriate interventional technique (balloon, stent, atherectomy, in selecting the 
appropriate size of the device and in assessing the effect of the intervention 
thereby it will help to determine whether a beller resuit may bc achieved. At the 
Thoraxcenter during the last five years a large clinical experience has been 
accumulated through the application of the Philips DCI Automated Coronary 
Analysis System [10, II]. A recent in vivo study of stenosis "phantoms" placed 
in porcine coronary arteries has confirmed that the accuracy, and precision, of the 
DCI on-line measurements are closely comparable to those obtained off-line lIsing 
the CAAS system, with a mean difference between true "phantom" stenosis 
diameter and DCI minimal luminal diameter measurements of O,08±O.15 mill, 
for stenosis diameters ranging from 0.5 to 1.9 mm [12]. We believe, therefore, 
that the data information presented here, mainly derived from the analysis of cine-
film images, can now be immediately applied to guide the operator during 
diagnostic and interventional procedures. Over the past few years there has been 
a substantial amount of progress in the field of quantitative angiography. In 
particular, several new measurement systems have been developed and wiJI be 
introduced in clinical practise in the near future. At the Thoraxcenter, we have 
had the opportunity to validate three systems with the cinefilm approach and one 
digital angiography system [12]. 
Technical consideration.\' and limitations (!( QCA ill clinical practise: 
Firstly, the lise of the catheter as a scaling device has certain limitations, such as 
those due to the out-of-plane position of the catheter with respect to the measured 
coronary segment, which require complex corrections. We believe, however, that 
many possible sources of inaccuracy can be easily minimized with the use of a 
strict protocol of calibration, including the measurement, with a micrometer, of 
the true size of the catheter, the avoidance of catheters with excessive tapering or 
poor radiopacity and the acquisition, before the coronary angiogram, of the 
catheter image (saline or blood filled in the same projection and Held of view 
[15], positioning the catheter in the center of the radiographic illlage or operating 
a correction for pinclIshion distortion. 
A second important technical point for all serial studies is the requirement for 
coronary vasodilation lIsing agents of comparable efficacy for every study. In a 
recent study [16] the mean diameter of a normal segment of a nondiJated vessel 
pre PTCA, post PTCA and at follow-up was analyzed in 202 patients. Thirty-four 
of these patients, who received intracoronary nitrate pre-PTCA, but not prior to 
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post-PTCA angiography exhibited a decrease in diameter of 0.11 ml1l versus the 
small increase of 0.02 mIll in the group which did receive post procedural nitrate. 
Lack of control of vasodilator therapy at follow-up angiography may also partially 
explain an earlier observation, from our group, of a significant deterioration in 
the mean reference diameter at four months post angioplasty as several subsequent 
studies employing coronary vasodilators have produced contradictory ~nfonnation 
[17,18]. However, we still believe that in certain patients, the reference segment 
is involved in the restenotic process invalidating the lise of percent diameter 
stenosis as an accurate measurement of lesion severity at follow up. 
Third, the computer generated interpolated measurements may be unreliable for 
ostial lesions or lesions located at sidebranches. Manual contour correction may 
also be necessary when the angiogram is of poor technical quality which is, 
fortunately, relatively infrequent, with only 0.9% of films, from ll1ulticentre 
trials, being rejected due to poor technical quality [19]. 
A m'\ior /imilalion of edge detection (aside from the technical quality of the 
cinefilm represenls its diftlculty to accurately analyse the post angioplasty result. 
In particular, dissections are a frequent occurrence following PTCA and the 
resulting haziness, irregular borders or extravasation of contrast medium makes 
edge detection difficult. There is no ideal solution to this problem. If a dissection 
is present on the post-angioplasty angiogram, the analyst must decide whether to 
include or exclude the extraluminal filling defect in the analysis. As advised by 
the MERCATOR Angiographic Committee, the computer should "decide" 
whether to include or exclude the extraluminal defect in the analysis, thereby 
avoiding subjective bias. If there is no clear separation between the lumen and the 
extravasation (large communicating channel, the computer will include the 
dissection in the analysis as the interpolated edge detection technique will detect 
a small although not signitlcant difference in brightness. However, in cases where 
the extravasation is distinctly separate from the true vessel lumen, (small 
communicating channel, the computer will exclude the dissection from the 
analysis as there will be a steep difference in brightness between the extravasation 
and the true lumen 
QCA and Comllmy Inten'(,lIliol/.\': 
Prior to a disclIssion of the lise of directional athercctomy for coronary 
intervention, the utility of the information generated by QCA in general (and the 
CAAS system specifically must be addressed. Anatomic information, slich as 
minimal luminal diameter, reference diameter and percentage diameter stenosis, 
represent the most useful and reliable information obtained by this system. The 
physiologic and clinical significance of any individual value can not be inferred, 
although the CAAS system can generate theoretical measures of resistance based 
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on the lesion characteristics and assumed coronary flow rates. Angiographic 
features of a particular lesion, which may be important to the clinical outcome 
such as ulceration or complex, ragged morphology have not been a focus of our 
research, in terms of their natural history in large populations undergoing 
coronary interventions. 
Although the absolute minimal luminal diameter is one of the parameters of 
choice for describing changes in the severity of an obstruction as a result of an 
intervention, percent diameter stenosis is a convenient parameter to work with in 
individual cases. The conventional method of determining the percent diameter 
stenosis of a coronary obstruction requires the user to indicate a reference 
position. It is clear that this computed percent diameter stenosis will depend 
heavily on the position of the selected reference. In arteries with a focal 
obstructive lesion and a clearly normal proximal arterial segment the reference 
region is straightforward and simple. However, in cases where the proximal part 
of the arterial segment shows combinations of stenotic and ectatic areas, the 
choice Illay be vcry difficult. To minimize these variations, we have implemented 
many years ago an illfl'''lJO/aled technique, which is operator-independent, to 
determine the reference diameter at the actual stenosis site without operator 
interference. The basic idea of this technique is the computer estimation of the 
original diameter at the site of the obstructive region (assuming there was no 
coronary disease present based on the diameter function. In this approach the 
reference diamcter is taken as the value of the polynomial at the position of the 
minimal luminal diameter. The interpolated percent diameter stenosis is then 
computed by comparing the minimal diameter value at the site of the obstruction 
with the corresponding value of the reference diameter function. An important 
practical advantage that the arbitrary choice of the reference, either proximal or 
distal to the stenosis, is avoided representing a major advantage particularly in the 
analysis of repeated allgiograms. On the other hand, this technique requires that 
the coronary segments are analyzed in a standard manner, i.e. from branch point 
to branch point, so that the length of the segments are approximately equal in 
repeated analyses. 
Although different approaches to the analysis of a coronary artery obstruction 
have been described, it is impractible to compare the various systems 
quantitatively. In particular, the lack of data about accuracy and precision and the 
lise of different parameters to describe the validation make such comparisons 
difficult. It goes without saying that comparisons of data from angiographic 
studies performed in various core-laboratories the procedure Illllst be properly 
standardized and validated. 
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QCA alU/ directiollal cOl'Onal), atlierectmny: 
Few problems have been encountered in the angiographic analysis of lesions 
treated by directional atherectomy [20]. The radiopacity of the device, particularly 
when the support balloon is inflated, allows excellent visualization of the position 
of the eccentric cutting apparatus. The vessel luminal contours are typically 
smooth and much less ragged than after PTCA, facilitating the edge detection 
program. Despite the apparent smooth contours, however, similar discrepancy 
exists between analyses performed by edge detection and densitometry, as occurs 
post angioplasty [21], which suggests that the vessel wall assumes a less circular 
configuration as a result of at he rect 0 my. As Baim's group has suggested, this may 
be due to preferential expansion of the bases of the athcrectomy cuts [22]. 
Insights illlo the mechanism qf athereclomy: 
Using directional atherectomy, the atherosclerotic plaque is selectively removed 
as the cutting device is directed towards the protruding plaque. With plaque 
removal in stead of plaque disrupture with balloon angioplasty, it was initially 
hypothesized that a greater gain in luminal area can be achieved and may account 
for the main mechanism of action. In recent years, QCA of atherectomy-treated 
lesions has provided some insight into the mechanisms of lesion improvement. 
Penny et al have shown that an average of approximately 28% of the effect of 
atherectomy could actually be attributed to tissue removal, although the individual 
values had a wide range (7-92% [22]. The correlation between the volume of 
tissue retrieved and the change in luminal volume was poor. The authors 
concluded that the major component of luminal improvement was due to 
"facilitated mechanical angioplasty" resulting from the high profile of the device 
and the low pressure balloon intlations. Data from our angiographic core 
laboratory seems to support this hypothesis. The "Dottering effect" of the device 
accounted for 62 % of the luminal improvement [23] in 10 patients who had QCA 
performed before, after crossing the lesion with the device and after atherectomy. 
Longterlll olllcOIlIe ({Iier direct;(J/lal atherl'C((}fI1Y: 
In experimental work, Schwartz and colleagues have demonstrated a relationship 
between vessel wall injury induced by an intervention is related to a reparative 
process. This approach has become known as the biological approach and can be 
readily studied by quantitative coronary angiography using the loss in minimal 
luminal diameter as the angiographic parameter. In a matched comparative study 
[24,25], we found that atherectomy indeed resulted in a larger immediate gain 
when compared with balloon angioplasty (1.17 ± 0.29 to 2.44 ± 0.41 mm versus 
1.21 ± 0.38 to 2.00 ± 0.36 mm; p<O.OOI. During follow-up however, this 
immediate favorable acute result is partially lost by a larger luminal loss so that 
at 6 months follOW-lip the minimallulllinal diameter was not significantly different 
in the atherectomy group compared with the PTCA group (1.76 ± 0.62 versus 
I. 77 ± 0.59 mm. 
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The illlmediate efficacy of coronary atherectomy should be established by 
reproducible quantitative coronary analysis [1]. The name "directional 
atherectomylf suggests that the device can be selectively directed toward the 
plaque and that its cutting mechanism is potentially less disruptive on vascular 
architecture than other angioplasty modalities. As a result of this selectively 
debulking action, the vessel may asslime a more circular contiguration and cross-
sectional area measurements obtained by edge detection and videodensitometry 
should become more comparable. Since the optimal method to analyse the 
immediate result after atherectomy has not yet been established this study was 
undertaken to determine whether videodensitometry and edge detection were 
equally acceptable methods in assessing the immediate results following 
atherectomy. Cine-angiograms of 20 patients who underwent directional coronary 
atherectomy were analyzed with a computer-based coronary angiography analysis 
system. The results of the cross sectional area derived from contour analysis and 
videodensitometry were compared before and after directional atherectomy. 
From September 1989 through September 1990, 55 patients underwent 
directional coronary atherectomy at the Thoraxcenler. Patients were selected for 
atherectomy when an eccentric stenosis was present in a proximal coronary artery. 
This series consists of the initial 20 atherectomy patients (17 men, 3 women). 
Edge detection and videodensitometry were used to evaluate the immediate results 
of the atherectomy. All patients underwent a successful procedure without 
preceding or adjunct balloon angioplasty. The patients ranged in age from 42-76 
years with a mean of 62 years. Coronary angiography showed single vessel 
disease in 14, two-vessel disease in 3 and three- vessel disease in 3 patients. The 
site of the obstruction was located in the left anterior descending coronary artery 
in 10 patients, in the circumflex coronary artery in 2 patients, in the right 
coronary artery in 6 patients and in a coronary artery bypass vein graft in 2 
patients. 
After administration of local anaesthesia, a 11 French sheath was inserted into 
the femoral artery. All patients received 250 mg acetosalicylatic acid and 10,000 
U heparin intravenously. Intracoronary injection of isosorbide dinitrate was 
performed to relief any possible spasm. After the initial angiograms in multiple 
views were completed, a special II French guiding catheter was placed into the 
ostium of the coronary artery. Under fluoroscopy the guide-wire was advanced 
into the distal part of the artery. Then, the atherectomy device was slid over a 
guide-wire and positioned across the stenosis. After proper positioning the support 
balloon was inllated up to 0.5 atm, the cutter was retracted and balloon inflation 
pressure was increased to 2 to 3 atm. The driving motor was activated and the 
rotating cutter was slowly advanced to cut and collect the protruding 
atherosclerotic lesion in the collecting cha'lllber located at the tip of the catheter. 
After each pass, the balloon was detlated and either removed or repositioned. On 
average, 6.7 (3-14) passes were performed across a stenosis. Atherectomy was 
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considered sllccessful when the residual stenosis was < 50% after tissue retrieval. 
After atherectomy the arterial and venous sheaths were lIsually left in place for 
6 hours. Patients were monitored for 24 hours and electrocardiograms and cardiac 
enzyme levels were obtained twice a day. Nifedipine was given every 2 hours 
aftcr the procedure and the patients were maintained on aspirin for one year. 
The quantitative analysis of the stenotic coronary segments were carried out with 
the computer assisted Cardiovascular Angiographic Analysis System (CAAS), 
which has been described in detail elsewhere [2-7]. To analyse a coronary arterial 
segment a 35 mill cilleframe was selected. Elecfronically a region of interest (512 
x 512 pixels) encompassing the arterial segment to be analyzed, was digitized 
with a high fidelity videocamera. Contours of the arterial segments were detected 
automatically on the basis of the weighted slim of the first and second derivative 
functions applied to the digitized brightness profile. From these contours, the 
vessel diameter functions are determined by computing the shortest distance 
between the left and right contour positions. A computer-derived estimation of the 
original arterial dimension at the site of the obstruction is llsed to define the 
interpolated reference diameter. This technique is based on a computer-derived 
estimation of. the original diameter values over the analyzed region (assuming 
there was no disease present) according to the diameter function. Conversion of 
the diameter measurements of the vessel to absolute values was achieved by lIsing 
the contrast catheter as a scaling devise, after correction for pincllshion distortion. 
The minimal cross-sectional area of the narrowed segment and the interpolated 
percentage area stenosis are then derived by assuming a circular model and 
comparing the observed stenosis dimensions to the reference values. The 
angiographic analysis was done lIsing the average of multiple matched views with 
orthogonal projections whenever possible. 
To determine the changes in cross-sectional area of a coronary segment from the 
density prollle within the artery, the calibration of the brightness levels in terms 
of the amount of X-ray absorption (Lambert Beer's Law) is required. The 
videodensitometric method used with Ollr system, corrects for spatially variant 
responses in the imaging chain and for daily variations in the cine-film 
processing. Details of this technique have .bcen described elsewhere [2-7]. 
Contours of the artery are detected by automated contour detection with the 
CAAS system as previollsly described. From the measured diameters along the 
analyzed segment, the diameter data described above are derived. On each scan 
line perpendicular to the centerline of the vessel, a prol1le of brightness is 
measured. This profile is transformed into an absorption profile by means of a 
simple logarithmic transfer'function. The background contributioil is estimated by 
computing the linear regression line through the background points directly left 
and right of the detected contours. Subtraction of this background portion from 
the absorbed proi1le within-the arterial contours yields the net cross-sectional 
absorption profile. Integration of this function gives a measure for the cross-
20 
sectional area at the particular scan line. By repeating this procedure for all 
scanlines, the cross-sectional area function is obtained. A reference densitometric 
area is ohtained following the same principles as described above for the diameter 
functions. Calibration of the densitometric area values is accomplished by 
comparing the reference area calculated from the diameter measurements 
(assuming a circular cross-section) with the corresponding densitometric area 
value. The complete procedure has been evaluated with the cine-Iilms of perspex 
models of coronary obstructions [6]. 
The individual data for diameter and densitometric area measures were used to 
calculate the mean ± SD (table 2). Analysis of variance was performed to 
compare the area measurements derived from edge detection (assuming a circular 
cross-section) and densitometry before and after atherectomy and when significant 
differences were found, two-tailed paired t-tests were applied. A statistical 
probability of < 0.05 was considered significant. To Illeasure the strength of the 
relationship between the two methods of analysis, edge detection and 
videodensitometry, in the determination of minimal cross-sectional area, the 
product-moment correlation coefficient (r) and its 95% confidence intervals were 
calculated at two distinct times of study. The agreement between the two 
measures was assessed by determining the mean and the standard deviation of the 
between-method difference as suggested by Bland and Altman [8]. At each 
interval this was done by computing the Slim of the individual differences between 
the two methods to determine the mean difference and the standard deviation. 
In this study, the angiographic projection showing the severest narrowing was 
analyzed. The individual data obtained by edge detection and videodensitol11ctry 
are presented in Table I and 2, 
Tlhle I Edge detection hero(!;'. anti 'Ifter tliredionai atherectomy 
-
Pre-alht:rec\omy Pm\-alheredomy p-value 
Reference diameter (mill) 3.05 + 0.55 3.40 + 0.44 0.05 
Ooslnlclion diameter (mill) 1.08 ± 0.43 2,68 ± 0.42 0.000001 
Diameter skn().~js (%) 66 + 10 20 ± 9 O,OOOOOt 
On average, the reference diameter increased from 3.1 to 3.4 mill (p< 0.05); the 
obstruction diameter increased frol11 1.1 to 2.7 mill (p<O.OOOOOI); thus the 
interpolate" diameter stenosis was reduced from 66% to 20% (p<O.OOOOOI). 
Quantitative analysis of the atherectomy device showed an increase of its diameter 
from 2.0 ± 0.2 111111 to 3.4 ± 0.4 111111 following intlation of the support-balloon. 
The minimal JUll1in~1 cross-sectional area (MLCA) determined by densitometry 
was compar.cd with the 1l.1inimal luminal cross-sectional area measurements from 
edge detection which assumes a circular configuration. The comparative data 
before and after corollary athercctomy are show,n in Table 2 and figures I and II. 
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The minimal luminal cross-sectional area increased after atherectomy from 1.12 
± 0.72 mm2 to 5,91 ± 1,95 mm2 (p<O,OOOI). In patient 15, a coronary artery 
side branch ran parallel to the stenotic coronary artery and contributed to an 
increase in the background brightness value. Subtraction of this increased 
background contrihution yielded a negative cross-sectional absorption profile at 
the site of the coronary artery obstruction. Before atherectomy, correlation 
coefficient was 0.914 (95% confidence interval: 0,791 to 0.966) indicating a 
reasonable linear relationship between the two techniques. However this 
deteriorated slightly following atherectomy resuiting in a correlation coefficient 
of 0,816 (95 % confidence interval: 0.584 to 0,924). The agreement between the 
two measurements is illustrated in Table 2 and Figures III and IV. The mean 
difference of the minimal cross-sectional area between the two methods before 
atherectomy was -0,01 mm' while this difference was slightly larger after 
atherectomy (mean difference 0.48 mm2), The variability as determined by the 
standard deviation of the between-method difference was higher in the post-
atherectomy analysis (1.21 mm') compared to the pre-atherectomy analysis (0.52 
mm2). 
The use of quantitative angiographic analysis for assessing both the immediate and 
long-term results of interventional techniques appears mandatory. Whether edge 
detection or the videodensitometry should be used as the gold standard continues 
to be debated. Densitometry has been proposed as an alternative method of 
quantitative assessment of the severity of coronary stenosis. It is based on the 
linear relationship that exists between the optical density of a contrast enhanced 
lumen and the absolute dimensions of the arterial segment, and is therefore 
independent of the geometric shape. Discrepancies between edge detection and 
videodensitometry are most likely to occur when the shape of the vessel wall at 
the level of the stenosis deviates furthest from a circular configuration, since it 
is a basic assumption in the calculation of minimal luminal cross-sectional area 
by edge detection [2]. Previous angioplasty studies have shown discrepancies in 
the post-balloon analysis between edge detection and videodensitometry [2). Since 
the cutting mechanism of atherectomy is expected to remodel the treated coronary 
artery into a more concentric and circular configuration, densitometry should 
correlate closely with the cross-sectional area measurements derived from edge 
detection. 
Since comparing 2 methods in clinical practice should not only be limited to the 
assessment of the strength of the relation (correlation coefticient,r) [8], we also 
included the assessment of the degree of agreement or variability which is 
determined by the mean and the standard deviation of the between-method 
difference. This comparative study illustrates that a linear relationship exists 
between the 2 methods both before and after atherectomy. However it must be 
emphasized that the strength of the relationship deteriorates slightly after 
atherectomy. 
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Overall a good agreement exists between the two methods, although edge 
detection slightly underestimates the minimal luminal cross-sectional area before 
atherectomy and overestimates the minimal cross-sectional area after atherectomy. 
Tahle 2. Minimal luminal cross-sl!dionai ar~a deriv~tI from edge dekction and videodensilomelry 
hefore and after coronary ather~clotlly 
Minimal cross-sectional ar~a (mm2) Minimal cross-sectional area (1111U2) 
pre-ather~ctomy post-alherectomy 
pI ED VD Differ~m.'e ED VD Difference 
I 0,70 0,66 0,04 7,60 5.40 2,20 
2 <.00 0,56 0.44 6,70 6,90 -0,20 
3 0.40 0,26 0,14 6,20 5,00 <.20 
4 0,50 0,16 0,34 7,30 7,30 0,00 
5 <'10 1.33 -0.23 10,0 9,06 0,94 
6 <.60 <.65 -0,05 6,60 2,99 3,61 
7 0,60 0,56 0,04 3,20 2,86 0,34 
8 0,92 0,67 0.25 4,81 4,22 0,59 
9 0.49 0,25 0,24 4,80 4,19 0,61 
10 2,70 3,58 -0,88 6,50 5,)2 0,78 
II 2,00 1.75 0,25 3,90 5,35 -1.45 
12 0,70 0,58 0,12 5,70 6,37 -0,67 
13 0,90 0,70 0,20 1.80 1.80 0:00 
14 <.80 3.4 - <.60 3,30 3,98 -0,68 
15 0.50 -0.42 -1.60 3,30 3,98 -0,68 
16 0.50 -0.42 0,92 7,80 7.23 0,57 
17 0,60 0,17 0.43 6.30 5.50 0,80 
18 <.20 <'60 -0.40 8,50 10,1 - <.60 
19 <'79 <.88 -0,09 5,30 5,20 0,10 
20 0,33 0,65 -0,32 6,70 4,79 <.91 
Illl!an ± SD: -0,01 ±0.52 ml!'lll ± SD: 0.48 ± 1.21 
Quantitative coronary angiography shows that a similar discrepancy exists in the 
post-atherectomy analysis between edge detection and videodensitomelry when 
compared wilh the resuits in a previous balloon angioplasty study [2], This 
observation suggests that edge detection and videodensitometry are equally 
acceptable methods to assess the results of interventional techniques although 
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small differences exists in the post-interventional analysis. The possible 
explanation for those differences in the post-intcrventional analysis is the 
occurrence of trauma to the vessel wall by the devices. This obviously results in 
the formation of intimal tlaps and dissections with subsequent distortion of the 
vessel configuration. Secondly the recoil phenomenon as assessed after balloon 
angioplasty may play an important role [9]. Stent implantation apparently 
counteract these influences by acting as a scaffolding device and by its self-
expanding property [10, II]. This suggests that the cutting mechanism of 
atherectomy and the baro-trauma of angioplasty result in similar eccentric vessel 
contours. 
In conclusion, despite small differences in minimal luminal cross-sectional area 
in the post-interventionai results, edge detection and videodensitol11ctry are equally 
acceptable methods. Atherectomy as well as angiopiasty induce substantial trauma 
to the vessel wall which result in a non-circular vessel configuration. The 
smoothing process of stenting results in more circular vessel contours compared 
to angioplasty and atherectomy. 
REFERENCES 
1. Beatt KJ, Serruys PW, Hugenholtz PG. Restenosis after coronary 
angioplasty: New standards for clinical studies. J Am Coli Cardiol 
1990; 15:491-498. 
2. Serruys PW, Reiber lHC, Wijns W, van den Brand M, Kooijman Cl, ten 
Kate HJ, Hugenholtz PG. Assessment of percutaneolls transluminal 
coronary angioplasty by quantitative coronary angiography: diameter 
versus videodensitometry. Am J Cardiol 1984;54:482-488. 
3. Reiber JHC, Serruys PW. Quantitative coronary angiography. In MarclIs, 
Schelbert, Skorton and Wolf (cds) Cardiac Imaging: A Companion to 
Braunwald's Heart Disease. Philadelphia W.B. Saunders; 1991 :213-280. 
4. Reiber lHC, Kooijman C, Slager CJ, Gerbrands JJ, Schuurbiers JHC, den 
Boer A, Wijns W, Serruys PW, Hugenholtz. Coronary artery dimensions 
from cineangiograms: methodology and validation of a computer assisted 
analysis procedure. IEEE Trans Med Imaging 1984;MI3: 131-141. 
5. Reiber lHC, Serruys PW, Slager CJ. Quantitative coronary and left 
ventricular cineangiography. Methodology and clinical applications. 
Dordrecht, Martinus Nijhof Publishers,1986: 1-247. 
6. Reiber JHC, Slager CJ, Schuurbiers JCH, den Boer A, Gerbrands JJ, 
Troost GJ, Scholls B, Kooijman eJ, Serruys PW. Transfer functions of 
the x-ray cine video chain applied to the digital processing of coronary 
angiograms. In: Heintzen PH, Brennecke R, eds. digital imaging in 
cardiovascular radiology. Stuttgart-New York: George Thieme Verlag, 
1983:89-104. 
26 
7. Reiber JHC, Serruys PW, Kooijman CJ, Wijns W, Slager CJ, Oerbrands 
11, Schuurbiers eJ, den Boer A, Hugcnholtz PG. Assessment of short-
mcdiulll- and longtenn variations in arterial dimensions from computer 
assisted quantitication of coronary cineangiograms. Circulation 
1985;71 :280-288. 
8. Bland 1M, Altman DG. Statistical methods for assessing agreement 
between two methods of clinical measurement. Lancet 1986;307-310. 
9. Rensing Bl, Scrruys PW, Beatt KJ, Suryapranata H, Laarman Gl, de 
Feyter P1. Densitometrically observed differences in elastic recoil of the 
three main coronary arteries after coronary angioplasty. J Am Call Cardiol 
1990;43A. 
10. Serruys PW, Juilliere Y, Bertrand ME, Pliel J, Rickards A, Sigwart U. 
Additional improvement of stenosis geometry in human coronary arteries 
by stenting after balloon dilatation. Am J Cardiol 1988;61:710-760. 
11. Serruys PW, Strauss B, Beatt K, Bertrand M, Puel J, Rickards A, Meier 
B, Ooy JJ, Vogt P, Kappenberger L, Sigward U. Angiographic follow-up 
after placement of a self-expanding coronary artery stent. N Engl J Med 
1991;324:13-17. 
27 

Chapter 3 
THE MECHANISM OF DIRECTIONAL 
CORONARY ATHERECTOMY 
VA Ulllans MD, E Haine MD, J Renkin MD, PJ de Feyler MD PhD, W Wijns 
MD PhD, PW Serruys MD PhD 
Ell!" Heart J 1993;14:505-510 
29 

ABSTRACT 
An attempt to assess the mechanism of directional coronary atherectomy was 
made using different methods of analysis. Quantitative coronary angiography was 
lIsed as the golden standard to assess the immediate results of atherectomy. A 
comparative quantitative analysis of atherectomy and balloon angioplasty was 
made. To determine whether the post-atherectomy cross-sectional area is close to 
a circle, we compared the area measurements obtained by edge detection with 
those obtained by videodensitometry. Finally, the extent of a 'Dotter' effect was 
established by quantitative angiography following crossing the stenosis with the 
atherectomy device. For the purpose of this study, the results of the first 113 
sliccessful atherectomy procedures were reviewed. In matched lesions, directional 
atherectomy induced a greater increase in minimal luminal diameter than balloon 
angioplasty (1.6 mm versus 0.8 mm;p<O.OOOI). However, 62% of this luminal 
improvement is due to a 'Dotter' effect induced by the bulky atherectol11Y device. 
Following atherectomy only a slight difference in cross-sectional area 
measurements between edge detection and videodensitometry (mean difference: 
0.28 mm2) is found. Histologic examination of an atherectomized coronary artery 
shows a near-circular post atherectomy area geometry. In conclusion, directional 
atherectomy is a very effective device with a substantially better initial result than 
balloon angioplasty. However, insertion of this bulky device itself causes a 
luminal enlargement dlle to the 'Dotter' effect tbat accounts for 62% of the 
luminal improvement. 
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INTRODUCTION 
Directional coronary atherectomy has been introduced as a novel percutaneolls 
technique for the treatment of coronary artery disease. The exact mechanism 
through which directional atherec(omy enlarges the vessel lumen is under 
extensive investigation. As its name indicates, 'directional' atherectomy 
selectively removes the atheromatolls plaque as the cutling device is directed 
towards the encroaching plaque. With plaque removal instead of remodelling, a 
greater gain in luminal area is expected. Furthermore the luminal lining may 
become smooth and the vessel wall may assume a more circular configuration. 
Based on quantitative coronary analysis, we [I] and others [2] have suggested that 
a non negligible 'Dotter' effect is part of the "angioplastic" process. Whether this 
effect is an important determinant of the final result has not been Ilrmly 
established. Together with quantitative coronary angiography, histopathologic 
examination of atherectomy specimens and postmortem examination may also 
shed light onto the mechanism of directional coronary atherectomy. Therefore, 
to elucidate some of the mechanism of directional coronary atherectomy, we have 
reviewed 1110st of the quantitative coronary angiographic data (videodensitometry 
and edge detection) and histologic information collected in two institutions. 
METHODS 
Alherec/Omy procedul'e: 
From September 1989 through July 1991, 113 patients underwent a successtil1 
directional coronary atherectomy at the Thoraxcenter and St Luc Hospital. A 
successful procedure is defined by tissue retrieval and a visually assessed post-
procedural diameter stenosis < 50%. Using a standard over the wire technique, 
an 11 French guiding catheter is positioned in the coronary ostium. All patients 
received 250 mg acetosalicylatic acid and 10,000 U heparin intravenously. 
Intracoronary injection of isosorbide dinitrate was performed to relieve any 
possible spasm. The atherectomy device, either 6 or 7 French, is advanced 
through the guiding catheter, slided over a guide-wire and positioned across the 
stenosis. After proper positioning the support balloon was inflated lip to 0.5 atm, 
the cutter was retracted and balloon inflation pressure was increased to 2 to 3 
atm. The driving motor was activated and the rotating cutter was slowly advanced 
to cut and collect the protruding atherosclerotic lesion in the collecting chamber 
located at the tip of the catheter. After each pass, the hal100n was detlated and 
either removed or repositioned. On average, 5.8 (3-14) passes were performed 
across a stenosis. 
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QU(JI/{iradvl' COrtJlWI)' al/alysis: 
Edge delcction. The quantitative analysis of the stenotic coronary segments were 
carried out with the computer assisted Cardiovascular Angiographic Analysis 
System (CAAS), which has been described in detail elsewhere [3-7]. In essence, 
boundaries of a selected coronary artery segment are detected automatically from 
oplically magnified and video digitized regions of interest (512 x 512 pixels) of 
a cine-frame. Each individual catheter is measured by a micrometer and used as 
a scaling device. Correction for pincllshion distortion was performed. The 
computer-estimation of the original dimension of the artery at the site of the 
obstruction was used to define the interpolated reference diameter. The percentage 
diameter and area stenosis as well as the minimal cross-sectional area of the 
narrowed segment are then derived by assLiming a circular model and comparing 
the observed stenosis dimensions to the reference values. The angiographic 
analysis was done lIsing the average of Illultiple matched views with orthogonal 
projections whenever possible. 
Vidt'odt'!l.v;{o/1/('/J),. To determine the changes in cross-sectional area of a coronary 
segment from the density prot1\e within the artery, the calibration of the 
brightness levels in terms of the amount of X-ray absorption (Lambert Beer's 
Law) is required. Details of this technique have been described elsewhere [3-7]. 
Calibration of the densitometric area values is accomplished by comparing the 
reference area calculated from the diameter measurements (assuming a circular 
cross-section) with the corresponding densitometric area value. The complete 
procedure has been evaluated with the cine-films of perspex models of coronary 
obstructions [6]. 
A1atchil1}.! pmcess: 
Out of the initial cohort of II) patients, tifty-one atherectomy patients (group A) 
were individually matched with 51 patients who underwent conventional balloon 
dilatation. The matching proces has bcen described earlier [I]. Briefly, the lesions 
were matched by location and quantitative angiographically determined reference 
diameter and minimal luminal diameter. 
E(/gl' detection ve/:vus videot/c'lIsitOll1efl),: 
In 29 patients (group B), edge detection and videodensitometry were used to 
evaluate the immediate results of the atherectomy. The change in minimal cross-
sectional area before and after the procedure was determined by both methods and 
subsequently compared. 
"Sham" (I(/}el'('cloI11Y: 
In 10 consecutive patients (group C) quantitative coronary angiography was 
performed before atherectomy, after crossing the stenosis with the device and 
after directional atherectomy. 
His{opotlllJlo}.!y ,fiJlhnv; II}.! otlll'l'('(:ItJlI1Y: 
Post-mortem examination was available from I patient ,who died 2 days after a 
successful atherectomy procedure as a result of a delayed rupture of the right 
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coronary artery which resulted in a tamponade leading to the death of the patient 
[8]. Post-mortem examination revealed a tissure of the alherectomized vessel. 
RESULTS 
A/herfC/()JUY w'/:ms h(fllm", (f1l1:iophIS/Y: 
The pre-procedural stenosis characteristics of the matched patients (group A) are 
sllmmarized in table I. The immediate eflicacy of atherectomy and angioplasty 
as assessed by quantitative angiography are detailed in figure I. 
Tahle I. Makhed pre-procedural stenosis t:hllracteristics of 37 patients with su<.'ce,ssful coronary 
alhcredomy \,:ompared to successful Inlloon :mgiorlusty 
Pre-alhen,:chHny P()sl-alheredomy 
Referelll.:e diamekr (mill) 3.0 ± 0.6 3.0 + 0.6 
Minimal luminal dianwtcr (mm) 1.1 + 0.4 1.1 + 0.3 
Diameter stenosis (%) 64 + 10 63 + 9 
Ar ... a phulue (nun1) 9.1 :1:: 6.0 8.4 ± 4.6 
Curvature value 15.9 + 7.0 22.2 + 13. I * 
Symmetry intkx 0.5 + 0.3 0.5 + 0.4 
p -value < U.O:l. 
As expected alherectomy and balloon angioplasty significantly improved the 
minimal lumen diameler (1.1 ± 0.4 mm to 2.7 ± 0.4 mm;p<O.OOOI vs 1.1 ± 
0.3 mm to 1.9 ± 0.4 mm;p<O.OOI). Immediately following atherectomy. the 
increase in minimal lumen. diameter was superior compared to conventional 
balloon angioplasly (1.6 vs 0.8 I11I11;p<O.OOOI). 
Ed1:f de/fCri(JI/ verSli.\' v;d(,(U/l'IISi/(J/II(,/I),: 
In group B, the minimal luminal cross-sectional area (MLCA) as determined by 
densitometry was compared with the minimal luminal cross-sectional area 
measurements from edge detection which assLimes a circular configuration. 
Analysis of variance was performed to compare the area measurements derived 
from edge detection and densitometry hefore and after atherectomy and when 
significant differences were found, two-tailed paired T-tests were applied. A 
statistical probability of < 0.05 was considered significant. The agreement 
between the two methods was assessed by determining the mean and the standard 
deviation of the between-method di fference as suggested by Bland and Altman [9]. 
The comparative data before and after coronary atherectomy in group Bare 
shown in figure 11. The minimal luminal cross-sectional area as determined by 
videodensitol11elry increased after alherectomy from 1.03 ± 0.77 1111112 10 5.18 ± 
1.64 111m2 (p < 0.0001). The mean difference of the minimal cross-sectional area 
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between the two methods before atherectomy was -0.12 mm 2 while this difference 
was slightly larger after atherectomy (mean difference 0.28 mm'). The variability 
as determined by the standard deviation of the between-method difference was 
higher in the post-atherectomy analysis (1.55 mm') compared to the pre-
atherectomy analysis (0.47 mm') suggesting that atherectomy induces a near-
circular lumen area contiguration. Quantitative analysis ofthe atherectomy device 
showed an increase of its diameter from 2.0 ± 0.2 mill to 3.4 ± 0.4 111m 
following inflation of the support-balloon. 
"Sham" atheri'ctomy: 
The extent of the 'Dotter' effect as assessed by quantitative angiography in 10 
consecutive patients of group C is summarized in table 2. The 'Dotter' effect 
accounts for 62 % of the luminal improvement. 
Tahle 2 QlI'Intil'ltive asseo.:slllent of the MOntier" effect uurin.g directional COrofl'lfy atberedomy 
Pre·atherectomy Dotter effed Pos!-alberectomy 
Reference diamder (mm) 3.46 ± 0.36 3.34 ± 0.39 3.6t ± 0.3t 
Minimal luminal diamekr (mill) 0.97 ± 0.32 1.85 ± 0.37 2.38 ± 0.33 
Diamder sknosis (%) 71 ± 8 43 ± 8 34 ± 6 
Hislop(Jlli%}.:y: 
A histologic cross-section of the atherectomized coronary artery of the patient 
who died aftcr the procedurc shows that all 3 layers of the vessel wall had been 
resected while the obstructive plaque remained unchanged (figure III). 
DISCUSSION 
In this report we lIsed 4 different methods of analysis (edge detection, 
videodensitometry, matching and histology) to elucidate the mechanism of 
directional coronary atherectomy. Using our matching technique, we clearly 
showed that directional coronary atherectomy results in a superior immediate 
angiographic enlargement of the luminal area when compared to conventional 
balloon dilatation. These findings are in accordance with the observations reported 
by Muller el "I [10], Plaque removal and remodelling rather than remodelling 
alone can be accounted for this superiority. However, we demonstrate that the 
introduction of the bulky atherectomy device is associated with a substantial 
IlDotter ll effect. This report shows that 62% of the luminal improvement is due 
to a "Dotter" effect and thus supports the "ndings of Penny et a1 [2] who could 
only retrieve 30% of the expected amount of atherosclerotic tissue which indicates 
the complementary role of the cutting action to the dilating action of the 
atherectomy device. Videodensitometry has been suggested as a superior 
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alternative to edge detection for the post~interventional analysis since it is 
independent of geometric shape. Comparing these two techniques of quantitative 
analysis provides information regarding the luminal area geometry after coronary 
atherectomy. Discrepancies between videodensitometry and edge detection are 
most likely to occur when the cross~section of the vessel wall deviates furthest 
from a circular configuration since this is a basic assumption using edge detection. 
Because atherectomy selectively removes the atherosclerotic plaque, it is expected 
Ihal Ihe vessel wall afler alhcreclomy is less disrupled and Iherefore Iheorelically 
may assume a configuration which is close to a circle. Following atherectomy, 
only a small discrepancy in minimal luminal cross~sectional area between edge 
detection and videodensitometry is found which means that the post~atherectolllY 
vessel lumen is close to a circle. Indeed, this study tends to demonstrate that 
atherectomy results in a relative circular lumen area configuration. This finding 
is at variance with the clover~lcaf post~atherectotlly lumen area configuration as 
proposed by Penny [2]. If Ihis clover-leaf configuralion as hYPolhesized by Penny 
et al [2] was a predominant feature following atherectomy, than our cross-
sectional area measure derived from videodensitometry would be inferior to the 
measurcment derived from edge detection since edge detection would overestimate 
the cross-sectional area: the largest diameter of this trilobated lumen would be 
interpreted as the diameter of a perfect circle, irrespective of the angiographic 
view in which it is filmed. Our study offers an alternative explanation for the 
change in vessel conl1gllration after alherectomy: insertion of the bulky 
atherectomy device itself causes a lumen enlargement due to the 'Dotter' effect 
and a symmetrical stretching of the vessel wall as a result of its cylindric 
dimensions. Subsequent intlation of the support balloon with an increase in 
diameter from 2.0 mm to 3.4 mm and activation of the debulking device may 
lead to further luminal improvement by stretching of the non diseased vessel wall 
and excision of the encroaching plaque. Indeed we demonstrate that 62 % of the 
luminal improvement achieved by directional atherectomy results from a 'Dotter' 
effect when crossing the stenotic lesion with the housing of the device. For ethical 
reasons protocol design including a balloon intlation of the support balloon has 
not been carried aLit, although it would presumably demonstrate that the balloon 
inflation with or without activation of the cuttcr also considerably contrihutes to 
the already observed amount of "Dotter j ' effect. Finally, the histologic cross 
section at the level of atherectomy (l1gure III) shows a relative circular post-
atherectomy area geometry and not a clover-leaf geometry although directional 
cutting sometime results in a small resection of quadrangular appearance. 
In conclusion, directional atherectomy results in a superior immediate 
angiographic result when compared to balloon angioplasty. However, lIsing 4 
different analytical approaches we demollstrate that a 'Dotter' effect accounts for 
62 % of the luminal improvement. Future developments should therefore be aimed 
at reducing the bulky design thereby limiting the Ileed of balloon inflations. 
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ABSTRACT 
Interventional cardiology has branched in two directions: devices that primarily 
dilate coronary stenoses and those that debulk coronary tissue. Presently the 
optimal coronary intervention has not been found, While awaiting randomized 
trials, a comparison based on matched quantitative coronary analysis may be 
useful to evaluate results of new interventional techniques, Therefore we 
compared 5 I atherectomy patients with individually matched PTCA and stent 
patients. The lesions were matched according to stenosis location and reference 
diameter. Atherectomy and stenting resulted in larger gains in lumen diameter 
compared to conventional balloon angioplasty. The minimallulllinal diameter was 
increased from 1.2 ± 0.4 mm to 2.6 ± 0.4 mm in the atherectomy group and 
from l.2 ± 0.5 mill to 2.5 ± 0.4 mill in the stent group compared to an increase 
from 1.2 ± 0.3 111111 to 1.9 ± 0.4 111111 in the angioplasty group (p<O.OOOOI). 
Atherectomy and stenling resulted in a similar gain in minimal luminal diameter 
(1.4 111m versus 1.3111111, p=NS). 
In addition, atherectomy and stenting appear to be more effective devices in 
resisting elastic recoil due to an intrinsic dilating effect and tissue removal 
respectively. 
In matched populations, directional atherectomy and stenting appear to be more 
effective intracoronary interventional devices than balloon angioplasty based on 
the immediate result. However, atherectomy is limited in smaller coronary vessels 
by its larger size. 
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INTRODUCTION 
Directional atherectomy has recently been introduced as an alternative to 
conventional balloon dilatation [I]. It has been shown to be safe and effective 
when applied in human coronary arleries [2,3]. It was initially hypothesized that 
removal of the atherosclerotic plaque would result in a better immediate result 
with fewer acute complications and a reduced restenosis rate compared to 
conventional balloon angioplasty [4]. However, at the present time, it is difficult 
to compare the respective merits of variolls mechanical interventions since no 
randomized studies have been attempted. While awaiting these trials we utilized 
information from our quantitative angiography database to compare patients 
treated with variolls coronary interventions. Coronary lesions from 51 patients 
who underwent directional atherectomy were analyzed with the computer-based 
coronary angiography system and matched with similar lesions treated with 
balloon angioplasty, intracoronary stenting and rotational ablation. The immediate 
results from geometric assessment of the stenotic lesion by edge detection before 
and after atherectomy are presented and compared with the results of conventional 
balloon angioplasty, intra-coronary stenting and rotational ablation. 
METHODS 
Patient Xroup: 
From September 1989 through September 1990, 51 patients (43 men and 8 
women) underwent an atherectomy procedure for symptomatic coronary artery 
disease. Three patients underwent two procedures and one patient had three 
procedures. The atherectomy procedure was successful in 54 of the 56 procedures 
(post-procedural diameter stenosis < 50%). The mean age (±SD) was 58.2 
(± 10. I) years. At the time of atherectomy 21 patients were in New York Heart 
Association functional class IV, II in III and 19 in II. Coronary angiography 
showed single vessel disease in 39 patients, two-vessel disease in 8 and three-
vessel disease in 4. The site of obstruction was located in the left anterior 
descending coronary artery in 31 patients, in the right coronary artery in 13 cases, 
in the circumflex artery in 9 cases and in the venous bypass graft in 3 cases. 
At/tel'l'cto11lY PmCl'tiure: 
After administration of local anaesthesia, a II French sheath was inserted into the 
femoral artery. All patients received 250 mg acetylsalicylic acid and 10,000 U 
heparin intravenously. Intracoronary injection of isosorbide dinitrate was 
performed to minimize any possible spasm. After initial angiograms in multiple 
views were made, a special II French guiding catheter was placed into the ostium 
of the coronary artery. Under fluoroscopy the guide-wire was advanced into the 
distal part of the artery. Then, the athercctomy device was directed over the 
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guide-wire and positioned across the stenosis. The support balloon was then 
inflated up to 0.5 atm, the cutter was retracted and balloon inflation pressure was 
increased to 2 to 3 atm. The driving motor was activated and the rotating cutter 
was slowly advanced to cut ancl collect the protruding atherosclerotic lesion in the 
collecting chamber located at the tip of the catheter. After every pass the balloon 
was detlated and either removed or repositioned. On average 6. I ± 2.9 passes 
in multiple directions were performed across a stenosis. Atherectomy was 
considered successful when the residual stenosis was less than 50% after tissue 
retrieval. Following atherectomy, the arterial and venous sheaths were lIsually left 
in place for 6 hours. Patients were monitored for 24 hours and electrocardiograms 
and cardiac enzyme levels were obtained twice a day. Nifedipine was given every 
2 hours after the procedure and the patients were kept on aspirin medication for 
one year. 
Qual1litaave caml/tII)' (lflgh)graplly: 
Quantitative analysis of the coronary segments was performed with the computer 
based Coronary Angiography Analysis System (CAAS), previously described in 
detail [5,6]. In essence, boundaries of a selected coronary artery segment are 
detected automatically from optically magnified ancl video digitized regions of 
interest (512 x 512 pixels) of a cine-frame. The absolute diameter of the stenosis 
in mm is determined lIsing the guiding catheter as a scaling devise. Calibration 
of the catheter in absolute values (mill) is achieved by comparing the mean 
diameter of the guiding catheter in pixels with the measured size in millimeters. 
Each individual catheter is measured by a micrometer. To correct the detected 
contour of the arterial and catheter segments for pincllshion distortion, a 
correction vector is computed for each pixel based on a computer- processed 
cineframe with a centimeter grid placed against the input screen of the image 
intensifier. Since the functional significance of a stenosis is related to the expected 
normal cross sectional area of a vessel at the point of obstruction, we use a 
computer-estimation of the original dimension of the artery at the site of the 
obstruction to define the interpolated reference area. The percentage diameter and 
area stenosis as well as the cross sectional area (111m2) are then calculated. The 
length of the lesion (mill) is determined from the diameter function on the basis 
of a curvature analysis. Using the reconstructed borders of the vessel, the 
computer calculates the symmetry coefficient for the stenosis. The symmetry 
index ranges from 0 (totally eccentric stenosis) to I (symmetric). The degree of 
coronary bend is assessed by the curvature value at the obstruction site. This 
parameter is computed as the average value of all the individual curvature values 
along the centerline of the coronary segment, with the curvature defined as the 
tirst derivative of the tangent as it moves along the centerline which for a circle 
is equal to the reciprocal of the radius. 
HaemmlYllamic asse.\'.\'I1lCflt: 
The haemodynamic results were determined as described earlier [7,8,9,10]. 
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Briefly, the theoretical pressure decrease was calculated using the arteriogram and 
digital computation, according to the formula: Pgrad = Q . (Rp + Q . Rt), where 
Pgrad is the theoretical transstenotic pressure decrease (mm Hg) over the stenosis, 
Q the mean coronary flow (mils), Rp the Poisseuille resistance and Rt the 
turbulence resistance. The theoretical trans-stenotic pressure decrease was 
calculated for a theoretical blood flow of I, 2 and 3 mils. The Poiseuille and 
turbulence contributions to flow resistance were determined from stenosis 
geometry assessed by quantitative coronary angiography. 
Matdling proCl'ss: 
To avoid patient selection bias we selected populations with comparable base-line 
stenosis characteristics. The coronary artery tree was subdivided into 15 segments 
according to the American Heart Association guidelines. The lesions were 
individually matched according to stenosis location and reference diameter. 
Matching was considered adequate if the mean difference of the reference 
diameter between the groups were identical. Three patients who were treated for 
bypass graft stenosis and two patients with an unsuccessful procedure were 
excluded from the matching process. Thus 51 intra-coronary atherectomy lesions 
were individually matched with "twin" lesions treated by balloon angioplasty or 
self-expandable slenL The rotablator patient group was not individually matched 
since only 7 patients were included. Their results are represented as a group. 
Currently the Thoraxcenter angiographic registry contains quanlitatively assessed 
stenosis data for 2300 patients either treated by angioplasty (n= 1847), intra-
coronary stenting (n =406), directional atherectomy (n =56) or rotational ablation 
(n =7). 
Device pn!lill',\'; 
AtherectoJ1/Y devices: In 50 of 51 atherectomy patients a 6 French catheter was 
lIsed while in one case a 7 French atherectomy device was employed. The mean 
diameter of the atherectomy device was 2.1 mm by quantitative angiographic 
assessment. 
Ballooll-(m~iopla.\'ly: The transverse diameter of the deflated balloon is an 
important determinant as to whether a stenosis can be crossed. Currently used 
balloons have favorable profile characteristics as expressed by their small 
diameter (1.0 mm: ranging from 0.8 to 1.1 mm). The balloon sizes were matched 
to the reference diameter with the goal of achieving a ratio of 1: 1 (inflated 
balloon diameter:artery diameter). The following balloon diameters were lIsed in 
this study popUlation: 2.0 mm (n= 1),2.5 1111n (n= 12),3.0 mm (n=27), 3.4 111m 
(n= 1),3.5 (n=9) and 4.0 mm (n= I). 
Stl'ntill~: The self-expanding stent is constrained on a small diameter-delivery 
catheter, but assumes its unconstrained larger diameter up to 6 I111ll when the 
constraining membrane is removed. The stent-calheter profile mounted on its 
delivery device is 1.57 mm [Ill. In the 51 study patients the unconstrained 
diameters were 3.0 mm (n=5), 3.5 mm (n=29), 4.0 mill (n=9), 4.5 mm (n= I), 
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5.0 mm (n=3) and unknown in 4. The stent sizes were selected based on the size 
of the arterial segment, taking into account that the stent in its unconstrained form 
must have a diameter 0.5 III Ill. larger than the reference diameter of the stented 
vessel [II). 
Rotational aMalian: With rotational ablation the device consists of a rotating 
abrasive burr of variable protile characteristics (from 1.5 Illill to 3.5 111111). In this 
series the largest burr size used was 2.25 mill. Choice of burr size was selected 
according to the reference diameter. 
QU(lllfitatiw' assessml'llI (!f Ihe expansion ratio ~f the mriofls devices: 
Recently the concept of the expansion ratio has been addressed [12]. Briefly, the 
mechanism of all intra-coronary interventions l11ay be divided in three stages. The 
first or "prefullctional stage", is characterized by the introduction of the device. 
The device is not yet operational and its intrinsic dimensions determine to which 
extent the device may be introduced into the coronary tree. During the 
introduction of a bulky device across a stenotic lesion, some degree of dilatation 
occurs as a direct result of a Dotter effect. The second or "operational stage", 
starts when the devices become operational and exhibit their specific mode of 
action (dilatation,cutting,ablation,vaporization). In becoming operational, the 
diameter of the device may expand (atherectomy, balloon, stent) or maintain its 
original dimensions (laser, rotational ablation). During this stage, the maximal 
effect of the device is achieved. The final result, after the removal of the device, 
is then determined by the recoil phenomenon and vascular reactivity. 
Consequently. the net luminal gain will he less than the initial gain when the 
device is operational. 
To distinguish the acute effect of the variolls devices from the vascular reactivity 
and recoil phenomenon we subdivided the expansion ratio into the theoretical 
expansion ratio, which occurs during the "operational" stage, and the fUllctional 
expansion ratio, which takes into account the elastic recoil phenomenon and 
describes the net result [13). Both the theoretical and functional ratios were 
assessed for all interventional devices used in our study. The maximal achievable 
diameter of the vessel is calculated according to the {lial11eter of the operational 
device while it is active. In case ofhalloon angioplasty and self-expandable stent, 
this corresponds to the diameter of the inflated balloon and to the unconstrained 
diameter of the self-expandable stenL For atherectomy, this was assessed by intra-
coronary quantitative analysis during intlation of the support-balloon. The 
rotablator does not alter its diameter while operational. The post procedure 
diameter has been measured immediately following withdrawal of the {Ievice. 
For example, when the diameter of an intra-coronary atherectomy device 
increases from 2.1 mill to 3.5 mm upon balloon inflation, the maximal achievable 
vessel diameter becomes 3.5 mm However the tinal luminal diameter at the end 
of the procedure measures 2.6 mill. Thus, the theorelical and functional expansion 
ratios are 1.7 (3.5/2.1) and 1.2 (2.6/2.1), respectively. 
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FiXIffl'la, D('I('('(('d cOIltour.I' ,1-UI'('rilll{Jtl.IH/IIII the origilltll video illlllgt' for a n'/)f('.\'('lI!lItiv(' riglir 
COI"OIUI/)' lIIklJ' .I'tellosis, filllled ill right (HAO) all/('I"iol" o/Jliqlw projl'l'lirm bl:/im'dineliollal 
lItll('n'l'loIIIY. 17/(' dhlllll'tl'l'fllllctioll i.I' sllOWlIlIt IIII' /JoftOI/J, 17ll' white a/'{'/1 i,l" lIl1Il'lIs/lf'l!for till' 
"allll'to.l'c/l'l'Otic pl(/q/(/'~. 1he lIIillil/l(/lllIlIIilllll dillllll'll'I' (I'l'f/it'll' lim') is O. 71111111, ('mTl'.ljJOI/(lillg 
10 (/ diall/eter ,\'ll'IIOS;,\' of 79% (/Ild 1111 tll'l'll .I'/{'lIt!.1'j.l" (!f96%. 
Figure Ih, Col/IlJur lIIwlyxi.\' (!fllle illlra-mmlllU)' IIfll(,tH'IOI1l), dl'I'in' without il/j7alnl supporl 
bal/ooll. 1711's rt'II1'l'.H'III,\' tlll'prst or "PJ'{'-Jullt'fill//lIl,I'tag(''' l!fllll illtrtf-('OIYIIIIII), ;1I/('1'\'('lIlioll which 
is chlln/unjzed hy tlte ill/til/sic ditUlll'la (!flhe d('I'in'. 
FiNN/'(,1e. COlltOl/1' IIIwly,\'i,~ {if thl' iJllrtf-COI'fJIuu)'filllllY/ ll/lInn'tomy dl'l'ic(' with illj7a/cy/.I'llPl'ort 
hal/ool/. Bl'lIl'll/1i lhis is ,I-!JOII'II tliedimm'tl'l'Ji/l/{liol/, Ilw 1//('/111 diallleter i.I' ),0611111l. 1M\' 1II111IY,I'i.\' 
repn'se/lf,I' Ihe ,H'(,(IIIt! or ~(lpl'r(/lilll/(//.11l1gc'~ ill II'hh'h Ihl' lIthereclolllY del'icc exhibits il.I'lIIode of 
(lelioll. 
Figl/re /d, A ,\'illgit'-Jnwll' 1Il1giog/'{//II lif ,Ill' righ/corOlwl)' arll'I)'jillll('d ill HAO aft!>r directiollal 
a/Ill'reclOllly. 111l' millima//llf11il/a/ diem/l'tl'r il/cH'm'ly/to 2,27111111, COI'fl'.ljlOIldiI/X to (/ diaml'tl'r 
,I,/el/O,I-;S of 21 % IIlId /111 arc/I .1/{'lIo.t'i.I- (!f 38%. 
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Statistical atudy,\'is. 
All values are expressed as mean values ± I standard deviation. Morphologic and 
hemodynamic variables before and after atherectomy were compared by the paired 
Student's Hest. Comparisons of the severity of minimal luminal diameter, area 
plaque and diameter stenosis between the groups were performed using analysis 
of variance, If significant differences were found, the unpaired Student's Hest 
was applied. Differences were considered statistically significant at p<0.05. 
RESULTS 
Dir('ctional atl1('r('£'toI1lY: 
Fifty-six lesions in 51 patients were studied and a mean of 1.4 angiographic 
projections per lesion were analyzed. The morphologic and hemodynamic data are 
presented in tables I and 2 respectively. 
Tahle J Effect of direction'lI coron'uy ,ttherectol11Y on 55 ohstmclive lesions 
Pre-alhehxtomy Post-athercctol1lY p-value 
Extent (mill) 6.4 + 2.5 4,7 + 2.1 <0.00001 
.Reference diameter (mill) 3.0 ± 0.6 3.2 + 0.4 0.03 
Minimal luminal diameter (111m) 1.1 + 0.4 2.5 + 0.5 <0,00001 
Diameter stenosis (%.) 63 + II 22 + 15 <0.00001 
Minimal cross-.~cdional art-'a (1l1I1ll) I.t ± 0.8 5.2 ± 1.8 <0.00001 
Plaque arca (mml) 8.8 ± 5.6 2,6 ± 2.t <0.00001 
SYlllmetry index 0.6 + 0.3 0.7 + 0,2 NS 
The mean value for the minimal luminal diameter before and after atherectomy 
were 1.1 Illill ± 0.4 mill and 2.5 mill ± 0.4 mm, respectively. This morphologic 
improvement was associated with a significant decrease in the calculated 
Poiseuille and turbulent resistance, as well as a theoretical trans-stenotic gradient 
decrease for a theoretical flow of J mJ/s, 
Atl1er('('lmllY VeI:ws (lII;,:iopla,\'fY alld sl('/}fiJl;':: 
Matching according to lesion distribution and reference diameter was considered 
adequate since the reference diameter was equal in all groups (3.0 ± 0.6 !TIm) 
while the mean difference for this parameter between the groups was 0.0 ± 0.1 
mill. No pre-procedural differences were found between the atherectomy, PTCA 
and stellt group in minimal luminal diameter (1.2 ± 0.4 mill vs 1.2 ± 0,3 mm 
vs 1.2 ± 0.5 mm), diameter slenosis (63 ± 10% vs 62 ± 10% vs 60 ± 12%), 
area plaque (8.8 ± 5,8 mm' vs 8.2 ± 4.5 mm' vs 8.4 ± 4.5 mm') and 
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'PRE OPERATIONAL" 
LASER 11.6mm 
ROTA-~ 
BLATO~13mm STENT~ 
I L THEORETICAL EXPANSION R~;r~~iOiiALT,<Pi'NSION L. _________ FUNCTIONAL 
Figure 2. Selic'llIlIlie repl"lWl'lIIl1rjoll of fhe COIIClP' olflllll'liolll// lIlId 1//('or(,(jwll'Xl'lIl1sio/l I'lIt;o of 
,hl' ~'aI'i(lIl,\' illfrll-corolltll}' ;1l/('rI'l'lIfiOI/ /cc/llliqlll'.I'. 7111' first or "pn!tll/('timllll sIIlXC", is 
characterized by the illfrot/Ilc1;ol/ (If fhe "l'vin'. III "{'comiIlX opcra/iollal soIl/(' (if the tll'vice,I' Xl'l 
("'l'llllr/C'd (ath('fC'c/oJIIY. hallOO/I, ,I'(ellt) while others llIaill/a;n their origillal dilllC'//,\';OI/S (laser, 
rotatio1lal lI/J/a/ion). TI/(' elld r('sllll i,I' de/crlllilled II}' ,fw n'('oil ,,11('1101//('1/01/ alld \'I/.\·('ulal' 
rl'llcliviry. Aftcr rt'lIIm'iIlX l//l' dC'I'in' lit" maxill/al {/mfe cjj('CI lIIay he IllIff;al/y 10.\'( due (0 the 
<'1m-Ii<' r{'coil (if rill' \'/'s,vd. 71/(' l'.t/llIl/sioll mf;o i,l· .l"IIhdh'idn/ illlo Ihe Ihl'ore/ica/ ('xpal/sioll ralio, 
which is dell'l"lI/illcd h)' Ih(' (lpl'l"lIlioll(/1 tlel'iel', alit! 1/U'JIIIlClioIlUI l'xpullsioll rlllio, whiclliakes inlo 
/lCCOUIIl llle l'ill.l"/k rl'("IIi/ 1'"('11011/('1/011 lIlId t!('.I·(·rih('.\· II/(' /1l'1 1"l'.l"ull. 
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symmetry value (0.5 ± 0.3 vs 0.6 ± 0.3 vs 0.5 ± 0.2). Curvature value was 
less in the atherectomy group compared with the PTCA group (15.9 ± 7.0 vs 
22.2 ± 13. I). 
Table 2 Hemodynamic results immeJiately before and after directional coronary alherectomy 
Pre·atherectomy Posl-atherechlll1Y p-value 
Poiseuille ft'sislance (dynes s cm"5) 39.2 ± t24.8 0.30 ± 0.40 0,025 
Turhulence resistance (dynes s cllr5) 20.6 ± 59.7 0,05 + 0.17 0.013 
Pressure gmdienl 
now I mils 48.0 ± t54.5 0.40 ± O.lO 0.026 
flow 2 mils 105.5 + 380.9 0.60 + 1.0 <0,01 
flow 3 mils 197.5 + 697.0 1.00 ± 1.60 0.042 
Table 3 represents the changes in minimallulllinal diameter, diameter stenosis and 
area plaque induced by presently available intra-coronary interventional devices 
as assessed by quantitative angiography in our institution. A significantly Iarger 
gain in lumen diameter was achieved by directional atherectomy and stenting 
compared with balloon angioplasty (1.4 mill and 1.3 I11Ill versus 0.7 mm; 
p<O.OOOOI). Rotational ablation resulted in the smallest luminal increment (1.2 
± 0.4 to 1.6 ± 0.1 mm). 
Tahle 3, Comparative qmlntitativeanalysis of the imm~diate result of atherectomy. angioplastyand 
sl~nting 
MinimalluminHI dillmeter Ar~a pla<lue (mrn2) Diameter 
(mill) stenosis (%) 
Atherectomy 
pre 1.2 ± 0.4 8.8 ± 5.8 63 ± 10 
post 2.6 ± 0.4 2.6 ± 2.t 20 ± t t 
PTCA 
pre 1.2 + 0.3 8.2 + 4.5 62 + to 
post 1.9 ± 0.4* 5.3 ± 4.0 36 ± 11* 
St~nt 
pre 1.2 ± 0.5 8.4 + 4.5 60 + t2 
post 2.5 ± 0.4** 3,5 ± 2.4** 20 ± 9** 
*: p <0,00001 alhereciom y vs PTCA. stent vs PTCA. **: r not SI 'nlilcant llihereciorn g y vs sten! 
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QuantitatiVl' analy,\'js (?f' !hi' !heoretical and /imc!iol1al expansion ratio: 
Quantitative analysis of the intra-coronary atherec!omy device shows a mean 
diameter of 2, I mm which increases to 3,3 111m after inflation of the support 
balloon, Compared to the other devices, atherectomy has a larger catheter 
delivery system which limits the theoretical and effective expansion ratio ( 1.6 and 
1.2 respectively), Balloon angioplasty and stenting give superior expansion ratios 
since they are introduced on smaller delivery systems, Rotational ablation had the 
lowest expansion ratio since the rotablator does not change in size while in 
operation (table 4). 
Tahle 4, Quantitative assessment of the theordical ami functional expansion ratio of intra-coronary 
devices 
Balloon Self-expandable Din~ctional R(ltalinnal 
angioplasty stent athert'clomy alhert'ctomy 
Device proi1le 1.0 (0.8 - 1.1) 1.6 2.1 (2.0 - 2.4) 2.0 (1.5 - 2.3) 
(111m) 
Maximlllllchiew(1 2,8 ± 0,5 3.3 ± 0,3* 3,3 ± 0.5 1.9 ± 0.4 
uiameter (mill) 
Post- 1.9 ± 0.4 2.5 ± 0.4 2.6 ± 0.4 1.6 ± 0,2 
interwlltiollAI 
ujamcter (mm)** 
Theoretical 2.9 2.5 1.6 1.0 
expansion ratio 
Functional 1.9 1.6 1.2 0.8 
expansion ratio 
.: unconstramed sten! tlJamder, "'''': assessed h~ (. uanlltallve coronar Y 1 y lInal\SIS y 
DISCUSSION 
Over the past 5 years, there has been a rapid increase in the development of new 
interventional devices aimed to supplement conventional balloon dilatation. This 
progress in technology resulted in the introduction of directional coronary 
atherectomy, intra-coronary stenting, rotational coronary ablation and laser-
assisted angioplasty. Clinical studies have demonstrated the feasibility and the 
safety of these interventions, however the relative efficacy of each technique 
remains to be assessed, 
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Edge detectioll W'tSII.\' vhhJ(}(/l'l1.\'it()JJll'tt)l: 
The immediate efficacy of the various coronary interventions should be assessed 
by reproducible quantitative angiographic measurements [14]. Visual estimation 
of the stenosis severity alone results in unacceptable variation in the assessment 
of changes of coronary artery lesions. To obtain objective and reproducible 
values, a computer-assisted technique using automated edge detection or 
videodensitomelry should be applied [15]. Whether edge detection lechniques are 
inferior to videodensitometry remains an unresolved issue. A previous study from 
our group demonstraled that the edge deleclion melhod correlates well wilh 
densitometric analysis of the stenosis severily before angioplasly [5]. However 
after angioplasty, discrepancies between these types of measurements may be 
observed when using a single-plane view [16]. Recenlly we have shown that a 
linear relationship exists between the edge detection and videodensitometry both 
before and aftcr atherectomy although the strength of this relationship deteriorates 
after atherectomy [17]. Therefore we fell juslified to assess the immediale efficacy 
of coronary athereclomy by edge detection analysis. 
At/1ctcctomy versus ollMiop/asty {flld .\'fclltiIlM: 
With an increasing number of interventional modalities, current indications and 
patient selection becomes difticult. This study demonstrates the important finding 
that atherectomy as well as stenling result in a larger increase in minimal luminal 
diameter compared to balloon angioplasty (1.4 and 1.:1 mm versus 0.7 mm, 
p<O.OOOOI). In addition no differences in the post-interventional angiographic 
result were observed between athercctomy and stenting groups. This study 
confirms the findings of Muller [18] however, with our Illore refined matching 
technique, individual atherectomy lesions were directly compared to 
angiographically similar lesions treated by angioplasty or slenting. Although a 
randomized trial is the optimal method to compare the short and long-term results 
of new interventional techniques, matching based on quantitative analysis might 
become an acceptable alternative while awaiting these trials. Using this matching 
program we selected populations with comparable base-line stenosis parameters. 
The lesions were adequately matched since no differences were found in reference 
diameter, obstruction diameter, area plaque and symmetry index between the 3 
groups. Whether the superior immediate results after atherectomy and stenting 
will be associated with a reduction in restenosis remains to be assessed in 
randomized trials. 
Illfra-coroumy devices: 
Expansion ratio is an important concept that relates the final effect of the intra-
coronary device on the arterial diameter to the size of the catheter required to 
deliver this effect [12]. The maximal effect of the device may be partially losl due 
to the elastic recoil of the vessel. The expansion ratio has been subdivided into 
two components, theoretical and functional, to separate these influences [13]. 
Balloon angioplasty and stenting give extremely favorable theoretical and 
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functional expansion ratios (2.9 and 1.9 versus 2.5 and 1.6 respectively) since 
they may be delivered on low prolile catheters. The directional atherectomy 
device is more limited by the size of the housing and collecting chamber. The 
dimensions of the rotational atherectomy device does not change during operation 
and therefore exhibits the lowest theoretical expansion ratio. 
Although balloon angioplasty has the most favorable expansion ratio, the linal 
result is profoundly influenced by the elastic recoil of the vessel [19,20]. Stenting 
and atherectomy appear to be more effective devices in resisting elastic recoil 
although the mechanisms are likely different. Stenting effectively prevents this 
recoil phenomenon presumably due to its scaffolding function and its intrinsic 
dilating effect [10,13]. By physically removing tissue, atherectomy appears to 
diminish the potential elastic recoil effect. However, the actual diameter of the 
atherectomy device limits its suitability in smaller coronary arteries. 
Limitations: 
There are several limitations of this study. First, it is an uncontrolled, 
retrospective observational study limited to a subset of patients who underwent a 
successful coronary intervention. Although matching for angiographic variables 
is a promising technique to assess the efficacy of intracoronary interventions, 
patient and procedure related variables should also be included in the analysis. 
Second, this study is based on the early experience with atherectomy and stenting. 
Future design changes and improved operator experience may further improve the 
immediate and long-term results. Finally, the efficacy of all intracoronary 
interventions will be limited by the restenosis problem which necessitates careful 
and complete angiographic follow-up. Thus controlled clinical trials are 
imperative in the future to determine the immediate angiographic result, the long-
term efficacy of these interventions and if any benefit can be shown in particular 
patient subgroups. 
Conclusions: 
Quantitative angiographic assessment of the immediate result after directional 
atherectomy show significant improvement in stenosis geometry and 
hemodynamics. While awaiting randomized trials, matching based on quantitative 
analysis might become an acceptable alternative for objective and comparative 
assessment of various interventional techniques. In matched populations, 
directional atherectomy and stenting appear to be more effective intracoronary 
interventional devices than balloon angioplasty based on the immediate result 
however, atherectomy is limited in smaller coronary vessels by its larger size. 
Theoretically stenting has the most favorable characteristics as a dilating device 
although its clinical use is limited by its more complicated patient management. 
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ABSTRACT 
We have attempted to assess the Ilutility" of directional atherectomy, through a 
new quantitative angiographic index. This index can be subdivided into an initial 
gain component and a restenosis component. The initial Xaill index is the ratio 
between the gain in diameter during the intervention and the theoretically 
achievable gain i.e. the reference diameter. The resfenosis index is the ratio 
between the loss at follow-up and the initial gain during the procedure. The net 
result at long term is characterized by the wilily index which is the ratio between 
the final gain in diameler at follow-up and what theoretically could have been 
achieved. For this purpose, 30 coronary artery lesions were selected from a 
consecutive series of successfully dilated primary angioplasty lesions and were 
matched wilh the initial 30 successfully treated primary atherectomy lesions. 
Matching by stenosis location and reference diameter resulted in two comparable 
groups with identical pre-procedural stenosis characteristics, Atherectomy resulted 
in an increase in minimallulllinal diameter twice larger than angioplasty (1.53 vs 
0.77 mm;p<O.OOOI). AI follow-up, however, Ihere was a significant decrease in 
the minimal luminal diameter and a significant increase in percentage diameter 
slenosis in Ihe athereclOmy and angioplasly group (1.69 ± 0.58 vs. 1.57 ± 0.58 
mm p=NS and 37 ± 18 vs. 47 ± 18% p=NS, respectively). The loss in 
minimal luminal gain was more pronounced in the atherectomy group when 
compared with the angioplasty group (0.92 ± 0.69 vs. 0.35 ± 0.51 mm; 
p=0.0005). Consequenlly, directional atherectomy resulted in a significantly 
higher initial gain ralio when compared wilh balloon angioplasty (0.84 versus 
O.4I;p<O.OOOOI). At follow-up, the restenosis ratio and utility ratio were 
comparable in bOlh groups (0.56 versus 0.62;p=NS and 0.29 versus 0.23;p=NS 
respectively), In matched populations, directional atherectomy is a very effective 
device with a substantially beller initial result than can be achieved with balloon 
angioplasty. But it appears to be a potent stimulator of the restenosis process 
because at follow-up this inilial favorable result is lost and the minimal luminal 
diameler is comparable 10 Ihat after balloon angioplaslY. Thus the final utility of 
directional coronary athercctomy is not signilicantly different from conventional 
balloon angioplasty. 
59 
INTRODUCTION 
Restenosis after conventional balloon angioplasty remains the major limitation of 
this procedure [1-5]. Despite extensive efforts to elucidate this phenomenon our 
knowledge remains incomplete. In recent years studies have suggested that intimal 
hyperplasia is the major mechanism responsible for restenosis [6-9] and that lesion 
characteristics and regional flow dynamics are influencing this proliferative 
process [10]. Since improved operator experience and angioplasty techniques have 
not led to a reduction in restenosis rates, interventional cardiologists have 
designed new devices aimed at debulking instead of dilating the atherosclerotic 
plaque. Directional atherectomy is such a new technique with the potential 
advantage of creating smooth luminal surface. However early experience with 
atherectomy indicates that the restenosis rates are comparable to those following 
conventional balloon angioplasty although a randomized study has not been 
initiated [11-13]. Recently it has been demonstrated that the immediate results of 
atherectomy are superior to those achieved by balloon angioplasty [14]; whether 
this initial advantage can be maintained during follow-up and may ultimately 
result in a reduction of the restenosis rate remains to be assessed. Therefore, the 
present study was performed to determine whether this initial favorable result 
obtained with atherectomy affects the incidence of restenosis. 
METHODS 
Patient Xt'Oup: 
From September 1989 through January 1991, 66 patients underwent 74 
atherectomy procedures. For the purpose of this study, the initial 30 consecutive 
patients (23 men and 7 women) who underwent an angiographically sliccessful 
procedure (post-procedural diameter stenosis < 50%, with tissue retrieval) of a 
primary lesion in a native coronary artery were selected. The mean age (±SD) 
was 60.2 (± 10.1) years. At the time of atherectomy 16 patients were in New 
York Heart Association functional class IV, 7 in III and 7 in II. Coronary 
angiography showed single vessel disease in 25 patients, two-vessel disease in 4 
and three-vessel disease in I. The site of ob-struction was located in the left 
anterior descending coronary artery in 18 patients, in the right coronary artery in 
7 cases, and in the circumflex artery in 5 cases.. 
Alhcrcclo/lIY Procedure: 
After administration of local anaesthesia, a 1 I French sheath was inserted into the 
femoral artery. All patients received 250 mg acetylsalicylic acid and 10,000 U 
heparin intravenously. Intracoronary injection of isosorbide dinitrate was 
performed to optimally vasodilate the vessel. After initial angiograms in multiple 
views were made, a special I 1 French guiding catheter was placed into the ostium 
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of the coronary artery. Under fluoroscopy the guide-wire was advanced into the 
distal part of the artery. Then, the atherectomy device was directed over the 
guide-wire and positioned across the stenosis. The support balloon was then 
inflated up to 0.5 atm, the cutter was retracted and balloon inflation pressure was 
increased to 2 to 3 atm. The driving motor was activated and the rotating cutter 
was slowly advanced to cut and collect the protruding atherosclerotic lesion in the 
collecting chamber located at the tip of the catheter. After every pass the balloon 
was deflated and either removed or repositioned. On average 6.7 ± 2.9 passes 
in multiple directions were performed across a stenosis. Atherectomy was 
considered successful when the residual stenosis was less than 50% after tissue 
retrieval. Following atherectomy, the arterial and venous sheaths were lIsually left 
in place for 6 hours. Patients were monitored for 24 hours and electrocardiograms 
and cardiac enzyme levels were obtained twice a day. Nifedipine were given 
every 2 hours for 24 hours after the procedure and the patients were kept on 
aspirin medication for olle year. 
FollOW-liP emIU({liO/I: 
After a successful athercctomy or angioplasty procedure (i.e. <50% post-
procedural diameter stenosis on visual inspection), the patients were seen at the 
outpatient clinic. The follow-up coronary angiogram was performed within two 
weeks after an exercise test. Angiography was performed earlier if symptoms 
occurred within 6 months. 
Quml/;lative corolllllY ({11~io~mphy: 
Quantitative analysis of the coronary segments was performed with the computer 
based Coronary Angiography Analysis System (CAAS), previously described in 
detail [4,5,15,16]. In cssence, boundaries of a selected coronary artery segment 
are detected automatically from optically magnified and video digitized regions 
of interest (512 x 512 pixels) or a cine-frame. The absolute diameter of the 
stenosis in mill is determined using the guiding catheter as a scaling device. Each 
individual catheter is measured by a micrometer and used as a scaling device. 
Correction for pincllshion distortion was performed. The computer-estimation of 
the original dimension of the artery at the site of the obstruction to define the 
interpolated reference diameter. The percentage diameter and area stenosis as well 
as the cross sectional area (l1l1n2) are then calculated. The length of the lesion 
(mm) is determined from the diameter function on the basis of a curvature 
analysis (figure I). Symmetry is defined as the coefficient of the left hand distance 
between the reconstructed interpolated reference diameter and actual vessel 
contours and the right hand distance between reconstructed and actual contours 
at the site of the obstruction. The symmetry index ranges from 0 (totally eccentric 
stenosis) to I (symmetric). The degree of coronary bend is assessed by the 
curvature value at the obstruction site. This parameter is computed as the average 
value of all the individual curvature values along the centerline of the coronary 
segment, with the curvature defined as the first derivative of the tangent as it 
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moves along the centerline which for a circle is equal to the reciprocal of the 
radius. The area between the actual and reconstructed contours at the obstruction 
site is detined as the area plaque and is expressed in mm 2 . To standardize the 
method of analysis of the interventional and follow-up angiograms, the following 
measures were taken [16]. First, the x-ray system was exactly positioned as was 
noted at the time of the intervention. Second, for all study frames to be analyzed 
were selected at end diastole to minimize foreshortening. Third, the user 
determined beginning and endpoint of a segment of a major coronary artery were 
identified according to the definitions of the American Heart Association [17]. 
Finally, Polaroid photographs were taken of the video image with the detected 
contours superimposed to ensure that the analysis was done on the same coronary 
segments in the consecutive angiograms. The balloon angioplasty patients were 
enroled in ongoing restenosis trials and therefore according to the protocol 
systematically received intracoronary nitroglycerine prior to angioplasty, 
following angioplasty and at follolV-up catheterization whereas the atherectomy 
patients were less frequently given intra-coronary nitroglycerine at 
recatheterization. 
Resteno.\';s: 
Two different criteria were used to detine the restenosis rate. We have found a 
change in minimallul11en diameter of 0.72 111111. or more to be a reliable indicator 
of angiographic progression of vessel narrowing [4,15,16]. This value takes into 
account the limitations of coronary angiographic measurements and represents the 
long term variability for repeat measurements for a coronary stenosis using 
CAAS. The second criterion for restenosis chosen was an increase of the diameter 
stenosis from <50% after an intervention to ;,,50% at follow-up. The criterion 
was selected since clinical practice continues to assess lesion severity by 
percentage stenosis. 
Asse~'sl11el1f (?f initial Nain, restenos;,\' {Jnd wility ratio: 
To compare the relative efficacy of various interventional techniques, it is critical 
to relate the procedural outcome and changes during follow-up to the maximal 
achievable result. Therefore we propose the lise of the aforementioned ratios in 
the evaluation of intracoronary interventions. Briefly, quantitative angiographic 
changes following intra-coronary interventions may be divided in three stages as 
is summarized in figure n. The first or "operational stage", is characterized by 
the interaction of the operational device with the lesion. In becoming operational} 
the diameter of the device may expand (directional atherectomy, balloon, stent) 
or maintain its original dimensions (laser, transluminal extraction catheter, 
rotational ablation). During this stage, the maximal effect of the device is 
achieved and determines to which extent the minimal luminal diameter may be 
increased. The initial gain index represents the ratio between the achieved luminal 
improvement and the maximal achievable luminal improvement (reference 
diameter minus minimal lumen diameter (MLD) before intervention) and is 
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described by the following equation: 
Initial gain index: change MLD at intervention / reference diameter - MLD pre 
intervention. 
The initial gain index ranges from 0 (no effect) to I (no residual stenosis). 
The second stage or "restenosis slagel! starts during follow-up when biological 
processes determine the extent of intimal hyperplasia ultimately leading to a loss 
of luminal gain. 
The restenosis index represents the ratio of the loss of lumen diameter 
improvement 
during follow up and the achieved changes induced by the intra-coronary 
intervention and is described by the following equation: 
Restenosis index: MLD post intervention· MLD follow up / change in MLD at 
intervention. 
The restenosis index ranges from 0 (initial benefit intact) to 1 (initial benefit 
completely lost). 
The utility index represents the ratio of the net gain in lumen improvement at 
follow-up and the maximal achievable luminal improvement and is described by 
the following equation: 
Utility index: change in MLD at intervention - change in MLD at follow-up I 
reference diameter - MLD pre intervention. 
The utility index ranges from 0 (no utility) to I (perfect result). 
Matching process: 
The coronary artery tree was subdivided into 15 segments according to the 
American Heart Association guidelines [18] and the lesions were individually 
matched according to stenosis location and reference diameter. The principles of 
matching are threefold: the angiographic dimensions of matched lesions are 
assumed to be !1identical!1, the observed difference between the two "identical" 
lesions must be within the range of the CAAS analysis reproducibility of 0.1 mm 
(= I SD)[5] and tinally the reference diameter of the to be matched vessels are 
selected within a range of ± 0.3 mm (=3 SD; contidence limits 99%). To assess 
the immediate result of atherectomy and balloon angioplasty, 30 coronary artery 
lesions· were selected by an independent technician from a consecutive series of 
successfully dilated balloon angioplasty lesions while complying with the selection 
criteria of matching. At the time of selection, the investigators were unaware of 
the 6-Illonths angiographic outcome of these lesions and were thlls blinded. 
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Matching was considered adequate if the mean difference of the reference 
diameter between the groups were equal to zero with a SD < 0.3 mm [19]. 
Currently the Thoraxcenter angiographic database contains quantitatively assessed 
stenosis data for 2300 patients either treated by angioplasty (n ~ 1847), intra-
coronary stenting (n ~406), directional and rotational atherectomy (n ~ 120). 
Statistical analysis: 
All values are expressed as mean values ± I standard deviation. Comparisons of 
the severity of minimal luminal diameter, area plaque, diameter stenosis, 
curvature value symmetry index and length between the groups were performed 
using analysis of variance and the unpaired Student's T-tes!. Differences were 
considered statistically significant at p<O.05. 
RESULTS 
The pre-procedural stC'lIosi.\' charactl'l'istics of the matched patients are 
summarized in table 1, Matching for stenosis location and reference diameter 
resulted in comparable patient groups as far as severity of their lesions is 
concerned. Matching was considered adequate since the reference diameter was 
equal in both groups (3.03 ± 0.57 nlln vs. 3.07 ± 0.55 mm; p~NS) while the 
mean difference for this parameter between the groups was 0.0 mill (sd 0.2 111111.). 
Tahle 1. Matched pre-procedural .-;kno.-;i.-; characteri~tics of 30 patients with successful coronary 
·t!heredomy cOll1pueo tn successful hatloon angiopi'tsty .. 
Pre-atheredomy Post-atheree!oIl1Y 
Reference diameter (mill) 3.03 ± 0.57 3.07 ± 0.55 
Minimal luminal diamekr (mm) to.9 + 0.37 1.15 ± 0.36 
Diameter stenosis ($f.) 64 ± to 63 ± 8 
Area plaque (mml) 9.5 ± 6.4 8.4 ± 3.6 
Curvature vulue t5.9 ± 7.0 22.2 ± 13.t* 
Symmetry value 0,6 ± 0,2 0,5 ± 0.3 
Length (Illm) 6.8 ± 2.7 6,5 ± 2,6 
* .  p<O,02 
Pre-procedural minimallulllen diameter in the atherectomy and angioplasty group 
were 1.09 ± 0.37 mm. and 1.15 ± 0.36 mill respectively. The other stenosis 
parameters (diameter stenosis, area plaque,symmetry index and length) did not 
differ signiticantly with the sole exception of the qlrvature value which was lower 
65 
CUMULATIVE FREQUENCY IN MLD 
100;%~ __________ ~~ __ ~,,~,~(~N'~370~L~E~S~IO~N~S) 
90 ~~.! 
,-
80 Pre ", .' :~ / Post 
:: / 
20 ./ 
; 
10 ,/ 
I DCA I 
,-, PTCA 
oL-~L---~~~~--~--~--~--~ 
o 0,5 1.5 2 2,5 3 3,5 4 
MLD (mm) 
FIgur(' Ill. ClIlIIlIlarh'e in'quC'm)' of fIll' illlllledialc' r(',w/J.., of dine/iOlW! all/at'crt/III), alld balloon 
al/giop/ast)' ill 30 matched !e.\'jo/ls, Din'{'{iO/l/Illllhl'rt'c{(lJII), ri'.mlll'li ill all iIlCrl'a.H' ill lIIil/ill/lll 
lumillal diameter (MLD)frolll 1,08111111/0 2,6/ /1/11/ while lIl/giop/ust)' il/(/uCl'd /11/ illcreasejrolll 
I, /5 to 1.9211/111. DCA = a/haec/oJ/l}'. PTCA = IIl/giol'll/stY,I"'l' = /IlfOrt' illk/Ti'l/lion, 1'0.\'/ = 
lifter illfl'rW'lIIioll. 
CUMULATIVE FREQUENCY IN MLD 
% (N'30 LESIONS) 
100 
90 . 
" 
,,-
; 
" 80 F-up 
70 
60 
50 
40 
30 
20 ~ 10 ,-, PTCA 
0 
0 0,5 1.5 2 2,5 3 3,5 4 
MLD (mm) 
Figure IV. 'flu' C/I/llu/(/fil'{' jn'(jul'II(}' of the' IOllg-term 1'('.1"11/(,\' of din'cliO/wl lIf}/ln'ClOJIIY lIlId 
ullgioplasfy ill tllis III(/fchct! pOPUlllfiol/, At 6 IIwllfh /0/1011'-111' fhe' illilial fin'orable rt'sull of 
atherectomy is /em Wl/l'lI compared to ballooll lIlI1;iopla;<;ty. MLD = millimallllll/illal diameter, 
DCA = lItlU'rl'CIOIllY, PTCA = 1Il1NhlpfllSty, pre = befort' illll'I'I'l'lIlioll, F-u!' = at /<,lIoll'-u!'. 
66 
in the atherectomy group when compared with the angioplasty group (15.9 ± 7.0 
vs 22.2 ± 13.1; p < 0.02). 
171C immetiimf (~fficacy (~f arhen'c/oI1lY and (J11~ioplasry as assessed by quantitative 
angiography arc detailed in table 2 and tigure Ill. As expected, both atherectomy 
and balloon angioplasty significantly improved the minimal lumen diameter (LOS 
± 0.37 mm to 2.61 ± 0.33 mm;p<O.OOOI vs LIS ± 0.36 mm to 1.92 ± 0.31 
mm;p<O.OOI), but the increase in minimal lumen diameter was superior in the 
atherectomy group compared with the angioplasty group (1.53 vs 0.77 
mm;p <0.0001). Accordingly, the initial gain ratio of atherectomy is also superior 
when compared with angioplasty (0.S4 ± 0.36 vs. 0.41 ± O.IS;p <0.00001). The 
percentage diameter stenosis is thus reduced from 64 ± 10% to 19 ± 9% 
(p<O.OOOI) in the atherectomy group and from 63 ± 8% to 37 ± 10% 
(p<O.OOI) in the angioplasty group. 
Tahle 2. Quantitative comparison of the immediate and long-term results of alhercctomy with 
balloon 3ngioplasty (0=30) 
Alhere-ctomy Angioplasly I-test 
Reference diameter pre (mill) 3.03 ± 0.57 3.07 ± 0.55 NS 
Referl.'!nce diameter post (mm) 3.24 ± 0.32 3.09 ± 0.56 NS 
Referenctl diumder fup (null) 2.81 + 0.57 3.04 + 0.65 NS 
Minimal luminal diameter pre (mm) 1.08 ± 0.37 1.15 ± 0.36 NS 
Minimal luminal diameter post (nun) 2.61 ± 0,33 1.92 ± 0.31 0.0000 
Minimal huninal diameter fup (mm) 1.69 ± 0.58 1.57 ± 0.58 NS 
Diameter stenosis pre (%) 64 + 10 63 + 8 NS 
Diameter stenosis post (%) 19 ± 9 37 ± 10 0.0000 
Diameter stenosis fup (%) 37 ± 18 47 ± 18 0.04 
Difference in diameter stenosis (%) 
pre - post 45 ± t2 26 ± 12 0.0000 
post - fup 18 ± t7 10 ± 17 NS 
'J~: non SI 'niIH:ant g 
AI,fi>/IOlV-IIP, all atherectomy and angioplasty patients included in this study 
underwent a 6-month control catheterization. Angiographic follow-up in the entire 
atherectomy and angioplasty populations were 95% and 92% respectively. 
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Angiographic analysis at follow-up (table 2 and figure IV) showed a decrease in 
minimal lumen diameter in both groups: frol11 2.61 ± 0.33 111m to 1.69 ± 0.58 
mm in the atherectomy group and frol11 1.92 ± 0.31 111m to 1.57111111 ± 0.58 
mm in the angioplasty group. Thus, the loss in minimal lumen diameter was morc 
pronounced in the atherectomy group when compared with the angioplasly group 
(0.92 ± 0.69 mill vs 0.35 ± 0.51 111m; p<0.0005) 
Accordingly, the percentage diameter stenosis increased frolll 19 ± 9% to 37 ± 
18% in the atherectol11Y group and from 37 ± 10% to 47 ± 18% in the 
angioplasty group. The concomitant restenosis and utility ratios are tabulated in 
table Ill. 
Tahle 3, Quantitative assessment ()f initial gain ratio, reslcnosis ratio and utility mlio after 
atheredomy and halloon angioplasty (n=30) 
Athere;;{omy Angioplasly Hest 
Initial gHin mlio 0.84 + 0.36 0041 ± 0.18 0.0000 
Restcnosis ratio 0.56 + 0.55 0.62 ± 1.10 NS 
Utility ratio 0.29 ± 0.33 0.23 ± 0.28 NS 
s: not 51 'mhcant, I-test: un HIred I-test g p 
The percentage restenosis (detectable hyperplasia by quantitative coronary 
analysis) according to the 0.72 mill loss in minimal lumen diameter (which is 
twice the standard deviation of the long term variability of the minimal luminal 
diameter measurements using the coronary angiography analysis system (CAAS) 
criterion is 60% in the atherectomy group versus 36% in the angioplasty group. 
When restenosis is defined by an increase of diameter stenosis ~ 50% at follow-
up, the restenosis percentages are 20% and 16% (atherectomy versus angioplasty). 
DISCUSSION 
Coronary angioplasty is now an accepted form of treatment for patients with 
coronary artery disease. In the past years exponential growth in angioplasty has 
been partly the result of an increase of patients returning with restenosis. Despite 
extensive efforts in improving catheter equipment we are still unable to effectively 
reduce the rate of restenosis. Since ilO fundamental design-changes in balloon or 
balloon-derived catheter techniques arc emerging, debulking techniques like 
directional athercctomy have been introduced in order to improve the angioplastic 
process and to presllmably reduce the restenosis rate. The potential advantages of 
debulking atheromatolls tissue over remodelling the plaque by balloon angioplasty 
include: minimize smooth muscle cell injury by wall stress, eliminate smooth 
muscle cells thereby reducing their proliferative potential, improve regional blood 
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flow and rheology by inducing less fissures or dissections, reduce radial stretch 
forces as applied with a (lilating balloon and create larger gain in minimal luminal 
diameter. Indeed, recent studies have reported a larger increment in luminal 
improvement following atherectomy when compared with conventional balloon 
angioplasty [14] while other investigators observed a low incidence of post-
procedural dissections [11,12,14]. 
Study desi;::,n: 
Whether atherectomy is superior to balloon angioplasty can only be assessed by 
a randomized study. This type of study would take several years during which 
continuing refinements and improvements of catheter systems would take place, 
rendering the comparison unreliable and open to criticism. Therefore, we 
proposed a matching technique based on stenosis location and reference diameter 
to compare the results of variolls intra-coronary interventional techniques. At 
present, this technique might be the best surrogate for a randomized trial when 
one tries to compare the short and long-term results of atherectomy with 
conventional angioplasty. Using our matching program we selected comparable 
stenotic lesions with respect to base-line characteristics (minimal luminal 
diameter, diameter stenosis,iength, area plaque and symmetry index) as assessed 
by quantitative angiography. This study population renects the base-line stenosis 
characteristics in patients treated by atherectomy [20] or balloon angioplasty 
[4,21]. 
Immedia/e l'e.\'fIlls: 
This study confirms the previous reports on improved luminal gain after 
atherectomy when compared with conventional angioplasty [14]. Atherectomy 
resulted in a two-fold increase in minimallulllen diameter from 1.09 ± 0.37 mill. 
to 2.61 ± 0.33 mm., compared with angioplasty (from 1.15 ± 0.36 nlln to 1.92 
± 0.31 mill.). Accordingly, the percentage diameter stenosis decreased more 
dramatically after atherectomy than after angioplasty. This improvement in lumen 
gain by atherectomy may be due to three mechanisms: first, the introduction of 
the bulky device and subsequent inflation of the support balloon may result in a 
HDoHer effect", second its debulking action results in plaque removal rather than 
remodelling which finally reduces the extent of the elastic recoil phenomenon. 
Res/C'nos;s: 
Recurrence of a stenosis after an intra-coronary intervention may be assessed by 
clinical symptoms, stress testing or coronary angiography. Since symptoms and 
functional achievement at exercise testing have low predictive values in predicting 
restenosis, the diagnosis of restenosis should be based on reproducible quantitative 
angiographic measurements lIsing a computer-assisted technique with either 
automated edge detection or videodensitometry. Furthermore, the definition of 
restenosis is a matter of ongoing debate. It has been shown by our group [4,22] 
as well as by others [3] that the determination of stenosis severity lIsing 
percentage diameter stenosis does not reflect the changes following angiopiasty 
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since the adjacent part of the dilated vessel may also be involved in the restenosis 
process or the reference diameter may he simultaneously reduced. Therefore, we 
selected minimalltllllen diameter as a parameter for the morphologic changes after 
atherectomy or angioplasty. 
The follow-up minimal luminal diameter for the atherectomy group is 1.69 111111 
cOl11pared with 1.57 111111 for the balloon angioplasty group (p=NS). These 
findings are similar to previollsly documented late follow-up studies of coronary 
balloon angioplasty (1.69-1.82 111m) [4] and stenting (1.68 mill) [23]. Using the 
~50% diameter stenosis criterion, the restenosis rates after atherectomy and 
angioplasty are 20% and 16% respectively. Previous reports on restenosis after 
primary coronary atherectomy reported a'restenosis incidence of 20% [11,12] 
using the ~50% criterion. 
Thus during follow-up, the initial greater gain in luminal diameter after 
atherectol11Y when compared with balloon angioplasty is totally lost. At follow-up 
the loss in minimal luminal diameter after atherectomy was 0.92 mill compared 
with 0.35 111111 in the angioplasty group (p=O.OOO.)). Although the l11inimal 
luminal diameter changes morc dramatically in the atherectomy group when 
compared with the angioplasty group, both groups have an equal restenosis (0.56 
versus 0.62;p=NS) and utility ratio (0.29 versus 0.23;p=NS) indicating that the 
relative changes are equal for both interventional techniques. 
Animal and atherectomy studies [11-13,20] have demonstrated that tibrointimal 
hyperplasia lllay develop in coronary arteries previously treated by balloon 
angioplasty or athercctomy. Pathologic findings have raised a theory that deeper 
vascular injury is associated with a greater intimal proliferation. Injury beyond the 
subintimal level has been shown to be associated with more extensive intimal 
proliferation [24]. These data are supported by Webster [25] who found a greater 
smooth muscle proliferation after high inflation pressurc with the same balloon 
size when compared to low pressures. Furthermore, an initial follow-up study 
after atherectomy indicates that this process may be accelerated when deep vessel 
wall components like media and adventitia are removed [13]. Additionally, 
atherectomy may lead to profound disrupture of the vessel wall architecture [26]. 
Finally, the introduction of the bulkier atherectomy device itself l11ay potentially 
lead to a greater amount of vessel wall stretching when compared to the smaller 
balloon catheter system. All these influences may account for the greater cellular 
proliferation of the lesion treated by atherectomy. 
Oll/i/a/ions: 
There are several limitations of this study. First, it is an uncontrolled, 
observational study limited to a subset of patients with a successful coronary 
atherectomy or balloon angiop/asty. This consecutive series of patients were 
studied by Ilblind tl investigators unaware of the late angiographic results. 
Although matching for angiographic variables is a promising technique to assess 
the efficacy of intracoronary interventions, patient and procedure related variables 
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are not included in the analysis. Second, lesion complexity was not incorporated 
in the analysis. This is usually defined qualitatively [27] however, recently an 
objective and quantitative description of stenosis morphology has been introduced 
[28]. Further improvement in quantitative analysis may assess lesion morphology 
in a continuolls scale fashion rather than assigning lesions to discrete categories. 
This type of analysis should be incorporated in future trials studying the efficacy 
of variolls interventional techniques. Third, this study is based on the early 
experience with atherectomy. Careful patient selection, future design changes and 
improved operator experience may further improve the immediate and long-term 
results. Thus controlled clinical trials are imperative in the future to determine the 
immediate angiographic result, the long-term efficacy of these interventions as 
well as the benefit, if any, in particular patient subgroups. These studies should 
also address the presumed time frame for restenosis after any particular 
intervention. 
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ABSTRACT 
Bac:kgrOlllld. Directional coronary atherectomy has been introduced as an 
alternative technique for balloon angioplasty which Illay reduce the incidence of 
reslenosis. 
Objectives, Late luminal narrowing following directional atherectomy as assessed 
by quantitative coronary angiography and compared with balloon angioplasty. 
Melhods. A prospectively collected consecutive series of 87 successfully 
atherectomized native coronary artery lesions were matched with 87 coronary 
artery lesions selected from a consecutive series of lesions which had been 
successfully dilated by balloon angioplasty. Late angiographic analysis was 
performed in 158 lesions. The lief gain index, represents the ultimate gain in 
minimallul1linal diameter at follow-up, normalized for the vessel size. This index 
is the resultant of the re/(I/ive gaill attained during the procedure (the ratio of the 
change in minimal luminal diameter and reference diameter) and the relative loss 
observed during follow-up (the ratio of the change in minimal luminal diameter 
during follow-up and the reference diameter). 
Results. Matching for clinical and angiographic variables resulted in two 
comparable groups with quite similar baseline stenosis characteristics. 
Atherectomy resulted in a more pronounced increase in minimal luminal diameter 
than balloon angioplasty (mean ± SD: 1.17 ± 0.29 mm to 2.44 ± 0.42 mm 
versus 1.21 ± 0.38 nll11 to 2.00 ± 0.36 mm;p<O.OOI), this favorable immediate 
result was subsequently lost during late angiographic follow-up so that the 
minimal luminal diameter at follow-up and the net gain index did not differ 
signiticantly between the two groups (1.76 ± 0.62 mm versus 1.77 ± 0.59 mm; 
p=0.93 and 0.18 ± 0.19 versus 0.17 ± 0.17;p=0.70). Consequently, the 
relative gain and relative loss were higher in the atherectomy group. For both 
techniques, the relative gain is linearly related to the relative loss but, the slope 
of the regression line is steeper for atherectomy suggesting that the relative loss 
is proportionally even larger for a given relative gain when compared to the 
balloon angioplasty group. 
Conclusion. In matched populations, atherectomy induces a greater initial gain in 
minimal luminal diameter than balloon angioplasty however, the vascular wall 
injury induced by the device is of another nature (debulking versus dilating) which 
led to more relative loss over the follow-up period in the atherectomy group. 
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INTRODUCTION 
Restenosis following intra-coronary interventions remains the most vexing 
limitation of these techniques [1-4], In the past 5 years atherectomy, stenting and 
laser techniques have been introduced as an alternative Of adjunct to balloon 
dilatation and as potentially safer techniques with better immediate and latc 
results. Considerable difficulty exists in making valid comparisons between the 
different modalities with regard to outcome. We have previously shown that 
directional coronary atherectomy yields a superior immediate improvement in 
coronary luminal diameter than balloon angioplasty as judged by quantitative 
coronary angiography [4]. Because of the differing methods of action this 
discrepancy is not unexpected. Whether directional alherectomy indeed has a more 
favorable longtenn result has not been proven. Therefore, we studied the 
longterm results following directional at he recto my and compared them with those 
of balloon angioplasty, as assessed by quantitative angiography. Since the 
restenosis phenomenon seems to be a systematic process affecting virtually every 
dilated stenotic lesion [2,3] it should therefore be assessed by a continuous 
analytical approach rather than applying categorical definitions of restenosis when 
the longterm results of two different types of interventions -such as directional 
coronary atherectomy and balloon angioplasty - need to be compared. For the 
purpose of this quantitative angiographic study, the initial consecutive 87 
successfully treated de novo atherectomy lesions [83 patients) were matched (for 
clinical and quantitative angiographic variables) with 87 coronary artery lesions 
which were selected from a consecutive series of sLiccessfully dilated primary 
angioplasty lesions. Three recently conceived angiographic endpoints (minimal 
luminal diameter, relative gain versus relative Joss and net gain index) at follow-
up were assessed to compare the long-term results of directional coronary 
atherectomy and balloon angioplasty. 
METHODS 
Patient ~rollp: 
From September 1989 through January 1992, III patients completed a six month 
follow-up period following 117 atherectomy procedures for coronary artery 
disease. Of these, 4 patients (4 lesions) had an atherectomy for bypass graft 
stenosis and 18 (19 lesions) underwent atherectomy for restenosis following a 
previous percutaneous intervention. For the purpose of this study, therefore, 89 
patients (94 lesions) underwent an atherectomy procedure for native de 110VO 
coronary artery disease. However, during hospitalization one patient died as a 
result of tamponade [5], four patients (5 lesions) underwent emergency surgery 
following an unsllccessful procedure and one patient (one lesion) had surgery 
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because of presumed pericardial tamponade. 
Ultimately, 83 patients with 87 de I/O\'(} coronary artery lesions who underwent 
sliccessful alhercctomy were eligible for 6 month follow-up and were individually 
matched with patients undergoing successful balloon angioplasty. Late 
angiographic follow-up, and the tinal late comparative analysis, was obtained in 
75 patients (90%) or 79 of 87 lesions (angiographic follow-up rate 91 %) in each 
group. The mean age (±SD) of the 83 patients was 58 (± 10) years. The site of 
obstruction (n =87) was located in the left anterior descending coronary artery in 
56 cases, in the right coronary artery in 18 cases, and in the circumtlex artery in 
13 cases. Clinical and angiographic details of the matched groups are described 
in table I. 
Tahle I Patient and lesion demographics of the IlI<ltcheti groups 
Atherect(HllY Angioplasly I-test 
Lesion (no) 87 87 
Age (yr) 58 ± to 57 ± 8 
% mlile 82 82 
Vessd treated (%) 
LAD 65 65 
RCA 19 19 
LCX 16 16 
Unslahle angina (%) 43 43 
Diaheles (%) 3 3 
Hypercholt'~~lcrolcmia (%) 4 4 
Lesion length (mm) 6.4 ± 2.5 6.5 ± 2.4 NS 
Area plaque (111m2) 9.3 + 6.8 9.2 ± 4.2 NS 
Rd~renl'e diameter (mill) 3.22 ± 0.60 3.18 ± 0.56 NS 
Minil11l1l luminal diamelcr (nun) I. 16 ± 0.38 l. 19 ± 0.28 NS 
Diameter stenosis (%) 64 ± 12 62 ± 8 NS 
Reference ,lrea (nun1) 8.72 + 4.03 8.18 ± 2.75 NS 
Area stenosis (%) 85 + 10 86 ± 10 NS 
Cross-sediOlHlI area (mml) 1.27 ± 0.94 I. II ± 0.80 NS 
A,herec/(Jluy PrtJCl'ilure: 
The procedure was performed as described before [4], the alherectomy device was 
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directed over the guide-wire and positioned across the stenosis. The support 
balloon was then innaled lip 10 7.5 psi, Ihe clitter was retracled and balloon 
inflation pressure was increased from 7.5 to 45 psi. The driving motor was 
activated and Ihe rolaling cutter was slowly advanced 10 cui and collect the 
protruding alherosclerotic lesion in Ihe collecting chamber localed at the tip of the 
calheler. After every pass the balloon was denated and either removed or 
repositioned. On average 5.6 ± 2.2 passes in multiple directions were performed 
across a stenosis, resulting in tissue retrieval in all cases. Atherectomy was 
considered successful when the residual stenosis was less than 50% after tissue 
retrieval. Before and after the procedure, intracoronary nitroglycerine was 
administered to prevent coronary spasms. Pre-dilatation with a conventional 
balloon was performed in 2 patients and in 4 cases balloon angioplasty was 
performed following atherectomy for cosmetic reasons where there was persistent 
haziness after a successful atherectomy procedure. Following atherectomy, the 
arterial and venous sheaths were usually left in place for 6 hours. Patients were 
monitored for 24 hours and electrocardiograms and cardiac enzyme levels were 
oblained twice a day. Nifedipine was given every 2 hours for 24 hours after Ihe 
procedure and the patients were maintained on aspirin medication for one year. 
Follow-up ewl/uolioll : 
After a successful atherectomy or angioplasty procedure (i.e. <50% post-
procedural diameter stenosis on visual inspection), the patients were seen at one 
month for clinical evaluation at the outpatient clinic. An exercise test was 
performed within two weeks prior to the 6 month follow-up coronary angiogram. 
Angiography was performed earlier for symptomatic recurrence within 6 months. 
Quantitalive COI'O"OfY all){iography : 
Quantitative analysis of the coronary segments was performed with the computer 
based Coronary Angiography Analysis Syslem (CAAS), previously described in 
detail [1,4,6,7,8], In essence, boundaries of a selected coronary artery segment 
are detected automatically from optically magnified and video digitized regions 
of inlerest (512 x 512 pixels) of a cine-frame. The absolule diameler of the 
stenosis in 111111 is determined Llsing the guiding catheter as a scaling device. Each 
individual catheter is measured by a micrometer and lIsed as a scaling device. 
Correction for pinclIshion distortion was performed, The computer-estimation of 
the original dimension of the artery at the site of the obstruction to define the 
interpolated reference diameter. The percentage diameter and area stenosis as well 
as the cross sectional area (n1l112) are then calculated. The length of the lesion 
(mm) is determined from the diameter function on the basis of a curvature 
analysis. Symmelry is den ned as the coefticienl of Ihe left hand dislance belween 
the reconstructed interpolated reference diameter and actual vessel contours and 
the right hand distance hetween reconstructed and actual contours at the site of the 
obstruction. The symmetry index ranges from 0 (totally eccentric stenosis) to 1 
(sYlllmetric). The area between the actual and reconstructed contours at the 
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obstruction site is defined as the area plaque and is expressed in ITIm 2 , To 
standardize the method of analysis of the interventional and follow-up angiograms, 
the following measures were taken [8], First, the x-ray system was exactly 
positioned as was noted at the time of the intervention. Second, for all study 
frames to be analyzed were selected at end diastole to minimize foreshortening, 
Third, the user determined beginning and endpoint of a segment of a major 
coronary artery were identified according to the definitions of the American Heart 
Association. Finally, Polaroid photographs were taken of the video image with the 
detected contours superimposed to ensure that the same coronary segments were 
analyzed in the consecutive angiograms. At follow-up catheterization, the 
administration of intracoronary nitrates was recommended prior to angiography. 
Categorical approach: 
Two different criteria were used to define restenosis. We have found a change in 
minimal lumen diameter of 0.72 mill. or more to be a reliable indicator of 
angiographic progression of vessel narrowing [1,4,6-8]. This value takes into 
account the limitations of coronary angiographic measurements and represents the 
long term variability for repeat measurements fOf a coronary stenosis using 
CAAS. The second criterion for restenosis chosen was an increase of the diameter 
stenosis from < 50% after an intervention to ~ 50% at follow-up since in clinical 
practice lesion severity is still assessed using percentage stenosis. 
COlI/illllOUS {Jpprt}{J('h: 
Three criteria were defined to assess the long-term efficacy of directional 
coronary atherectomy and balloon angioplasty using a continuous approach. We 
[2,9,10] and others [II] have found that the minimal luminal diameter at follow-
up is associated with the onset of exercise induced thallium perfusion defects and 
symptoms. The second criterion relates - the gain achieved during an intervention 
and the observed loss during follow-up - to the vessel size, allowing a comparison 
between vessels of different sizes [9,12]. The relative gain is defined as the 
change in minimal luminal diameter (MLD) normalized for vessel size. The 
relative loss is defined as the change in minimal luminal diameter (MLD) during 
follow-up (fup) normalized for hy vessel size. 
Relative gain: MLD post - MLD pre / vessel size 
Relative loss: MLD post - MLD fup / vessel size 
The third criterion relates the final outcome of a procedure to the reference 
diameter. The net gain index represents the net gain in lumen improvement at 
follow-up normalized for vessel size and is described by the following equation: 
Net gain iudex: MLD fup - MLD pre I vessel size. (::::: I'elative gain-relative 
loss) 
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Matchinl{ proc('ss: 
The coronary artery tree was subdivided into 15 segments according to the 
American Heart Association guidelines and the lesions were individually matched 
according to stenosis location, reference diameter, minimal luminal diameter as 
well as the clinical parameters gender, anginal status, diabetes and 
hypercholesterolemia. Unstable angina was defined as chest pain at rest while 
hospitalized and treated with intravenous nitroglycerin and/or heparin. 
Hypercholesterolemia was defined as elevated levels of serum cholesterol > 6.5 
mmolll requiring treatment with lipid lowering drugs [13). The principles of 
matching by quantitative angiography are threefold: (I) the angiographic 
dimensions of matched lesions are assumed to be flidentical", (II) the observed 
difference between Ihe two "identical" lesions must be within Ihe range of the 
CAAS analysis reproducibility of 0.1 mm (= I SD) and (Ill) the reference 
diameter of the lesions to be matched are selected within a range of ± 0.3 mm 
(=3 SD; conlidence limils 99%) [4,14,15]. 
To compare the result of at he recto my and balloon angiopiasty, 87 coronary artery 
lesions from a consecutive series of 2500 successfully dilated balloon angiopiasty 
lesions (residual stenosis < 50% on visual inspection) were selected by an 
independent analyst according to the above mentioned selection criteria of 
matching. These lesions were matched with the prospectively collected 
consecutive series of 87 successfully atherectomized native coronary artery 
lesions. Late comparative analysis between athercctomy and angioplasty was 
performed in 79 lesions since in the atherectomy group 8 lesions were lost to late 
angiographic follow-up. Consequently, Ihe 8 twin malched angioplasty lesions 
were also not eligible for comparative follow-up analysis. At the time of selection, 
the analyst was unaware of the 6-l11onths angiographic outcome of these lesions 
and was thus blinded. The Thoraxcenter angiographic database has now 
accumulated quantitative angiographic data on 2500 lesions treated by angioplasty, 
535 lesion Ireated by in Ira-coronary stenting, 153 lesions trealed by directional or 
rotational atherectomy and 73 lesions treated by laser angioplasty. Because neither 
angiographic, nor clinical benefit of the tested compounds could be demonstrated 
in the previous PTCA restenosis trials [8,10] the placebo and active treatment 
groups could be pooled for the presenl sludy. 
Statistical analysis: 
The unit of analysis reported here is the stenotic lesion, not the patient. All values 
are expressed as mean values ± I standard deviation. Comparisons of the severity 
of minimal luminal diameter, area plaque, diameter stenosis, symmetry index and 
length between the two groups were performed using analysis of variance and the 
paired student's t-test. Levene's test for variance was used to examine the equality 
of group variability and if significant difference was found, the Welch and Brown-
Forsythe tests for equality of means were applied. The Bonferroni correction was 
applied for multiple comparisons. Linear regression analysis by groups was 
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performed (BMDP statistical package, program 1 R) as a formal test for 
comparison of correlations and slopes. Differences were considered statistically 
signiticant where the p-value was less than 0.05. 
RESULTS 
Malchinx: 
Baseline clinical and quantitative angiographic parameters of the matched 
population are listed in Table l. No differences in gender, anginal status and 
stenosis location were observed. Minimal luminal diameter and reference diameter 
measurements were not significantly different in both groups; 1.16 ± 0.38 mill 
and 3.22 ± 0.60 mm for the atherectomy group and 1.19 ± 0.28 mm and 3.18 
± 0.56 mm for the angioplasty group (p=NS). The use of this matching 
technique resulted in the selection of patients treated by two different 
inlervenlionai techniques with similar clinical and preprocedural stenosis 
parameters (table I). Figure I shows an example of two matched lesions which 
were treated by atherectolllY or angioplasty. 
Tuhll;l 2, Quanlil<ltivc comparison of Ihl;l immediHtl;l Hlld long-krill n',snlts of alhere,clomy wilh 
h'llloon 'mgiophsly in 79 stenoses .. 
AlheredolnY Angi()plasty Hcst 
Rl;llerence diamekr prl;l (mill) 3.26 ± 0.62 3.23 ± 0.60 0.71 
Relerl;lllcl;l dimndl;lr post (mm) 3.29 ± 0.41 3.23 ± 0.58 0.45 
Relerence diamder fup (mill) 3.02 ± 0.55 3.21 ± 0.63 0.05 
Minimal luminal diamekr pre (mill) 1.17 + 0.29 1.21 + 0,38 0.67 
Minimal luminal diamekr post (mill) 2.44 ± 0.42 2.00 ± 0.36 <0.001 
Minimal luminal diamckr fUJl (mm) 1.76 ± 0.62 I. 77 ± 0.59 0.93 
Diumdcr stl;lnosis pre (%) 64 + 12 62 + 9 0.28 
Diamdl;lr stl;lnosis post ($'o) 25 ± II 37 ± to <0.001 
Diameter stenosis flip (%) 41 ± 17 45 ± 15 0.09 
Relative gain O.4t + 0.20 0,25 ± 0.12 <O.OOt 
Relalive loss 0.23 + 0.24 0.08 + 0.16 <0.001 
Nd gain indl;lx U.18±0.19 0.17±O.17 0.70 
83 
FiXII1'l'I. A H'pn',I"/'lItativc' ('.((IlIIp/l' 0/11/1 IIl1xioXrtlm o/nlllfdll'd h',I'hJl/.I' ill/h,' riXIi/ cO/'oJ/m)' ar/l'I)' 
hejiwC' IIlhl'fl'ctoIllY (AJ or ballooll ltIIX;0l'llI.I'ty (BJ and (if/l'ralhC'rt'('lolII), (C) or hallooll all!:ioplast)' 
(DJ. Ed!:l' (,OJI/Ollr 11/1(/ dC'lIsitOlIll'lri(' (//1II/),si,l' o/Ihe ,I'e\'('rily (ifllll' obSlrllclioll IIrt' ,l'IIperimjlo,I'(Y/. 
111e !:nll'h,\' sholl' IlIc' dill!:lIo,I,ti(' dilllll('/c'rjllllc,tioll (flPI'I'1' (,fln'c,) alld dellsilomefrie area /lIl1ctioll 
(lolI'er ('IIn'c,), LOlVCf I'cnimllim' is liIe millilllllilulllil/al diallleler (1.171/1/11 ill A (llId B), Ollt.\'ide 
vcl'licallilll',I' 011 Ihc' gl'(//)/i allfllhc' tll'O Iille,l' WI Iii,' III1XioXl'fllII are /(,,1';011 hOlll/darics. 17ll'lIIeall 
Hfl'n'lIce' dillllll'la 111('(/.\'111'('(/ illfhe or/hogollal projection\" is 3.55 11//11 (AJ (/lId 3.56111/11 (il). 7l1erc 
was a larger gaill ill millilllallulllillal ditll1/{'Ic'1' (if/C'/' dirC'uilllllll 1I1IwrC'('(o/llY (C) tlum jil/lowill!: 
hallool/ (ll/gioplll,I"y (0). 
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ImlJlediate I'('sufls: 
The reference diameter did not change significantly following either atherectomy 
or balloon angioplasty (3.26 ± 0.62 mm to 3.29 ± 0.41 nllll in the atherectomy 
group versus 3.23 ± 0.60 mm to 3.23 ± 0.58 mm in the angioplasty group). 
Atherectomy resulted in a greater increase in minimal luminal diameter than 
balloon angioplasty with consequently greater "initial gain" (1.27 ± 0.48 mm 
versus 0.79 ± 0.34 mm;p < 0.001) and post-procedural minimal luminal diameter 
(2.44 ± 0.42 mm versus 2.00 ± 0.36 mm;p<O.OOI) and concomitantly lower 
percent diameter stenosis (25 ± II % versus 37 ± 10%;p<0.001). The relative 
gain following atherectomy was, accordingly, significantly greater than following 
balloon angioplasty (0.41 ± 0.20 versus 0.25 ± 0.12;p<0.001). 
Tahle 3. Relative gain relative loss Hml net gain per reference diameter group 
Atllln~tlllny f,lrHUp (n=79) 
Rdic!rcnctl # Ahsolute Relative Absolute loss Relative loss Net gain RR 
diameter gllin (mill) g1lin (llllll) (%) 
< 2.5 8 1.68 ± 0.45 0.79 ± 0.16 1,40 ± 0,49 0.68 ± 0.27 0.11 ± 0.28 50 
2.5 - 3.0 t6 1.28 + 0.54 0.46 + 0.20 0.67 + 0.49 0.24 + 0.18 0.22 + 0.2t 25 
3.0 - 3.5 27 l.15 ± 0.49 0.36 ± 0.t5 0.51 ± 0.52 O.16±0.t6 0.20 ± 0.16 22 
3.5 - 4.0 19 1.25 ± 0.38 0.34 ± 0.11 0,48 ± 0.55 0.13 ± 0.15 0.21 ± 0.18 26 
> 4.0 9 1.26 ± 0.56 0.29 ± 0.14 0.99 ± 0.80 0.23 ± 0.19 0.06 ± 0.14 44 
al10va 0.1171 0.0000 0.000) 0.0000 0.t951 
Angiuphl'\ty j.!;I'OUp (n=79) 
Relert'nce # Ahsolute Relative Ahsolute loss Relative loss Net gain RR 
diameter gain (mm) gain (mm) (%) 
< 2.5 10 0.59 ± 0,48 0.27 ± 0.21 0.24 ± 0.22 0.16 ± 0.19 0.11 ± D. JO 10 
2.5 - 3.0 17 0.78 ± 0.24 0.27 ± 0.09 0.27 ± 0.38 0.09 ± 0.13 O.IS±O.tS 18 
3.0 - 3.5 27 0.88 ± 0.34 0.27 ± 0.10 0.42 ± 0.56 O.13±0.I7 0.14±0.16 37 
3.5 - 4.0 18 0.84 ± o.:n 0.23 ± 0.09 0.14 ± 0.64 0.04 ± 0.17 0.19±0.17 39 
> 4.0 7 0.66 ± 0.40 0.16±O.IO -0.34 ± 0.37 -0.08 ± 0.09 0.23 ± 0.15 0 
anova 0.1(,76 0.1272 0.0045 0.0194 0.7401 
<K rt:\~knosls rate (I.e. lhameler stenosIS at lollow-u r 2)U'Io) 
LOII!{-I£'rJII re,ml!s: 
Angiographic follow-up studies were performed in 90% of eligible patients in 
each group. Tahle 2 and tigure II summarize the quantitative angiographic results 
at follow-up as analyzed according to a continuous and categorical approach. The 
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minimallulllinal diameter at follow-up for the atherectomy and angioplasty groups 
was not signiticantly different (1.76 ± 0.62 mill versus 1.77 ± 0.59 mm; 
p=0.93) nor was the net gain index (0.18 ± 0.19 versus 0.17 ± 0.17;p=0.70). 
The relative gain was greater in the atherectomy group compared with the balloon 
angioplasty group (figure III). A linear relationship exists between the relative 
gain and relative loss for each treatment group although the coefficient of 
correlation was superior in the atherectomy group (r= 0.64 versus r= 0.32). 
Thus, the amount of loss during follow-up is more clearly related to the gain 
achieved at intervention with respect to atherectomy. Furthermore, the slope of 
the regression line is steeper in the atherectomy group (0.75) when compared to 
the balloon angioplasty group (0.46), although this was not statistical signilicant 
(p=O.07) due to a large scatter in the angioplasty group. However, the 
relationship between relative gain and relative loss suggests that the vessel wall 
injury as well as the reactive hyperplasia is more intense for the same amount of 
gain. Finally, the vessel size plays an important role in the amount of relative 
gain and relative loss as described in table 3. It appears that the relative gain 
observed during the procedure and the relative loss at follow-up are both 
decreasing in vessels of increasing size. 
As analyzed by the categorical approach using the > 50% diameter stenosis 
criterion, 27% of the atherectomy and 29% of the angioplasty popUlation had a 
restenosis (ligure IV). 
DISCUSSION 
The Ubiquitous phenomenon of reslenosis has been the subject of much interest 
and attention since the introduction of percutaneolls transluminal coronary 
angioplasty as a treatment for symptomatic coronary artery disease. Over the last 
few years, various new devices, including directional atherectomy [4,14-ISt 
stenting [6,7,19], rotational ablation [20] and laser therapy [21] have been 
introduced to reduce the acute complication rate after balloon angioplasty and 
more importantly to lower the restenosis rate. Furthermore a variety of 
pharmacological agents [22,23] presumably liable to prevent restenosis have been 
tested in randomized clinical trials to reduce the restenosis rate. Unfortunately, 
none of these trials or device registries have been able to convincingly 
demonstrate a significant reduction in the restenosis rate, Many of these studies, 
however, have been fraught with methodological problems [24] and the 
interpretation of the results arc confounded by the variety of definitions of 
restenosis used, rendering any comparison invalid. 
Malchill)!,: COil/patin}!, fhi' comparuhle : 
With the introduction of variolls new intracoronary {Ievices it becomes critical to 
assess the relative merits of each system. We have introduced and validated the 
87 
Relative loss 1.4r~~=-=-=-----------
1.2 
0.8 
RL • 0.77 RG - 0.09 
R • 0.66 
0.6 + 
04 _++ 
+ 
.ft+ 
+ 
+ 
. • + + + .. "" + 
+Ie"" + + + 
+ 
+ 
+ 
+ 
+ -,. 
DCA 
0.2 ++ + +. *+ -P- +++ 
o f---,.~-"T=-+'+:±~-+"""+Jc+L--- ---- -. 
++ + 
-0.2 + +++++ 
-0.4'--~-~--'---~-~--·~-.-1 
o 0.2 0.4 0.6 0.8 
Relative gain 
Relative loss _______ _ 1.4-
1.2 
0.8 
0.6 
0.4 
0.2 
0 
-0.2 
-0.4 
RL • 0.36 RG • 0.0 
R • 0.26 
' .. 
'0 
'.' .. ' 
. ', . 
' .. 
. : . .:': 
..... ". 
0 0.2 0.4 
PlCA 
0.6 0.8 
Relative gain 
1.2 
1.2 
Figurt' III: Scalier hi.l"lo!:ntm of \'(//11('.\' olifllillC'd jiJl' rcla(iI'l' ):(/;11 aJh'r IIlllan/olll)' (DCA) or 
hallooll IIl1g;oplmty (PTCA) /l1U/ fl'l(/l;I'(' /0.1'.1' durillg jilllol\'-lfp. A liI/('/l1' rl'lariol/.lMp ('lIIergl'sjor 
bolll 1l'Clllliquc'.\·!UHI'CI'l',. II higha ('m:Oldc'lIf (if {'oneill/hili (,.=0.65 \'{'rslIx 0.26; P < 0, 001 \'('fSlI,\' 
p=O.OO7 rt'.11J('cf;l'dy) lind II ,I'tapa s/opc' (0. 77 \'('1'.\'1/.\' 0, .l.'i,-I' =0. 07) ixfillllld ill tiJl' athl'/"('CfOIIIY 
group. 
88 
concept of matching a.1i a surrogate for true randomized trials [4,14,15] 
anticipating their eventual results or at least allowing a more accurate calculation 
of power of upcoming randomized trials. The present study confirms that the 
longterm beneficial effect of directional atherectOlny might be less pronounced 
than expected, and indeed important information may be derived by the evaluation 
of matched lesions which may be useful for the design of future randomized 
trials. For example, it can be calculated from this study how many patients should 
be included in a randomized trial in order to demonstrate a statistical difference 
in minimal luminal diameter between angioplasty and atherectomy. However, this 
should not preclude attempting a randomized trial which includes less patients 
(such as the CA VEAT trial) since subgroup analysis might nevertheless unravel 
a subset of patients (or lesions) who may especially benefit from the new 
intervention. 
Dynamic \'('/:\"1(,\' ,\'/alic r('sfl'lIosi.v crileria : 
Restenosis criteria currently in lise can be divided into those which describe the 
change in lesion severity during follow-up (dynamic criterion) and those which 
merely describe lesion severity at follow-up (static criterion). Examples of the 
first category are the loss in lumen diameter of more than 0.72 111m as proposed 
by Serruys et al [4,6-8] and a change in pcrcent diameter stenosis. Examples of 
the second category are the criterion of > 50% diameter stenosis at follow-up and 
a minimaliliminal diameter of more than 1.4 mill at follow-up [11]. In the present 
study we carefully selected comparable patient groups with identical stenoses by 
matching for clinical and angiographic parameters. However this technique does 
not reconcile the discrepancy arising out of the divergent immediate effects of two 
difterenl interventional techniques rendering the dynamic restenosis criteria that 
describe a change in lesion severity from post-intervention to follow-up 
angiography inappropriate. Therefore a static restenosis parameter which describes 
the lesion severity at follow-up angiography should be used while comparing two 
different interventional techniqucs - stich as directional coronary atherectomy and 
balloon angioplasty. 
A1LD atjbllow-up, 11/(' qlf(lIIfi/ativ(' al/~io~l'tIphic fliti-poiJII : 
Of all directly acquired measurements by quantitative coronary angiography, the 
absolute value of the minimal luminal diameter has been shown the greatest 
single determinant of the hemodynamic consequence of a stenosis and is therefore 
the only non-ambiguous, objective and reproducible parameter with which to 
describe the caliber of a coronary artery and changes therein following 
intervention [25]. In placebo-controlled restenosis. prevention trials following 
PTCA, the change in minimal luminal diameter during follow-up has been 
traditionally Llsed to assess the value of a new pharmacological strategy and this 
approach is justil1ed since the luminal enlargement observed in the two arms of 
the trial were, by detinition, comparable. Due to the different nature of the 
interventions applied here (ie. athercctomy versus angioplasty), the immediate 
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post-procedural results are different and no longer comparable. This is clearly 
shown in the cumulative distribution curve (figure II): atherectomy induces a 
larger gain in minimal luminal diameter than angioplasty which makes the 
immediate post-procedural characteristics dissimilar so that the loss during follow-
up is no longer a helpful comparison of the long-term benefit. The most valid 
parameter for the comparison of two interventional devices is the minimal luminal 
diameter at follow-up because this static parameter, in itself, represents the final 
luminal improvement at follow-up. Moreover, the minimal luminal diameter at 
follow-up may have some.lill/cliol/o/ COmpOl1flll; in accordance with Danchin et 
al [II), we [26) found that a minimal luminal diameter of 1.45 mm correlates 
with the recurrence of angina pectoris (sensitivity and specificity of 72%). This 
information suggests that the absolute value of the minimal luminal diameter at 
follow-up may prove to be an even more useful parameter than parameters 
ohtained by clinical examination or exercise testing. 
In this study comparing two patient groups with similar clinical and preproceduraJ 
stenosis characteristics, using quantitative angiographic parameters of 158 
coronary lesions, there was no significant difference in minimal luminal diameter 
at f'allow-up between the atherectomy and balloon angioplasty group. 
COJlliflllOllS W'f:'lUS c(f/('~(}ric(f/ approach :Restenosis has been shown to be a 
proliferative response affecting virtually all lesions which have been subjected to 
the trauma of an intracoronary intervention [16,27-30]. Using quantitative 
angiography, our group previously demonstrated that a loss in minimal luminal 
diameter indeed occurs in all treated lesions, irrespective of localization in the 
coronary artery tree [12], and more importantly, that narrowing after balloon 
angioplasty follows a near Gaussian distribution [2], Therefore, restenosis should 
be viewed as the tail end of an approximately Gaussian-distributed phenomenon 
rather than a unique disease entity, occurring in some lesions but not in others 
[2,3]. Given these facts, analysis with parametric statistical tests is appropriate 
and by lIsing a continuous approach we may take advantage of all information 
made available by follow-up angiographic studies. 
Relativ(' ~(lill as all 'iI{illf)' .\,eore', re/mive lo.\'s {IS an index l?/ nco-i11limal 
hypl'JP/asia: 
The important observation that a greater gain in lumen (i.e. injury) is associated 
with a greater loss (ie repair) during follow-up has previously been described by 
Schwartz et al [31,32). In a domestic swine stented model, which accurately 
mimics the proliferative nature of human restenosis, the extent of the proliferative 
response was strongly associated with rupture of the internal elastic lamina as 
induced by oversized and overpressurized balloon intlations, with, or without, coil 
implantation. In order to test this hypothesis in a clinical setting, we have 
substituted the concept of "injury score" and IIneo-intimal hyperplasia" as 
observed in the animal model with the angiographically derived parameters of 
relative gain and relative loss. Quantitative angiographic analysis of 522 coronary 
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artery lesions [8] treated by balloon angioplasty with a 95% angiographic follow-
up, reveals a linear relationship between relative gain and relative loss, although 
the coefficient of relation is low (0.4). The present study indeed confirms these 
observations for balloon angioplasty but unveils a stronger correlation between 
relative gain and relative loss for atherectomy, compared with balloon 
angioplasty. More importantly, the slope of the regression line is steeper in the 
atherectomy group than in the angioplasly group implying thai not only is the 
relative gain greater in the atherectomy group but also that the reactive response 
(ie relative loss) is more pronounced after athereclomy than following angioplasty. 
As seen in figure III, the slope of the regression line between relative gain and 
relative loss, which renects the inherent relationship between the degree of wall 
injury and the degree of repair represent an index of luminal renarrowing specific 
for each treatment modality (athereetomy, balloon angioplasty). Furthermore, the 
reference diameter emerged as a potentially important parameter which may affect 
the procedural outcome since it appears that the relationship between relative gain 
and relative loss is a function of the vessel size, with less gain during the 
procedure but also less loss during follow-up in larger vessels (table III). Indeed 
an earlier observation from our group [9,12] dcmonstrated that the relative loss 
is significantly smaller, in vessels with a reference diameter above 3.5 mm. This 
phenomenon might be related to less medial disrupture and a better artery/device 
ratio. 
Umitatiolls: 
Several limitations of this study are to be acknowledged. First, it is an 
uncontrolled, observational study limited to a subset of patients with a successful 
coronary atherectomy or balloon angioplasty without inclusion of patient and 
procedure related variables. Second, this study is based on the relative early 
experience with atherectomy. Careful patient selection, future design changes and 
improved operator experience may further improve the immediate and long-term 
results. Controlled clinical trials, slIch as the CA VEAT trial, are imperative in the 
future to determine the immediate angiographic result, the long-term efficacy of 
these interventions as well as the benefit, if any, in particular patient subgroups. 
These studies should also addrcss the presumed time frame for restenosis after 
any particular intervention. 
Practical Implicath}/l,\' : 
At present debate still exists whether atherectomy should be performed while 
aiming at the maximal achievable result. On the one hand, studies have reported 
that !lbiggcr is better" [33] while on the other hand controversy still exists 
regarding the inlluence of medial or adventitial tissue retrieval on the final 
restenosis rate [30,34,35]. Animal studies suggest a direct relationship between 
intimal hyperplasia and vessel wall injury at intervention. Introduction of 
quantitative angiographic correlates for these parameters in this clinical study, 
relative loss and relative gain respectively, clearly supports this hypothesis in the 
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context of directional atherectomy and balloon angioplasty. The biological control 
of the healing process has to be elucidated before we may take full advantage of 
the superior initial gain provided by this powerful interventional technique. 
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Chapter 7 
OPTIMAL USE OF DIRECTIONAL CORONARY 
ATHERECTOMY IS REQUIRED TO ENSURE 
LONG-TERM ANGIOGRAPHIC BENEFIT: A 
STUDY WITH MATCHED PROCEDURAL 
OUTCOME AFTER ATHERECTOMY AND 
ANGIOPLASTY. 
VAWM Vmans, D Keane, D Foley, E Boersma, R Melkert MD, PW Serruys 
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ABSTRACT 
Objectivl's. This study is designed to examine whether restenosis is related to the 
extent or mechanism of luminal improvement and to explore angiographic 
determinants for optimal atherectomy. 
Background. Directional atherectomy induces a greater extent of acute gain and 
late loss but has not been found to yield a better late angiographic lumen than 
angioplasty in randomized trials. The difference in luminal renarrowing may be 
related to either the extent or the mechanism of acute gain. The design of 
previous studies has precluded the detection of a device specific effect on 
restenosis. 
Methods. A retrospective analysis based on matching of a prospectively collected 
series of 80 native coronary arteries successfully treated with atherectomy with 
a prospectively collected series of 80 native coronary arteries successfully treated 
with balloon angioplasty. Angiographic analysis was performed in 160 lesions to 
explore whether a specific device related effect exists. Multivariate analyses were 
performed to determine the correlates of minimal luminal diameter at follow-up 
and late luminal loss and to identify the procedural characteristics for optimal 
atherectomy. 
Results. Matching resulted in two comparable groups with equivalent baseline 
clinical and stenosis characteristics. By study design, atherectomy and angioplasty 
resulted in similar acute luminal gain (1.15 ± 0.44 mm vs 1.10 ± 0.40 
mm;p=O.50). However, IUlllinalloss was more pronounced after atherectomy and 
thus the minimal luminal diameter at follow-up differed significantly between the 
two groups (1.78 ± 0.57 mm vs 2.00 ± 0.56;p=0.01). Device type was retained 
in the multivariate analysis as an independent predictor of late minimal luminal 
diameter and luminal loss. Multivariate analysis identified vessel size and acute 
gain as determinants of optimal athcrectomy. 
COllclu.\'ioIlS. Restenosis is not only the consequence of the extent of luminal 
improvement but also of the mechanism of vessel wall injury (debulking versus 
dilating). While performing atherectomy, the operator should strive for an optimal 
procedural result in order to accolllmodate an increased intimal hyperplastic 
response. 
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INTRODUCTION 
It has been conclusively demonstrated that a large post-procedural diameter 
achieved at coronary intervention yields a greater long-term residual luminal 
diameter [1-11). It has not been shown, however, whether this angiographic 
outcome is also related to the specific mechanism of the interventional device 
deployed. Thusfar, the design of coronary interventional studies has precluded the 
detection of a device specific effect on luminal renarrowing. In particular, 
previous studies have been confounded by the effects of unequal vessel size and 
acute luminal gain [3,4,7) which have been shown to be independent predictors 
of restenosis [4,5,9). 
When we first studied the differences between restenosis after atherectomy and 
balloon angioplasty in a matched series [7), we observed a significant difference 
in luminal renarrowing between the two devices when deployed in vessels of 
similar size, Specifically, late loss was larger in the alherectoJllY than angiopiasty 
group (0.68 mm vs 0.23 mm). While we believed that this effect was due to the 
superior illlmediate luminal gain with consequent greater luminal loss associated 
with atherectomy, we recognized that the difference in luminal renarrowing 
following atherectomy and angioplasty may relate to either the extent or the 
mechanism (debulking verSllS dilating) of luminal improvement ("vessel wall 
injury"). The purpose of this study is to extend our observations and to test the 
hypothesis that each device has unique properties with respect to luminal 
renarrowing which are independent of vessel size and lesion severity and luminal 
gain. Therefore, we compared the long-term angiographic outcome of directional 
coronary atherectomy and conventional balloon angioplasty in a prospectively 
collected series of 160 patients with comparable vessel size, lesion severity and 
acute gain. Multivariate analyses were performed to determine the correlates of 
minimal luminal diameter at follow-up and late luminal loss and to identify the 
angiographic characteristics for optimal atherectomy. The immediate and late 
changes in stenosis geometry were assessed by quantitative coronary angiography. 
METHODS 
A/herectomy pariellls: 
From September 1989 through March 1993, 178 patients underwent 184 
directional atherectomy procedures for native coronary or bypass graft lesions. Of 
these, 120 consecutive patients (who underwent 127 sLiccessful .v/mul-alollc 
procedures) had a 6 months follow-up angiography. For the purpose of this study, 
the late outcome of atherectomy was compared with that of angioplasty for 
consecutive native primary lesions. Therefore patients with restenolic lesions, 
lesions which underwent post-athcrectomy adjunctive balloon angioplasty and 
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patients with a subacute coronary occlusion < 24 hours were excluded. Of the 120 
patients, 3 were treated for a lesion in a venous bypass graft and 13 had an 
atherectomy for 18 restenotic lesions after a previous angioplasty. Therefore, 104 
patients who underwent 106 sliccessful atherectomy procedures for native primary 
coronary artery disease were eligible for matching. Ultimately, 80 patients with 
80 coronary artery lesions were individually matched with patients undergoing 
successful balloon angioplasty whereas the remaining 26 patients could not be 
matched. The clinical and angiographic details of the atherectomy and angioplasty 
groups are given in Table I. 
Prior to atherectomy, patients had documented myocardial ischemia which 
required revascularization. Patients were selected for directional atherectomy 
when they presented with a stenosis in a proximal non-tortuous coronary artery 
with a presumed reference diameter > 2.5 mill. All patients gave informed 
consent and were prospectively scheduled for 6-months angiography which was 
completed in 92% of the patients. The study was approved by the hospital's 
Institutional Review Board. All clinical and angiographic data were collected 
prospectively. 
Balloon (lllgiop/asfy paliN/I.\, were collected from the angioplasty database which 
contains clinical and angiographic details of 3072 patients who underwent 3736 
angioplasty procedures and participated in previous angioplasty restenosis 
prevention trials in Europe and North America [8,12,13]. The mean age of these 
3072 patients was 56 ± 9 years; 81 % were men. The majority of the patients 
(52%) were treated for Canadian Cardiovascular Society class III or IV angina. 
In the entire angioplasty population, 47% of the dilated lesions were located in 
the len anterior descending coronary artery, 23% in the left circumflex and 30% 
in the right coronary artery_ On baseline quantitative angiography, mean vessel 
size and minimal lumen diameter pre-angioplasty were 2.62 ± 0.53 111111 and l.09 
± 0.29 mill, respectively. The pre-angioplasty percentage diameter and area 
stenosis were 58 ± 10% and 84 ± 16%. Balloon dilatation in these 3736 lesions 
resulted in a post-angioplasty minimal lumen diameter and diameter stenosis of 
1.77 ± 0.36 mm and 33 ± 8% respectively. At follow-up the minimal lumen 
diameter decreased to 1.53 ± 0.47 mm with a concomitant increase in diameter 
stenosis to 42 ± 14%. The loss index for these 3736 lesions was 0.30 ± 1.65. 
An angiographic and clinical follow-up rate of > 90% was obtained. Because 
neither angiographic, nor clinical benetit of the tested compounds could be 
demonstrated in these restenosis trials the placebo and active treatment groups 
could be pooled for the present study. 
Alherec/omy alit! anxiop/a.\'ly pf()cedlll'l': 
The procedure was performed as described previollsly [7,8,12-16]. Briet1y, the 
atherectomy device was directed over a guide-wire and positioned across the 
stenosis. The support halloon was then inflated up to 7.5 psi, the cutter was 
retracted and balloon inflation pressure was increased to maximally 45 psi. The 
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driving motor was activated and the rotating cutler was slowly advanced to Cllt 
and collect the protruding atherosclerotic lesion in the collecting chamber located 
at the tip of the catheter. After every pass the balloon was deflated and either 
removed or repositioned. While an optimum angiographic result was sought for 
each lesion treated, the procedure was considered angiographically successful 
when the residual diameter stenosis was less than 50% after tissue retrieval. This 
classic defmition of success should be viewed in the historical perspective, while 
nowadays a luminal gain of at least 0.7 mm or a post-atherectomy diameter 
stenosis < 20% may be deemed necessary before considering the procedure as 
successful as recently observed in retrospective analyses [2) and as defined in the 
upcoming atherectomy trials (BOAT, OARS, EUROCARE). 
Balloon angioplasty was performed with a steerable, movable guidewire system 
via the femoral route. Standard available catheters were used. Choice of balloon 
type, size as well as inflation duration and pressure was left to the discretion of 
the operator. Balloon dilatations were repeated until the severity of the obstruction 
was at least below 50% diameter stenosis as judged visually by the operator on 
coronary angiography. Following all interventions, the arterial and venous sheaths 
were usually left in place for 6 hours. Patients were monitored for 24 hours and 
electrocardiograills and cardiac enzyme levels were obtained twice daily. A 
calciulll antagonist was given every 2 hours for 24 hours after the procedure and 
the patients were maintained on aspirin therapy for six months. 
Quantitative corollaty aIlKiop,raphy: 
Quantitative analysis of the coronary segments was performed with the computer 
based Coronary Angiography Analysis System (CAAS), which has been 
previousl y validated and described in detail [8,12, -17). In particular accuracy and 
precision measurements for in-vivo phantom measurements are 0.09 and 0.23 
[18]. In essence, boundaries of a selected coronary artery segment are detected 
automatically from optically magnified and video digitized regions of interest (512 
x 512 pixels) of a cine-frame. The absolute diameter of the stenosis in mill is 
determined using the guiding catheter as a scaling device for calibration. The 
external diameter of each individual catheter is measured by a precision 
micrometer with a tolerance of 0.001 mill. Correction for pincllshion distortion 
is performed. Computer-estimation of the original dimension of the artery at the 
site of the obstruction provides an interpolated reference diameter. The percentage 
diameter stenosis is then calculated. To standardize the method of analysis of the 
interventional and follow-up angiogram, the following measures are routinely 
applied. First, the x-ray gantry is exactly repositioned to the setlings which were 
documented at the time of the intervention. Second, all study frames to be 
analyzed were selected at end-diastole to minimize foreshortening and blurring 
effects of systolic motion. Third, the lIser determined beginning and endpoint of 
a segment of a major coronary artery were identified according to the definitions 
of the American Heart Association [19). Finally, Polaroid photographs were taken 
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of the video image with the detected contours superimposed to ensure that the 
analyses were performed on the same coronary segments. intracoronary isosorbide 
dinitrate (l-3 mg) was given prior to and following intervention. Administration 
of intracoronary nitrates was recommended prior to angiography at follow-up 
catheterization. 
MatchinK process: 
To obtain patients with comparable pre- and post-procedural stenoses, lesions 
were matched according to reference diameter, pre-interventional minimal luminal 
diameter and post-interventional minimal luminal diameter. The analysis is thus 
independent of vessel size, lesion severity and extent of device-induced luminal 
gain. The process of matching has been previously described [7,16]. Briefly, the 
principles of matching by quantitative angiography are threefold: (i) the 
angiographic dimensions of matched lesions are assumed to be UidenticalU, (ii) the 
observed difference between the two "identical" lesions must be within the range 
of the reproducibility of the CAAS analysis, 0.1 mm (~I SD) and (iii) the 
reference diameter of the lesions to be matched are selected within a range of ± 
0.3 mm (~3 SD; 99% confidence limits) [8,12,13]. 
Statistical analysis: 
The unit of analysis reported here is the stenotic lesion, not the patient. All values 
are expressed as mean values ± 1 SD). Comparisons of the severity of reference 
diameter, minimal luminal diameter, diameter stenosis and area stenosis between 
the two groups were performed using the paired student's !-test. Levene's test for 
variance was used to examine the equality of group variability and if significant 
difference was found, the Welch and Brown-Forsythe tests for equality of means 
were applied. The Bonferroni correction was applied for Illultiple comparisons. 
Linear regression analysis by groups was performed (BMOP statistical package) 
as a formal test for comparison of correlations and slopes. Selected angiographic 
variables were evaluated by univariate regression analysis for their correlation 
with absolute luminal loss and for their correlation with minimal luminal diameter 
at follow-up. Independent contribution of variables was assessed by multivariate 
stepwise regression analysis lIsing a commercially available statistical software 
package (SAS, SAS Institute Inc, Cary, North Carolina). Multiple linear 
regression analysis was utilized to account of the influence of pre-procedural 
minimal luminal diameter, aCLIte luminal gain and vessel size in evaluating their 
contribution to the minimal luminal diameter at follow-up and late luminal loss. 
Differences between categorical variables were tested with the chi-square and 
Fisher exact tests as appropriate. A p-valuc less than 0.05 was considered 
statistically significant. 
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RESULTS 
DU/come q{ Ihe marching proc(','\,v (Table I): 
Although 104 patients (l06 atherectomy procedures) were eligible for the 
matching study, 24 patients (26 lesions) could not be matched with a twin balloon 
angioplasty patient. Therefore, the final analysis was performed on 160 patients 
treated by either directional atherectomy or balloon angioplasty. The baseline 
clinical and angiographic characteristics of the atherectomy patients were 
compared with those of the matched angioplasty group. The 160 patients were 
predominantly male with a mean age of 57 ± 11 years. Patients were 
predominantly treated for stable angina according to the American Heart 
Association classification. Atherectomy was preferentially performed in the left 
anterior descending (65 % vs 25 %) while the right coronary artery was more 
frequently treated by angioplasty (21% vs 56%;p<0.OOI). 
Tahle. 1. Clinical <Inu :mgiogmphic characteristics of the study population. 
Atherectomy Angiopla.~ty 
not-matched Illl.ltched group matched group 
group (n=26) (n~80) (n~80) 
Age (yr) 58 ± 12 57 ± II 58 ± 10 
Male (%) 70 81 91 
Vessel treated (%) 
LAD 59 65 25 
LCX 7 12 19 
RCA 33 23 56 
Unstahle angiml (%) 38 30 37 
Previolls infarction (%) 31 27 36 
Previous CABO (%) 0 I 2 
Diabetes (%) 4 2 6 
Hyperchoit>,stert1Iemia( %) 24 15 20 
Multivessel disease ($'o) 23 25 32 
Reference diameter (mm) , 3.64 ± 0.93 3.21 ± 0.49 3.22 ± 0.48 
MLD (111m) 1.34 ± 0.52 1.16 ± 0.32 1.16 ± 0.28 
Diameter Stenosis (%) 63 ± t2 64 ± 10 63 ± 9 
Area Stenosis ($'o) 83 ± 17 84 ± 16 84 ± 17 
LAD =Ielt antenor tles('endlll' g coronar ' arter '. LCX'=iett cm;umIJex hntnch, RCA rI' I g
coronary artery, CABG=cownary artery hypa.~s gnttiing. MLD =minimalluminal diameter. 
The incidence of left circumflex artery lesions was similar in both groups (12% 
vs 19%). No differences between the groups were found for risk factors for 
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coronary artery disease or preceding cardiovascular events, By study design, no 
significant differences between the atherectomy and angioplasty groups were 
found in baseline quantitative angiographic parameters: mean vessel size (3,21 ± 
0.49 vs 3.23 ± 0.48 mm), pre-procedural minimal luminal diameter (1.16 ± 
0.32 vs 1.16 ± 0.28 mm) and percentage diameter stenosis (64 ± 10 vs 63 ± 
9%) respectively. The baseline characteristics of the 26 unmatched atherectomy 
lesions revealed no difference in clinical prome between matched and unmatched 
patients, Although the percentage diameter stenosis and percentage area stenosis 
in the unmatched group was equal to the matched group, atherectomy was 
performed in larger vessels (reference diameter 3.64 ± 0.93 mm) with a 
concomitant larger minimal luminal diameter pre-procedure (1.34 ± 0,52 mill) 
than in the matched group. Matching with similar angioplasty lesions was not 
possible due to either a large acute lumen gain with concomitant low % residual 
diameter stenosis or because of large vessel sizes, 
The 80 matched angioplasty patients had similar clinical and angiographic 
characteristics compared with the entire angioplasty population with respect to 
gender, age (56 vs 58 years) and diabetes (6% vs 7%). By virtue of matching 
with atherectomy lesions, the matched angioplasty group had bigger vessels (3.23 
Illill vs 2,62 mm) and minimalllllllcn diameters (1.16 111m vs 1.09 111m) than the 
entire angiopiasty population, although their lesion severity was similar (% 
diameter stenosis 63% vs 58%), 
111llJlediare allKioKraphic ollfco/}/e in matched parients (Table II): 
By virtue of our matching protocol, the pre anti post-procedural lllinimallllll1inal 
diameter in both groups were similar (2.31 ± 0.38 vs 2.26 ± 0.37mm;p=0.98) 
and (2.31 ± 0.38 mm vs 2.26 ± 0.38 mm;p=0.46) respectively. Therefore, the 
acute luminal gain achieved with atherectomy was comparable with the gain 
achieved at angioplasty (1.15 ± 0.44 vs 1.10 ± 0.40 mm). Relative gain, defined 
as gain divided by vessel size, was similar in both groups, In figure I, the graphic 
display of the immediate results after atherectomy and balloon angioplasty are 
shown, As displayed, the matching process was adequate with superimposition of 
the distribution frequency curves of the minimalluminai diameter before and after 
atherectomy and angiopiasty indicating similar pre- and post-procedural stenosis 
severity irrespective of the deployed device, 
Lale allJ.!iographic Oil/COllI(' ill }}wtcl/ed patil'III,\' (Table IT): 
Angiographic follow-up was obtained in all patients, The restenosis rate according 
to the> 50% diameter stenosis categorical criterion was comparable between the 
atherectomy and angioplasty group (28% vs 22 %;X'= 1.038,p=0.30). Although 
a similar acute gain was achieved irrespective of the device lIsed, the atherectomy 
patients had a significantly higher late loss during follow-up (0.53 ± 0.58 mm vs 
0,26 ± 0,60 mm;p<O.005), Therefore, the residual minimal luminal diameter 
at follow-up was signillcantly smaller after atherectomy than after angioplasty 
(1.78 ± 0.57 nll11 vs 2.00 ± 0.56 mm;p<O.OOI)(figure I). 
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Relative loss (loss divided by vessel size) and loss index (late loss divided by 
acute gain) were significantly higher after atherectomy indicating a more intense 
renarrowing process. A linear relationship was found between relative gain 
(injury) and relative loss (repair) in the two groups, with a steeper relative 
gainirelative loss regression line slope in the directional atherectoJllY group (0.56) 
than in the balloon angioplasty group (0.44) although this difference did not 
achieve statistical significance due to a wide data scalier (large standard error of 
the mean). 
Table 2. Comparison of quantitative angiographk data in matched patients who underwent 
atbereclomy O( halloon angioplasty 
AtherC{:tomy Balloon angiopiasly p~value 
(n~80) (n~80) 
Rderenc(;} dhllnder pre (111m) 3.21 + 0.49 3.23 + 0.48 NS 
Minimal luminal diameter pre (mm) 1.16 + 0.28 1.16 + 0.32 NS 
Minimal luminal diameter post (mill) 2.3t ± 0.38 2.26 ± 0.38 NS 
Minimal luminal tliameter f-up (mill) I. 78 ± 0.57 2.00 ± 0.56 O.Ot 
Diameter stenosis pre (%) 64± 10 63 ± 9 NS 
Diameter stenosis post ($'o) 28 ± tl 31 ± 10 0.02 
Diameter .~kn(lsis f.-up (%) 41 + 18 38 + 16 NS 
Ahsolute luminal loss (mm) 0.53 ± 0.58 0.26 ± 0.60 0.005 
Relative luminal loss 0.18±0.21 0.08 ± 0.19 0.002 
Loss index 0.52 ± 0.8t 0.17 ± 0.68 0.004 
Lesion len£th (mm) 6.73 ± 2.51 6.90 ± 2.34 NS 
Curvature value 15.5 ± 6.9 12.7 + 5.8 NS 
Symmetry index 0.55 + 0.25 0.44 ± 0.25 NS 
Area plaque (l1lT}12) 9.33 ± 4.94 9.96 ± 4.45 NS 
F-u p at tollow-u ,NS p not SI 'OIt1c;mt, g p no he tore IOterventlon, p ost ;dter interventIOn. 
Multivariate analysis (?f luminal 10.\'.\' and late residual diameter: 
To characterize the luminal changes after directional atherectomy and balloon 
angioplasty according to a continuous approach, two multivariate stepwise models 
were generated in which (I) residual lumen at follow-up and (2) absolute loss 
were taken as the dependent variables. 
Univariate predictors of minimal luminal diameter at follow-up were minimal 
luminal diameter post-intervention, device type and vessel size. In multivariate 
analysis, vessel size was found to have an independent positive influence on 
minimal luminal diameter at follow-up while device had a comparable negative 
influence on late residual lumen. 
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Therefore, it is apparent that the late results after successful interventions are 
superior in larger vessels and that there is a device effect on luminal renarrowing 
and late minimal luminal diameter at follow-up. The influence of vessel size may 
in part account for the results observed in new device studies because typically 
these devices are used in larger vessels. The multivariate model to predict residual 
late lumen was found to be: Minimal luminal diameter at follow-up = 1.28 + 
0.22 vessel size - 0.23 Device (where angioplasty=O and atherectomy=l). 
Minimal luminal diameter after intervention, luminal gain, relative gain, minimal 
luminal diameter before intervention and device type were univariate predictors 
for absoillfe luminal loss during follow-up. Of these, luminal gain and device type 
were retained in the multivariate model to predict the renarrowing process. In 
multivariate analysis, the relationship between gain and loss is demonstrated as 
acute gain is found to exert a positive influence on late loss. In addition, pre-
interventional minimal luminal diameter and device type were positively 
associated with luminal loss. This may indicate that the lise of a bulky device is 
associated with an increase in late luminal loss because the use of the atherectomy 
device is associated with an additional late loss of 0.24 mm as compared with the 
use of the balloon. The model to predict absolute luminal loss in this population 
can be described by the following equation: Absolute loss = -1.0 + 0.64 Gain 
+ 0.46 Minimal luminal diameter pre + 0.24 Device (where angioplasty=O and 
atherectomy = 1). 
Optimal atherectol11Y: 
Given the distinct renarrowing properties of the atherotome, we sought to identify 
which angiographic variables yield independent information for the prediction of 
late lumen. Therefore, the atherectomy population was divided into two groups 
a~cording to the median post-atherectomy minimal luminal diameter. Table III 
summarizes the changes in stenosis geometry for all atherectomy procedures. A 
large post-procedural atherectomy lumen was associated with a large vessel (3.48 
± 0.70 mm vs 3.13 ± 0.54 mm;p=O.OOOI), a large minimal luminal diameter 
before atherectomy (1.29 ± 0.41 mm vs 1.11 ± 0.34 mm;p=0.02) and a large 
luminal gain (1.50 ± 0.39 mm vs 0.98 ± 0.42 mm;p=O.OOOI). The residual 
diameter stenosis for this group was 20 ± 8%. Although the late loss during 
follow-up was higher (0.S6 ± 0.64 mm vs 0.42 ± 0.59 mm;p=0.004), the 
minimal luminal diameter at follow-up was larger in the group that underwent a 
favorable compared with the less favorable atherectomy (1.92 ± 0.62 mOl vs 1.67 
± 0.56 mm;p=O.03). This preserved favorable long-term angiographic outcome 
was also reflected in the acute gainllate loss regression equation which showed a 
shallower slope in the optimal atherectomy group than in the suboptimal group 
(0.35 vs 0.45), although its difference did not reach statistical signiticance: loss 
= 0.33 + 0.35 gain (r=0.22;p=0.1173, optimal group) versus loss = 0.45 + 
0.45 gain (r=0.32;p=0.02, suboptimal group). The restenosis rate, defined as 
diameter stenosis < 50% at follow-up, was lower in the optimal than suboptimal 
lOS 
group (25 % vs 34 %) although it did not reach the level of significance. 
Tahlc 3.0ptilllHI versus sn!Hlptim,ti atherectomy: luminal change.~ after alheredomy per minimal 
iumill'll di'Hllder post-alheredomy 
MLD post> 2.47 MLD post <2.47 p-value 
mill (n=53) mm (11=53) 
Reference diumdO;;)( pre (null) 3.48 ± 0.70 3. t3 ± 0.54 O.ooOt 
Minimal luminal diameter pre (mill) L29 ± O.4t 1.11 ± 0,34 0.0208 
Minimal luminal diameter post (mm) 2.78 ± 0.27 2.09 ± 0.28 O.ooOt 
Minimal luminal diameter fup (mm) L92 + 0.62 L67 ± 0.56 0.03t7 
Diameter stenosis pre (%) 63 + to 65 + tl NS 
Diameter '''ienosis post (%) 20 ± 8 32 + to 0.0001 
Diameter stenosis fup (%) 39 ± 17 44 ± 18 NS 
Gain (mill) L50 ± 0.39 0.98 ± 0.42 O.Ooot 
Loss (min) 0.86 ± 0.64 0.42 ± 0.59 0.0004 
Relative ,gain 0.47 ± 0.20 0.34 ± 17 0.0004 
Relative loss 0.28 + 0.25 0.16+0.21 0.0004 
Net gain (null) 0.63 ± 0.67 0,56 ± 0,60 NS 
Loss index 0.59 ± 0.46 0.49 ± 0.96 NS 
Fu p - at follow-u) I, NS not ."j 'nificant, g p re - before IIltavcniwn, p osl - after intervention. 
Thus, these dala indicate that optimal at"erectomy seems to be related 10 not only 
to a large post·procedurallumen or large acute gain (procedural outcome) but also 
due to large vessel sizes (patient selection). Indeed l11ulfivariare analysis 
distinguished vessel size, luminal gain and pre-procedural minimal luminal 
diameter as independent predictors of minimal luminal diameter at follow-up and 
late loss. Figures II and III provide a three dimensional reconstruction of the 
regression planes for late lumen and latc loss. The regression plane is the 
resultant of loss, gain and minimaliulllinal diameter pre-atherectomy. Vessel size 
may be seen as the fourth dimension which will shift the regression plane 
downward (late loss) or upward (late lumen) by 0.21 nlln for every increase in 
vessel size by 1 mill. Both regression equations are: minimal luminal diaml'ter at 
.fiJI/ow·up ~ 0.50 + 0.21 vessel size + 0.22 gain + 0.29 pre·procedural minimal 
luminal diameter. Ai>.I'I!III/(' 11I,U ~ ·0.50·0.21 vessel size + 0.78 gain + 0.71 
pre-procedural minimal luminal diameter. Therefore, an optimal atilerectomy 
(large late absolute lumen) is thus associated with large vessels, a large gain and 
a large initial lumen. 
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DISCUSSION 
Restenosis has been shown in animal models to be the net result of injury inflicted 
on the vessel wall during an intervention and the subsequent biological healing 
response [20-22]. High pressure balloon inflation at angioplasty may yield 
excessive vessel wall damage with disruption of the internal elastic lamina and 
provoke an intense fibro-proliferative reaction. Low pressure balloon inflation and 
selective plaque removal by directional atherectomy potentially induces less vessel 
wall trauma. However, it is unknown whether atherectomy is less prone to induce 
an exuberant healing response after plaque excision than balloon dilatation for 
an equivalent degree of luminal enlargement measured on angiography. In order 
to explore the influence of a device effect on the renarrowing process we studied 
a matched patient population with similar baseline vessel and lesional 
characteristics and acute gain after atherectomy or angioplasty. 
The major findings of this study are threefold: (I) in matched patients which 
underwent the same amount of luminal gain, atherectomy induces more 
subsequent luminal Inss than angioplasty, (2) device type is retained in the 
multivariate model as a predictor of luminal renarrowing and (3) the benefit may 
not be sllstained in the long-term if atherectomy is not performed optimally. 
MafchillK. 
Matching a study population with a reference patient group of similar 
characteristics can compensate for some of the limitations of nonrandomized 
studies [24]. Furthermore, it may serve as a surrogate for randomized trials [25]. 
Indeed, its analytical value in predicting the outcome of true randomized trials 
comparing angioplasty with atherectomy [7,10, J IJ and angioplasty with stenting 
[25,26] has been demonstrated. In the present study, patients were matched not 
only for vessel size and lesion severity but also for the acute luminal gain. 
Therefore, although the patients were treated with two different devices they have 
apparently undergone the sallle extent, albeit a partially different mechanism, of 
Itvessel wall injurytl intlicted by either the balloon or the atherotome. In this 
matching study, we found that device is an independent predictor of IUlllinalloss 
(i.e. renarrowing process) and residual lumen at follow-up (Le. angiographic 
outcome) which indicates that not only the extent of luminal gain but also the 
specific mechanism of action (debulking versus dilating) has an intluence on 
restenosis. In non-matched observational studies, Kuntz et al [2,3,6] precluded, 
by virtue of their study design, the detection of an independent device effect 
because of the highly statistical differences between their device groups in acute 
luminal gain, which is known to be the strongest predictor for late outcome 
[3,9,10]. While prospective randomized trials are traditionally regarded as the 
methodology of choice for comparing long-term outcome of different 
interventional procedures such as CA VEAT, CCAT, BENESTENT and STRESS 
III 
[10, II ,26,27), only an approach which includes matching for luminal gain will 
elucidate a specific device mechanistic effect on luminal renarrowing. 
Multivariate! analysis. 
A comprehensive analysis of the restenosis phenomenon has recently demonstrated 
that the predictors of the residual lumen at follow-up and late luminal loss should 
be determined simultaneollsly to assess the restenosis phenomenon from a clinical 
outcome and biological process viewpoint [9,28,30]. The rationale for inclusion 
of device, vessel size, pre-interventional minimal luminal diameter and luminal 
gain for our multivariate analytical model was (i) to consider the potentially 
"confounding effect" of one variable on another and (ii) to use only absolute and 
not derived variables which accurately describe the lesion and can be modified by 
the clinician. The analysis of the late luminal changes of a matched population, 
indicated that device was an independent predictor of the renarrowing process and 
angiographic outcome. The cutting mechanism of the atherectomy device leads to 
more luminal loss with a smaller late lumen at follow-up compared to balloon 
angioplasty in patients who had similar post-procedural results. In the near future, 
this finding that the mechanism as well as extent of luminal improvement 
determines the subsequent rellarrowing process should be analyzed prospectively 
and confirmed by multicenter studies. 
The present results of our matched series may provide further insights into the 
atherectomy resuits of the CAVEAT and CCAT trials [10,11]. In these 
randomized trials, as in our matched atherectomy group, the moderate 
atherectomy procedural gain yielded a post-atherectomy minimal lumen of 2.31 
mm (our matched DCA patients), 2.02 mm (CAVEAT) and 2.34 mm (CCAT). 
The greater luminal loss during follow-up ultimately led to late residual lumen 
diameters which were similar to those of the angiopiasty group. 
Oplimal versus suhoptimal atlier('c/Omy. 
The present matching study identit1ed a worse long-term outcome of atherectomy 
when the immediate results are comparable with angiopiaslY. This indicates that 
a moderate luminal gain achieved at atherectomy cannot compensate for an 
increased late luminal loss. In other words, if atherectomy is not optimally 
performed (large acute gain), the bene lit may not be sustained in the long-term 
and the clinician should thus strive for a large luminal gain at directional 
atherectomy. To test this hypothesis we further analyzed our tutal atherectolllY 
population and divided the angiographic results into two equal groups according 
to the distribution of the post-atherectomy lumen diameter. Indeed the patients 
who underwent an optimal atherectomy (post-atherectomy minimal luminal 
diameter 2.78 ± 0.27 nlln and residual diameter stenosis of 20 ± 8%) had a 
significantly greater late lumen at follow-up (1.92 ± 0.62 mm vs 1.67 ± 0.56 
mm;p=O.03) and a conventional restenosis rate of25% versus 34%. In addition, 
we also observed a difference in the slope of the gain/loss regression line between 
the optimal and suboptimal groups (0.35 vs 0.45) although this difference did not 
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reach statistical significance. This trend towards less proportional loss with larger 
gains was also found in a preliminary analysis of the CAVEAT data which 
suggested a clirvi-linear relationship between acute gain and late loss with a 
steeper slope for smaller gains and a shallower slope for larger gains [29]. 
Thusfar, the influence of optimal atherectomy on late angiographic outcome is not 
entirely resolved and further information will be provided by the imminent 
Balloon versus Optimal Atherectomy Trial (BOAT), Optimal Atherectomy 
Restenosis Study (OARS) and European Cardivolol Restenosis trial 
(EUROCARE). Although these will evaluate the effect of optimal atherectomy, 
BOAT and OARS are designed from the perspective "bigger is better" with 
emphasis on optimal performance while EUROCARE is designed from the 
perspective "the more you gain, the more you lose" and combines a large acute 
gain with a pharmacological agent to reduce late luminal loss. In other words, 
BOAT will increase the "doughnut's hole" while EUROCARE will also try to 
reduce the "doughnut" [9,21,28,30]. Ultimately the restenosis process may be 
controlled by the combination of a large luminal gain which will provide a large 
lumen at follow-up and pharmacological/biological/gene therapy to reduce the 
greater luminal loss. 
Clinical implicatioJ/.\', 
The extent of luminal renarrowing is not only the consequence of the extent of 
luminal improvement hut also of the mechanism of vessel wall injury (debulking 
versus dilating), While performing atherectomy, the operator should strive for an 
optimal procedural result in order to accommodate an increased intimal 
hyperplastic response. 
Study limiftlfiolls. 
It could be argued that matching leads to a selection bias of the control group. 
Our data indicate, however, that the matched angioplasty lesions are a 
representative cohort of the angioplasty population with identical lesion severity 
as judged by percentage diameter stenosis. Furthermore, the matched angioplasty 
patients had similar lesion characteristics and outcome as the balloon angiopiasty 
patients in the CAVEAT and CCAT trials [10, II]. Despite these angiographic 
similarities between the groups, a difference exists in lesion distribution which is 
similarly found by others [2,3,6]. This is due to dissimilar vessel sizes with 
smaller left anterior descending arteries than non left anterior descending vessels. 
Whether the left anterior descending artery is more prone to restenosis 
independent of vessel size has yet to be determined [5,6,9,23]. To our knowledge 
there is 110 pathophysiological evidence to suggest that one coronary artery should 
display an inherently more aggressive neointimal healing response to injury than 
others, Available information on the intluence of lesion location on angiographic 
outcome is conllicting and merits further investigation, particularly with 
intravascular ultrasound imaging. The AHA/ ACC lesion classification [31] was 
not lIsed in this matching study because "it groups an array of lesions with a 
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heterogeneous morphology and dissimilar PTCA results" [15,16,32]. Quantitative 
morphologic assessment using automated edge detection derived length, symmetry 
index, curvature and in~ and outtlow angle values may overcome this limitation 
and also allows a continuous rather than categorical analysis [33]. 
This study did not assess the influence of recoil on the final outcome of the 
interventions however, previous studies have indicated that no significant 
difference in minimal luminal diameter 24 hours after angioplasty was observed 
[34] when appropriate 'measures where taken to control vasomotor tone [9]. This 
matching study however did take the difference in acute recoil which has been 
reported by Kimball et al [35] into consideration since matching was performed 
also for the post-procedural resuit. 
Although matching seeills a suitable statistical technique to explore such 
relationships, this study also indicates one of the limitations of matching. In order 
to find 80 angioplasty patients with similar pre- and post-intervention stenosis 
characteristics to be matched with the 80 consecutive atherectomy patients, 3637 
angiopiasty lesions were screened. This indicates that it is unlikely that a similar 
subanalysis could be performed to the CAVEAT and CCAT study groups. 
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Chapter 8 
ANGIOGRAPHIC, ULTRASONIC AND 
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ABSTRACT 
Objectives. The purpose of the present study was to use the complementary 
information of angiography, intravascular ultrasound and intracoronary angioscopy 
before and after directional atherectomy to better characterize the post-atherectomy 
appearance of the vessel wall contours and the mechanism of lumen enlargement. 
Background. Directional coronary atherectomy aims at debulking rather than dilating 
a coronary artery lesion. The selective removal of the plaque may potentially 
minimize the vessel wall damage and lead to subsequent better late outcome. Whether 
plaque removal is the main mechanism of action has only be assessed indirectly by 
angiography and warrants further investigation using detailed analysis of luminal 
changes and vessel wall damage by ultrasound and direct visualization with 
angioscopy. 
Methods. Twenty-six patients have been investigated by quantitative angiography, 
intravascular ultrasound and intracoronary angioscopy (n = 19) before and after 
atherectomy. In addition all retrieved specimens were microscopically examined. 
Results. Ultrasound imaging showed an increase in lumen area from 1.95 ± 0.70 
mm2 to 7,86 ± 2.16 mm1 at atherectomy. The achieved gain mainly resulted from 
plaque removal since plaque + media area decreased from 18.16 ± 4.47 mm2 to 
13.13 ± 3.10 111m2• Vessel wall stretching (Le. change in external elastic lamina 
area) accounted for only 15 % of lumen area gain. Luminal gain was higher in non-
calcified (6.52 ± 2.12 111m') than in lesions containing deeply located calciu111 (5.19 
± 0.99111111') and lowest in superficially calcified lesions (5.41 ± 2.41 111111'). 
Ultrasound imaging identified an athercctomy byte in 85 % of the cases, while 
angioscopy revealed stich a crevice in 74%, The complimentary use of the 3 
technique revealed an underestimation of the presence of dissection/tear and new 
thrombus by angiography (10% anel 4%) and ultrasound imaging (12% and 0%) 
c0111pared with angioscopy (26% and 21 %). 
Conelusions. The combined lise of angiography, ultrasound and angioscopy reveals 
that the post-atherectomy luminal lining is not as regular and smooth as seen by 
angiography. Luminal enlargement with atherectomy is achieved by plaque excision 
rather than arterial expansion. 
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INTRODUCTION 
Directional coronary atherectomy has been introduced as an alternative interventional 
technique aimed at debulking rather than dispersing the protruding coronary artery 
plaque [1-13]. The selective removal of the plaque may potentially minimize the 
vessel wall damage by avoiding the induction of large dissections and promoting the 
restoration of a large regular vessellumcn. The potential mechanisms responsible for 
the luminal improvement achieved by directional atherectomy may include (i) plaque 
removal, (ii) vessel wall stretching, (iii) creation of dissections, (iv) normal vessel 
wall cutting, (v) plaque redistribution and (vi) plaque compression. Some of these 
features of directional atherectomy have been assessed in a limited number of 
angiographic and ultrasound studies but a comprehensive appreciation of all 
mechanisms involved in luminal gain after atherectomy has safar not been performed. 
The introduction of intracoronary ultrasound imaging and coronary angioscopy in 
clinical practice permit detailed analysis of coronary artery lesion morphology and 
vessel wall damage in a manner not available with angiography [14-24]. In theory, 
the combined lise of these three imaging techniques may provide insights into the 
working action of directional coronary atherectomy and may identify factors 
determining acute sllccess and late outcome. The purpose of this study, therefore, is 
to use the complementary information of these imaging techniques to describe the 
vessel wall changes and lumen area configuration after directional atherectomy in 
order to elucidate the mechanism of atherectomy. 
METHODS 
Patil'11Is: 
The study group comprised 26 patients who underwent directional atherectomy for 
symptomatic native coronary artery disease (Table I). There were 22 men and 4 
women with a mean age of 57 ± 9 years. The majority of the patients (54 %) was 
treated for unstable angina according to the Braunwald classification [25]. Four 
patients had a history of a myocardial infarction and 1 patient was treated for 
restenosis after a previous balloon dilatation. The majority of the lesions (65%) was 
located in the left anterior descending coronary artery. 
Directional atherectomy was performed as previously described [6,7]. All patients 
had a sllccessful procedure defined as an angiographic residual diameter stenosis of 
< 50% on visual inspection. On-line quantitative coronary angiography (DCI Philips) 
before and after the atherectolllY was performed to optimize device selection and to 
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assess the procedural result. 
Intracol'O!wfY 1Iltra.wJllnd imaging: 
All patients underwent ultrasound imaging before and after atherectomy. The 
ultrasound images were obtained with a 4.3 F, 30 MHz ultrasound catheter 
(Cardiovascular Imaging Syslems Inc., Sunnyvale, CAl. The calheter lVas guided by 
simultaneous f1uoroscopic monitoring. Ultrasound gain settings were adjusted for 
optimal visualization of the arterial wall-lumen interface in normal segments while 
saline injections were performed to improve the delineation of the leading edge echo 
when necessary. 
Qualitative assessment of the ultrasound images was performed by a consensus of 
three observers lIsing the integrated information acquired from a pullback manoeuvre 
[26-28] and comprised (i) plaque composilion, (ii) plaque topography, (iii) the 
presence or absence of dissections and (iv) the presence or absence of an atherectomy 
byte. A lesion was judged as concentric when a thickening was circumferential along 
the entire vessel wall as opposed to an eccentric when a part of the vessel waJl was 
disease-free. The I()liowing definitions were llsed to describe plaque morphology: soft 
plaques: more than 75 % of the plaque area is composed of thickened intimal echoes 
with echodensity less than the reference adventitia. Fihroll.\· plaques: more than 75% 
of the plaque area is composed of bright echoes, as bright or brighter than the 
reference adventitia, but without acoustic shadowing. D~IJ"ilse calc(/ic plaques: bright 
echoes within a plaque with acollstic shadowing and occupying more than 180 0 of 
vessel wall circumference. Mixed plaques: when there is a combination of different 
types. The following definition was lIsed to assess the presence of a dissection: a 
demarcated break in the linear continuity of the plaque with circumferential or 
longitudinal involvement or the internal elastic membrane. An atherectomy byte was 
defined as a rectangular excision into the (sub)intimal layer. 
Quantitative measurements were made off-line from a videotape. Lumen area was 
defined as the area within the leading edge echo; external ('Iasr;c membrane' area was 
defined as the area within the media-adventitia boundary; plaque pIlls media area was 
defmed as the difference between external elastic membrane area and luminal area 
[27]. Variability measurements including interobserver variability and the correlation 
between ultrasound measurements with circular phantoms and human coronary artery 
casls have been reported previously [29]. 
Coronal), angiosc{}py: 
In 19 patients the target artery was also evaluated by coronary angioscopy before and 
after alhereclomy as previously described [19,30,31]. Unsuitable lesions for 
angioscopy included (i) proximal stenosis location « 1.5 em from the left main 
ostium) not allowing effective balloon intlation and (ii) excessive tortuosity not 
allowing visualization of the lumen. Angioscopy was performed with a 4.5 F 
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angioscope (Baxter-Edwards, Irvine, CA). During angioscopy the distal artery was 
flushed with Ringer lactate solution injected with a flow of 30 to 40 cc/min. To 
facilitate the review process a real-time fluoroscopy or cineangiography is combined 
with real-time angioscopy and ultrasound imaging by using split screen videotaping. 
Angioscopic images were assessed according to the recolllmendations of the European 
Working Group of Angioscopy [31]: reI/thromhus was defined as lilting or lIIural 
thrombus when a red, predominantly mural, non-mobile, superticial mass adherent 
to the vessel surface was observed, as prorrutiillM when a red, intimal protruding, 
mobile or non-mobile mass adhered to the vessel wall was seen and as ocelusive 
thrombus when a red intraluminal mass occluded completely the lumen. Dissections 
were distinguished into small sUlface disruptiolls (small, very mobile structures which 
are contiguous with the vessel wall) and lilrMe dissections (visible cracks or fissures 
on the luminal surface and/or large mobile or non-mobile structures which are 
contiguous with the vessel wall and of homogeneous appearance with the vessel 
wall). An mhereClomy illl/llci'd hyt" was defined as deep rectangular crevices 
extending into the wall in conjunctions with a mobile !lap. 
Qua1llitative commll)' al1MioMraphy: 
Quantitative analysis of the coronary segments was performed with the computer 
based Coronary Angiography Analysis System (CAAS), previously described in detail 
[6,7,32-37]. In essence, boundaries of a selected coronary artery segment are 
detected automatically from optically magnified and video digitized regions of interest 
(512 x 512 pixels) of a cine-frame. The absolute diameter of the stenosis in mm is 
determined lIsing the guiding catheter. The computer-estimation of the original 
dimension of the artery at the site of the obstruction allows to define the interpolated 
reference diameter. The percentage diameter stenosis is then calculated. To determine 
the changes in minimal cross-sectional area of the coronary artery segment from the 
density profile within the artery, videodcnsitometric algorithm was applied. 
Calibration of the densitometric area values is accomplished by comparing the 
reference area calculated from the diameter measurements (assuming a circular cross-
section) with the corresponding densitometric area value. lntracoronary isosorbide 
dinitrate (l-} mg) was given prior to and following atherectomy. At follow-up 
catheterization the administration of intracoronary nitrates was recommended prior 
to angiography. To standardize the method of data acquisition and data analysis and 
to ensure reproducibility of post-at he recto my and follow-up angiograms, measures 
were taken as previously described [34-}6]. 
Histology: 
The paraffin-embedded specimens were stained with haematoxylin-azophloxine as a 
routine slain. vOIl Kossa staining was used as a stain for calcium. The definitions of 
intima, media and adventitia have been described previously [38] and are in 
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accordance with the recommendations of the AHA Medical/Scientific Statement [39]. 
Slali.wical (/nalysis: 
All values are expressed as mean values ± I SD), Tbe paired student's Hest was 
lIsed to detect differences between continuoLls variables. Differences between 
categorical variables were tested with the chi-square and Fisher exact tests as 
appropriate. Differences were considered statistically significant where the p-value 
was less than 0.05. 
RESULTS 
Lesion 1JI00pI1O/ogy: 
On al/MioMrtlp/ly, the majority of the culprit lesions (88%) were considered typc B 
lesions according to the AHA/ ACe classification, 8S % of the lesions were eccentric. 
None of the lesions were calcified or showed angiographic signs of thrombus 
(discrete mling defect surrounded by contrast in the absence of calcifications, or 
persistent contrast staining in the area of the stenosis), 
T'lhle I Patient 'illd lesion cinral'leristics 
" 
Age (ye<lrs) 57 + 9 
Gender (M/F) 2214 
Unstable Angina t4 
Previuus infarclion 4 
Previous PTCA 1 
Lesion loclltion 
LAD 17 
RCA 6 
LCX 3 
AHA/ACC classitkation 
type A 1 (t2%) 
type B 21 (88%) 
typtlC 0(0%) 
Angiography Ultrasound Angioscopy 
Eccentric 22 (85%) 20 (77%)* ** 
Calcificali(lIl 0(0%) t4 (55%) ** 
Thromhus 0(0%) 0(0%) 7 (37 %) 
*; eccentncll ' 111{I~x sO.5 (clIOI'd as Illlllllllal IUllllllal diamd~rllllaXJlnii liminal (tamder "'*: no 
VHlue 
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Figun'/. Immwrm/(//}' II/fra.w!/Iic ill/IINi'S liff/in'e pllfil'IIfS iIlusrmfillX fill' /llIffi'mS lifllf/i('f'('Ctomy hy/l's 
(white arrow.I). A: 1II11/liph' hY'i's lI'i'/'(' 11l'ljimlled in Ihe lIormll/ Vi'S,H'1 lI'all oPPOSi/i~ 10 lIie 
(flhaosc/el"Olic pll/qui', E: S;IIXft' tllhen'l'foIllY byli' /leXI /(J II/(' (1'('(Ilt'l/Ic'.l'iOlj .1'11011';11),' dC/11l1'its of deep 
caldjicariolJ.l', C: pllffem lif 111'0 allii'fertolll), hyli'.\' with (/ r('1/1l1illill[.: parI Iy" the calcificd plaque 
bnwci'll hoth byli'S. Appaf('lIliy, the al/J('f'olo}//I' 11'/1.1' IIl1lrMe fO rCII/OVl' Illix pial' of caldjicalioll, 
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The illlrava.w .. :ular ulrrasolllul catheter could be advanced through the stenosis in all 
26 cases. In 18 patients the ultrasound probe was wedged into the stenosis. The 
majority of the lesions (58%) was characterized as soft lesions with minimal calcific 
depositions. One lesion was diffusely calcified with a calcific arch of > 180 0 while 
10 palienls (38%) exhibiled focal calcificalions eilher superficially (n=5) or deeply 
localed (n =5). 
Direct visualization of the vessel wall by anxioscopy prior to atherectomy was 
performed in 19 palienls and showed an irregular lesion in 12 patienls. Yellow 
plaques were seen in 14 patients. Red masses suggestive of thrombus was noted in 
7 patients (4 prolruding and 3 lining Ihrombi). No flaps or disseclions were observed. 
Procedural resulrs: 
All 26 palienls had successful alhereclomy procedures Ihal reduced Ihe residual 
diameler slenosis 10 <50%. Noballoon predilatation was performed. Athereclomy 
was performed with a 7 French atherotome in 84 % of the cases and a mean of 8 ± 
3 cuts were made in multiple'directions>: Although all atherectomy procedures were 
judged sllccessful on angiography, 4 patients underwent an adjunctive balloon 
dilalation 10 oplimize Ihe final result. No major clinical complications (i.e. death, Q-
wave myocardial infarction and coronary artery bypass surgery) were observed. In 
one patient a non-Q wave inf~lrction (max. CPK 600 U/I) occurred due to a guiding 
catheter induced occlusive dissection of the right coronary ostium after a sllccessful 
atherectolllY. During coronary angioscopy, the majority of the patients experiences 
ches't pain with conc~)Jnitant electrocardiographic changes suggestive for ischemia. 
Tahle 2. Quantitative;lin£iugraphic and ultrusonic Ill~asurcmcnls of lesion severIty and procedural result 
after directional coronary atherectomy 
pre-athercctomy post~alherectOlny p-value 
Angiography 
..... 
Reference diameter "(mm) 3.52 ± 0.52 3.70 ± 0.59. NS 
Minill1allumen Jiamckr (Illlll) 1.16 ± 0.43 2.85 ± 0.62 <0.0001 
Diameter ~(el"i.~)~is (%) 67 ± II 23 ± 13 <0.001 
Minimal cross-sectional ar~n (mml) 1.20 ± 0.87 6.67 ± 2.70· <0.0001 
Area stenositi'(%) 88 ± 8 39 + 20 <0.001 
Ulfra.wJ/lI/d 
External ela"~lic lamjn"~ area (nun2) "" 20.11 ± 4.43 21.00 ± 3.9'1 0.02 
Plaque + media arc.a (IJlm2) 18.16 ± 4.47 13.13 + 3.10 <0.0001 
Lum~n area (IlUIl2) 1.95 ± 0.70 7,86 ± 2.16 <0.0001 
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FigUrl> /I, AI/~iographic lIlId CllIgiosl'Opic ohsl'rmflon\' of(/// alhl'reC/OIl1;zed Sll'IIO.I';.\' illihe mid porlioll 
of/he left a1/fl'rior d('scelldillK nmll/(//)' lI/'Il'I)'. Followi,,!: afliC'reclomy, 'Ill' ('01'01101)' (/1'(l'/)' wall had 
(/ SI/Ioolh collfollr (left IIpper pal/el) while oll-Iille qUClmitatil'C' coramll)' llllgiogrtlphy shows (/ mild 
1'l'sidlwl ,\1l'lImi,I' (riKlif IIpper p(/I/el). 0" allgioscopy, tire proximal parI of "w lIrl<'1y '/lid indeed II 
SlIIooth wall cOl/figuralion (right 1011'('1' palll'I), llOl\'l'\'('r ol'po,l'('d 10 Ihl' (/IIKio~raphicfilldillgs, II small 
flap alld (f ('n~\'i('(' ,I'IINKl',I'I;I'(' for an flIhl'rt'l1OJny CIII a//Iie tarxet h'.I'itm l\'l'n~ ,H'e/! (hft lower pIlIIC/). 
Figllre lJ/, AIIXio,I'w/lh' il/U.I"/l'lIlioll (!!'Ille 1'('.I'.I'c'!lwlll ('my/xurt/lioll Iflier dir(,ctiol/al lIfhercc(o/llY, nil! 
while alTO\\' il/dim/c',1' Illl' sif" (if III" (~td.l'i(!J/ which 1//1,\' limned II !T1'1'i('l' illl/) (he wall. A ,1"/IlIlll flap 
rl' oh.I'cn'n/ af tlil' ,1';1(' lif IIIl' rt'.I'idlllll /t',I'io/l (hll/('k arrow). 'Ill(' "".I'idllllll('.I'ioll cO/lfllim' ydloll' plaque 
/l/a/erial alld hilS 111/ irrexular .l'Il1jl/n', 
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After balloon detlation, these abnormalities subsided and the chest pain disappeared. 
QU(JJllilalive mlJ.:io;:raphy (Table II): 
The mean vessel size of this patient population was 3.52 ± 0.52 mm. Atherectomy 
induced an increase in minimal luminal diameter from 1. 16 ± 0.43 mm to 2.85 ± 
0.62 mm (p < 0.001). After atherectomy, the diameter stenosis and area stenosis were 
23 ± 13% and 39 ± 20% respectively. Correspondingly, the minimal luminal cross· 
sectional area as derived from videodensitometry also increased from 1.20 ± 0.87 
mm2 to 6.67 ± 2.70 ",,,,2 (p<O.OOI) 
QU(JJllitafive lfllrasollud me(J.mremellls: 
External elastic membrane area, lumen area and plaque+media area at the normal 
reference segment proximal to the stenotic lesion did not change significantly during 
the procedure. 
Tahle 3. Ullrasonil; assesslllent of plaque reduction and lumen area gain achieved at atherectomy 
according its localisation und hi~lol('gkal c(lIlfinnation 
Phl(lUe rt'duclion (mm2 ) 
Ultrasound Histology 
calcium no calcium 
Suhellllotheliaicalcium 4.13 ± 2.11 . 4.13 ± 2.11 
(n~5) (n~O) (n~5) 
Base of the plaque l'alciull1 4.95 ± 1.36 3.85 ± 1.49 4.40 ± 1.46 
(n~5) (n~5) (n~ 10) 
No culciulll 6.21 ± 4.75 5.62 ± 2.26 5.89 ± 3.47 
(n~5) (n~6) (n~lI) 
5.16±3.16 4.88 ± 2.10 
(n~15) (n~ II) 
Lumen Ilre<l gain (1111n2) 
calcium no calcium 
Suhendo(hdiHI cakium 5.41 ± 2.41 . 5.41 ± 2.41 
(n~5) (n~O) (n~5) 
Base of the p];Rlue calciulll 5.19 ± 0.99 5.83 ± 1.57 5.51 ± 1.28 
(n~5) (n~5) (n~ 10) 
No calcium 6.34 ± 2.72 6.68 ± 1.66 6.52 ± 2.12 
(n~5) (n~6) (n~ II) 
5.69 ± 2.13 6.33 ± 1.61 
(11= 15) (n~ II) 
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Figun! IV. 711l' ('IJI//hilllyl /lxe oj allgiography, IIltra,\'Olllld iwagillg (/ml IIl1gioscopy ill a path'm who 
1111t/1'111'{'111 t/in'('{iol1l1/ (ltl/erectolllY, 71w II:!t tipper (jlladrallt iIlustrate,I' thl' cOl/cOII/itt/llt IIl1giographic 
~'iew ,\1/Owillg tI l'o/U'l'lItriC lesiol/ withour ('!'it/I'IICl' oj tlfnl/l/III/,l', nil' right IIppl'l' quadralll ,~//Ow.\' Ihe 
l'Iliargl'd IIIII/el/ /IS c/.I'w'.I',I'ed II)' IIbra,Hllllul /111//,\1/011',1' rIll' oril'llflltiol/ (!flhe (/1//('I"£'CIoIII), lIyl(' (arl'OlI'j, 
17'1' left/OIl'I'1" quor/flllIt ,I-hows IIil' al1gioxmpi<- I'iel\' oj ,III' lar"J.:l't sf/'lIo,I'i,I' /Jl'j()J"l' athl'l'l'l'/omy with It 
t"roll/bu.\" pre,I'l'IIf, After atll(,I"I,(,tOIl1)" (lIIg;O.l'COflY irklltij;ed /111 ;lIen'II,H' ill 11/11/('11, (/protnulillgjlap 
withoul 1'~';dl'IIc(' oj throm/ills (right /OW{'f quadrant). 
Angloscopy 
(n=16) 
Angiography 
(n=1) 
o 
13 
o 
o 
IVUS 
(n=3) 
Figure V. Vellil diagra/l/ /0 iIII/S/fafl' Ih(' (,(lIlIplillll'lItlll)' il1j(ml1l1titm obtail1ed by allgiography, 
imfacorO/I/lI)' 1I/lra,I"O/llIiI ;/l/ag;l/g and CO/Willi)' al/gios('()/~Y 11';/11 re,lpeel /0 till' deteetioll (if di.l'.I'C'ClioJl.5. 
As SllOIl'II, ullg;ogrlljllly 11l1d ullra.l'OIl11d ill/aging llllt/I'I'l'slilllll/I' lh(' il/dr/mcl' ojdi,l:I'l'ctiulls ax compared 
with 1Il1Xio.l"COpy. 
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No difference in external clastic membrane area between the reference and stenotic 
segment (20.94 ± 5.39 mm' vs 20.11 ± 4.43 mm';p~NS) was fonnd, in other 
words no compensatory enlargement at the site of the stenosis could be documented. 
Directional atherectomy induced a significant increase in lumen area from 1.95 ± 
0.70 mm' 10 7.86 ± 2.16 mm' (p < 0.000 I) and a decrease in plaque plus media area 
from 18.16 ± 4.47 mm' to 13.13 ± 3.10 mm' (p<O.OOOI). The exlernal elastic 
membrane area changed from 20.11 ± 4.43 mm' to 21.00 ± 3.91 mm' (p~0.02) 
which implies that vessel wall stretching is responsible for only 15% of the lumen 
area improvement achieved at directional atherectomy. The gain in lumen area was 
not dependent on lesion morphology (6.33 ± 2.05 vs 5.49 ± 1.68;p~0.30 soft vs 
mixed lesions) but did differ between calcitied and non-calcitied lesions; the change 
in lumen area varied with the location of calcium and was lowest in those lesions 
which contained (superficial) subendothelial calcium as compared to (deep) calcium 
at the base of the plaque (5.41 ± 2.41 mm' vs 5.51 ± 2.41 mm'). Plaque reduction 
in cross-sectional lumen area was greatest in ultrasonic non-calcified lesions when 
compared with calcitied lesions ( 5.89 ± 3.47 mm' vs 4.13 ± 2.11 mm'). There 
were too few patients with three or four quadrant calcifications to assess the influence 
of the calcification arc on area improvement. Subsequent histological examination 
confirmed the presence of calcium in all plaques containing ultrasound evidence of 
superficial calciulll (n =5) whereas it confirmed the presence of calcium in 50% in 
those cases with deep calcium (n= 10). In addition, plaque reduction and lumen area 
gain were higher in those cases with histological evidence of calcium than those 
without calciulll in the retrieved specilllen (table Ill), 
The posl-ath('l'('ctOlIlY 111111('1/ area cOIffiNlII'lIIio1/ (Figure I-IV): 
AnNioNraphy atter atherectomy revealed a sl1100th luminal lining in 19 patients, 
persistent haziness in 4, a dissection in 2 and thrombus in 1. Ultrasollnd imagillR 
showed a regular lumen contiguratiol1 in 4 of the 26 patients, an irregular 
configuration in 15, a subintimal tear in 4 (15%) and a dissection in 3 patients 
(12%). The appearance of a tear (Jr dissection was not related and did not apparently 
contribute to lumen area gain as assessed by ultrasound because the gain in lumen 
area was not different in this group compared with patients without evidence of 
dissections/tears (5.81 ± 2.82 mm' vs 5.95 ± 1.68 mm';p~NS). 
In 22 (85%) patients evidence of an atherectomy bytes were seen which resulted in 
a non-circular lumen area configuration. A clover-like post-atherectomy area 
configuration was never observed. Although the atherotome was directed towards the 
plaque in I patient the atherectomy bytes were made into the non-diseased area next 
to the plaque. Corollmy aIlNio.w .. :opy revealed an intracoronary thrombus after 
athereclomy in II patients (61 %). In 4 of these patients (21 %) this was a new 
thrombus while in the remaining 7 patients thrombus was already observed before 
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atherectomy. Dissections were observed in 5 patients (26%) and multiple or single 
subintimal naps were seen in 9 (42%) and 2 (II %) patients. In 14 patients (74%) a 
crevice suggestive of an atherectomy byte was observed (figure III). 
Complemclllmy iI//ormation (!f the three ima~iJlg techniques; 
Figure V shows the frequency of dissections and thrombi detected by angiography, 
ultrasound and angioscopy. Angiography definitely underestimates the incidence of 
dissections (10%) compared with ultrasound (12%) and angioscopy (26%). The 
dissection seen on angiography was also detected by ultrasound and angioscopy, 
however, angiography detected only 33 % of the dissections observed by ultrasound 
and 9% of the small and 0% of the big dissections noted by angioscopy. Although 
none of the big dissections visualized by angioscopy were demonstrated by 
ultrasound, all these patients had an irregular luminal contour on ultrasound 
examination. The incidence of post-atherectomy thrombus detected by angioscopy 
was 58% compared to 0% and 4% by ultrasound and angiography. 
DISCUSSION 
Because intra-coronary ultrasound imaging and coronary angioscopy permit detailed 
analysis of coronary artery lesion morphology and vessel wall damage in a manner 
not available with angiography, the complementary information obtained with these 
3 imaging techniques is of pivotal value for the assessment of the mechanisms of 
luminal improvement during directional coronary atherectomy. The major findings 
of this study arc threefold. First, the present study demonstrates that the combined 
use of quantitative angiography, coronary ultrasound imaging and intracoronary 
angioscopy may be applied safely in patients who underwent athereclomy for stable 
and unstable angina. Second, the main mechanism of action of athercctomy appears 
plaque reduction by excision rather than vessel wall stretching. Although selective 
plaque removal should in theory lead to a circular vessel lumen, ultrasound imaging 
in this series detected atherectomy bytes olltside the plaque area and non-confluent 
bytes in the plaque. Subsequent direct visualization by angioscopy confirmed these 
bytes as vessel wall trenches. Therefore, the post-atherectomy vessel wall 
configuration is not circular or smooth as previollsly demonstrated in angiographic 
observations [3]. Whether this irregularity ultimately may facilitate the renarrowing 
process by allowing ingrowth of hyperplastic tissue within these areas remains to be 
assessed. Third, unlike the angiographic observations, detailed angioscopic imaging 
showed evidence of substantial vessel wall trauma leading to an irregular post-
atherectomy lumen configuration with dissections, bytes and thrombi. 
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Plaque redflc/ion: 
The present study offers more detailed information on the mechanism of plaque 
reduction because, unlike in other studies, all lesions were crossed by the ultrasound 
device before and after atherectomy, Subsequently, plaque reduction was found to be 
the major determinant of the final luminal improvement achieved by directional 
atherectomy. These findings concur with those of other groups [22-24) and clearly 
differ from those of balloon angioplasty studies. These differences in action of 
devices may be of importance when examining the long-term results of variolls 
interventions. The present observations indicate that secondary to differences in 
luminal improvement, the renarrowing process after atherectomy Illay be of another 
nature (i.e. hyperplasia) than after balloon dilatation (i.e. recoil). 
Ves.\'el wall s/J'('/cliinp,: 
aLir observations indicate that although a significant plaque reduction occurred in 
most cases, accounting for most of the luminal gain, vessel wall stretching was the 
mechanism of luminal enlargement in some individual cases. In the entire group, 
vessel wall stretching, defined as the difference in external elastic membrane area 
before and after atherectomy, was found to a major contributor in the lumen area 
increase which is opposed to findings in previolls angiographic studies [12,13]. This 
observation underscores the limitations of angiographic studies when assessing the 
mechanism of interventions. 
NOI11I0I wall retrieval: 
Disease-free wall excision, which is unique to athereclomy, indeed plays a role in the 
mechanism of lumen area enlargement. In the present patient population, ultrasound 
was the only technique which could determine whether the atherectomy bytes were 
appropriately targeted. Until now, this feature of atherectomy has not been 
highlighted with exception of a case report on the death of a patient due to coronary 
artery rupture [40]. There are two possible explanations for the occurrence of 
inappropriate directional cutting. First, device positioning was achieved under 
fluoroscopic guidance yielding a two-dimensional representation of the arterial 
geometry. Subsequent inappropriate positioning may well occur and not be visualized 
by angiography. Second, device rotation during cutting Illay have happened due to 
lesion characteristics or device under/oversizing. In our series, no stenosis 
characteristics were found to he predictive of the occurrence of disease-free vessel 
wall cutting while adequate device sizing was performed using digital quantitative 
angiography to estimate vessel size and lesion severity. In the cases with predominant 
disease-free wall oriented shaving, angiography showed a small residual stenosis after 
atherectomy and is thus of limited value in determining the post-procedural lumen 
area geometry. Additional passages with the atherotome to remove the plaque under 
angiographic guidance may in these cases be hazardous and our observations call for 
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the urgent need of ultrasound guided atherectomy to avoid this complication. 
Compressioll (llId refl/{ull'llill;':: 
Whether the amount of plaque reduction represents tissue removal rather than 
redistribution can not be elucidated from this study since three-dimensional 
reconstruction of the stenosis was not performed rOlltinely. 
Dh'secriol1s: 
In a previolls angiographic study, Hinohara et al [49] concluded that atherectomy 
resulted in a smooth vessel wall contour with less dissections than after balloon 
angioplasty. The present study offers the benefit of using the complementary 
information obtained by ultrasound and angioscopy and shows that these two imaging 
techniques more accurately detect dissections and irregular walJ abnormalities. These 
findings are in agreement with observations of the GUIDE I trial in which dissections 
were seen in 40% by ultrasound compared to 19% by angiography [50]. In concert 
with these observations, the combined use of two imaging modalities may provide 
further insights into the origin of dissections. Indeed, our study indicates that 
dissections Illay be due to the specific cutting mechanism of atherectomy since the 
dissections were located at the site of the atherectomy bytes as visualized by 
angioscopy. Tenaglia et al [51] demonstrated the clinical significance of these 
observations and fOllnd that patients with an adverse outcome after athcrectomy had 
a significant higher incidence of dissections compared to patients without adverse 
events. In keeping with these findings we have performed addition balloon dilatation 
after post-atherectomy ultrasound assessment in two patients to improve the 
atherectomy result thereby avoiding the risk of adverse events. The absence of such 
events in this population may reflect the advantage of such ultrasound guided 
atherectomy procedures. 
711romhus: 
The detection of intracoronary thrombus by angiography has been hampered by the 
low resolution of the image intensifiers. Therefore it is understandable that direct 
visualization of the coronary vessel wall by angioscopy proved to be more accurate 
to identify thrombi than angiography [17,41-43]. Like dissections, the clinical 
significance of post-atherectomy thrombi resides in the high acute event rate 
associated with this finding [52] and therefore, the prevention or treatment of post-
atherectomy thrombi lllay beneficially influence the short-term and late outcome after 
atherectomy. In particular, thrombi resection by atherectomy has been associated with 
less restenosis [53,54] while residual intraluminal thrombus is a potential stimulus for 
an augmented proliferative vessel wall response. Although angioscopy revealed post-
atherectomy thrombi in 33% of the present patients, no acute events were seen. 
Whether subsequent intervention (thrombolysis, angioplasty) after the detection of 
thrombi results in a decrease in the restenosis rate remains to be determined. 
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Afh('f('C{oIJlY jhr c([I('(thY/lesions: 
Although angiography did not detect the presence of calcium in any of the 
atherectomized lesions, 10 lesions contained focal deposits of calciulll as 
demonstrated by ultrasound while 14 were calcified according to histological 
definitions. Although no statistical differences were detected in quantitative ultrasound 
measurements before and aftcr directional atherectomy. a trend towards less plaque 
reduction and lumen area gain was observed in calcified lesions. More specifically, 
the localization of the calcium appears to be a determinant of the acute procedural 
result of atherectomy with less gain in those plaques with superficially located 
subendothelial calcium. Apparently, the cutting mechanism is less effective when the 
atherotome has to cut through areas containing calcium. The combined use of 
intravascular ultrasound and histology also provides evidence that directional 
atherectomy removes calciulll. Specifically, all lesions that contained superficially 
located spots of calcium had histologic evidence of calcium in their atherectomy 
specimens whereas only 50% of the deeply situated calcium could be retrieved. 
Because acoustic shadowing of the calciulll, the thickness of the calcium spots cannot 
be measured and therefore the amount of calciulll removed can not be determined. 
These results suggest that micro-calcification of coronary artery lesions does not play 
a negative rolc when performing directional coronary atherectomy. 
Posl-alliereCltJlIlY 111I1'/{'11 area (.'ol!li~uratit)/1: 
Luminal renarrowing after new interventions remains an equally vexing problem than 
after conventional balloon angioplasty. Recent publications on long term results after 
interventions with new devices sllch as stenting and atherectomy have taught us that 
the acute procedural result partially determines the late angiographic outcome 
[1,4,5,7-10]. However, even when an optimal angiographic procedural result after 
atherectomy or stenting is obtained, restenosis remains the major limitation of these 
procedures [1-11,36]. With the clinical application of ultrasound imaging and 
angioscopy, more detailed information regarding the effect of the disruptive process 
of an intracoronary intervention on the luminal geometry can be obtained. In 
particular, ultrasound imaging has been shown to be superior in detecting dissections 
than angiography [16,18] while angioscopy is more efficient in visualizing Ihrombus 
[41-43]. Subsequent analyses of such images may identify predictors for restenosis. 
Preliminary findings have indeed indicated that vessel wall stretching and tearing may 
lead to an increased IIbro-proliferative response [44]. Also disruption of the internal 
elastic lamina leads to an enhanced luminal renarrowing process in human stented 
venous grafts [45] and swine stented coronary arteries [46-48]. 
COIic/II.vioIlS: 
The complementary information of ultrasound imaging and coronary angioscopy have 
revealed further insight into the mechanism of directional atherectomy. In particular 
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atherectomy yields a less circular vessel wall area configuration with a higher number 
of dissections and more residual thrombi than detected on angiography. These results 
suggest that ultrasound and/or angioscopy may be lIsed to guide atherectomy 
procedures thereby identifying an adverse angiographic outcome that may lead to 
serious clinical complications. 
Limitations: 
This study has several limitations. First, although at the outset of the study it was 
foreseen that all patients who would undergo atherectomy and had suitable anatomy 
for intracoronary angioscopy would be included in this prospectively collected series, 
it was not to perform angioscopy in some patients. Second, the size of the 
intravascular ultrasound catheter and the guidewire-artifact may have led to an 
underestimation of the number and orientation of the atherectomy bytes. Third, 
because a motorized pull-back procedure with three-dimensional ultrasonic 
reconstruction was not routinely performed, the extent of compression and 
remodelling could not be assessed. 
Fourth, we recognize the relative small sample size of our study population which 
precludes further subgroup analyses. However, this pilot study does provide useful 
information on the working mechanism of alherectomy and the complementary 
information provided by the three imaging techniques. Finally, although the 
procedure was occasionally influenced by the ultrasonic and angiocopic information, 
it was not our intention to examine the impact of these imaging techniques on 
procedural outcome. 
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CLINICAL OBSERVATIONS 
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ABSTRACT 
Directional coronary atherectomy has been introduced as an alternative for 
conventional balloon angioplasty when treating coronary artery stenoses with 
complex lesion morphology. To determine the immediate efficacy of coronary 
atherectomy in patients with slIch lesions, the first 113 attempts at directional 
atherectomy in two centers using quantitative angiography were reviewed in 105 
patients. The lesions were classified as complex stenosis since 95 % of the lesions 
had a symmetry index < 1.0 and a length of 6.83 ± 2.55 mm on average and an 
area plaque of 9.77 ± 6.69 nlln'. Procedural success defined as a residual 
stenosis S 50% after tissue retrieval was obtained in 90 (85.7%) of 105 patients. 
The primary angioplastic success rate, combining atherectomy and balloon 
angioplasty in case of failed attempt at atherectomy was 95.2%, 
Coronary atherectomy was unsuccessful in 5 patients; three of these were referred 
for emergency coronary artery bypass grafting. Major complications (death, 
emergency surgery and transmural infarction) were encoLlntered in 5.7% of the 
patients. 
Assessed by quantitative coronary analysis, a residual minimal luminal diameter 
of 2.42 ± 0.52 mill and a diameter stenosis of 26 ± 12% were obtained 
immediately after directional coronary atherectomy, 
We conclude that directional coronary atherectomy is particularly suitable for the 
treatment of stenosis with complex lesion morphology and is associated with 
acceptable complication rates, Randomized trials comparing atherectomy with 
balloon angioplasty are warranted to clarify the role of atherectomy in the 
treatment of lesions in the proximal part of the three major epicardial coronary 
arteries. 
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INTRODUCTION 
Percutaneolls translul1linal coronary angioplasty was reported in 1978 by 
Gruentzig [1] as a non-operative technique for the treatment of single, discrete 
and proximal coronary artery stenosis in patients with symptomatic ischemic heart 
disease. Over the past decade improved technology and operator experience have 
led to a greater use of conventional balloon angiopiasty with an excellent 
immediate Sllccess rate [2,3]. As indications for coronary angiopiasty expand and 
more difl1cult anatomy is approached, the likelihood of acute complications has 
increased. Potential causes of an initial suboptimal and unsatisfactory angiographic 
result after conventional balloon angioplasty include arterial recoil, dissections and 
presence of thrombus. In the past 4 years, interventional cardiologists have 
designed new devices aimed at debulking the atherosclerotic plaque. Directional 
coronary atherectomy is such a new technique having the potential advantage of 
creating a smooth luminal surface by removing rather than remodelling the 
plaque. We report the immediate quantitative angiographic results of the initial 
113 clinical applications of directional coronary atherectomy in two european 
centers lIsing the same methodology to assess the eftlcacy of intra-coronary 
interventions. Patients were referred for elective transcatheter treatment of an 
angiographic complex lesion and selected for directional coronary atherectomy 
when they presented with a suitable coronary anatomy (a stenosis in the proximal 
part of a coronary artery with a reference diameter ~ 2.5 mm). Quantitative 
coronary angiographic analysis (CAAS) was used to evaluate the immediate 
efficacy of directional athcrectomy. 
METHODS 
Palient sl'll'cfhm: 
From September 1989 through April 1991, 105 patients underwent 113 attempts 
at directional coronary atherectomy at the two participating centers. Both 
medically stable and unstable patients were considered candidates for directional 
atherectomy when they presented with a large and eccentric coronary artery 
stenosis in the proximal part of an epicardial coronary artery with an anticipated 
reference diameter of at least 2.5 mm. 
Coronal), alhfreetDlIIY: 
The atherectomy procedure was carried out as previously described [4]. Briefly, 
all patients were pretreated with 250 mg acetosalicylatic acid and 10,000 U 
heparin intravenously. To prevent coronary spasm, intra-coronary isosorbide 
dinitrate was given. Following the initial angiograms, the atherectomy device was 
advanced lIsing the over the wire technique and positioned across the stenosis. 
After proper positioning the support halloon was inflated up to 2 to 3 atm, the 
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driving motor was activated and the rotating cutter was slowly advanced to cut 
and collect the protruding intimal lesion in the collecting chamber located at the 
tip of the catheter. After each pass the balloon was deflated and either removed 
or repositioned. Atherectomy was considered successful when the residual stenosis 
was less than 50% and plaque material was present in the collecting chamber. 
Following atherectomy, the patients were monitored for 24 hours and 
electrocardiograms and cardiac enzyme levels were obtained twice a day. 
Nifedipine or nitrates were given every two hours for 24 hours after the 
procedure, and aspirin was given for one year. All atherectomy procedures were 
performed after obtaining informed consent. 
QU{JJ1lifativf! coronmy an~ioMraphy: 
Qua~titative analysis of the coronary segments was performed with the computer 
based Coronary Angiography Analysis System (CAAS), previously described in 
detail [4-8]. In essence, boundaries of a selected coronary artery segment are 
detected automatically from optically magnified and video digitized regions of 
interest (512 x 512 pixels) of a cine-frame (ligure I and II), The absolute diameter 
of the stenosis in mill is determined lIsing the guiding catheter as a scaling device. 
Calibration of the catheter in absolute values (111m) is achieved by comparing the 
mean diameter of the guiding catheter in pixels with the measured size in 
millimeters. Each individual catheter is measured by a micrometer. To correct the 
detected contour of the arterial and catheter segments for pincllshion distortion, 
a correction vector is computed for each pixel based on a cOlllputer- processed 
cine frame with a centimeter grid placed against the input screen of the image 
intensitier. Since the functional significance of a stenosis is related to the expected 
normal cross sectional area of a vessel at the point of obstruction, we use a 
computer-estimation of the original dimension of the artery at the site of the 
obstruction to define the interpolated reference diameter. The percentage diameter 
and area stenosis as well as the cross sectional area (mI112) are then calculated. 
The length of the lesion (mm) is determined from the diameter function on the 
basis of a curvature analysis. Symmetry is defined as the coefficient of the left 
hand distance between the reconstructed interpolated reference diameter and actual 
vessel contours and the right hand distance between reconstructed and actual 
contours at the site of the obstruction. The symmetry index ranges from 0 (totally 
eccentric stenosis) to I (symmetric). The degree of coronary bend is assessed by 
the curvature value at the obstruction site. This parameter is computed as the 
average value of all the individual curvature values along the centerline of the 
coronary segment, with the curvature defined as the first derivative of the tangent 
as it moves along the centerline which for a circle is equal to the reciprocal of the 
radius. The area between the actual and reconstructed contours at the obstruction 
site is defined as the area plaque and is expressed in 111m2. The severity of a 
stenosis can also be expressed as a percentage area stenosis assuming circular 
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Figure I. De/('c/c'd COlllol/l:\' slIperimposed 011 tlw origil/fli vi"('o illlagc,/or II {'olllpkt le,\'iol/ lI'ilhill 
a .\'{(,1I1 ill a Vl'1I0Il,\' hyplI.I's graft ,fiIIlIfY/ ill/ateral (LAT) pl'Ojl'l'/iolll}(jim~ din'l,tio//al athera/omy, 
111l' diall/c/l'rfimClioli is ,l'lIoWII III fill' hO(fOIl/. 711l' Wllifl' area is (/ IIIl'(/,\'/(/'('/OI' the "alhl'ro.l'c/l'I'Olic 
p/a(jlll!". 11u' lIIil/illlallumillal d;mlll'l('/' (vatiml lille) is 0.63 111111, col'n',llw1/(/illg 10 1I ditlllu'Il'1' 
stenosis (if 78% /llId WI arC'a ,1'fl'lIo,d,I' 0/95%. 
FiRlire /I, A :I'ill){/l"/rlill/C' fllIgiogmm 0/ /lle \'('//0/1.1". hypos,l' gwjt 1UlIIl'" ill LAT a/fl'!' directiollal 
IIIlIl'/'('('/o/llY, 111l' /IIllIillllllllllllil/al dim/wlt'l' im'/'l'a,I"('(/lo 1.77111111, coln'slw/lfiillg to a diameter 
s/(,}lOsi,s (if JJ% alld //1/ (//'C'/I.I"/I'I/o.dl" 0/55%. 
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cross sections at the obstruction and reference position. Corresponding luminal 
areas (mm2) were calculated by comparing the minimal area value at the 
obstruction with the reference value obtained following the interpolated diameter 
technique. 
RESULTS 
Technical Sllccess in crossing the stenosis with the atherectomy device was 
achieved in 95 of 105 patients (90.5%). In 10 patients atherectomy was not 
performed since the stenosis could not be reached by the atherectolllY device; 
twice the guiding catheter could not be placed selectively in the coronary ostium 
and eight times the lesion could not be crossed by the atherectome itself. Nine of 
these patients underwent a successful conventional angioplasty procedure while 
one patient was electively referred for coronary artery bypass grafting. These 10 
patients belonged to the cohort of the initial 25 patients treated by atherectomy in 
each center. 
Clinical and lesion characteri.ytics: 
Of the 95 patients in whom directional coronary atherectomy was performed, 24% 
had a history of a previous balloon angioplasty (n=15), stenting (n=6) or 
coronary atherectomy (n=2), 24% had two or three-vessel disease and 41 % had 
a previous myocardial infarction (table I). Two patients had previously undergone 
a heart transplantation. At the time of atherectomy, 41 patients were in New York 
Heart Association functional class IV, 27 patients in class III, 26 patients in class 
"and one patient in class I. The target stenosis (n=103) in these 95 patients was 
located in the left anterior descending artery in 63 cases, in the left circumflex in 
12 cases, in the right coronary artery in 24 cases and fOllr times in a venous 
bypass graft. 
Procl'dural results: 
In all but 4 patients a 6 French atherectomy device was used. One patient was 
treated with a 5 French and in 3 patients a 7 French atherectomy device was used. 
On average 5.8 ± 2.8 passes in multiple directions were performed. The primary 
sllccess rate as defined by a residual stenosis < 50% and tissue withdrawal was 
85.7% (90 of 105 patients). The primary angioplastic success rate, combining 
atherectomy and balloon angioplasty in case of failed attempt at atherectomy was 
95.2% (100 of 105 patients). In five patients directional atherectomy lVas not 
successful; in one patient an obsfructive dissection occurred which was 
successfully treated by a stent implantation, a second patient presented with. a 
persistent total occlusion despite conventional balloon angioplasty and subsequent 
atherectomy. This patient was referred for elective coronary bypass grafting. 
Three palients were referred. for emergency coronary artery bypass surgery 
because of guiding-catheter induced dissection 
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of the right coronary ostium (n= I), a total occlusion one hour after the 
atherectomy procedure which persisted despite emergency balloon angioplasty 
(n = I) and because of an obstructive dissection induced by the manipulation of the 
device into a curved coronary artery (n=I). 
Table I. Clinical and lesion characteristics of 95 patients treated successfully hy directional 
alhereclomy 
Gel/der NYHA classification 
Male 8t class I t 
Female 14 class II 26 
Histmy class III 27 
Prior infarction 43 class IV 41 
Prior angiupla.~ty t5 Vi'.Ue/ disci I.\'{' 
Prior stenting 6 One 67 
Prior atherectomy 2 Two 22 
AI/Kintl du.\".\" Three 6 
Stahle Ilngiml 54 Target lesitlJl 
Unstable angina 41 LAD 63 
LCX 12 
RCA 24 
Graft 4 
QutJlllifative (JJIMiop,raphy: 
Quantitative angiographic analysis was performed on all successfully treated 
coronary lesions. The quantitative angiographic parameters which describe the 
complexity and the severity of the lesions are tabulated in table 2. With respect 
to lesion complexity, the length of the stenosis was on average 6.83 ± 2.55 mm 
while all but 5 lesions were found to be eccentric (symmetry index < 1.0) 
according to quantitative angiographic detinitions. The mean curvature value for 
all analyzed segments was 15.3 ± 7.5. The lesion severity can be characterized 
by the area plaque, area stenosis and minimal cross-sectional area. The mean 
value for the area plaque was 9.77 ± 6.69 111m2 while the area stenosis averaged 
85 ± 8% and Ihe minimal cross-sectional area was 1.12 ± 0.75 111m2. 
The sequential changes in angiographic parameters before and after coronary 
atherectomy are shown in figure III and IV. The reference diameter did not 
change signiticantly (3.17 ± 0.64 nlln to 3.26 ± 1.13 mm). As expected the 
minimal luminal diameter and mean cross-sectional area increased significantly 
(1.13 ± 0.38 mm to 2.42 ± 0.52 mm;p<O.OI and 1.12 ± 0.75 mm' to 4.84 ± 
1.78 mm';p<O.OI respectively). Accordingly, the diameter stenosis and area 
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stenosis decreased signiticantJy from 64 ± II % to 26 ± 15% (p <0.01) and from 
85 ± 8% to 43 ± 18% (p<O.OI). 
ComplicalhJn.'I: 
Major complications (death, emergency coronary bypass grafting and Q-wave 
myocardial infarction) were observed in 5.7% of the patients (not mutually 
exclusive). One patient (0.9%) died three days after an angiographic successful 
procedure due to a delayed rupture of the atherectomized coronary artery and has 
been previously reported [9]. Three patients (2.8%) underwent emergency surgery 
and five patients (4.7%) sustained a transmural infarction either peri-operatively 
(n=3) or after an angiographically successful procedure (n=2). These last two 
patients developed an infarction due to an occlusion after a baUoon angioplasty 
distal from the atherectomy site (n = I) and due to an embolization (n = I). 
Minor complications (non Q-wave infarction, transient ischemic attack) were seen 
in 4 patients (3 and I respectively). No patients required blood transfusions or 
vascular surgery because of vascular problems at the femoral puncture site. 
Table 2. Quantitative angiogntphie ha,~eline stenosis characteristics of 113 successfully treated 
coronary artery lesions 
Extent (mm) 6.83 ± 2.55 
Symmetry index 0.53 ± 0.25 
Curvature value 15.3 ± 7.50 
Area plaque (mm2) 9.77 ± 6.69 
Area stenosis (%) 85 ± 7 
Reference afea (mm2) 8.25 + 3.30 
Reference diameter (nun) 3.17 ± 0.64 
MLCA (nun2) 1.12 ± 0.75 
MLD (nun) 1.13 ± 0.38 
DS (%) 64 ± tl 
y, <JIamder stenoSIS, MLLA minI/mil ummal cross sectIOnal area, MLU nunllnH 
Iliminal diameter. 
DISCUSSION 
The data from this study show a primary success rate of 85.7%. This success rate 
did not differ between the two centers and was markedly influenced by the 
learning curve effect since the 10 patients in whom the lesion could not be crossed 
by the device belonged to the cohort of the initial 25 patients treated by 
atherectomy in each center and therefore represent an inappropriate selection 
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process. Thus, the primary angioplastic ~uccess rate of 95.2% represents more 
closely the actual success rate and is comparable with other reports [10-13). 
However, despite this experience, the procedure was unsuccessful in 5 patients. 
In three patients this was due to procedural and patient selection factors: 2 
patients developed a guiding catheter induced dissection and in one patient the 
device caused a dissection while passing through a non-negotiable coronary artery 
bend. 
Study t/esif!,lI: 
Patiel]ts with both stable (n ~54) and unstable angina (n ~41; typical ischemic 
chest pain associated with electrocardiographic changes) were selected for 
coronary atherectomy when they presented with a stenosis in the proximal part of 
an epicardial coronary artery. The clinical characteristics of this patient population 
do not differ significantly from those treated by balloon angioplasty [14,15) or 
stenting [16] at our institutions. However, this patient population is characterized 
by the high incidence of angiographic complex lesions when compared with 
balloon angioplasty patients. Meier et al [17) reported a mean lesion length of 4.6 
mill in a conventional angioplasty patient population and they reported a higher 
complication rate in their patients with eccentric and long ( > 5.0 mm) stenoses. 
Quantitative coronary angiography in our patient population ~ell1onstrates a 95% 
incidence of asymmetric coronary artery stenoses with a long lesion (6.83 ± 2.55 
mm), a large atherosclerotic plaque (area plaque ~ 9.77 ± 6.69 mm') which 
severely obstructs the coronary artery lumen (area stenosis = 85 ± 8%). 
Therefore, this patient population is characterized by a high incidence of 
angiographic complex lesions. We confirm the result of Hinohara [13) that 
coronary atherectomy achieves a high success rate in lesions with complex 
stenosis characteristics. 
Mec1wllisll1: 
Luminal improvement after conventional balloon angioplasty is created by 
compression or remodelling of the atheromatous plaque and by overstretching the 
vessel wall. Frequently many of the lesions are not effectively dilated because of 
elastic recoil of the vessel wall or incompressibility of the encroaching plaque. 
Furthermore, the barotrauma of the balloon may induce substantial damage to the 
vessel wall which may result in dissections or total occlusions. Recent studies 
report an incidence of acute coronary artery occlusion of 2 to 11 % following 
conventional halloon angioplasty [14, 18, 19). These studies have demonstrated that 
unstable angina and the complexity of the coronary artery lesion arc important 
factors associated with risk of coronary artery occlusIon [15,19,20]. Therefore, 
new techniques like directional atherectomy which remove rather than remodel the 
atheromatolls plaque have been introduced to supplement conventional balloon 
angioplasty especially when treating complex lesions. Theoretically, these 
techniques have several advantages over dilating techniques. First, selective 
("directed") plaque removal becomes possible with less dissections. Second, with 
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directional atherectomy plaque removal results in a superior luminal improvement 
when compared to balloon angioplasty [20,21] and finally, atherectomy induces 
less recoil of the arterial wall [20). 
This study demonstrates the efficacy of directional atherectomy in treating 
coronary artery lesions with a complex morphology with a low incidence of acute 
occlusions (0.9%) when compared with balloon angioplasty. These results are in 
accordance with the observations of Hinohara [13]. Furthermore, atherectomy 
resulted in a large gain in luminal improvement when compared with historical 
[15] and matched [20,21) controlled angioplasty patients. 
Complicatiolls: 
Directional coronary atherectomy is associated with potential new problems due 
to the specific mechanism of atherectomy which may offset the well known 
incidence of complications observed with balloon angioplasty. Firstly, because the 
depth of the resection and precise spacial orientation of the device are not 
controlled it is possible to remove either medial or adventitial tissue. Tn recent 
studies [10,12,22] adventitia was identitled in 30% of the resected specimen. The 
most feared complication after directional atherectomy is a coronary artery 
perforation. In our consecutive series this has been documented once (0.9%) three 
days afler the procedure [9]. Improved operator experience and techniques with 
incorporation of intravascular imaging may avoid removal of vessel wall 
components. Secondly, directional coronary atherectomy may induce embolization 
of excised plaque material with subsequent development of a myocardial 
infarction. In this series myocardial infarction due to plaque embolization was 
observed in 3.7% of the patients (I Q-wave infarction). This complication rate is 
not higher than that reported in large PTCA trials including stable and unstable 
patients [2,3,14,15,18,19]. Finally, acute coronary occlusion at the site of 
atherectomy occurred in 0.9% of the patients which is substantially lower than the 
reported 5 to II % incidence after balloon dilatation [15,18,19]. 
Cone/usions: 
We confirm the results of other studies [10-13): directional coronary atherectomy 
is technically feasible , is particularly suitable for the treatment of stenosis with 
complex lesion characteristics as assessed by quantitative coronary analysis and 
is associated with low complication rates. Success rates are further improved with 
adjunctive lise of conventional balloon angioplasty for a failed atherectomy 
attempt. Randomized trials comparing atherectomy with balloon angioplasty are 
mandatory to clarify the specific role of atherectomy in the treatment of coronary 
artery disease. 
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ABSTRACT 
The clinical efficacy and safety of directional coronary atherectomy for the 
treatment of stable and unstable angina was assessed in 82 stable and 68 unstable 
procedures. Therefore, clinical and angiographic follow-up were obtained in a 
prospectively collected consecutive series of 150 atherectomy procedures. 
Restenosis was assessed clinically and by quantitative angiography. The overall 
clinical sliccess rate of atherectomy for unstable and stable angina was 88 % and 
91 %, respectively. No significant differences were found for in-hospital event 
rates between the unstable and stable groups: death (1.5% vs 0%), myocardial 
infarction (10% vs 6%) and emergency bypass operation (3% vs 2%). These 
clinical events were related to the occurrence of abrupt occlusions (8.8% in stable 
and 6.1 % in unstable angina;p~NS). Clinical follow-up was achieved in 100% 
of the stable and unstable patients at a mean interval of 923 and 903 days 
respectively. Two year survival rales were 96% and 97% in the unstable and 
stable populations. There were no significant differences with respect to bypass 
surgery and angiopiasty. but event-free survival at 2 years was significantly lower 
in the unstable group (54%) than the stable group (69%). Quantitative coronary 
angiography did not detect any difference in luminal renarrowing during the 6 
month angiographic follow-up period. AlthQugh directional coronary atherectomy 
can be performed effectively for unstable and stable angina, the long-term clinical 
outcome was less favorable in the unstable group. The overall higher incidence 
of adverse events in unstable patients occurred despite the excision of unstable 
plaque material, and may therefore refiect the inherent instability of the syndrome 
rather than the inability of atherectorny to establish a persistent sliccess. 
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INTRODUCTION 
Increasing operator experience has rendered directional coronary atherectomy a 
safe and sliccessful treatment for patients with symptomatic coronary artery 
disease. However, the long-term outcome of atherectomy is still limited by 
unpredictable progression to recurrent stenosis. Although it was hypothesized that 
controlled plaque removal by the atherotome might lead to favorable short and 
long-term results, this was not confirmed in the two recently completed 
randomized trials, Coronary Angioplasty Versus Excisional Atherectomy Trial 
and Canadian Coronary Atherectomy Trial which compared atherectomy with 
balloon angioplasty [1,2]. Despite these findings, directional coronary atherectomy 
may be beneficial in particular patient groups. 
The management of patients with unstable angina continuous to receive much 
attention, and conventional balloon angioplasty has assumed an important role in 
the treatment of this condition. However, most reported series demonstrated 
complication rates in excess of those seen in stable patients undergoing 
angioplasty [3-5]. This is thought to be related to the complex nature of unstable 
lesions where plaque ulceration and mural thrombus appear to be important [6-8]. 
Also it has been suggested that angioplasty in the context of unstable angina is 
associated with increased restenosis rates [9,10] although this has not been 
confirmed by others [3-5, II]. 
The potential for atherectomy to improve the outcome of unstable angina has not 
yet been determined. We therefore examined whether pre-procedural anginal 
status influenced immediate and late clinical progress in a prospective cohort of 
143 patients undergoing 150 directional coronary atherectomy procedures in our 
institution. 
METHODS 
Patienr selection: 
Between September 1989 and January 1993, 143 patients underwent 150 
directional coronary atherectomy procedures for stable and unstable angina. 
Patients were considered candidates for directional atherectomy when coronary 
angiography revealed a severe. eccentric non-calcified stenosis in the proximal 
nOIl-tortuollS part of an epicardial coronary artery with an anticipated reference 
diameter of at least 3.0 Illill. 
Clinical d{~finitions: 
Unstable anlIil/ll was defined as chest pain at rest while hospitalized accompanied 
by electrocardiographical evidence of myocardial ischemia (ST segment or T 
wave changes) despite optimal medication including intravenolls nitroglycerin and 
heparin amongst others without evidence of subsequent myocardial necrosis. All 
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other clinical syndromes of ischemic heart disease were considered stable angina. 
Recent myocardial iI!t(If'(.'/iol1 was defined as transmural (electrocardiographic Q-
wave) or non-transmural (no Q-wave) when chest pain was associated with a peak 
CK elevation greater than twice the upper limit of normal values during the 
preceding 7 days. 
Abrupt occ1l1.rion: a total occlusion of the coronary artery at any time during or 
after the atherectomy procedure, further classified as procedural occlusiqn (Le. 
during the procedure) and subacute (i.e. after the procedure within 24 hours) in 
association with clinical or electrocardiographic evidence of ischemia. 
Clinical endpoints: 
The follow-up of all patient treated by atherectomy was started at the end of the 
procedure. The following clinical events were recorded: 
Demh: all death are considered cardiac unless they are documented to the 
contrary. 
Myocardial iI/j(lre/ioll: defined as the development of new abnormal Q waves on 
the ECG or an enzyme change by more than two times the upper limit of normal 
creatinine kinase. 
TallIe I Cliniclli dl'lrllCleristics of sl'lble amI unslable palients .. 
Un stahle (n=68) Siahle (n=82) 
Age (years) 58 + " 58 + 10 
Male gender 57 (84%) 66(81%) 
NYHA functional elass 
II - 33 (41 %) 
III 49 (59%) 
IV 68 (100%) -
Previous intflf(~lioll 21 (31 %) 16 (19%) 
Previous PTCA 12 (18%) l7 (20%) 
Mulli-vessel disease to (15%) 14 (17%) 
Target arlery 
LAD 45 (67%) 57 (68%) 
RCA 18 (26%) 15 (19%) 
LCX 5 (7%) 10 (13%) 
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Figure I. Corol/my IlI11:ioKrUIII alld 1u',\"wio1:lcjilldiIlK.I' ill 1111 tllls/ah/e palie'll' hliOrt' 1l1l/ert'ClolIIY. 
Corollaty I1II!:hJ!:raphy s//{!I\w/ (/// eC("('//Iric /(>.I'ioll 11';111 smooth b()rd('r,~ lowled ill llie lIIid porlioll 
of tlie hft allfer;or d('scendiIlK corOIlIlI)' Ilr/('I)'. IlIlracorollmy ullra,WIII/{l iowgiut: n'w'llll'd 111/ 
wulerlyill}: ('('('('I1I";c plaqul' lI';t" he/t'rog('ll('olfs echo1{nlidty (/11£1 \I';II/OUI calcific del'osils. 
Hislopat/IO/ng;<'a' eXlIlI/illalioll (!.{lhe retri('l'('(/lI/flll'f;fll d;self/.I'ed arm.l· lifthrll/lllwlie material (T) 
with diffi.'f"('lIt dl'gn'I',I' liforglllliwtioll (OT) ill dow appo.\·it;oll 10 IIWdt'rllfdy cdlulurjlhroticlis.l"II(! 
IF). 
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Carol/my arlelY hypas,r ,\'urgl'I)': is classified as emergency, in-hospital elective 
and during follow-up. 
Repeat anxioplasty: defined as any re-insertion of a guiding catheter followed by 
a new angiopiasty. 
Atherectomy procedure. 
The procedure was carried out as previously described [12-17]. Briefly, all 
patients were pretreated with 250 mg acetylsalicylic acid and 10,000 U heparin 
intravenollsly. To prevent coronary spasm, intra-coronary isosorbide dinitrate was 
given. Following the initial angiograms, the atherectomy device was advanced 
using the over the wire technique and positioned across the stenosis, On optimal 
deployment, the support balloon was inflated up to 2 to 3 atm, the driving motor 
was activated and the rotating cutter was slowly advanced to cut and collect the 
protruding intimal lesion in the collecting chamber located at the tip of the 
catheter. Pl'Ocedural ,,'ucce,\'.\' was defined as a residual diameter stenosis of less 
than 50% after atherectomy with or without balloon angioplasty. Clinical success 
was defined as a procedural success without in-hospital adverse clinical events 
(death, myocardial infarction, bypass surgery). Following atherectomy, the 
patients were monitored for 24 hours and electrocardiograms and cardiac enzyme 
levels were obtained twice a day. Nifedipine or nitrates were given every two 
hours for 24 hours after the procedure, and aspirin was given for one year. All 
procedures were performed after obtaining informed consent. 
Quantitative cOl'Ol/my angiography. 
Quantitative analysis of the coronary segments was performed with the computer 
based Coronary Angiography Analysis System, previously described in detail [15-
19]. In essence, boundaries of a selected coronary artery segment are detected 
automatically from optically magnified and video digitized regions of interest (512 
x 512 pixels) of a cine-frame. The absolute diameter of the stenosis in mill is 
determined using the guiding catheter as a scaling device. Calibration of the 
catheter in absolute values (mm) is achieved by comparing the mean diameter of 
the guiding catheter in pixels with the measured size in millimeters. Each 
individual catheter is measured by a micrometer. To correct the detected contour 
of the arterial and catheter segments for pincllshion distortion, a correction vector 
is computed for each pixel based on a computer- processed cineframe with a 
centimeter grid placed against the input screen of the image intensifier. Since the 
functional significance of a stenosis is related to the expected normal cross 
sectional area of a vessel at the point of obstruction, a computer-estimation of the 
original dimension of the artery at the site of the obstruction to define the 
interpolated reference diameter is used. The percentage diameter and area stenosis 
as well as the cross sectional area (mm') are then calculated. The length of the 
lesion (111m) is determined from the diameter function on the basis of a curvature 
analysis, The area between the actual and reconstructed contours at the 
obstruction site is detincd as the plaque area and is expressed in Illm 2. The 
163 
severity of a stenosis can also be expressed as a percentage area stenosis assuming 
circular cross sections at the obstruction and reference position. Corresponding 
luminal areas (111m2) were calculated by comparing the minimal area value at the 
obstruction with the reference value obtained following the interpolated diameter 
technique. 
Statistical analysis. Mean values and standard deviations are given for continuous 
variables. Comparisons of mean values were performed using a two-tailed paired 
t-test. Categorical variables were compared lIsing chi-square tests with Yates' 
continuity correction applied were appropriate. A p-value of greater than 0.05 was 
considered non-significant. 
RESULTS 
Clinical alll! al1~;oKmphic demoKraphics: 
Of the 150 procedures, 82 were performed for stable and 68 for unstable angina. 
Baseline clinical and angiographic characteristics are reported in Table I. By 
study design, the unstable angina group contains only patients with New York 
Hea.rt Association functional class IV angina. Similar baseline characteristics were 
found between the groups except that unstable patients sustained more infarctions 
before atherectomy. Most atherectomy procedures were performed in the left 
anterior descending coronary artery (68%) with more right coronary artery lesions 
in the unstable group. Most narrowings were primary stenosis although 19% of 
the patients underwent atherectomy for restenosis after previous angioplasty. 
Procedural re.wlts. 
In the group with unstable angina, stand-a/olle alhereclomy was performed in 64 
cases with a clinical success in 62 (97%). In one patient plaque embolization with 
subsequent side-branch occlusion occurred, and another patient underwent elective 
bypass surgery after an unsuccessful emergency atherectomy procedure. 
Adjunctive balloon ang;oplasfy (n =4) after atherectomy was performed for the 
following angiographic complications: a nose cone dissection (n =2) and an abrupt 
total occlusion (n=2). When employed, balloon dilatation was angiographically 
successful in all cases, however one of these patients was subsequently referred 
for emergency coronary artery bypass surgery because of refractory threatening 
occlusion. 
In the group with stable angina. sIalic/-alone atlwrectomy was performed in 77 
patients (94 %). Clinical success was achieved in 76 (99%) as one patient 
underwent emergency bypass surgery for an occlusive catheter induced dissection. 
Acl/lil/clive hallooll lIf/;:ioplasty was performed in 5 patients to improve the post-
atherectomy result. In this group no procedural abrupt occlusions were seen. 
The procedural sllccess rate for unstable and stable angina was 96% and 99% 
(p=NS), respectively. 
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In-hospilal success alld complicaliol1S: 
The clinical success rate detlned as an angiographic success in absence of death, 
myocardial infarction or emergency or elective in-hospital bypass surgery was 
88 % (60/68 patients) for unstable angina and 91 % (75/82 patients) for stable 
angina (p=NS). 
Major clinical complications developed in 15 patients, usually related to the 
occurrence of an abrupt occlusion. In total the incidence of abrupt occlusion was 
7.3% (8.8% vs 6.1 % in the unstable and stable groups;p=NS). Procedural 
oce/usions occurred in four (5.9%) unstable and one (1.2 %) stable patient. In the 
unstable group, these were guiding catheter induced in 2 and nose-cone induced 
in I or occurred after dilatation of an occluded sidebranch (n = I). Three of these 
were treated by angioplasty andlor stenting. One patient was subsequently referred 
for emergency surgery after successful dilatation. One procedural occlusion 
(guiding-catheter induced) occurred in the stable group. Subacllfe occ/usions 
occurred in 2 (2.9%) patients in the unstable and in 4 (4.8%) patients in the stable 
group (p=NS). All patients were immediately transferred back to the 
catheterization suite for subsequent sllccessful balloon angioplasty but all except 
one suffered a myocardial infarction. Therefore, an occlusion al Ihe sile of 
a(herec(omy occurred in 4.4% of the unstable and 4.8% of the stable procedures 
(p=NS). 
In-hD.\jJilal d('alh occurred in one unstable patient 3 days after a successful bail-
Ollt atherectomy. This patient developed cardiac tamponade secondary to a 
coronary perforation at the site of athereclomy. 
Q-ware myocardial {f!/clrcthm occurred in 7 (10%) unstable and in 5 (6%) stable 
patients (p=NS). In the unstable group, 5 (71 %) of the 7 infarctions were due to 
a (sub)acllte occlusion, I patient had an unsuccessful emergency atherectomy after 
failed thrombolysis in the setting of an acute myocardial infarction and I patient 
had a plaque embolization that resulted in a sidebranch occlusion. Four (80%) of 
the 5 infarctions in the stable group occurred in the setting of a subacute 
occlusion. 
Coronmy hypass SlII/-:l'l)' was performed immediately in 2 patients in each group 
and on an elective basis in one patient in each group. All patients who underwent 
emergency surgery except one developed a transmural infarction. 
LOI1!~-lenn clinical outcome: 
Clinical follow-up was achieved in 100% of stable and unstable patients at a mean 
follow-up interval of 903 days in the unstable group and 923 days in the stable 
group. This analysis involved all patients including those with an unsuccessful 
atherectomy procedure. Event-free survival was defined as 
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survival in the absence of myocardial infarction, coronary bypass surgery or 
repeat transluminal intervention. Figures II and III show the initial and late 
freedom from events as assessed by the Kaplan-Meier analysis for the unstable 
and stable groups. One and two year survival were 98% and 96% in the unstable 
and 100% and 97% in the stable group. During follow-up, I (1.4 %) patient from 
the unstable group died suddenly. Four (4.9%) palients from the stable group died 
during follow-up: one cardiac and 3 non-cardiac deaths. No other patients than 
those with a cardiac death suffered a 11I)'ocanHal infin'Cfioll. Coronmy bypass 
surgNy for recurrent angina was performed in 5 unstable and 2 stable patients 
(7.5% vs 2.4%;p~NS). Repeal angioplasty was performed in 12 (17.9%) 
unstable and 15 (18.3%) slable patients including 4 patients who had an 
angioplasty for a lesion other than at the site of the index atherectomy. Thus at 
one and two years 57 % and 54 % of the unstable and 74 % and 69 % of the stable 
patients were event-free. The difference in event-free survival between the groups 
was statistically significant (p<0.02). 
Tahle 2. Quantitative angiographit~ analysis of the immediate and late effects of dirlXtional 
coronary atiJerectomy for unsl'lhk '1m] st·\hk angina .. 
I I Unstahle I Stable I 
Reference diameter pre (mill) 3,29 + 0,59 3.17 ± 0.63 
Minimal luminal diameter pre (mm) I. 17 ± 0.39 I. 17 + 0.40 
Minill1ulluminal diameter post (nun) 2.38 ± 0.48 2.36 + 0.58 
Minimal luminal diameter fup (mill) I. 70 + 0.49 1.66 + 0.56 
Diameter .~tcnosis pre (%) 64 + II 63 + II 
Diameter stenosis post (%) 28 + 12 29 + 15 
Diameter stenosis fup (%) 46 + 18 41 + 18 
An~a stenosis pre (%) 85 + 9 85 + 7 
Are,i stenosis post ($'c.) 46 + t2 47 + 17 
Are,-I stenosis hlp (%) 68+ 17 62 + 21 
Ahsolute gain in lumen (mill) 1.20 + 0.52 1,20 + 0,57 
Rel<ltive gain in lumen 0,39 + 0,22 0.38 + 0.21 
Ahsolute. loss in lumen (mm) 0,68 + 0,68 0.74 ± 0.62 
Rdati\'~ loss in IUlIlen 0.23 ± 0,27 0,25 ± 0.20 
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Quantitative an;tio;tmphy: 
Follow-up angiography was performed in 92 % of the unstable and 90% in the 
stable eligible patients. The results of quantitative angiographic assessment of 
atherectomy for unstable and stable angina are detailed in Table 2. No differences 
in reference diameter and lesion severity (minimal luminal diameter, diameter 
stenosis and area stenosis before athereetomy) were observed. Following 
atherectomy there was, as expected, a significant improvement in minimallul11inal 
diameter, diameter stenosis and area stenosis for unstable and stable patients 
(p<O.OOI). The luminal gain achieved at atherectomy was identical for both 
groups (1.21 ± 0.52 mm vs 1.20 ± 0.57 mm;p=NS). During follow-up, both 
groups showed a comparable deterioration in luminal geometry, as reflected by 
a decrease in minimal luminal diameter and an increase in diameter stenosis. 
Using the 50% diameter stenosis criterion, restenosis occurred in 39% of unstable 
and 32% of the stahle lesions (p=NS). At follow-up, no statistical difference in 
minimal luminal diameter between unstable and stable procedures for proximal 
left anterior descending artery lesions was found (1.68 ± 0.55 mm vs 1.61 ± 
0.64 mm) nor was a difference in restenosis rates observed (30% vs 32%). 
DISCUSSION 
The aim of this study was to evaluate the immediate and long-term clinical and 
quantitativeangiographic follow-up of patients undergoing directional athcrectomy 
for stable and unstable angina in the same institution. To determine whether 
patients with unstable angina have a less favorable outcome than stable patients 
in terms of major complications both groups were evaluated at a mean follow-up 
period of 2 years. An additional analysis was performed to determine whether 
these two distinct clinical entities behave differently with respect to luminal 
renarrowing as assessed by quantitative angiography. 
The major findings of this study are threefold. First, a similar high acute 
angiographic and clinical sllccess rate was found for unstable and stable angina. 
Second, during a 2 year follow-up period, patients initially treated for unstable 
angina have a significantly lower event-free survival compared with stable 
patients, Third, quantitative coronary angiography revealed that luminal 
renarrowing after atherectomy for unstable angina was similar to that for stahle 
angina patients and thus ullstable patients have no higher incidence of restenosis. 
Study tiesi;tn: 
In single and Illulticentre angiographic follow-up series, directional atherectomy 
has been demonstrated to be a safe and effective alternative to coronary 
angioplasty in selected patients [1,2,12-17]. Multivariate analysis has revealed a 
limited number of lesion and procedural variables, but no clinical characteristics 
as independent, albeit weak predictors of restenosis [20]. In particular, anginal 
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status at the time of atherectomy (unstable vs stable angina) has not been found 
to correlate with late outcome. Recent balloon angioplasty data, however, suggest 
that unstable angina is associated with restenosis on univariate analysis [21,22] 
while recent onset angina was retained in the multivariate analysis model as a 
predictor for angiographic restenosis [21]. Whether these discrepancies between 
atherectomy and angioplasty data are due to the different mechanisms of action 
(debulking versus dilating) or could be due to selection bias or heterogeneity of 
the (un)stable population has not been determined and merits further investigation. 
Therefore, we assessed the clinical and angiographic outcome after atherectomy 
in these groups and demonstrated that our strictly defined homogeneolls patient 
population, with objectively documented unstable angina, experienced more 
clinical complications during a two year follow-up period. 
!mmediate clinical outcollle: 
The association between the clinical anginal syndrome and the occurrence of 
(sub)acute complications after atherectomy has not been reported to date. The 
previous angioplasty experience of oLlr group and others is of a less favorable 
clinical course after angioplasty for unstable angina compared with stable angina 
[3-5,2S]. The present study concurs with these observations and indicates that 
atherectomy for unstable angina is related to a higher, although not statistically 
significant, incidence of (sub)acute occlusion when compared with stable angina 
(S.S% vs 6.1 %;p=NS). Although an occlusion rate of 7.3% is higher than 
previously reported [12,29], this may be due to the higher incidence of unstable 
angina (45%) in the present study population. Popma et al [29] found an occlusion 
rate of 4.3% after directional atherectomy with a higher incidence in de novo 
lesions, right coronary artery stenoses and diffuse lesions. In addition Ellis et al 
determined other adverse angiographic lesion characteristics that increase the risk 
of acute complications [30]. The (sub)acute occlusion phenomenon after 
atherectomy in stable and unstable patients demands adequate bail-out strategies, 
and additional caution is appropriate with regard of the use of the bulky, stiff 
atherectomy device. The introduction of new, lower profile, atherectomy devices 
may further increase procedural success rates, particularly as the initially 
occurring nosecone-induced dissections have not been observed since their 
introduction. 
The difference in acute complications between unstable and stable patients (12% 
vs 9% respectively; p=NS) indicate that the 11 % clinkal complication rate in the 
CAVEAT atherectomy patients may indeed be related to the clinical syndrome of 
unstable angina which was present in 66% of the population [I]. A higher 
incidence of immediate post-atherectomy complications in unstable patients is 
presumably related to the presence of complex coronary artery lesions [23-25]. 
These lesions contain more thrombus as observed at angioscopy [25], and 
confirmed by histology [26,27], and have more calcium [26], known to be 
associated with unslIccessful atherectomy procedures. 
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LOIl~-/erJll eli nicoljiJllmv-up: 
The 2-year actuarial event-free survival rate after atherectomy was 54% for 
unstable and 69% for stable patients. The total population had a similar incidence 
and time-frame of events as reported previously by Fishman et al [31]. 
Complimentary to these findings, our study design allows us to analyse and 
explore the effect of unstable angina as the index cardiac syndrome on the long-
term outcome after directional atherectomy. The present study indicates that 
atherectomy for unstable angina was associated with a less favorable long-term 
clinical follow-up. In particular, at one year 57% of the unstable patients were 
event-free compared to 74% of the stable patients. The majority of these adverse 
events consisted of revascularizatiol1s which occurred earlier in the unstable than 
stable patients. No differences in balloon angioplasty for angiographic restenosis 
was observed during follow-up in both groups while a trend towards illore 
coronary artery bypass surgery in the unstable patients was found. These results 
strongly suggest that anginal status at the time of athercctomy had an impact on 
late clinical outcomc. Differences in baseline patient characteristics could not 
contribute to these dissimilar follow-up results as the two patient groups were 
comparahle apart from previous myocardial infarctions. The higher incidence of 
previolls myocanlial infarctions may rellect the inherent instability of the ullstable 
coronary syndrome, likewise accounting for the higher incidence of acute and late 
events in such patients. It would appear that the syndrome of unstable angina is 
not wholly explained by lesion characteristics as excision of the unstable plaque 
by atherectomy did not yield a long-terlll clinical outcome similar to that of stable 
angina patients. These findings concur with the observations of Foley et al [32] 
that restenosis after balloon angioplasty for unstable angina is associated with an 
aggressive pattern of angina. A similar difference in clinical outcome has been 
reported for balloon angioplasty for stable and unstable angina [32,33]. Althongh 
these results suggest that there is no advantage of atherectomy over balloon 
angioplasty, a comparison with historical data should not be made because of 
clinical and angiographic differences between these popUlations. 
Dol',\' 1I11sfahle allNino reslIll ill 11101'l' res/el1osis? 
A major finding of this study is that the luminal renarrowing process in the 
unstable group was similar to that of the stahle group. At latc angiographic 
follow-up, thc residual lumen as expressed by minimallulllinal diameter at follow-
up was 1.70 ± 0.48 111111 in the unstable and 1.66 ± 0.56 111111 in the stable 
population. The frequency distribution curves for the minimal luminal diameter 
at follow-up are virtually superimposed confirming the lack of difference between 
the two groups. This is also confirmed \~'ith restenosis assessed as a categorical 
phenomenon defined by a diameter stenosis of ~ 50%. Using this clinical 
definition) no statistical difference in rcstenosis rate was ohserved at 6 month 
angiography: 39% in unstable) and 32% in stable patients (p=O.55). These results 
are consistent with angioplasty reports [3-5,1 I ,32] and confirm our previous 
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observation that clinical parameters are not independent predictors of late residual 
lumen or late loss after directional atherectomy [20]. The inconsistency between 
the long-term clinical and angiographic outcome may be related to the 
aggressiveness of the anginal pattern in unstable patients prompting repeat 
interventions at the time of restenosis [32]. 
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ABSTRACT 
Objecliv('s: To characterize predictors of restenosis following successful 
directional atherectoIllY (DCA), we reviewed the clinical, angiographic and 
procedural data obtained during 132 consecutive procedures (125 patients). 
Methods: Clinical and angiographic follow-up were obtained in a prospectively 
collected and consecutive series of 125 patients who underwent J 32 atherectomy 
procedures for de-novo (89%) or reslenolic (II %) lesions in nalive coronary 
arteries. Restcnosis was assessed clinically and by quantitative coronary 
angiography. A dual approach 10 dala analysis was taken in order 10 gain insighl 
into factors affecting the clinical outcome and the vessel wall healing response. 
Therefore, multivariate analysis was performed (1) to determine the correlates of 
residual luminal diameler al follow-up (angiographic ollltollle) and (2) to 
characterize the determinants of the late luminal loss (renarrowing proce,\'s). 
Results: Clinical and angiographic follow-up after successful atherectomy were 
obtained in 100% and 95% respectively. Atherectomy achieved an acute luminal 
gain of 1.28 ± 0.48 mill (mean±SD) resulting in a minimal luminal diameter of 
2.44 ± 0.47 111111. AI follow-lip Ihe minimal IUlllinal diameler decreased to l. 78 
± 0.64 111m. The angiographic restenosis rale was 28% if Ihe Iraditional 50% 
percentage stenosis cut-off criterion was applied. Larger vessel size and post-
atherectomy minimal luminal diameter and right coronary or circumflex lesions 
were independent predictors of a larger minimal luminal diameter (angiographic 
outcome). Luminal loss during follow-up (renarrowingproCt's.r) was independently 
predicted by relative luminal gain and pre-procedural minimal luminal diameter. 
Conc!uJiol/s: In analyzing the long-term results of new interventional techniques, 
such as directional atherectomy, the late luminal loss during follow-up 
(renarrowing pmce,ys) - which is characterized by the vessel wall healing response 
after an intervention - should be considered together with the residual luminal 
diameter at follow-up (clinical outCOIlIl' ). It is clear that whereas improved 
clinical outcome is associated with larger vessel size and post-procedural luminal 
diameter and nOll-LAD location, greater relative gain at intervention is predictive 
of Illore extensive luminal renarrowing. 
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INTRODUCTION 
Directional coronary athcrectomy is now accepted as a feasible alternative to 
conventional balloon angioplasty for the treatment of coronary artery disease [1-
8]. While examining the long-term results of intracoronary interventions, two 
aspects must be considered: (I) the residual minimal luminal diameter at follow-
up which determines the angiographic ou/eome and (2) the renarrowing proC('.\'s 
which can be characterized by the late luminal loss during follow-up which is 
initiated by the injury inflicted to the vessel wall during intervention. From a 
clinica/ poillf ~f view, Kuntz et al [9] have demonstrated that a large post-
procedural lumen was the principal determinant for the best outcome at 6 months 
(i.e. a large lumen at follow-up) and they have advocated the motto that "bigger 
is better" [9]. Although this may be valid findings, the analysis was based on the 
relationship of the minimal luminal diameter after the intervention and at follow-
lip without taking the vessel size and proportional gain into account. The intlucnce 
of these two parameter should be considered for two reasons. Firstly, the range 
of vessels treated in interventional experience is 2-5 mill, secondly restenosis rate 
has been reported to vary with vessel size [10, II]. Furthermore greater lumen 
increase at intervention has been shown to be associated with greater risk of 
coronary ectasia after atherectomy [12], acute complications [13] and increased 
luminal loss after angioplasty [14]. Studies have demonstrated that procedural 
luminal gain is the greatest single detenninant of subsequent iuminalloss [15-17]. 
Our group [15-17] has focused their attention on the renarrowing process and 
have reported the relationship between relative Iliminal gain and relative luminal 
loss (i.e. gain and loss normalized for the vessel size) as correlates ot' the 
biological response of the vessel wall after an intervention. This "/Ji%}{ical 
approach" has unveiled the general biological law relating healing process to 
vessel wall injury and has been encapsulated in the following motto Uthe more you 
gain the more you lose". 
The purpose of this study was to attempt to reconcile these apparently opposite 
viewpoints into a coherent methodologic approach by assessing the determinants 
of the angiographic OU/COJl/£' and renarrowing process in a consecutive series of 
patients treated by atherectomy. 
METHODS 
Patients: 
One hundred thirty-one patients underwent 138 sllccessful consecutive directional 
coronary atherectomy procedures at the Thoraxcenter (n=97) and at University 
of Louvain Hospital (n~41). Although all patients completed clinical follow-up, 
6 patients did not undergo a 6 month angiographic follow-up (5 %) and were 
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excluded from the study. 
Alherecfomy Proce(/lItl': 
The procedure was performed as described previously [5,6,8, I 7]. On average 5.9 
± 2.8 (2 to 14) ClIts in selected directions were performed across a stenosis. 
While an optimulll angiographic result is sought for each lesion treated, the 
procedure was considered angiographically sliccessful when the residual diameter 
stenosis was less than 50% after tissue retrieval. Patients were monitored for 24 
hours and electrocardiograms and cardiac enzyme levels were obtained twice a 
day. A calcium antagonist was given every 2 hours for 24 hours after the 
procedure and the patients were kept on aspirin medication for six months. 
Quantilatiw~ corollary allKioNraphy: 
Quantitative analysis of the coronary segments was performed with the computer 
based Coronary Angiography Analysis System (CAAS), previously described in 
detail [8,16-21]. In essence, boundaries of a selected coronary artery segment are 
detected automatically from optically magnified and video digitized regions of 
interest (5 12 x 512 pixels) of a cine-frame. The absolute diameter of the stenosis 
in mm is determined using the guiding catheter. The computer-estimation of the 
original dimension of the artery at the site of the obstruction allows to define the 
interpolated reference diameter. The percentage diameter stenosis is then 
calculated. lntracoronary isosorbide dinitrate (1-3 mg) was given prior to and 
following atherectomy. At follow-up catheterization the administration of 
intracoronary nitrates was recommended prior to angiography. To standardize the 
method of data acquisition and data analysis and to ensure reproducibility of post-
atherectomy and follow-up angiograms, measures were taken as previously 
described [17-19,21]. 
Resfel1osis: 
Two different approaches (categorical versus continuous) were used to define 
restenosis. Using the categorical approach, the criterion chosen was an increase 
of the diameter stenosis from < 50% after the intervention to ~50% at follow-up, 
as is generally applied in clinical practice. Using a continuolls approach, minimal 
luminal diameler at follow-up (MLD fup), luminal loss during follow-up and 
relative loss (normalized loss for vessel size) were determined. 
Luminal changes at intervention and during follow-up are calculated as follows: 
Loss: MLD post - MLD fup Relative loss: (MLD post - MLD fup) / 
vessel size 
Gain: MLD post - MLD pre 
vessel size 
Relative gain: (MLD post - MLD pre) / 
Normalization of absolute luminal changes for the individual vessel size thereby 
eliminating the bias of vessel size has been previously described in detail [15-17]. 
Mulfimriafl' analysis approach: 
The long term angiographic luminal changes after successful directional 
atherectolllY was thus evaluated lIsing two separate multiple linear regression 
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analyses with minimal luminal diameter at follow-up or luminal Joss respectively 
as the dependent variables. 
Variables potentially predictive of restenosis were divided into three general 
categories. PatieJ1l J'('lateti WlJ'iable,\' included age, gender, diabetes, hypertension, 
hypercholesterolemia (defined as elevated levels of serum cholesterol > 6.5 
mmol/l requiring treatment with lipid lowering drugs [22] and unstable angina 
(defined as pain at rest requiring treatment with intravenous nitrates and 
intravenolls heparin). 
Lesion tela/etl !acfOr .. 't are characteristics unique to each lesion. The following 
factors were assessed: vessel size, pre-atherectomy minimal luminal diameter, 
post-atherectomy minimal luminal diameter, diameter stenosis before and after 
atherectomy. absolute gain and relative gain in minimal luminal diameter, treated 
vessel (left anterior descending coronary artery, left circumtlex artery or right 
coronary artery), de novo versus restenotic lesion. 
Procedure rela/ed !actor,\' assessed included: the center (Rotterdam or Louvain), 
number of atherectomy cuts, device size, device/artery ratio (defined as device 
size divided by the interpolated reference diameter) and the presence of media 
and/or adventitia in the excised specimens. 
Statistics: 
All continuolls variables are expressed as mean ± I SD. A p-value < 0.05 was 
considered as significant. Differences between variables measured before 
atherectomy, after atherectollly and at follow-up were assessed using one-way 
analysis of variance for repeated measurements. When the result was signiticant, 
paired t-tests were performed to find the signiticant differences. Selected 
angiographic and procedural variables were evaluated by univariate regression 
analysis for their correlation with absolute loss in luminal diameter during follow-
up and for their correlation with minimal luminal diameter at follow-up. To avoid 
arbitrary subdivision of continuolls variables, cutpoints were derived by dividing 
the data in two groups each containing roughly 50% of the total population. The 
groups were compared with lise of two-group I-tests. Two-group t-tests for 
continuous variables and chi-square test for categorical variables were also used 
to compare the results from the two centers. Independent contribution of variables 
was assessed using a Illultivariate stepwise regression analysis with F-to-enter tests 
based on the mean square error criterion [23]. All analyses were performed lIsing 
the BMDPC 90 statistical software. 
RESULTS 
Patient c/wf'(Jcll'r;sr;cs (Jlld procedural results (Tah/e I): 
The present study population consists of 125 consecutive patients who underwent 
132 coronary athcrectomy procedures for symptomatic de novo (n= 117) and 
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restenotic (n= 15) native coronary artery disease. The mean age was 58 ± 10 
years and the majority of the patients were males wi th single vessel disease. The 
target stenosis (n=132) in these 125 patients was located in the left anterior 
descending artery in 89 cases, in the left circumflex in 14 cases, in the right 
coronary artery in 29 cases. The clinical and immediate angiographic success as 
well as the complication rates for both centers have been described in detail 
elsewhere [5]. 
Tahle 1 Clinical demographics of 125 patients with 132 stenoses undergoing coronary athere-ctomy 
Age (yr) 58 + 10 
Male gender (%) 82 
Angina status (%) 
stahle angina 60 
unstable angina 40 
Multivessel disc,lse (%) 23 
Re·stenotic lesions (%) II 
Angiogmphic tollow~lIp (%) 93 
The iongterm results of the initial Rotterdam patients with a primary lesion were 
previously reported in a comparative study with balloon angioplasty [17]. All but 
23 patients were treated with a 6 French atherotome, 21 were treated with a 7 
French and 2 patients with a 5 French atherotome. The angiographic follow-up 
rate in the present study popUlation is 95%. Of the six patients who did not 
undergo repeat angiography, I patient died 3 days after successful atherectomy 
[24], I patient had bypass surgery 7 days after the procedure for presumed 
tamponade while 4 asymptomatic patients refused angiography. At six months, 38 
patients (31 %) had recurrence of their anginal symptoms. Fifteen patients 
underwent either a balloon angioplasty, or repeat atherectomy (n=3) or stent 
implantation (n= 1) for symptomatic restenosis of the previously treated segment. 
During the follow-up period, three patients were referred for elective coronary 
bypass surgery. 
Quanti/alive anNio{:raphic (/nalysis (TaMe 2,3): 
Reference diameter did not change from pre to post procedure. The minimal 
luminal diameter increased from 1.16 ± 0.39 mm by 1.28 ± 0.48 mm resuiting 
in a minimallulllinal diameter 01'2.44 ± 0.47 mm post-procedure. At follow-up, 
the minimal luminal diameter was 1.78 ± 0.64 mm (figure I). Thus the late loss 
was 0.65 ± 0.64 mill. Likewise percent diameter stenosis decreased from 65 ± 
11 % pre-atherectomy to 26 ± I I % post-atherectomy and increased during 
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follow-up to 41 ± 18% (p<O.OOI). The reslenosis rate was 28% if Ihe 50% 
diameter stenosis criterion was applied. Although no statistical difference was 
found in luminal loss or minimal luminal diameter at follow-up between patients 
with stable and unstable angina, a trend towards a larger minimal luminal 
diameter at follow-up was observed in the stable group. "Restenotic ll lesions did 
not differ significantly from primary lesions with respect to luminal loss during 
follow-up nor with respect to retrieval of subintimal tissue. Subintimal tissue was 
excised (media (n= 19) and/or advenlilia (n=3)) and found to be relaled to Ihe 
number of alhereclomy cuts (5.7 ± 3.0 versus 7.5 ± 2.8;p=0.04) but not 10 Ihe 
other procedural or angiographicaJ variables. 
Table 2. Quantitative angiography analysis of the immediale and Inle eftects of directional 
atheroctol11Y 
Reference diameter pre (mm) 3.29 + 0.64 
Reference diameter post (nun) 3.30 ± 0.50 NS 
Rtlferenctl diameter fup (mill) 3.02 + 0.60 < 0.001 
Minimal luminal diameter pre (mm) 1.16 + 0.39 
Minimallumillal diameter post (mill) 2.44 ± 0.47 < 0.001 
Minimal luminlll diu meter fup (1l1J11) I. 78 ± 0.64 < 0.001 
Diumeter );tenosis pre (%) 65 + tl 
Diameter stenosis post (%) 26 + II < 0.001 
Diameter stenosis fup (%) 4t + 18 < 0.001 
Absolute ,gllin in lumen (111m) 1.28 ± 0.48 
Relative ,gain in lumen O.4t ± 0.19 
Absolultl loss in lumen (mill) 0.65 + 0.64 
Rdative loss in lumen 0.20 ± 0.19 
-u p - follow-u p. p re - hel()(t~ al lerec(Ol1l ' os! - alter alheredmn '. 
Univarhlfl' aflll multivariate mUllysis (?r residual IlIl11ell til ji)I/ow-up: clinical 
(IU/COI//(' (1([/,{(' 3,4): 
A greater minimal luminal diameter at follow-up was associated with I) vessel 
size > 3.25 mm, 2) minimal luminal diameter after atherectomy > 2.42 mm, 3) 
device/artery ratio:::; 1.09, 4) pre-procedural minimal luminal diameter> 1.11 
mill, 5) device size> 6 French and 6) lesion locate-d in a vessel other than the left 
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anterior descending coronary artery. Multivariate stepwise regression analysis 
revealed that I) vessel size, 2) minimal luminal diameter after atherectomy and 
3) non-LAD lesions were independently predictive of minimal luminal diameter 
at follow-up. 
The multivariate model can be described by the following equation: MLD at 
[allow-up = 0.21 + 0.25 x vessel size + 0.37 MLD post - 0.25 x LAD (where 
LAD = 1 and non-LAD = 0). 
Unimriate ant! l1IultiWll'ia/(' analysis qf late luminal loss: hiolo~ical approach 
(Table 3, .1i!:lIr" 11,/11). 
Relative gain > 0.38, absolute gain > 1.29 111m, post-atherectomy minimal 
luminal diameter >2.42 mm, post-procedural diameter stenosis ::;;26%, lesion 
located in the left anterior descending artery and device/artery ratio> 1.09 were 
univariate predictors of a large absolute luminal loss during follow-up. The 
stepwise multiple regression analysis showed that 1) relative gain in lumen and 
2) pre-procedural minimal luminal diameter were the only independent predictors 
of luminal loss during follow-up: absolute loss = -0.59 + 2 x relative gain + 
0.399 x MLD pre (tigure HA). Similarly, if luminal loss was normalized for 
individual vessel size, Illultivariate analysis revealed that relative gain is the 
strongest independent predictor of relative loss (Figure HB). It is readily 
appreciated that the wide scatter in the correlation plots implies that factors other 
than luminal dimensions (i.e. biological factors like diabetes or ultrastructural 
constituents like stellate cells and non-muscular myosin) clearly play a 
considerable part in the process of restenosis. 
In the univariate analysis, the relationship between absolute loss and pre-
procedural minimal luminal diameter is negative (Absolute loss = 0.76 - 0.094 
MLDpre), however due to the confounding effect of relative gain «MLDpost-
MLDpre)/vessel size), the mathematical sign becomes positive in the multivariate 
analysis (Fig !lA: Absolute loss = -0.52 + 2 Relative gain + 0.399 MLDpre). 
The reconciliation (!f aU/cOIne {lilt! proC{'S,\': 
As appreciated in figure II a linear relationship exists between absolute gain and 
absolute loss and between relative gain and relative loss. Although some lesions 
show further luminal improvement during follow-up, the observed linear 
relationships imply that a greater luminal gain achieved at atherectomy is 
associated with a greater luminal loss during follow-up. On the other hand a 
satisfactory atherectomy result (large post-atherectOlny minimal luminal diameter) 
is predictive of a better luminal diameter at follow-up. Although these results 
appear contradictory, the slope of the gain/loss relationship is clearly less than, 
and divergent from the identity line so that greater luminal gain is not fully offset 
by the subsequent loss. Thus a beneficial long term angiographic outcome (a large 
minimal luminal diameter at follow-up) will be achieved despite an augmented 
biological renarrowing process (a greater luminal loss). 
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DISCUSSION 
Lale angiographic renarrowing as assessed by coronary angiography remains the 
major limitation of any coronary intervention. Neither pharmacological [22,25~27] 
nor alternative interventionaltechniques such as atherectomy [19,28-33] have been 
shown to abate the restenosis rate. Accepting therefore that restenosis as a healing 
response to vessel wall injury is inevitable after atherectomy, it is appropriate to 
investigate the possibility of detecting patient, lesion and procedural factors which 
might be associated with a favorable or unfavorable influence. In this study we 
have used a well validated quantitative angiography analysis system (CAAS) to 
objectively assess immediate and long-term angiographic outcome after 
atherectomy. The angiographic follow-up rate of 95% further enhances the 
validity of the conclusions. Furthermore, we have considered the luminal 
renarrowing proce,Y,\' and the latc luminal diameter (angiographic oil/come) as 
parameters of equal interest in order to resolve currently conflicting views. 
Palhophy,\'iolo~ic considerations: 
Schwartz et al [34-36] have observed in experimental studies a strong positive 
correlation between vessel wall injury (i.e. rupture of the internal elastic lamina) 
and the subsequent neointimal hyperplastic response during follow-up. In order 
to test this hypothesis in a clinical setting, we have substituted the concept of 
"injury score" and "neo-intimal hyperplasia" used by Schwartz et al [34-36] with 
the angiographically derived parameters of relative gain and relative loss [15-17] 
so that the biological relationship between wall injury and the healing response 
could be more appropriately analyzed. It is crucial to elucidate whether the 
atherectomy procedure can to some extent escape the implacable consequences of 
the fundamental biological laws governing the healing response to wall injury. 
The scientific value of the relationship between relative gain and relative loss lies 
in the fact that this relationship constitutes a unifying approach which may 
characterize the intrinsic efficacy of a device independently from the vessel size 
in which it is operational. 
Residuallumell (II ji)llmv-up: 
Of all directly acquired measurements by quantitative angiography, the absolute 
value of the minimal luminal diameter has been shown to be the greatest single 
determinant of the hemodynamic consequences of a stenosis, since this parameter 
affects blood now by the fourth power term [37]. Moreover, the minimal luminal 
diameter at follow-up may have some functional component; we found that a 
minimal luminal diameter at follow-up of 1.45 mill correlates with the freedom 
from recurrence of angina [38]. Thus, from a clinical point of view, the largest 
minimal luminal diameter at follow-up is the goal for which to strive while 
performing intracoronary interventions [9]. Our study shows that a large reference 
diameter, a non-severe pre-procedural lesion, a large post-procedural diameter and 
presumably but not necessarily a bigger absolute gain at atherectomy are 
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associated with a large minimal Iliminal diameter at follow-up. Thlls previous 
findings of Kuntz e( al [9] are confirmed that greater lumen post-atherectomy 
provides greater late residual lumen. However, in addition we have found that a 
larger vessel of itself is predictive of a greater follow-up lumen. It is also 
noteworthy that the greatest acute procedural results were achieved in larger 
vessels in this as well as in other series [10, II ,41]. In addition, a large relative 
luminal loss was observed in smaller vessels, in which greater relative gain had 
been achieved. This indicates that atherectomy appears more traumatizing and 
would, in our view, infallibly be associated with a poor longterm outcome, i.e. 
a sillall minimal luminal diameter at follow-up. We surmise that this general type 
of response to the atherectomy procedure may be unveiled in the recently 
completed CA VEAT trial, comparing balloon angioplasty and atherectomy [32]. 
71w "re.wenosis" paradox: 
The apparent paradox of greater luminal increase at intervention associated with 
greater luminal renarrowing during follow-up has now been demonstrated in 
several clinical studies [16,39,40]. [n this study, tile greatest determinant of 
luminal loss or relative loss was the relative luminal gain achieved at atherectomy. 
This finding is in agreement with published findings in studies of balloon 
angioplasty [15,16]. Based on these findings it would appear appropriate to use 
the relative gain/relative loss relationship as angiographic correlates for the 
injury/hyperplasia phenomenon described in experimental models [34-36] and in 
clinical research [4,6-9,11,13,14,18-20]. 
While others have focused 011 the lIfl;,:io;,:raphic oIllCOJ1W i.e. final minimal luminal 
diameter and found a reduced restenosis rate with increased luminal gain achieved 
with newer devices [9], our group is focusing in clinical studies mainly on the 
degree of renarrowing as a measure of the extent of the "hjo/n;,:ica/" rellarrmvil1M 
proces.v i.e. the development of intimal hyperplasia. This is the difference, as has 
been expressed by Schwartz et al [35J between the "doughuut and the doughnut 
holel!. There is little doubt that a larger lumen at follow-up is clinically "better!! 
for the patient and this parameter is of great importance in assessing the long-term 
outcome of therapy. However, in large clinical trials directed at the prevention of 
renarrowing, the effect of therapy must be measured by its restricting effect on 
the thickness of the Ildoughnut", which we believe is best encapsulated 
angiographically by the relative luminal loss during follow-up. As described in the 
present report, we believe that application of both approaches (residual lumen and 
renarrowing process) to the same population yield equal findings. The apparently 
conflicting viewpoints arise not from differences in therapeutic results but from 
differences in focus and approach. The coherent douhle approach to restenosis 
reveals that the clinician may achieve the best flllal ollf(ol1te (large lumen at 
follow-up) by aiming for an optimal procedural resuit (large post-procedural 
lumen) particularly in large vessels. On the contrary, a large (relative) luminal 
loss is observed in slllall vessels in which a large relative gain is seen. This 
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indicates that the renarrowing proC('SS (luminal loss during follow-up) is 
augmented when a severe lesion in a small vessel is treated by atherectomy. 
Whether subintimal tissue retrieval leads to an increased incidence in restenosis 
remains an unresolved issue with conflicting reports in the literature [42,43]. In 
this observational study, medial or adventitial tissue retrieval was not an 
independent variable related to more extensive luminal renarrowing although the 
frequency of retrieval of media and adventitia was only 20% compared with 
greater than 50% in other studies [2,43]. 
In the present study, no cOnical and procedural parameters were found to be 
independent predictors of restenosis. In two recent multicenter restenosis trials 
[21,27] diabetes was the only patient related variable found to be independently 
related to the amount of renarrowing at follow-up. In our study, less than 10 
patients with diabetes or hypercholesterolemia underwent atherectomy. Therefore, 
the predictive value of this variable cannot be evaluated in this study. Using 
univariate analysis, the device/artery ratio was found to be correlated with luminal 
loss however, this was not retained in the multivariate analysis. This observation 
underscores the necessity to strive for an optimal selection of the atherotome. 
With the clinical implementation of quantitative angiography, proper device 
selection (device/artery ratio 1.0 - 1.1) can be performed and the final result can 
be guided by these on-line measurements. 
Compared to previollsly published data on luminal gain and loss after 
atherectomy, the acute luminal gain in this patient cohort s('(lms low [9, t 1,32,33]. 
These differences may be secondary to the applied method of quantitative 
angiographic analysis. Specitically, it has been observed that measurements 
obtained by visual assessment tend to overestimate the severity of tight stenoses 
and underestimate the degree of milder ones [44-46] whereas the opposite has 
been reported of automated contour detection using well known phantom 
diameters [47]. Therefore, visual or calliper measurements will yield higher 
values for luminal gain achieved at intervention when compared with 
quantitatively assessed measllrements. Nevertheless the relationship between gain 
and loss is maintained and similar to other reports [9]. Furthermore, a 
discrepancy between reference diameters will arise when comparing reports in 
which the average of the diameter of the vessel proximal and distal to the stenosis 
are used as the reference [9]. In order to avoid the bias introduced by the 
arbitrary selection of the lIser defined reference in the proximal and/or distal 
segment of the stenosis, we have implemented many years ago an intelpolated 
technique, which is not user detined, to determine the reference diameter at the 
actual stenosis site [8,16-21]. 
Clinical implications: 
Luminal renarrowing after sliccessful atherectomy is a process that cannot be 
accurately predicted by simple clinical and angiographic parameters. In analyzing 
the long-term results of new interventional techniques, such as directional 
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atherectomy, the renarrowing pl'm:ess (luminal loss during follow-up) -
characterized by the vessel wall healing response - is of equal importance as the 
angiographic outcome' (minimal luminal diameter at follow-up) which conveys 
some index of the clinical outcome in the longterm. 11 is clear that whereas 
improved clinical outcome is associated with larger vessel size and post-
procedural luminal diameter, greater relative gain at intervention is predictive of 
more extensive luminal renarrowing. 
Limitatio/l.\': 
Several limitations of this study are to be acknowledged. First, it is an 
uncontrolled, observational study limited to a subset of patients with a sllccessful 
coronaryatherectomy. 
Second, although angiography may detect luminal changes after intervention, it 
may not be the most reliable method to analyze the (biological) process taking 
place in the vessel wall itself. Because intravascular ultrasound provides an in 
vivo assessment of morphological changes in the vessel wall, this technique may 
provide more precise information, although reliable quantitative measures cannot 
yet be routinely obtained [48]. Third, it could be claimed that an acute gain of 
1.28 mill represents a cautiolls approach to atherectomy leading to a modest 
angiographic result. However, the post-procedural luminal diameter in this series 
is comparable with other groups [32,33,49] although smaller than in the series of 
Kuntz et al [9]. This observation does not intluence tbe conclusions of the present 
study because the linear relationship between (relative) gain and (relative) loss is 
maintained at all levels of (relative) gain. Four, luminal loss during follow-up 
may result not only from the biological proliferative response but may also be due 
to elastic recoil. From a methodologic aspect we have recoillmended a 15 minutes 
recovery time after balloon deflation before proceeding with the administration of 
intracoronary nitrates and assessment of the final angiographic result. 
Furthermore, it has been the experience of our group [50] and of others [51] that 
no further deterioration occurs in the 24 hours after balloon detlation if this 
methodologic premise is respected. Although the occurrence of elastic recoil was 
not studied presently, previous reports demonstrated a minimal, if any, elastic 
recoil after coronary atherectomy [6,52]. Finally, it should be appreciated that the 
predictive values of the models are weak due to a wide scalter of correlation 
plots. From a statistical viewpoint, the large standard error of the estimate found 
implies III at other major biological determinants of late angiographic outcome and 
renarrowing proces,\' have 110t yet been unravelled. Because the restenosis process 
appears inherently not controllable, pharmacologic control of the proliferative 
response appears more than ever mandatory. 
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Table 3. Categorical approach to assess correlates for renarrowing following directional coronary atherectomy by quantitative angiography 
-
MEDIAN N VESSEL MLD pre GAIN REL MLD LOSS REL MLD fup DS fup I 
SIZE(mm) (mm) (mm) GAIN post(mm) (rom) LOSS (mm) (%) 
VESSEL SIZE :::;; 3.25 67 2.80 ± 1.03 ± 1.30 ± 0.48 ± 2.34 ± 0.78 ± 0.25 ± 1.56 ± 43 ± I 
0.38 0.34 0.53 0.21 0.49 0.60 0.20 0.58 19 
> 3.25 65 3.79 ± 1.28 ± 1.26 ± 0.33 ± 2.54 ± 0.53 ± 0.15 ± 2.01 ± 39 ± ! 
0.42 $ 0.40 $ 0.43 0.12 $ 0.43 # 0.66 # 0.18@ 0.63 $ 16 
MLD PRE :::;; l.11 68 3.03 ± 0.86 ± 1.45 ± 0.49 ± 2.31 ± 0.70 ± 0.23 ± 1.62 ± 45 ± 
0.61 0.16 0.48 0.20 0.47 0.66 0.21 0.66 19 
> 1.11 64 3.56 ± 1.48 ± 1.10 ± 0.31 ± 2.57 ± 0.61 ± 0.17 ± 1.96 ± 36 ± 
0.55 $ 0.30$ 0.41 $ 0.12 $ 0.43$ 0.61 0.17 0.57@ 16@ 
MLD POST ::::; 2.42 66 3.11 ± 1.04 ± 1.02 ± 0.34 ± 2.06 ± 0.44 ± 0.15 ± 1.62 ± 45 ± 
0.57 0.32 0.38 0.15 0.28 0.55 0.19 0.62 18 
> 2.42 66 3.47 ± 1.27 ± 1.54 ± 0.47 ± 2.82 ± 0.88 ± 0.25 ± 1.94 ± 37 ± 
0.66@ 0.43$ 0.43 $ 0.20 $ 0.27 $ 0.65 $ 0.19@ 0.63@ 17@ 
DS PRE > 65 62 3.39 ± 0.91 ± 1.47 ± 0.44 ± 2.38 ± 0.66 ± 0.20 ± 1.72 ± 45 ± 
0.58 0.26 0.46 0.17 0.45 0.69 0.20 0.68 18 
:;: 65 70 3.20 ± 1.38 ± 1.11 ± 0.33 ± 2.49 ± 0.65 ± 0.20 ± 1.84 ± 37 ± 
0.68 0.36 $ 0.44 $ 0.14 # 0.49 0.60 0.19 0.60 17@ 
DS POST > 26 65 3.43 ± 1.10 ± 1.11 ± 0.32 ± 2.20 ± 0.50 ± 0.14 ± 1.71 ± 46± 
0.59 0.43 0.48 0.14 0.42 0.63 0.19 0.68 17 
:::;; 26 67 3.15 ± 1.22 ± 1.45 ± 0.48 ± 2.67 ± 0.81 ± 0.25 ± 1.86 ± 36 ± 
0.66 # 0.43 0.43 $ 0.20 $ 0.40 $ 0.61@ 0.19@ 0.60 $ 17$ 
GAIN :::;; 1.29 67 3.35 ± 1.30 ± 0.90 ± 0.27 ± 2.20 ± 0.47 ± 0.15 ± 1.73 ± 43 ± 
0.59 0.40 0.27 0.10 0.45 0.59 0.19 0.69 19 
> 1.29 65 3.23 ± 1.00 ± 1.67 ± 0.54 ± 2.68 ± 0.84 ± 0.25 ± 1.84 ± 38 ± 
0.68 0.32 0.30 $ 0.16 $ 0.35 # 0.63 $ 0.19 @ 0.54 16 
----- - ~--
MEDIAN N VESSEL MLD pre GAIN REL MLD LOSS REL MLD fup DS fup 
SIZE(rom) (rom) (rom) GAIN post(mm) (rom) LOSS (rom) ($I) 
RELGAIN ~ 0.38 66 3.53 ± 1.37 ± 0.93 ± 0.26 ± 2.30 ± 0.50 ± 0.15 ± 1.80 ± 42 ± 
0.56 0.41 0.31 0.07 0.52 0.61 0.18 0.70 19 
> 0.38 66 3.05 ± 0.94 ± 1.63 ± 0.55 ± 2.58 ± 0.81 ± 0.25 ± 1.77 ± 40 ± 
0.63 $ 0.24 $ 0.34 S 0.15 S 0.36 $ 0.63@ 0.19@ 0.58 16 
LESION RESTENOSIS 15 3.07 ± 1.17 ± 1.28 ± 0.43 ± 2.45 ± 0.79 ± 0.20 ± 1.65 ± 41 ± 
0.68 0.40 0.31 0.21 0.45 0.64 0.20 0.54 15 
PRIMARY 117 3.32 ± 1.16 ± 1.28 ± 0.40 ± 2.44 ± 0.64 ± 0.20 ± 1.80 ± 41 ± 
0.63 0.40 0.48 0.18 0.47 0.6' 0.20 0.65 18 
VESSEL LAD 89 3.19 ± 1.12 ± 1.29 ± 0.42 ± 2.41 ± 0.75 ± 0.23 ± 1.67 ± 42 ± 
0.64 0.37 0.49 0.20 0.46 0.66 0.20 0.63 18 
NOT LAD 43 3.48 ± 1.23 ± 1.26 ± 0.38 ± 2.49 ± 0.47 ± 0.14 ± 2.02 ± 38 ± 
0.60 # 0.44 0.46 0.16 0.50 0.55 # 0.17 # 0.61 @ 16 
DEV SIZE ,,;6 111 3.22 ± 1.14 ± 1.24 ± 0.40 ± 2.38 ± 0.67 ± 0.21 ± 1.71 ± 42 ± 
(Fe) 0.63 0.38 0.48 0.19 0.45 0.63 0.20 0.63 18 
> 6 21 3.67 ± 1.26 ± 1.47 ± 0.42 ± 2.75 ± 0.56 ± 0.15 ± 2.19 ± 37 ± 
0.52 0.44 0.46 # 0.17 0.44@ 0.67 0.19 0.56@ 17 
DEV/ART > 1.09 69 2.82 ± 1.03 ± 1.30 ± 0.33 ± 2.34 ± 0.74 ± 0.24 ± 1.60 ± 43 ± 
0.40 0.35 0.52 0.12 0.48 0.61 0.20 0.58 19 
:::;; 1.09 63 3.80 ± 1.29 ± 1.26 ± 0.47 ± 2.55 ± 0.56 ± 0.16 ± 1.99 ± 39 ± 
0.42 $ 0.39 $ 0.44 0.21 $ 0.43 # 0.66 0.18 # 0.65 S 16 
CUTS > 5 64 3.36 ± 1.12 ± 1.29 ± 0.40 ± 2.41 ± 0.63 ± 0.19 ± 1.79 ± 43 ± 
0.67 0.36 0.45 0.19 0.47 0.68 0.21 0.67 17 
~5 68 3.22 ± 1.19± 1.28 ± DAD ± 2.46 ± 0.68 ± 0.21 ± 1.78 ± 39 ± 
0.61 0.42 0.51 0.19 0.47 0.60 0.18 0.61 18 
HISTOLOGY MEDIA/ADV 22 3.08 ± 1.23 ± 1.19± 0.41 ± 2.43 ± 0.71 ± 0.22 ± 1.73 ± 43 ± 
0.65 0.48 0.42 0.20 0.42 0.60 0.20 0.73 21 
INTIMA 110 3.33 ± 1.14 ± 1.30 ± 0.40 ± 2.44 ± 0.65 ± 0.20 ± 1.79 ± 41 ± 
0.63 0.38 0.49 0.18 0.48 0.65 0.20 0.62 17 
AGE > 58.9 66 3.27 ± 1.07 ± 1.38 ± 0.43 ± 2.46 ± 0.67 ± 0.21 ± 1.79 ± 41 ± 
0.58 0.39 0.45 0.16 0.49 0.55 0.17 0.63 18 
::::; 58.9 66 3.31 ± 1.24 ± 1.18 ± 0.38 ± 2.42 ± 0.64 ± 0.20 ± 1.77 ± 41 ± 
0.70 0.38 # 0.48# 0.20 0.44 0.72 0.22 0.66 17 
GENDER FEMALE 24 3.27 ± 1.14 ± 1.31 ± 0.43 ± 2.44 ± 0.65 ± 0.19 ± LSO ± 38 ± 
0.74 0.39 0.53 0.22 0.49 0.71 0.23 0.68 20 
MALE 108 3.29 ± 1.16 ± 1.28 ± 0.40 ± 2.44 ± 0.66 ± 0.20 ± 1.78 ± 42 ± 
0.62 0040 0.47 0.18 0.49 0.62 0.19 0.64 17 
ANGINA STABLE 80 3.23 ± 1.14 ± 1.33 ± 0.43 ± 2.46 ± 0.65 ± 0.20 ± 1.82 ± 39 ± 
0.63 0041 0.46 0.18 0.46 0.60 0.18 0.63 18 
UNSTABLE 52 -3.39 ± 1.19± 1.21 ± 0.37 ± 2.40 ± 0.67 ± 0.20 ± 1.73 ± 44± 
0.63 0.39 0.51 0.19 0.46 0.70 0.22 0.66 18 
CENTER ROTTERDAM 91 3.18 ± 1.19 ± 1.24 ± 0.41 ± 2.42 ± 0.71 ± 0.22 ± 1.71 ± 41 ± 
0.57 0.39 0.47 0.20 0.52 0.60 0.18 0.55 17 
BRUSSELS 41 3.52 ± 1.09 ± 1.37 ± 0.39 ± 2.47 ± 0.53 ± 0.17 ± 1.94 ± 41 ± 
0.64 # 0.40 0.50 0.15 0.45 0.70 0.22 0.79 17 
Gain = absolute luminal gain. Dev size device sizt:o Dev/Art dt:vict:/artery ratio. OS diamt:t..:r stenosis. Fr french. MLD minimal luminal 
diamder. 
Rod gain = rdativ..: luminal gain. 
Student t-tcst: # = p<O.05: @ = p<O.Ol: $ p <0.001. 
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ABSTRACT 
Ohjectives: The safety and long-term results of directional atherectomy in stented 
coronary arteries were determined in 9 patients (10 procedures), Tn addition, 
proliferation rates and cell density of restenosis tissue removed at specific 
intervals of time were studied to better characterize the development of restenosis. 
Methods: [n 9 patients (10 procedures) directional atherectomy was performed 82-
1179 days for restenosis within a stented coronary segment. The tissue was 
subsequently studied. for the presence of intimal hyperplasia, extent of 
proliferation and cell density. A control (non-stented) group consisted of 13 
patients who had restenosis tissue removed 14-597 days following an initial 
procedure (PTCA, atherectomy or laser). 
Results: The atherectomy procedures within the sten! were all technically 
successful. In one case a small fragment of the sten! was removed, For the entire 
group, the post athercctomy result was similar to the initial result after stenting 
(2.31 ± 0.38 mm versus 2.44 ± 0.35 mm). Five patients had follow-up 44-131 
days after atherectomy, and three of the patients had diameter stenosis> 50%. 
Three patients required reintervention (surgery, n=2; repeat atherectomy and then 
laser angioplasty, n~ I). 
Intimal hyperplasia was identified in 80% of the specimens after stenting and 
in 77% after PTCA or atherectomy, No differences were seen in tissue removed 
from stenting versus PTCAiatherectomy. [n three stented patients (47-143 days 
after stenting) 70-76% of the intimal cells showed morphologic features of a 
contractile phenotype by electron microscopy, Evidence of ongoing proliferation 
(PCNA antibody studics) were absent in all specimens studied. Although large 
individual variability was present in the maximal cell density of the intimal 
hyperplasia, there was a trend toward a reduction in cell density over time, 
COIlc/llsioll.\': Atherectomy can be safely performed for restenosis in stented 
coronary arteries with excellent initial results, However, reslenosis continues to 
limit the late effectiveness after atherectomy. Intimal hyperplasia is a non-specific 
response to injury regardless of the method and accounts for about 80% of cases 
of restenosis, This preliminary study suggests that smooth muscle cell 
proliferation and phenotypic modulation towards a contractile phenotype are early 
events and largely completed by the time of clinical presentation of restenosis (ie, 
< 2 months). Cellularity resuits suggest that lesions may be predominantly 
cellular, matrix or a combination at a particular time after a coronary procedure, 
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INTRODUCTION 
Restenosis remains the major limitation of percutaneolls transluminal coronary 
angioplasty (PTCA), occurring in 20-40% of patients within the first 6 months 
after angiopiasty [1], The implantation of stents in coronary arteries or saphenous 
vein bypass grafts as an adjunct or alternative to PTCA was initially proposed to 
prevent late restenosis [2]. However restenosis has now been documented in a 
significant number of patients in the first 6 months following stenting [3,4]. The 
optimal method to prevent restenosis or to treat its occurrence (or recurrences) 
after PTCA or coronary stenling is unknown. No pharmacological treatment has 
been consistently successful in reducing restenosis rates after PTCA [5]. Although 
restenosis occurs with the lise of mechanical devices other than PTCA, no 
randomized trials have yet been reported to determine if more favorable restenosis 
rates result from their lise. Directional atherectomy is one of these alternative 
mechanical devices for nonoperative coronary vascularization. In selected patients 
excellent post procedural results have been documented [6]. Furthermore, since 
the tissue can be removed, it offers a unique opportunity to study the histological 
features of the restenosis tissue. 
III the past two years, we have collected data frolll 10 procedures performed for 
restenosis within a stented coronary segment that were treated with directional 
atherectolllY. The purpose of this study was twofold: I) to determine the 
feasibility, safety and late results of directional atherectomy for treatment of 
restenosis within coronary stenls and 2) to assess the tissue removed from the 
restenotic lesion that caused the narrowing within these stents. Although restenosis 
after PTCA has been characterized by proliferating smooth muscle cells associated 
with extracellular matrix formation, we were particularly interested if differences 
existed in restenosis after stenting. In addition, since the temporal changes in the 
histological pattern following PTCA are largely unknown and have been studied 
ill only a limited number of patients [7], we wanted to study the proliferation rates 
and cell {Iensity of restenosis tissue removed at specific intervals of time to better 
characterize the development of restenosis. For the pathological studies, we have 
compared tissue retrieved by coronary atherectomy in 9 patients with restenosis 
in stented arteries with tissue obtained from 13 patients with restenosis after 
PTCA or previous atherectomy without adjunct stenting. 
METHODS 
The stent study population consisted of 9 patients who underwent to separate 
athercctomy procedures within the sten!. Five of the patients were treated in 
Rotterdam, 2 patients in Belgium, 1 patient in United States and I patient in 
Toulollse, France. The clinical characteristics arc presented in Table I. Five of 
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the procedures were performed in stents placed in bypass grafts and the olher 4 
stents were implanted in native vessels (Table 2). Six of the stented vessels 
contained the Wallslenl' (Schneider, Zurich) which is a self expandable slainless 
steel woven mesh slenl [3,4]. Two patienls had been implanled with a Palmaz-
Schatz™ stent (Johnson and Johnson, Warren, New Jersey) which is a balloon 
expandable slain less sleel tubular slenl [8]. One patient had received a Wiklor'" 
slent (Medlronic, Minneapolis), a lantalum balloon expandable slent wilh a helical 
coil design [9]. Five of Ihe patients were slented for primary lesions. The 
remaining 4 palients were originally slented for restenosis after PTCA. Two of 
these patienls (Palient 4 and 9) had multiple reslenoses and one of Ihese patients 
(Patient 4) underwent a second atherectomy procedure within the stent for a 
restenosis recurrence after the initial atherectomy. All patients were treated with 
anlicoagulalion 42-124 days following slenling. Athereclomy was performed 
wilhin the narrowed slenl 82-1179 days post slenling. Three of Ihe patienls had 
separale PTCA procedures for slent-relaled problems prior 10 the athereclomy. 
Palienl I initially underwenl PTCA for reslenosis 97 days after slenling and then 
required an atherectomy procedure 47 days later for a second restenosis within 
the stent. Patient 4 underwent balloon angiopiasty for restenosis 210 days after 
slenl implanlation and Ihen atherectomy 156 days later (366 days after slenling). 
Due to restenosis, a second atherectomy procedure was done 96 days after the 
first alherectomy (462 days after stenling). Patient 8 had a symptomalic acute 
occlusion five days after stenting. After recanalization with intracoronary 
streptokinase and PTCA, he had an uneventful recovery until he experienced 
recurrence of angina 5 months later due to restenosis within the sten!. Patient 9 
received a second slenl for a different lesion in Ihe bypass graft 570 days after Ihe 
first sten!. A lesion subsequently developed in the initial stell! and was treated by 
alhereclomy 1179 days after Ihe lirst slenl implanlalion (609 days afler Ihe second 
stent). Following atherectomy, two patients remained on anticoagulation. 
For the histological evaluation of the tissue, we selected a control group which 
consisted of all patients in the Thoraxcenter experience who underwent an 
alhereclomy procedure for reslenosis after PTCA, alhereclomy or laser (n = 13) 
(Table 5). This group consisled of I I men and 2 women, and Ihe ages ranged 
form 40-71. The interval of time between the illost recent intervention and 
alhereclomy for reslenosis ranged from 14-597 days. 
Angiographic Analysi.\': 
All cineangiograms were analyzed lIsing the computer assisted cardiovascular 
angiography analysis syslem (CAAS) which has previously been discussed in 
delail [10]. The importanl sleps will be brietly described. Any area of size of 6.9 
X 6,9 mm in a selected cineframe (overall dimensions 18 X 24 III Ill) 
encompassing the desired arterial segment can be digitized by a high resolution 
CCD-camera wilh a resolulion of 512 X 512 pixels and 8 bils of gray level. 
Contours of the desired segment are determined automatically, based on the 
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Figu,." J: Tf"lIl/,rmi,r,\'iOIl cfCCtHlIl micmgmph .\'1101'.'111,1.,' A) (/ .\'/J/(/otlllll/l.\'c/l' cd/wilh Ihl' .\),II//J('fic 
phellol},p!>. 71un' (ire almfl(lal/t ()'top!asmh' orf{lIl1e1Il'.I' ineludillg I'lIdoplll,lmit' n'ticIIIIIIII, Golg; 
appl/mlUS, and riho,l"OlI/t'.I'. Dilly tlji.'II> myojilmll('III.I' tI/"t' j1!'('.I'l'lIf ami tin' fOel/fl't! illllll' pl'riplU'I)' 
oflh" all. il) COl/fractile smoot/lillI/sell' ('{'II Q'/opia,\'/II cm/.l'isf.I' 1II0.l'IIy oflllyojilmlll'"ls lIlId afi~w 
milocliwulrill. 
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weighted sLIm of the tirst and second derivative functions applied to the digitized 
brightness information along scanlines perpendicular to the local centerline 
directions of the vessel segment of interest. A computer-derived estimation of the 
original dimension at the site of the narrowing is used to define the interpolated 
reference diameter. This technique is based on a computer-derived estimation of 
the original diameter values over the analysed region (assuming there was no 
narrowing present) according to the diameter function. The absolute diameter of 
the stenosis as well as the reference diameter are measured by the computer which 
uses the diameter of the guiding catheter as a calibration factor, after correction 
for pincushion distortion. 
Tissue Analysis: 
Following extraction of the tissue with the Simpson coronary atherocathR, the 
specimens were carefully removed from the housing chamber of the catheter, 
washed with 0.9% saline and cut into pieces of approximately I mm by 1-2 mm. 
Representative pieces were fixed in 10% buffered formalin for light microscopy 
studies. The specimens were processed according to standard procedures and then 
paraffin sections were stained with l1aematoxylin and azophloxine, and with Van 
Gieson. Three to five slides were prepared at variolls levels through the paraffin 
block. The tissue was specifically assessed for the presence of intimal hyperplasia 
and atherosclerotic plaques according to the definitions of Johnson et al [II]. 
Intimal hyperplasia was defllled as highly cellular tissue consisting of randomly 
arranged stellate and spindle cells in an abundant, collagen containing 
extracellular matrix. Atherosclerotic plaques consisted of dense fibrous tissue with 
abundant collagen, scattered fibrohlasts and occasional mononuclear cells, 
including lymphocytes and macrophage/foam cells. 
/ll1l1lulU,hisloc/U'mical .wudie.\": 
In deparaftinized sections, immullostaining was performed with monoclonal 
antibodies directed against alpha-smooth muscle cell actin (Sigma, St. Louis, 
Missouri) using an indirect conjugated peroxidase procedure. Proliferating cells 
were identified imlllunocytochemically using a monoclonal mouse anti-human 
proliferating cell nuclear antigen antibody (PCNA) (DAKO-PCNA, PCIO, 
Giostrup, Denmark). This antigen is a DNA polymerase auxiliary protein, and is 
expressed during 0 I, S (DNA synthesis), and 02 phases of the cell cycle [12-14) 
but not in the quiescent G" phase. Small intestinal mucosa served as positive 
control for peNA staining. 
Eleelrm/ Micl"().\'coPY: 
Representative pieces were fixed in a solution of glutaraldehyde-formaldehyde 
(4CF-IG). Posttixation was done with OS04' The specimens were then embedded 
in epoll and ultrathin sections were stained with uranyl acetate and lead citrate. 
All specimens contained smooth muscle cells in an abundant 
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Figure II: S/l'I/{}sis ill proxim(/I b)~1(I"\,.\· xnif/ prior fo .\"/eming (A), illlll/edial(' 1"t'.l"IIlllljier .Hellfillg 
(B), f(wlello.\"is ill slt'lIl db"flll f{/ orir:ill(fl.l"i/e ol.1"I('IIosis (C), illlJl/cdia/e I"t'.\"ul/ lifler a/haec/omy 
within/lie slt'III (D). 
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extracellular Illatrix. Cells were assessed as either contractile or synthetic type 
smooth muscle cells based on the following morphologic features [7]. The 
synthetic cells were characterized by extensive cytoplasmic organelles, including 
endoplasmic reticululll, Goigi apparatus and ribosomes), and by peripheral 
location of myofilaments (Figure la). The cytoplasm of the contractile cells 
consisted mostly of myolilaments and a few mitochondria (Figure Ib). Cells were 
counted in multiple fields (at least 150 cells in total) and classified according to 
these criteria into two phenotypes. 
Cell Densil), 'If intimal H)1Je1pla,,;a: 
In haematoxylin and azophloxine stained sections, areas of intimal hyperplasia 
were identif1ed and cell number was assessed in several fields by a computerized 
morphometry system (IBAS, Kontron, Oberkochen, Germany). The maximum 
value recorded was lIsed for the detennination of cell density which was expressed 
as cell numberl mm2 intimal tissue. Specimens without intimal hyperplasia were 
excluded from this measurement since this part of the study was specifically 
designed to look for temporal changes in cellularity occurring in intimal 
hyperplasia formed in response to the coronary procedure. 
RESULTS 
(J) Clin;ca/: 
All atherectomy procedures were technically successful (residual stenosis < 50% 
with retrieval of tissue) and there were no procedural complications other than a 
transient ischemic attack that occurred during a PTCA of a separate lesion in one 
patient. The only technical problem occurred with the WiktorTII1 stent. Following 
the procedure, the configuration of the stent was disrupted although no 
complications ensued. Tiny fragments of the tantalum wire were observed in the 
atherectomy material. All of the patients experienced immediate improvement in 
their symptoms. At late follow-up (4-15 months), patient 2 had died following 
bypass surgery for restenosis after atherectomy and patient 5 had died due to end 
stage renal failure. Two other patients required additional interventions for 
recurrence of symptoms due to restenosis after atherectomy. Patient J underwent 
bypass surgery 6 months after the atherectomy and Patient 4 was treated with 
excimer laser therapy. Five of the patients remained in NYHA Class I-II. 
(2) Ql/aJ/lilaliv" Allgiog/'{fphy (Tabl" 3): 
Immediately after placement of the stent there was an overall significant increase 
in the minimal luminal diameter and a significant decrease in the percentage of 
the diameter with stenosis (changing from a mean [±SD] of 1.12±0.36 to 
2.44±0.35 mm and from 63±9% to 21 ± 10%, respectively; p<O.OOI). 
However, at follow-up prior to the atherectomy, all of the lesions had deteriorated 
to an overall value ofO.99±0.24 111111 and 64±7%, respectively. The immediate 
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Figllfl! III: Hacllloloxylill-lIl.ojllloxilll' ,\'taillcd sectiOIl o/fix.l'lle I'''lIIo\'('d frollll! .\'te1ll89 days after 
st('l1IiIlX, 77/t' sectiol/ //(/.1' t/'" typical IIppcarance of illlimal hYPl'lplasia (II/Xllly cellular tisslle 
colIsistillK of rail dOl Illy al'ntllXl'd .\'ldlale Ill/d.\'pilldle cell\" ill 1I IO(I,H' (~t/racelllllar 1II1I/rix). (ol'igil1al 
magnificil/ioll 25x) 
Figure IV; H(/('lIIoto,\}'lill-lI~lif1l1oxille ,\'/aim'd s('clioll fiftJ.Hlle rCllulI'edfrolllll ,I'lellt 156 days after 
s/('lIIill}:. No infimal hYf/('fp/(/,\'ia WliS "fl'sellt. l1w lisslle cons;sll'd of a/ell' c('/ls ('lIIhcdd('d ill all 
lIbUlldal1l. COIlIlKl'lI colI/ail/illK ('xll'(/c('//lilal' //IlltriX. (oriKillal magnificatioll lOx). 
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result after atherectomy was similar to the acute stenting results (2.31 ±O.28 mill, 
27±10%). Late follow-up after atherectomy was only done in 5 of the lesions, 
with significant deterioration (loss of ~O,72 mm) occurring in three lesions. An 
example of the angiographic appearance of the lesion pre and immediately post 
stenting, at follow-up/pre-atherectomy and post-atherectomy is shown in Figure 
2. 
(3) Hislo/OKY: 
(i) A.fier SlelllillX (Table 4): The characteristic feature in tissue obtained in 8 of 
the lesions was intimal hyperplasia defined as a proliferative cellular response 
associated with a matrix of loose connective tissue. The area of intimal 
hyperplasia was typically sharply demarcated from the underlying sclerotic 
plaque, However the cellularity, amount of collagen, and extracellular matrix of 
the intimal hyperplasia varied between patients (Figure 3 and 4). In eight of the 
lesions, the main cell type within the lesions was identified as smooth muscle cells 
based on presence of SMC specific alpha actin. Specific staining for endothelial 
cells and macrophages was negative in two specimens tested although lymphocytes 
were identified in tissue from Patient 3, No giant cells as evidence of a foreign 
body reaction were identilied in any tissue specimen. In three of the specimens 
prominent capillary ingrowth was evident. In two specimens, the internal elastic 
lamina and adjacent media were identilicd (Figure 5), No evidence of adventitia 
was recovered. 
Ultrastructural studies in three of the stented patients (patients 1, 6 and 8) 
showed that the majority (70-76%) of intimal cells were contractile in 
morphology. No differences could be appreciated at the different time intervals. 
No differences were found in the histology or immuno-chelllistry between lesions 
(primary vs de-novo), vessel (native vs bypass graft) or types of stents. 
(ii) A.fier PTCAIAlhC'/,C'cloII/Y (7ilhie 5): In the control PTCAlatherectomy group, 
the histologic appearance of the tissue was indistinguishable from the stent tissue, 
Intimal hyperplasia was evident in 10 of the thirteen specimens, and again various 
stages of cellularity were evident. Media was obtained in 3 of the specimens 
(22%), No evidence of adventitia was recovered. 
(4) Proliferalion sllldies (Table 5 alld 6): 
In all specimens studied, no cells could be identilied that reacted with the 
antibody to rCNA. 
(5) Cell Dl'nsilY: 
The maximal cell density of the intimal hyperplasia ill both the stent and control 
groups is shown in Figure 6. Although large individual variability was present, 
there was a trend towards a reduction in cell density of the intimal hyperplasia 
over time, 
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Figllre v.. Hm'll/%,\ylill-az(!/7uox;//(' ,I willed .l'ec/io/l of /i,",l'/Il' /'('II/()\'('r/ from a s(c'lII 82 da),s afta 
S/t'lItiIlK. VIC' pre,l'l'I/{'e '!/ tfw 1IIC't/ia ;.1' il/dim/l'd b)' /1I1' illt('l'l/a/ d(/.I'/ic lamillll (arrow) alld the 
/ypic(/l (ll'elli/l'C/lln' of Ille S/I/oolh III//,\'(,Ic' ('ell.\' ill (Ill' II/elfill. (orij{illallllaj{lIijlcalioll lOx), 
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Figure VI: Maximal ('c'lI demit)' (','1l1ll1llIhl,riIlIl1l 1) ill re,\'/('/lo.I';,\' h',I'iolls following s(ell/illg, alld 
PTCA of ",her('("IOII/),. 11/1' x-tl.ti,I' 1'C'f"e,\'t'IiIS llit' IIl/lI/ba of days aftl'l' the procedure, Dill)' 
rt'sl£'lIo.\'is !c',I'iol/." willi illlill/a/ hYPl'lplasia were em/llalni. 11ll'r" is a Irnul towards dl'creasing 
cel/ularity oW'r lilll(' ill Ihe,I'c' le,I,iol/.\" a/thol/xll col/sit/eraMe ;mlil'idllaf I'ariahilif), is ('videlll. 
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DISCUSSION 
Restenosis persists as an important limitation to all forms of non-operative 
coronary revascuiarization, despite increasingly morc complex forms of 
interventions stich as stenting, alherectomy and laser-assisted therapy. It remains 
to be established whether any mechanical method can effectively treat (and 
prevent recurrent) restenosis after coronary balloon angioplasty or stenting. We 
studied the efficacy of directional atherectomy in 10 cases as a procedure to 
prevent recurrence of reslenosis. This study illustrates in a limited number of 
patients that directional atherectomy can be safely performed within a coronary 
stenl and provide immediate results comparable to the initial stenting procedure. 
In fact, atherectomy may be a safer procedure in stented than in nonstented 
vessels since the wires appear to limit the depth of the cutter into the vascular 
wall and thus reduce the possibility of perforation. However it is still possible 
to remove media (as in Patients 3 and 6) either between the stent wires or if the 
stent wire has penetrated the internal elastic lamina. Restenosis occurred in both 
cases of medial resection. The problem of removing or disrupting part of the slenl 
should be particularly of concern when the restenosis occurs immediately 
proximal to the lesion and the cutter can abut against the proximal part of the 
stellt. Although the immediate results of atherectomy were excellent, the 
recurrence of restenosis in three of the patients less than 3 months after the 
alherectomy procedure emphasizes that athereclomy alone will not prevent the 
restenosis problem. The aggressive nature of the restenosis process, reflected in 
the brief period preceding recurrence of symptoms after the atherectomy, is in 
accordance with several series which have shown an association between the time 
from initial angioplasty to recurrence and the risk of second restenosis [15,16]. 
Similarly, a recent PTCA «4 months) predicted recurrent restenosis treated with 
directional atherectomy in a study where the restenosis rate was 44 % f.l7]. 
Histological eWlluation (!f fhe' tissue retrieved from restenosis lesions (after 
stenting, PTCA, atherectomy or laser) confirms the findings of previous studies 
that 1) in atherectomy specimens, intimal hyperplasia is the characteristic feature 
in 75-80% or cases, and that the remaining 20-25% of cases contain only 
atherosclerotic plaque material without the features of intimal hyperplasia [II] and 
2) smooth muscle cells are the predominant cell type found in restenosis lesions 
[18-20]. It is unclear whether the absence of intimal hyperplasia in restenosis 
lesions is due to a sampling error by the atherectomy catheter or another 
mechanism of restenosis stich as elastic recoil or inadequate initial dilatation. If 
larger studies confirm this observation, the clinical importance is that restenosis 
interventional trials (pharmacological or mechanical) with the intention to prevent 
smooth muscle cell proliferation and the formation of intimal hyperplasia, can 
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only potentially affect approximately 75% of the restenosis population at risk. 
Future study designs may consider this in the determination of sample size for 
restenosis trials. In addition our study also illustrates that intimal hyperplasia 
predominates in restenosis tissue, regardless of the initiating procedure, with no 
unique features attributable to stenting in general or to a particular type of stenL 
This underscores the fact that intimal hyperplasia is a nonspecific response to 
vascular injury regardless of the method of damage [21,22]. 
17le temporal sequence q{ evellls in the Jim"atio" <if illlimal hypel],lasia following 
coronary intervention remain largely unknown: Results from our study suggest 
that: 
1) Smoolh muscle cell prollii'mlioll i.I' all early evelll, alld harely deleclable 2 
mOlllhs ({fier the procedure: 
To date, there is no data on the cell proliferation rates in humans following 
balloon angioplasty although the use of cyclin to label proliferating cells in human 
de-novo atherosclerotic plaques has previously shown a labelling index ranging 
from less than I % to greater than 4% [23,24]. Our results, showing no 
proliferative activity in the smooth muscle cells 82 days to 700 days post stenting, 
suggest that smooth muscle cell proliferation is an early and limited process after 
vascular injury in humans. This is similar to the results following vascular balloon 
denudation in animals in which SMC proliferation is first observed 48 hours after 
vascnlar injury and peak proliferation occurs at about I week which is followed 
by a rapid decline reaching base-line values by a month after the vesseJ injury 
[25]. Due to the limited period of SMC proliferation early after coronary 
angioplasty, pharmacological agents designed to reduce proliferation may only be 
required in the first two months after the procedure rather than the six months 
usually prescribed. 
2) 71w vasl majority (!f smooth Illu,\'c/e cells modulale towards the cOlllractile 
phellolype early q{ier Ihe procedure: 
Therefore only a relatively small percentage of the smooth muscle cells (ie. those 
with the synthetic phenotype) appear to be responsible for the synthesis of 
extracellular matrix proteins since in-vitro studies have shown that the production 
ofproteoglycalls and collagen is 5 fold and 26-45 fold higher, respectively, in the 
synthetic phenotype [26,27]. In our study, synthetic type smooth muscle cells only 
comprised 24-30% of the overall smooth muscle cells in the three patients who 
had atherectomy performed 135-183 days post stenting. In contrast, Nobuyoshi 
et al identified "synthetic" type smooth muscle cells as the predominant cell type 
in the first 6 months and thereafter, the "contractile" type smooth muscle cell was 
dominant [7], This earlier predominance of contractile smooth muscle cells in our 
study may be due to differences in methods of assessment (electron microscopy 
versus less reliable light microscopic features in Noboyoshi's series) or possibly 
related to differences in procedures (stenting versus PTCA alone). Interestingly, 
in a balloon-injury model in rats, Kocher et al observed a similar phenotypic 
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change (toward a contractile type) as in our study in lesions 75 days after injury, 
based on the ratio of smooth muscle to nonmuscle actins that had returned to 
levels of normal medial (contractile) SMCs [28]. 
3) Lesion c(!llularity tieCI'ea,H',\' as a function of time hut with a large 
il1terintiivitiual variability: 
As a consequence, lesions may be predominantly cellular, matrix or a 
combination at a particular time after a coronary procedure. Restenosis has been 
regarded as a process that is largely completed by 6 months after a procedure. 
Although cellular proliferation and matrix synthesis are recognized as the 
components of the restenosis lesion, the remodelling of the vessel wall after vessel 
injury is not understood and the relative contribution (and possibly the preeminent 
role) of the matrix components (proteoglycans and collagen) has not been 
appreciated. An inverse relationship appears to exist between the cellularity of the 
intimal hyperplasia lesions and the number of days following a procedure 
(although large individual variability is present). 
A temporal relationship between the cellularity of the intimal hyperplasia lesions 
appears to exist (although large individual variability is present). Since cellular 
proliferation appears to be an early event, the cellularity of the lesion is primarily 
related to the amount of synthesized matrix. The wide range of cell density at a 
particular interval of time may be related to either inherent biological variability 
or possibly sampling error. The total amount of matrix present at a particular time 
is related to the synthesis and resorption of the particular component. The 
turnover of proteoglycans is unknown although the limited data shows low 
collagen and elastin turnover in experimental models of hypertension [29]. The 
individual variability in cell density emphasizes the differential importance of 
matrix deposition in individual lesions. Clearly determining the composition and 
extent of the matrix synthesis during remodelling of the vessel after atherectomy, 
stenling or PTCA is an important step in the understanding of the restenosis 
process and should lead to new and synergistic pharmacologic approaches beyond 
control of smooth muscle cell proliferation which appears. to be an early and 
difficult process to limit. 
Study Limitation; 
This study is primarily limited by the relatively small amount of tissue extracted 
by the atherectomy catheter, which causes a potential sampling bias error. In 
particular, the device may not have removed the region of intimal hyperplasia 
containing the highest cell density or high cell proliferation or possibly even may 
have completely missed areas of intimal hyperplasia in specimens that only 
showed old atheroma. Therefore the I1ndings from this stUdy with respect to the 
remodelling of the lesion over time should be confirmed in larger studies. 
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Table 1. Clinical Characteristics 
Patient Age Sex Previous Previous Smoker Hyper- DM Hwert=ion 
MI CABG cholesterolemia 
56 M 1986 1982 + 
2 58 M + 
3 41 M + 
4b 55 M Inferior,1977 197711983 + + 
5 64 M 1986/ 1987 + + + + 
6 67 F Posterior 1986 + 
7 67 M 1989 
4a 55 M Inferior. 1977 1977 /1983 + + 
8 44 M Inferior. 1989 + 
9 76 M Inferior. 1974 1974 + 
MI= myocardial infarction. DM= diabetes mdlitus. CABG= coronary artery bypass surgery 
Table 2. Stent Characteristics 
Patient Stent Vessel Stent Type Stent Diameter Reason For Stent Time to Present Status 
(nun) Atherectomy (NYHA Class) 
CABG Wallstent 3.5 Primary 47 days (144) surgery for restenosis 
2 LAD Palmaz-Schatz 3.0 Restenosis 82 days surgery for restenosis 
3 LAD Palmaz-Schatz 3.5 Primary 89 days 
4b CABG Wallstent 3.5 Restenosis 96 days (462) laser angiopla..<;ty 
5 Circumfl~x Wallstt:nt 3.5 Primary 130 days dead (renal failur~) 
6 CABG WaUsknt 4.0 Primary 135 days 
7 CABG WalIst~nt 4.0 Primary 143 days II 
4. CABG Wallstent 3.5 Restenosis 156 days (366) see above 
8 RCA Wiktor 3.5 Restenosis 183 days 
9 CABG Wa1lst~nt 5.0 Restenosis 609 days (1179) II 
CABG= bypass graft. ( ) r~pre$Cnts num~r of days after the stent procedur~ in cases wh~re additional procedures were required 
Table 3. Angiographic Results 
Pre Stent Post Stent FU-S Stent Follow-Up Post Atherectomy Ath Follow-Up FU-Ath 
Patient Reference Diameter MLD DS MLD DS (days) MLD DS MLD DS MLD DS (days) 
(nun) (rom) (51) (rom) (51) (rom) (51) (rom) (51) (mm) (%) 
2.37 1.07 56 1.95 22 49 (144) 0.91 62 2.58 8 0.63 74 131 
2 2.84 l.15 59 2.67 5 82 1.19 56 2.26 24 1.89 39 14 
3 3.14 1.84 49 2.84 14 89 1.34 58 2.18 32 1.34 58 44 
4b 3.1 96 0.90 58 2.33 47 
5 3.1 1.1 60 2.1 19 130 1.30 59 2.37 25 
6 2.9 0.6 72 2.0 38 135 0.63 78 1.77 32 2.46 22 186 
7 2.25 0.75 78 2.55 30 143 0.70 69 2.1 29 
4. 3.1 1.2 61 2.8 15 156 (366) 1.03 66 2.81 21 0.9 58 96 
8 3.33 0.96 71 2.36 28 183 1.11 62 2.34 29 2.37 20 75 
9 2.75 1.40 64 2.71 21 609 0.81 71 2.4 22 
Mean 2.89 !.12 63 2.44 21 0.99 64 2.31 27 1.79 39 
(±SD) (0.35) (0.36) (9) (0.35) (10) (0.24) (7) (0.28) (10) (0.67) (19) 
MLD= minimal luminal diameter. DS= diameter stenosis. - not done. FU-S = follow-up after stenting. ath=atherectomy 
Table 4. Histology Results 
Patient Duration Post Intimal Media Adventitia Actin PCNA 
Procedure Hyperplasia 
47 days (144) ++ 
2 82 days + + NA NA 
3 89 days + ++ 
4b 96 days (462) + ++ 
5 130 days + + NA NA 
6 135 days + ++ 
7 143 days + ++ NA 
4a 156 days (366) ++ 
8 183 days + ++ 
9 609 days (1179) + ++ 
Duration post procedure refers to the most recent procedure. ( ) represents number of days since stern implantation when another more recent procedure was 
required. + present. ~ not present. NA= not asses..~ 
Table 5. Histology Results of Restenosis after PTCA/Atherectomy 
Patient Age Sex Vessel Procedure Duration Post rntimal Media Adventitia PCNA 
Procedure Hyperplasia 
66 F LAD PTCA 14 days + 
2 51 M LAD Alh 27 days (58) + 
3 66 M RCA PTCA 56 days 
4 67 M LAD PTCA 80 days + 
5 60 M CX PTCA 88 days + NA 
6 75 M LAD PTCA 95 days NA 
7 56 M LAD PTCA 113 days + + NA 
8 52 M LAD PTCA 126 days (201) + NA 
9 40 M LAD Alh l33 days + 
10 71 F LAD PTCA 134 days + + NA 
11 49 M LAD Laser 165 days + NA 
12 64 M LAD Ath 195 days + NA 
13 58 M RCA PTCA 597 days + NA 
LAD= left anterior descending artery. CX= circumflex. RCA= right coronary artery. NA= not assessed 

Part III 
HISTOLOGIC OBSERVATIONS 

Chapter 13 
HISTOLOGIC CHARACTERISTICS OF TISSUE 
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Histologic Characteristics of Tissue Excised During Directional 
Coronary Atherectomy in Stable and Unstable Angina Pectoris 
Javier Escaned, MO, Robert J, van Suylen, I,~D, Donald C. Macleod, Ma, ChB, MRe?, Victor A. W. M. Umans, MD, 
Marcel deJong, BEng, fred T. Bosman, MD, PhD, Pim J. de Feyter, MO, PhD, and Patrick W. Serruys, MD, PhD 
U nslable angina is an acute coronary syndrome a~~od~ ated \\·ith mb~l,mtial short- and medium-leon mor-
bidity and mortality,l TIle understulldilJg of the patho-
genesis of this ~-yndrome has been ba<;ed largely on post-
mortem studies of coronary arterics1 and supported by 
indiret" evidence of coronary thrombosi.~ in relation to 
the syndrome,J--5 Because directional coronary atherec-
tomy is unique in extracting intact atheromatous tissue 
during coronary fl',:anaJtzation, it may facilitate the 
study of the processes laking place in Ihe vessel in dif-
ferent coronary syndromes, Tn the pre~enl ~Iud}' the 
histopathologic charactemlics of atherectomy $'lllples 
retrieved in 93 palienL~ with stahle or unstahle angina 
pectoris were compared and related to different clinical 
variables, 
Il'£> stlUlied 93 ptilieills II'ho lIIuff/welll diH'ftional 
romnary alheratomy prmidillg histoloXic II/atelial (II 
tlie TlulnH('('//ler tillrillg the periodfmlll 19M 10 1992, 
After the a/IVI/af')' at/ter('Cf(/lIfY pmtot'(J/lI'as approved 
by Ihe ThonHCClller Imtifllfhml1/ Rt'riell' Board. infrml/-
ed ('OIlSl'III lI'as (lblaincd ill all paticllts hef(/rt' ;lIfer-
I'el/liol/, Din'ftimwl nmmfll),(lllierct'fomy II'(IJ pelfO/1/It'!1 
using (lie femoml oppmllclt, All (H'CI'llXt' ofo ± 3 PllS,f-
es ill IIIlIltiple tiirafiolls Wefe pNfimned ((CfOSS tilt' 
slnl05;s, 
Clillicall'llrillNes /'('('onft'!l il/cluded age, se\'. prt'I'i-
O/IS 1I/I'ocardial illji/ll'tiOIl, (,11/1'('111 stahlc or /llIslahle 
aI/gina pUforis, pn'I'iol/s ('O/1J/1I1f')' il/fC/'rell/iOiI alld risk 
factors jill' coml1(11), (lrler), diseaH' (histOl)' of ltyperc!lO-
le.ltemlemia, 110n-illslllill-!lependem (/iabetes mdlill/s, 
c(liarl'lIe smoking, hypertcllsio/l al/d comnm)' artery 
dis('(Jst' ill the jillnily), Prill/(lry Imstahle tll/gilla lI'as {Ie-
jillal m continl/O/ls or illfermillcllf c/zest paill al rest re-
quiring ho.lpitalizalioJl, associated with dc('tmt'anlio-
graphic cvidt'llCl' of lIIyocmdial Isd/ell/ia hilt wi/hollt 
auod(/ted illerease il/ ('anliaC ellT)'II/('J, Till' fillle illfer-
from the ('ath~l~ri7.JJi~n Llb(lldtOfY. Thor.t~l~nter, and !he D~p:ntmem 
of P.ilhology. Emmu;; Uniwp;ity. Po,lt>llS 1738,3000 DR ROlteniam, 
the Nelherbrui,. Dr. r",",-\!l<d i~ <;upp.:'r!cd b, the FPlJ progrillIlJI\e (If 
the SpaJlilh l>tinj'IT)' of Scien.;e ami fodu<'atiofl. Dr. ~1~{L.x\!.t i, a recip-
ient of II Ie Briti,h I!earl Foundation InteTIl.1tional Re:>earrh Fellowship 
Mr. de Jong is a gldnt fl'.:ipienl fr(IIII the Dutch Heart F~'undati~n. 
l>tmu,cript fl'~<'i\'e.:I Scptffill:><r 23. 1992; fl'vj<ed manuscript recei,-e..l 
January 4, 1993. and aCl"'ple.:l January 5. 
I'lII hetween the OJ/wI of chest pain alld Ihe athu{'('w-
III}' procedure II'OS 7 ± 5 {lays. 
- Tile oiltailll'{/ spedlllclls were jlxed ill /0% forma-
/ill. ROlllillc proccssing for light microscopy al/d 
lIelllato.\}'IiIl-(lzoph/oxill /IIld I'I.'rllOe/l\,(/1/ Git'SSOl/ 
siaining was pelfonllcd. All spednlt'lls were rt,)'iFlI'ed 
by 2 independent nllsen'Cfs who II'I.'rt' IIl1ffil'al<' of tlte 
dilticaf data, 11/e r(fommclldations ill the Ameriwll 
Heart Associaliof/ Mf(/it'aIIScielllijic Slatemeni OIl the 
(ltjillitio!/ of ,he intima of I/Ilmlln arleries mill of ils 
athelOsdemsis-pmlle rcgioJ/.\l'i were fol/owed ill nilft'Ct-
ing information regarding illtilllol tOl/st;luell/s, Medial 
lisslle Il'as idellfifi('{l 011 llit' hasi.\' of paralfel atnlllg('-
lIIellf of smoolh IIl11sde al/s, emht'l/dcd ill col/agt'/I amI 
fre(llIt'IIlly associated I\'illl a/ragmen! of the imemal (II' 
e.\1Cfllal daslic IWI/illa. Adl't'nlilia lI'as recoXllizcd hy 
the prt'Jel/ce of cO{lrse hilI/tiles of deliS;' {"ol/agell illter-
TABLE t Characteristics 01 tile Studt Population 
Stot-Ie Uostlb'e pVolu~ 
(i,r"cal Va'i"b';s 
A~(,e.l's, ",ea~ ± SD) 57,89 ± 10.38 5684 ± 10,85 
'" p",,';C'l>S niyoca"l:MI 13/48127%) 21145 (4T%) 0,05 
;m'arction 
MaiesE< 39/48 (81",,) 37/45182%) tiS 
$elum choJ",telol 3/48 (6'4) 3/45(7%) NS 
;,,8mmo'/l 
D,ai>otesme!L:us 1/48 (2'},) 
St'5te",;ch)p"rt~", 12/48125%) 10145(22%) 
" C'ga'ettesmc;'ing 18/48 (37%) 16/45 (36%) lOS 
Fa".·d, h:,to<yol(o'v 6/48112%) 9/45120"10) 
"' n~<yd,~ease 
r(e'i;OllScoror~<y i"t~(_ 13/48(27",) 11/45(24%) 
" \","Ii,:)o 
Ani~~(la>s (NYHA) 11'22,111·26 1I1·3,tVA2 
H'sto!ogicV",iab!es 
De~-Ie ~brou, tl>SU~ 40148 (83%) 39/45(66%) "$ 
tOOlS ~b.-ous I:"ue 12/48 (25%) 5/45 (11%) "$ 
fleo'c,timal hiP"<Jl'as;, 14/48 (29%) 17/45 (38%) lOS 
Ch,)lestelol c'tIt> 4/48(8%) 4/45(9%) NS 
NE(:'oticdeN;s 3/48 (6%) 6/45 (13%) "$ 
Cllciumdepo<;o/s 9/48119%) la/45 (40%) 0.042 
T)-,rombus 1/4a12%) 10145(22%) 0,007 
Macrcph'ges 6/48 (12%) 9/45 (20%) 
"' /'(H~ Ii~~ Vo,k I-l~'~ Assoc"!,,,. 
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millgled wilh elastill fibers, sometimes ill associatioll 
with fragments of the external elastic lamina alUl mctfia. 
Fibrolls tisslle was classificd as dellse whcn composed 
of ace/iidar or poorly celfltlar connectire tisslle fom/cd 
predominantly by dClIsc callagell, alld classified as 
loose when the tLulle fragments sl/l7l':ed a moderate cd-
llilanty alld collagen oUl/dles sepawted by accl/mula-
liolls of 01rarellufar matrix. Neoil11imal hyperplasia 
was de filled as fibromuscular connectire tissue showing 
a wlldom onell/alion of spindle-shaped and sic/late 
cells embetldet! ill aOIll/(/al1/ extracef//tiar matrix. 
Cholesterol cl)'sral defts, /lecrotit- tlebris alUl mfch/!// 
deposils were reconled independently. No special slaill-
hlg lI'as used to (dell/if>, co/dum. TIle prcsel1ce of 
man-ophages was recorded ollly WllCII these form('({ 
dusters or II'hc/I the>, W<'I't' pres('l/t ill WillS/lOlly /tigh 
/lumber. Thrombus alld il1lroplaqlle hemorrhage were 
identified as amorpholls mmena/, in rlose opposition 
n#h atheroma/Oils material. frequelltly showing wllee-
lion~ of le/lko()'lCs betwcen layers of fibrin. Art'05 CO/l-
.lIsting mainly of fibrin alUl /101 dearly relaled 10 Ihe 
plaqlle thai cmdd hal'e formed during Ihe procedure 
228 
were 1101 recorded. Tlte Verhoef-mn Giessoll stail/illg 
was IIsed to diseriminale behl'Cen fibrill tIIld dellse col-
fagen, Orgallizalioll was judged whcn infiltratioll by 
ce/Ildar demel/Is, e.g" Sll/oO/It muscle cells, fibroblasts 
and capillary sprouts, was observed, and gmded from 
I to 111 all tlte basis of tlte /lumber muf characterislics 
of illfiltralillg cdflllar demMls. 
IlIlhe 43 paticnts wilh III/siable angina, lesion mor-
phology was classified according to the eri/aia pro-
posed by Ambrose el of by 2 il/depe/Ulent cardiologists 
11l1ffll'are of Ihe H'Slill of Ihe ltislOpathofogic sludies. 
Complex lesion morpllOfogy was recorded whell e<'{'('1/-
Inc lesions lI'ilh OI'erlulI1gillg or ragg{,ti edges, or le-
siolls with fIIullip!e irrc,f;ularies werc noted, III case of 
disa.~rtYmefll, the opinion of a third Ci.1rdiologisl II'OS 
lakell illlO aft'oul1l. 
MCIlIl m/lles ± SD are pmlCl/le({ fill' colllil11101U 
variables. Comparison of mean rallies was performed 
IIsing 2-tailt'd IInpaired t tests, DLlo.'/e )'anahles 1\'Crt' 
compared IIsil1g chi-sqllart' le.lts, alld Yales' nllllilluit)' 
correction \I'm applied II'hell indicaled. Stali,lliml sig-
nificallce was IIcCt'pla{ at the 5% level. 
BRiEF REPORTS 
No significollt differences were fOllnd in the clinical 
chamCledstics of both ffmuPS, with the exception of a 
higher prel'alellce of prel'ions myocardial illfarctioll in 
the IlIIslable group (1.1 of48/27%) and 21 of45/47%} 
ill stable vlld /lnstaMe palien/s, respectively,' p:=: 0.05) 
(Table I). Several associations betweefl dillicv( \"IId-
obfes were obsen'ed il/ the patient populatiol/. The 
mean age of male patients was significantly lower than 
thai of female palients (56 ± 10 \'s 64 ± 11 yeors,' 
p:=: 0.004). Paliellts with lIyperdw/eslerolemio fre-
quently ~lollged to families with a hislOI)' of ('Oronary 
arter)' diseose (67 \'s 13% ill other patiellfs, p :=: 0.00.1). 
~ .... \~ 
I~'~ 
FIGURE 3, MLlm! thrombosis In unstablo an-
glna, and histologic findings In IIther<tctomy 
~llMmI, A, eplsodfe thrombu, growth has 
boon proposed liS a dlaractetistIc feature 
of unstable angina, yielding atea& of difflli' 
ent degroos of organization, Fresher ruea, 
of thrombus may have been missed In 
alfHlredomy spe-elmen& due to spontaneous 
lysis 8M eom.:omitant heatment with Intr~ 
venous heparin (B), or by dislodgement lind 
embolization of the more lablle fraction of 
thrombus by tho atherocatheter (C), In $Of1\e 
t;;a$Os, complex anglogrnphle mOfpItofogy 
may have resatted from per&istlng Irregulari-
ties or muftlklmlnal channels In felallan to 
the recanalization of prior epl$Odes of 
plaque ule-eratfon (O), 
c fr.,h Il-"cn'b" .~!:-o! IT~~ b-I01'.'OXQ +,,'" 
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7i\'cnty~four patients had a prel'iolls history of corollary 
rllle/wlltioll, indudillg 14 balloon ollgiopias/ies, 6 s/em 
impiallfations, 3 alherec/omy plVcedures ami} e.reima 
laser allgiop/asty, The meall time inlen'lIl hetw('('/I 
preriolls imen'el1tiOIl alld alhert'Clmny was 147 ± 108 
{lays, 
The mllsl slrikillg differellcc he/wet'n the syndromes 
was the pn'sellce of foei of thrombus or illfraplaque 
hemorrhoge ill 10 of 45 (22%) IIl1stable lind ollly ill 1 
of 48 (2%) slable palients (p = 0,007). Dilly 1 of Ihese 
pafiellfs had had a prc;'iO/u COroliGlY inten'entioll, All 
the samples slwuw/ some degree of cel""ar organiza-
tion (illc/luling the pn'sellce of emfotlielial cells c(ll'cr-
illg IIm'ly formed challnds or capillary vessels pn's;'111 
ill thmmlmtic mass originating fmm the sWTOIwdillg 
fisme), fhe oppearallce of smoolh f1/lIw1e ('('lis or my-
ofibroMas!s, alld lite presClIce of thrombotic II/oterial 
embt'llded ill fibrocellular tisslle, the fat/er c/wracferis-
tic sllgg<'Stillg tltat Ihe mosses of fihrin and platelets de-
ril' .. d from (//1 episllde of thrombosis or plaque hemor~ 
r/lOge lI'ere heing ill(('gro/ed ill the atlieromatolls plaque 
(Figure 1, A to D), Thromhus 1m.\' apposed 10 fihrous 
tisslle in all cases, without endothelial cdls ill the ill-
terface between bolh, A lack of relation betwem the 
time inlen'al from the onsel of aI/gina al rest 10 atltel't'c~ 
/omy alltlfhe degree of Ihrombolic orgafliZaliOllll'as C;'-
ident, Likewise, fhe relatioll hetll'('Cllangiogmphic I/Ior-
plwlogy and the presence of thrombus ill fhe !1l/rifl't'd 
tiSSlif ,lid 1/01 rt'ach slatistical significance, Complex al/-
giogmphic mmphofogy was noted ill 17 of 45 lIT/staMe 
patiellls (37%) (Figure 2), ThrolllIJ/l.~ or plaque hemor-
rhage was present in 6 (If these paliellis (35%) alld ill 
4 of thos;, with nOll,complex allgiographic II/O/plwlogy 
(14%) (p = NS), 
Calcium deposils wert' also ohsen'l'lJ //lore /re-
qllemiy in patiel1fs wilh /II/stahle (18 of 45 ,\'(III/pies, 
40%) Illall slahle (9 of 48 samples, 19%) (Illgina 
(fl == 0'(142), No s(lillijinwl differellces \\'ere fO/lllil with 
regard to Ihe f/fl'SfllCe of fibrous tisslle, dwlestao/ 
clefts, I/ccmti(' ('Oft' (II" diU/CIS of lIU1Cmpltagl's, In tlte 
overalf populalioll, ('omple\' atheromatous s(/II/ph's 
(col1laillillg dense fibrous tisslle, caldulII ,h'/}(J.,ifS alld 
lIe('folic debris) were ohlained ill olda patients (58 ± 
10 vs 51 ± 12 years, p «),OJl), Necrotic debris was 
obsen'l'(} ill 7 of 34 cigarCl/e sll/okers (21'K.J \'CISIIS 2 
of 59 lIonsmokers (4%) (p = 0,019), Marrop/lOges were' 
idellfijied ill 4 of 15 (27%) alld 5 of 78 (6%) samples 
with ami witliout 1It'('mlic dehris, rcsputil'dy (p = 
0,05). 
NMilltimal h)perplllsia was obsen'ed ill 17 of 24 
patieills (71%) wilh prn'iolls corollary imenell/ioll al/d 
ill 14 of 69 patiellis (20%) wilh primary lesions 
(p = 0,0001), Neoilltimal hypapimia had idelltiwl 
c/tamcleristics in patients wi/h pre\'ioll,~ /!(/Ilooll allgio~ 
plm/y, SMIling, atliere('!olllY or laser ongiop/as/y. Pur-
timlar at/ention II'(lS paid to Ihe 14 palieilis lI'ith pri-
11/0/)' lesions showing t)pical IIMil1limal hypelpfasia, 
When compared lI'illl other primary lesions, 110 relatioll 
to the ope of COTO/IO/)' symlmme )I'(lS ohst'n'c{/: 6 pa-
tinlls had stahle alld 8 IIlIstable o/I,~il/(/ pectoris 
(p = NS), Likcwise, 110 associatioll lI'illl sex, corollary 
arfel)' (tisease risk factors or previolls lIIyocGlifiaf ill-
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fan-tioll was fOl/mi, However, the meall age of patiellts 
Hitll primary lesions showing IIMimimal h}perpfasia 
I\'as SigllijiCOlllty lower thall that of patients wilh pri-
mary lesions and otllt'!' histologic dlamctcrislics (51 ± 
13 vs 59 ± 10 years, p == 0.017), 
The retrieval of atheromatous material during direc-
tional (OronaI), atherectorny has created new pos.sibili~ 
tks in the study of coronar), s}ndromes, Although lim-
ited by lesion selection and sampling chamcleristks,8 the 
collection and analysis of the removed tissue has the 
considerable advantage of allowing the pathologic as-
sessment of coronary arter), disea~e "in-vivo," thus 
avoiding rue selection bias inherent in postmortem siUd~ 
ks. 1b our knowkdge, the present work represents the 
lirsl compamtive study of the hislopatholob.-jc substrate 
of 2 different coronary syndromes using atherectomy re-
trieyed material. 
Primary umtable anfina is considered 10 be an acute 
thrombotic s}lldromeh occurring predominantly in pa~ 
tients with widespread coronary artery disease,\! Coro-
nary Ihrombo~is dOl:s not result initially in tmru.muml 
myocardial necrosis because of inwmpiele, episodic ves-
sel obstruction, intemlitlent spontaneous vessel recanali-
zation, Of the presence of well-.developed collateral anas~ 
tomoscs,3,4 Different observations suggest that the 
associated mum.! thrumbus is ver), rich in platelel ag~ 
gregales and has a layered Olpp.:amnce.2 
In the present study a higher prevalence of mural 
thrombus and plaque hemorrhage in un~lable angina was 
also observcd; thrombus was identified in atherectomy 
samples obtained from the ischemia~rclated coronary le~ 
sion of 22% of unstable and in only 2% of ~table pa-
lient~, TIlls figure is lower than the prevalence of throm~ 
bus suspected in angiographic studies3 bUI similar 10 that 
reported in a necrop~y study of patients with unstable 
angina.9 rt is remarkable thai no statistit'ai relation re-
tween complex angiographic morphology and presence 
of thrombus in the (issue retrieved could be found, al~ 
though se\'eml explanation.s can be given for tbis. TIle 
penoistence of comple;.; angiographic morphology in the 
long ternl has been reported in 57% of cases by Haft 
and AI~Zarka 10 A wmple;.; angiographic morphology 
may also result from l1lultiluminal channels that are fre-
quent in ,atheromatous plaques of unstable patients II 
(Figure 3D). Unstable angina may also result from 
changes in plaque geometry secondary to inliOlplaque 
hemorrhage, which may be difficult to dilferentiate from 
muml thrombus during the study of isolated fragments 
of the arterial wall. 
An interesting finding is thai all samples containing 
thrombus or intraplaque hemorrhage material showed 
diftcrent degrees of cellular organization that, on the 
grounds of the time s(,ale of thromblls organization ob-
served in e,xperimcntal model~, 12 bore no relation to the 
lime interval btlween the onset of chest pain and 
atherectomy, This may suggest that the onset of coro-
nary thrombosis or plaque hemorrhage had preceded the 
development of angina at rest by several days or weeks, 
The n.'meved organizing thrombll~ may thll~ correspond 
to either an episode of plaque hemorrhage or to a first 
episode of subocdusive thrombosis that after episodic 
groV.1h or rethrombosis led to the development of symp-
BRIEf REPORTS 
toms1 (Figure 3A). The absence of fresh thrombus in 
these samples could be due to spontaneous lysis and 
inhibition of further thrombosis by continued systemic 
heparinization (Figure 38) or embolization of that labile 
fraction of thrombus during catheter manipulation (Fig~ 
ure 3C). 
These observations may have implications for thera-
peutic and diagnostic approaches in UIL~table patients. 
The low prevalence of observed thrombus and the de-
gree of organization or embedded thrombus in the 
atheromatous plaque may explain the therapeutic failure 
of thrombolytic agents in primary unslable angina.13·14 
One should clarify whether some of the angioscopic 
characteristics of coronary thromblL~ observed in unsta-
ble patients, such as the characteristic greyish appear-
ance reported by Mizuno et a1s could be related not only 
to platelet-rich thromblL~, but also to organizing charac-
teristics of thrombus, since it is well known that the 
macroscopic appeanmce and color of thrombus shifts 
progressively toward a pale, whitish color a~ organiza-
tion incrcases.15 
TIle cause of the initial event in the development of 
mural thrombosis, plaque rupture or fissuring, remains 
controversial. In this study, macrophages, which have 
been identified in areas of the fibrous cap that are prone 
to rupture,16 were not observed preferentially in umta-
ble plaques but preferentially in plaques with necrotic 
core. Only fibrous tissue wa~ found in close association 
with thrombus, an observation that may be relevant to 
the kind of initiating thrombogenic stimuli. Although no 
endothelium could be identified in the area covered by 
thrombus, no funl conclusions C,ill be drawn from this 
becaU';e experimental studies have Sho\~l1 that endothe-
lial cells are rarely observed 3 days after being engulfed 
by mum1 thrombosis.!l 
The higher prevalence of calcium deposits in un~ta­
ble plaques may be related to the frequent existence of 
severe and widespread coronary artery disease in unsta-
ble patienl~.1! A proportional relation between complex 
atheroma and age was also evident in the overal\ study 
population, in agreement with the current knowledge of 
the sequence of events kading to the progression of 
coronary artery diseaseY 
Our results also support previous observations in 
coronary atherectoTll}' sp..'cimens showing that neointi-
mal hyperplasia constitutes the pathologic substrate of 
restenosis after C1Jronary intervention, l~ irres~cti\'e of 
the revascularization technique used previously, Typical 
athero~clerotic !issue was also retrieved in a subst(mtial 
number of restenolic ksions, although this is probably 
due (0 the sanlpHng chanlclemtics of the device or in 
circumshmces where restenosis was due (0 mechanism.~ 
other than ncointimal hyperplasia. S In accoru,mce with 
a previous study,19 neointimal hyperplasia was also 
found in a substantial number of primary lesions. \Ye 
noted that these patients were significantly younger than 
othen; with typical primary atherosclerotic lesions, a fact 
that may have particular relevance since fibromuscular 
neointimal proliferation has been reported as the patho-
logic substrate for coronar), artery disea';e in the young, 
resulting in sudden dealh.lo The ultimate meaning of this 
observation as to the natural hi~tory of atherosclerosis 
remains unclear. Neointimal hyperplasia represents all 
unspecific vessel wall response 10 different kinds of in-
jury that lead to accelerated foiTI1S of atherosclerosis. 
Whether the presence of this type of tissue in primary 
lesions of young, s)mptomatic patients is a reflection of 
less·known fact on; initiating the atherosclerotic process 
(e.g., viral endothelial injury, genetical predisposition) 
remains hypothetical. 
Histologic studies based on atherectomy specimens 
are biased by selective plaque sampling,8 although in the 
present study this limitation was partially overcome by 
routinely performing multiple cut~ ill different seeton; of 
the Ye-ssel. Case selection may ha\'e occurred since only 
ycssels judged suitable for the technique were treated 
(e.g., coronary atherectoTll)' was perfomled in only I pa-
tient with total occlusion). The differentiation between 
muml thrombosis and foci of plaque hemorrhage is 
strongly limited by the analysis of isolated fmgments of 
atheroma. Atherectomy was perfomled in stenoses thaI 
were identified on the grounds of elinical, angiographic 
and electrocardiographic data as ischemia-related steno-
ses. However, this "culprit lesion" approach may not 
have been free from a number of confounding facton;, 
including the persistence of comglex angiographic mor-
phology from a previous event! (Figure 3D), and the 
development of myocardial ischemia "al a distance" by 
a different coromr)' narrowing. 
Despite these linIitations, the results of the present 
study empha~ize the use of directional coronary atherec-
tomy as a means of investigation during its therapeutic 
use. 1he identification of such features as an increased 
prevalence of organized thrombu~ in patients presenting 
with umtable angina, and of neointimal hyperplasia in 
primary coronary lesions of younger patients contributes 
further to our knowledge of the processes that take place 
in the coronar), arteries during the natuml history of 
coronary syndromes. 
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DIRECTIONAL ATHERECTOMY: COMBINING 
BASIC RESEARCH AND INTERVENTION 
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Directional atherectomy: Combining basic 
research and intervention 
Donald C. MacLeod, l\IB, ChB, 11RCP,a Marcel de Jong,b Victor A. Umans, MD,a 
Javier Esmned, MD,h Hobert-Jan VillI Suylen, r.,-ID,c Patrick W. Senuys, r\'ID, PhD,a 
and Pim J, de Feyter, MD, Phon Rotterdam, The Netherlands 
In 1985 Simpson at a1.1 first described the percuta-
neous transluminal removal of atheromatous mate-
rial from peripheral arteries by means of a novel 
catheter system. The technique was given the term 
"directional aiherectomy," denoting the selective 
excision of obstructive luminal atheroma to distin-
guish it from surgical endarterectomy. Initial experi-
ence indicated that directional atherectomycould be 
performed safely and effecti\'ely and might be an at-
tractive aiternath'o to conventional balloon angia· 
plasty in certain circumstances.2. 3 Developments in 
the atherectamy catheter and the design of suitable 
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guiding calheters allowed the extension of the tech-
nique to the cOHlnary arteries in 1986,4 Recently, di-
rectional coronary atherectomy has undergone com-
parison with coronary balloon angioplasty in a mul-
ticenter prospective, randomized trial, the CAVEAT 
study, After brief discussion of the technical aspects 
and clinical use of directional atherectomy, this arti-
cle will focus on the applic.1tion of atherectomy as a 
route to research, 
TECHNICAL DETAILS 
The Simpson AtheroCath (Devices for Vascular 
Intervention, Redwood City, Calif.) incorporates a 
rigid metal cylinder a short distance from the distal 
tip (Fig, I), This cylinder is windowed longitudinally 
on one side and carries an eccentric balloon on the 
other, Within the cylinder is a cup·shaped cutter that 
can travel the length of the window; the cutter is ad-
vanced and retracted by a hollow drive cable, The 
most distal part. of the cylinder serW~$ as a collection 
chamber. Proximally, the drive cable connects with a 
hand-held, hllttery-operated motor that spins at 
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FIg. 1. Simpson Atherocath. Tn window of cutler hou;;ing, cutter and drive cable are visibl€'. Guide wire 
has b€'€'n withdrawn. Bur scale, 1 mm. 
Fig. 2. Directional atherectomy device deployed in right coronary artery, 450 left anl('rior oblique projec-
tion. Eccentric balloon is inflated with contrast, opposing cutter housing to vessel wall. Rotating tuner is 
clearly visible (urroll'). 
±2,OOO rpm. To position the Atherocath, a conven-
tional O.014·inch guide wire is passed through the 
cable lumen and manipulated across the lesion. The 
device can then be advanced. For coronary use pre-
shaped, nonangled guiding catheters are first intro-
duced. On retraction of the cutter, low-pressure 
inflation of the eccentric balloon holds the window 
firmly against the selected area of atherosderotic 
216 
plaque. ~Iat(>fial intruding into the window is then 
shaved oJfand pushed into t.hecollection chamber by 
the advancing cutter (Fig. 2). After withdrawal ofthe 
device from the patient, specimens are flushed back 
into the window from where they can be extracted 
(Fig. 3). The amount oftissue retrieved varies widely 
but from peripheral lesions approaches 100 mg in 
weight5 und from coronary lesions approximately 20 
Macuod f'f al. 
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Fig. 3. ~11l~fOS~opic appearance of tiosue retrieved during directional coronary athercctomy. Bar sca/c, 1 
mm. 
mg.5,6 The rigidity and bulk of the cutting and col-
lection system (2':5F) limits coronary use to the 
proximal and middle sections of relatively large ves-
sels (2::2.5 mm); the largest de\>1ce (UF) may not be 
sufficient to allow satisfactory apposition in large pe-
ripheral arteries. 
CLINICAL APPLICATIONS 
There is debate regarding the most appropriate 
niche for atherectomy in vascular intervention: sev-
eral reports have focused on the therapeutic poten-
tial of the technique in peripheral and coronary ar-
teries.2.4, 7, 8 It is proposed that. atherectomy may be 
advantageous in dealing with complex lesions often 
seen in unstable angina, where conventional balloon 
angioplasty can be associated with suboptimal re-
sults. Threatened or abrupt occlusion resulting from 
balloon-induced dissection can be managed by using 
directional atherectomy to excise the intimal flap, a 
bail-out role, but this is controversial. Originally, 
athelertomy was thought less likely to provoke 
restenosis on the basis of leaving a smoother vessel 
lumen with fewer dissections. This is probably not 
the case, but. the increased initial luminal gain com-
pared with conventional balloon angioplasty may 
better accommodate subsequent_ restenosis. 
RESEARCH APPLICATIONS 
Directional atherectomy has created the potential 
for new directions in both clinical and laboratory re-
search (Fig, 4), Indeed, among the new interventional 
devices, atherectomy is unique in providing the 
means to investigate pathophysiologic phenomena 
by using human vascular tissue. First, the tissue re-
trieved by the device can be subjected to histopatho-
logic examination. Traditionally, the pathologic fea-
tures of atherosclerosis in human beings ha\'e been 
studied by using material excised in the operating 
theater or autopsy suite. What directional atherec-
tomy now offers is access to fresh vascular tissue for 
immediate fixation and examination in situations 
where precise details of the current and previous 
medical history and clinical investigations are avail-
able, Thus histopathologic appearances can be reli-
ably related to different clinical pictures; primary 
atherosclerosis and restenosis, stable and unstable 
angina, for exrunple, 
Second, this tissue constitutes a source of cells for 
experimental work. Of necessity, investigations of 
mechanisms at cellular level in atherosclerosis, rest-
enosis, and acute coronary syndromes have been 
performed in animal models to date. Studies have 
identified the vascular smooth-muscle cell as having 
a pivotal role in the response to injury of the vessel 
wa11.9 Smooth-muscle cells disaggregated or cultured 
from tissue excised at atherectomy can be examined 
with electron microscopy to identify subcellular or-
ganelles and myofibrilsand with immunohistochem-
istry or electrophoresis to identify cytoskeletal pro-
teinssuch as smooth muscle cell alpha-actin, to com-
ment on cell phenotype. The distinction between the 
contrnctile and synthetic phenotypes of the vascular 
smooth-muscle cell in culture is shown diagrammat-
ically in Fig. 5. Important behavioral properties of 
the smooth-muscle cell, migration, proliferntion, and 
extra-cellular matrix synthesis, can be examined in 
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Fig. 4. Directional athereetomy: possible directions of research based on basis of retrieved tissue. 
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Fig. 5. Diagrammatic representation of differences in smooth-muscle phenotype: synthetic and con! rac-
tile forllls. (Adapted from Thyberg et al. Arteriosclerosis 1990;10:966.) 
vitro. Also, cultured human vascular cells may be 
used as experimental models in the assessment of 
pharmacologic agents and the investigation of ge-
netic processes in the cell, including the effects of ge-
netic manipulation. 
Third, tissue can be frozen pending characteriza-
tion with molecular biologic techniques. Transcrip-
tion, the process by which the genetic code is con· 
\'eyed to the synthetic apparatus of the cell, and 
trnnslation, the interpretation ofthe genetic message 
and consequent production of specific proteins (Fig. 
6), can be unravelled by using monoclonal antibodies 
to recognize protein products and Northern blotting 
or in situ hybridization with selective radiolabeled 
gene probes to identify different messenger ribonu-
cleic acid (RNA) chains (Fig. 7). 
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Histopatholog1c studies. A number of reports have 
been generated by this aspect of directional athcrec+ 
tomy. i .... laterial excised from primary atherosclerotic 
lesions in peripheral vessels bore the typical appear· 
ance of dense, fibrous plaque with occasional choles-
terol crystals. IO Two thirds of restenotic lesions in the 
periphery displayed I he characteristic feature of the 
vascular response to injury, neointimal hyperplasia, 
but this featUre was also found in approximately one 
third of primary lesions. lO• ll Coronary artery histo-
logic features were similar; virtually all restenotic le-
sions revealed neointimal hyperplasia, a fealure seen 
nevertheless in a third ofprirnary lesions.6 In our own 
series neointimal hyperplasia (Fig. 8) indeed corre~ 
lated significantly with prior intervention, usually 
conventional baUoon angioplasty, and was detected 
MacLeod et al. 
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in 20~(, of primary lesions (Table O. The presence of 
neointimnl hyperplasia in a suhstantial proportion of 
primary atherosrlerotic lesions is consistent with the 
suggestion that ~Jlontaneous intramural injury in the 
form of plaque rupture occurs commonly, often ap-
parently without serious clinical consequence,!"' and 
confirms that the primary atherosclerotic plaque is 
far from inert. What cannot yet be drawl! from the 
literature is whether or not the primary ntheroscle-
rotic plaque demonstrating this evidence of vascular 
injury cao distinguish subgroups of patients with a 
different pattern of symptoms, rapid onset or cre-
scendo angina pectoris, for example. 
Neointimal hyperplnsia in plaque tissue testilies to 
recent or ongoing cf>Iiulllr proliferation. The prolifer-
ath-c status of intimal smooth musde eells in fresh 
tissue obtained at directional atherectomy can be 
documented by using a monoclonal antibody to a cy-
din, the proliferllting cell nuclear antigen (peNA), 
thus identifying cells in the S, O}, and G2 phases of 
the eell cycle.13 By thi,'; mf>allS a recent report con-
firmed that low rates of proliferation do exist in pri-
mary atherosclerotic, lesions, Il in agreement with the 
histologic data regarding neointimal hyperplasia. In 
a brief series of patients undergoing directional 
atherectomy for restenosis in coronary and \'enous 
bypw,'; graft stents, compared with patient,'; receiving 
alhereclomy for restenosis post balloon angioplasty, 
anli-PeNA labeling indicated that smooth-muscle 
cellular proliferation may wane within a relath'ely 
short period oftimc after coronary interventions:.f7 
days after stent implantation and H days after bal-
loon angioplasty.l~ 
There is continuing interest in the role of throm-
botic mechanisms in vascular events. In peripheral 
vessels adherent or incorporated thrombus was a 
common finding in relation to primary atheroscle-
rotic lesions but less so in relation to restenotic le-
sionsY)·l1 Although thrombus was not commented 
on in a report of 73 coronary specimens,6 a recent 
communication described the presence of thrombus 
in 18 of 19 complex coronary le~ionsY; OUf own 
groUp, examining 93 consecutive coronary atherec-
tomy specimens, noted that the presence of organized 
tbrombus within the plaque (Fig. 9) was rei flied to 
unstable angina (Table I), The proportion of cases 
was small, 10~c" but in these patients the degree of 
organization of the thrombus allows us to estimate 
with some confidence that spontaneous plaque rup-
tUre took place 7 to 10 days previously. Given accu-
rate clinical details, the comparison of primary ath-
erosclerotic lesions demonstrating either organized 
thrombus or neuintimal hyperplaqia, with lesions 
showing neither of these features, provides fresh in-
sights into the pathophysiologic nature of the plaque 
in diverse coronary syndromes. 
The features of the tissue excised at atherectomy 
may ba\'e further bearing on subsequent clinical out-
come. Garratt et al. 17 examined thedep!hofresection 
during coronary atherectomy and related this to the 
subsequent. development of restenosis; deep cuts 
wele suggested to be a risk factor for restenosis in 
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venous gmfts and ill already r{'stenotic lesions hilt 
not in pl'imary lesi(mg. In material from 126 periph-
eml and 39 coronary procedures, ohsen'ation of a 
highly ('{'Ilular intima, identification of the internal 
ela.~tic lamina nnd the presen('e of arterial media were 
found to be predictive of Lestenosis after atherecto-
my.1!> Analysis of specimens from 377 coronary ath-
erectomies revealed that the presence oflesion throm-
hw; and incision into the adventitia were the two 
fad or" a.~s(Jciat ed with proceciural com plication~ such 
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os \'e~"el flcdu~ion, myocardinl infarction, pC'ffora-
tion ami distal embolization in vein gwfts. w 
Information can also be ohtained regarding olher 
form~ (If vasculor intervention. In 3,Q patients under-
going dire('tional athereclomy for restenosis subse-
quent to balloon angioplasty, atherectomy, or laser 
angioplasty, WnHer el al.21) noted that the histologic 
appearances were similar l'egardless of the initial 
technique?) The enterpri~ing use of directional 
athel'ectomy in 21 patients immediately after either 
Mocl.('od ('/ 0/. 
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Fig. 8. S"ction ofprimaIY athero$c!erotk coronary arlery plaque excised at directional coronary atherec-
tomy demonstrating neointimal hyperplasia. (nematoxylin-azofloxin stain; x450). 
FIg. 9. Section of atherosclerotic coronary artery plaque €'xcised at dir€'ctional coronary atherE'ctomy 
de!Uon~trating organized thrombus (Tj. (hematoxylin-azofloxin stain, x40Oj. 
Table I. FrE'quencie., with whirh neoinlimol hyperplasia 
I .... IIS found in relation 10 [""ion type and orgalliCl"d throm. 
bus was found in relation to symptoms in coronary artery 
plaque (issue excised from 93 patients at directional 
atherectomy 
Primal')" le,irm 
Nfointimal hyper"la3ia 14/69" \21)~;) 17/24 (71 ',I 
P < 0.{H)1, XI fest 
Rhlble angina Un;;table angina 
Organ;,f"(t thromb\H 1/4~ {2~~) 10/45 (22:,) 
p < 0.01, Xl Ie,! 
Nd:Y AG ("hot ·tip"), holmium:YAG, or excimer laser 
angioplasty allowed Isner et al.21 to describe the 
pathologic eJfects of the three modes of la~er, which 
ranged from charring several ceil layers thick with 
the first to a mildly basophilic, serrated appearance, 
one cell layer deep with the last.21 Findings such a~ 
these may he useful when con~iderillg both the pro· 
cedural result and the longer.term outcome of laser 
thermal and photoahlatioll and may influence 
changes in clinical practice. 
Studies using directional atherectomy are en· 
hanced by the use of quantitative angiography where 
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edge-detection analysis in particular provides useful 
information on plaque geometry in relation to hoth 
the effect of the procedure~l and histopathologic 
data. Conceptually, the marriage of directional 
atherectomy and intravascular ultrasonography is 
very attractive, High-quality images of the vessel wall 
will help to assess the separate contributions of the 
three modes of action of the atherectomy device: the 
"Dotter" effect, the effect of balloon inflation, and 
the effect of the cutter, Also, examination of tissue 
retrieved Illay prove useful in corroborating the 
information provided by intravascular ultrasonogra-
phy with regnrd to the components and architecture 
ofthe vessel wall. In a similar manner, different types 
ofthromhus, or features of the plaque such as fissur-
ing, revealed by angioscopy, can be sought in atherec-
tomy samples, 
Cell and cell culture studIes. Bauriedel et nL23 were 
the first to embark on cell-based investigations with 
atherectorny material and demonstrated that celis 
dis-aggregated from atherectomy specimens could be 
identilied as smooth-musde cells by their staining 
with monoclonal antibodies to smooth-muscle cell 
alpha_actin.1~l An extension to this work included 
electron microscopic and electrophoretic studies of 
peripheral arterial atherosclerotic material.2-1 The 
mixed phenotype of the intimal smooth-muscle cells 
(Fig. 5), re\-ealed by the presence of peripheral my-
ofilaments together with dense perinuclear or-
ganelles, was consistent with the findings of studies 
of vascular injury in experimental animal models, 
and the distribution of cytoskeletul proteins, pre-
dominantly beta-, alpha- and gamma-actin and \'i_ 
melltin was similar to that found in studies of surgi-
cally excised human tissue. Immunofluorescence mi-
croscopy opplied to sections of tissue obtained from 
coronary arteries at athereCI{)my re\'ealed that vi_ 
mentin-pMitive smooth-musde cells of synthetic 
phenotype were also positive for cytokeratins 8 and 
18.2~ CytokeratinB afe proteins found in fetal and 
neonatal but not adliit vascular smooth-musele cells, 
indicating that asubset ofthecoronary lesion smooth-
muscle cells in this ~tudy had the characteristics of 
immature, dedifrerentiated cells commonly associ-
ated with proliferative properties. 
The material obtained at directional atherectomy 
can he exploited by using the technique of cell cuUure 
in the further use and investigation of the small 
pieces of tissue retrieved. Bauriedel et al. 23 were olso 
the first to describe the cultivation of fibroblast-like 
cells from atherectomy tissue explants.2.l It was sub-
sequently reported that cells isolated from primary 
atherosclerotic and restenosing lesions in hoth pe-
ripheral and coronary llIteries behaved differently in 
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Table II, Migratory velocity of smooth-muscle cells cul-
tured from primary nnd restenotic coronary and peripheral 
arterial lesions excised at directional atherectomy 
Cell source 
PII'mruy 
CoronMy 
Peripheral 
Restenotk 
Coronruy 
Peripheral 
19.4 .f. 5.1 (n = 1) 
2.Ll ±2..(;(n= 12.) 
48_2 ± 3,6 (0 = 5) 
48,0 ± ~,O (n = 6) 
Y"I"e~ are up,.,,<-J ~ ",'~n ± S£'\1. lInits ar~ ~mflu (a,bpl • .:! f"om 
Ilauriedd G. <t at Clrcul,ti<!n 1991,I,S:5'>4 &,I). 
initial c-ell culture and early subculture.2~. 27 Reste-
nosis cells demonstrated more rilpid growth, attrib-
uted to a significant subpopu!tltion of small, low-ad-
hesive proliferative cells that featured less among the 
cells of primary atherosclerotic origin. Two other 
findings were of particular interest. First, primary 
cells in culture did not respond to platelet-derived 
growth factor (PDGF), whereas resteno~is cells re-
~ponded by increasing their growth. Second, primary 
lesion cells proliferated in response to medium con-
ditioned by restenosis celis, allowing the authors to 
propose- an aut oerine growth -promoting (non-P DG F) 
function of smooth-muscle cells in restenosis lesions 
in human beings, a mechani~m previollsly suggested 
in animal studies. In a more recent study, this group 
describes their examination of cells cultivated from 
peripheral and coronary primary atherosclerotic and 
restenotic lesions by using a computer-assisted cell 
motion analysis system.5 Cell outgrowth was not re-
iated to any clinical parameter, incltlding the type of 
lesion, but restenosis cells were found to display in-
creased migratory activity during initial outgrowth in 
culture (Table II), which in conjunction with their 
earlier findings regarding proliferation, led the nu-
thorsto emphasize the importance of these aspects of 
cell behavior in the restenosis process, 
GUr own group has also sought to use initial and 
extended cell culture a~ a means of examining the 
behavior of human coronary smooth-muscle cells ob-
tained at directional atherectomy, Confluent cell,; 
cultured from retrieved tis5ue and electron micro-
graphic images of these cells reveal appearances con-
sistent with a mixed contractile/synthetic phenotype 
(Fig. 10). In agreement with the report of Datlsch et 
al.26 with respect to peripheral va~cular lcsion~, we 
found that smooth-muscle cells cultured from rest-
enotic coronary lesions demon~tratcd accelerated 
growth compared with cells from primary athcroscle-
rotic coronary !e~ions that had a growth pattern sim-
ilar to young control human umhilical artery medial 
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FIg. 10. A, Confluent cultured l'ells derived from tissue retrie\'ed at directional coronary atherectomy; 
typkal "hiU-and-mlley" culture morphologic features. Electron microscopic [eatures of smooth-muscle 
c"lIs [rom coronary artery athero~derotic plaque tissue excised at directional atherectomy, B, peripheral 
myofibrils (m). C, perinuderu: (II.') org.melles, endoplasmic reticulum (e), golgi bodies (g), and numerous 
riboSOllle~ are visible. 
cells (Fig. 11), Although we were also unable to relate 
gw\\1h in ('ulture to any clinical parameler, a factor 
favoring successful initial smooth-muscle cell out-
growth was the presence of organized thrombus in 
the nthereclomy specimen {Table 1m, hinting at 
links between complex lesions, unstable angina, and 
restenosis. Further, coronary cells derived from both 
types oflesion demonstrated inueased extracellular 
matrix production compared with the umbilical ar-
tery cells27 (Table IV), consistent with the concept 
that extracellular matrix synthesis is a property of 
the adult vascular smooth-muscle cell important in 
both primary atherosclerosis and restenosis. 
Cultured human vascular cells provide us with new 
alternative experimental models for the assessment 
of the in vitro actions of existing therapies ana, po-
tentially, for the development of novel treatment 
strategies. Having previously noted that material re-
triey{~d from patients receiving angiotensin-convert-
ing enzyme inhibitors was less likely to demonstrate 
successful smooth-muscle cell outgrowth, 29 Bauried 1'1 
et al.30 showed recently by means of celJ motion 
analysis and cell population douuling times that two 
a~pects of smooth-muscle ceil growth in culture, mi-
gration, and proliferation responded similarly but to 
different extents to a variety of exogenous pharma-
cologic agents, The conlbination of photosensitizing 
hematoporphyrin deri\'"ati,'es and photoradiation, a 
potential means of localizing and attacking the ath-
erosclerotic plaque, has been examined by using 
smooth-muscle cells cultured from tissue retrieved 
during peripheral arterial atherectomy.:H These cells 
were found to be more susceptible to damage than 
control vascular smooth-muscle cells cultured from 
healthy arteries biopsied postmortem. Cell-culture 
models need not be restricted to monolayers of one 
particular cell type. Cocuiture systems, as recently 
reviewed by Betz,51 can be constructed to mimic the 
vessel wall and thus cater for important interactions 
such as those that occur between the endothelium 
and the media. 
"Gene therapy",33 whereby new genetic materia.l is 
introdueed to the cell by using methods such as lipo-
fection,3-I retroviral vectors,S,,; engineered cells,31;·31 
and even particle bombardment,3B is a source of con-
siderable current· interest. Cells in culture lllay be 
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Table III. Frequency of smooth-muscle cell outgrov.1h in 98 
attempted cultures in relation to presence of organized 
thrombus in coronlll)' artery plaque tissue exdsed at 
directional atherectomy 
Thrombus ' .... 0 Illrombus 
SMC outgw,,-th 8/10 (M:;) 351M (40~d 
p < 0.026, Xl test 
Table IV. Extracellular matrb:: production of collagen and 
sulphated-glycosaminoglycans of human coronary cells 
cultured from plaque tissue exdsed at directional atherec-
tomy and of smooth muscle cells cultured from media of 
human umbilic.11 arteries 
Cdl source 
Re,tellO,;is 
PrimllI')' 
Umbilical 
Collagen 
0,034 ± 0.0061 
0.033 ± 0,00-\2 
0.019 ± 0,ocW· 2 
Glycosomi,wglycan_> 
11.5;1. 1.13 
15,4 ±. 3.l j 
5,4 ± 1.03,4 
("dlagon "Y1lthe;;i ........ determmed hy the "Vtake (of tfili,tod pro1in~ and 
mlphatfd-glyN;runinQglYCdn ')'nth""" by the il\corp-:,,"ti,m ~f l' ""lphat •. 
Valu,,"arena!WmolsdLigand vermitrogtrunoHotll1protoin,mt-an t ~E)'l; 
I' p < (l_D~, 'p < 0.(10.';. 
used to evaluate the success and effects of attempts 
to modify the genome and influence translation and 
transcription; human vascular cells obtained at 
atherectomy ale a logical prelimillllry testing groUiHi. 
Frozen tissue studies. The recent publication of 
Leclerc et al:"9 focuses on transcription (Fig. 6) and 
reports the illcreMed expression of messenger RNA 
for nonmuscle myosin heavy chain-B (l\.fHC-B) in 
the intimal smooth-muscle cells of restenosis tissue 
compared with primary atherosclerotic tissue re-
trieved at peripheral or corollary atherectomy.:;g This 
finding is of interest because nonmuscle myosin has 
been implicated in vascular smooth-muscle cell divi-
sion and proliferation; the method is a timely re-
minder oflhe application of molecular biologic tech-
niques in clinical science. The mRNA for MHC-B 
was detected by in situ hybridization (Fig. 7) by us-
ing an antisense complementary (c)RNA probe pre-
pared from recently cloned complementary deoxyni-
bonucleic acid (DNA) coding for an isoform of the 
human nonmuscle MHC-B gene. To control for the 
specificity of the antisense cHNA probe, parallel hy-
bridizations were performed with the sense cRNA 
probe; to control for cross-hybridization of the nOll-
muscle myosin probe to smooth-muscle myosin, hy-
bridizations were performed in normal human inter-
Ilal mammary artery media preparat ions. By using a 
similar technique, this research group has now in-
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Fig. 11, Growth curves of smooth·muscle cells derived 
fr(lm human coronary restenotic and primary atheroscle-
rotic lesions and from normal human umhilkal artery me-
dia in secondary culture. 
vt'stigated the possible role of transforming growth 
factor-,8 (TGF-,B) find sugg'ests that it may be in-
volved in vascular restenosis,40 Work of this nature, 
probing genetic regulation in plaque tissue, hM par-
ticular relevance in view of the possibilities of gene 
therapy, However, 011 a note of caution, as the llUIll-
ber of grow1h factors and other mediators impli('ated 
in atherogenesis and restenosis expands the dilli-
culty of interpreting this newfound knowledge of the 
cell renders the choice of optimal targets le~s straight-
forward. 
PROSPECTS 
The various research techniques we have men-
tioned are unlikely to excite the cell biologist, who is 
well acquainted with them. However, with the advent 
of directional atherectomy, it is now possible to ap-
ply such techniques in a systematic manner to the 
investigation of atherosclerosis, OUI most common 
source of mortality, and restenosis, the response to 
injury that hesets vascular intervention, by using 
human material, The identification of pathophysio-
logic mechanisms within the cell holds out the pros-
pect of discovering, de\'eloping, nnd testing new 
pharmacologic or genetic therapies that can then be 
assessed in human cell culture systems. Wurk oftn!>; 
nature represents an impurtant ndvance at a tillle 
when, in the field of restenosis, the failure of both 
empirlc drug tria!s and trials based on appnrently 
sound animal experimental evidence is a cause of 
concern.H , 42 Directional atherectomy opens up new 
MacLeod et ai, 
avenues of research, but it falls to the intervention-
alist to generate t he enthusiasm among colleagues in 
the basic sciences that is the stimulus for fresh col-
laborative research. 
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This thesis summarizes the clinical, angiographic and histologic findings in patients 
who underwent a directional coronary atherectomy in Rotterdam and Brussels 
between September 1989 and January 1994. In pari I, the concept of matching for 
angiographic and clinical parameters is introduced, validated and subsequently used 
as a technique to compare the angiographic results of new interventional devices, and 
atherectomy in particular, with those of conventional balloon angioplasty. In pari II, 
the immediate and late clinical outcome of this novel interventional procedure are 
reviewed. Pan Ill, provides an overview of the histologic information obtained from 
freshly harvested atherosclerotic plaque material. 
The purpose of this chapter is to review the results and to present some lessons which 
have been learned from the Rotterdam atherectomy program and provide a future 
perspective for directional atherectomy. Because restenosis still remains the Achilles 
heel of interventional cardiology, the merits of new techniques lay in reducing this 
phenomenon. Although patient care and clinical outcome remain the central issue, 
quantitative coronary angiography is the only reliable method to compare 
interventional techniques with respect to restenosis and remains the golden standard 
in interventional cardiology. Therefore, this chapter focuses on the values of 
angiography to summarize the data and provide a future perspective. 
How should quantitative corrmmy anxioRraphy data be applied to compare DCA alUI 
PTCA? 
We have now reached the stage where the safety and favorable immediate results for 
the various devices have been demonstrated in chapter IX-XII. The next logical step 
is the comparison of the devices to determine which specific features of a device may 
favor its use in a particular clinical situation [1,2]. In anticipation of such 
comparative trials, we have attempted to compare available data according to three 
methods. First, we extrapolated pathological findings in an animal model to clinical 
practice, secondly, introduced matching as a surrogate for randomized trials and 
thirdly we distinguished the angiographic outcome at follow-up from the renarrowing 
process dUl'illK follow-up (i.e. static vs dynamic restenosis criteria). 
J) Relative xain as all 'if/jUlY score', relative loss as all index of lIeo-
imimai hypflpiasia. The important observation that a greater gain in lumen (i.e. 
injury) is associated with a greater loss (ie repair) during follow-up has previously 
been described by Schwartz et al [3-5]. In a domestic swine stented model, which 
accurately mimics the proliferative nature of human restenosis, the extent of the 
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proliferative response was strongly associated with rupture of the internal elastic 
lamina as induced by oversized and overpressurized balloon inflations, with, or 
without, coil implantation. In chapter IX this hypothesis is tested in a clinical setting, 
by substituting the concept of lIinjury score" and linea-intimal hyperplasiall as 
observed in the animal model with the angiographically derived parameters of relative 
gain and relative loss. Previous balloon angioplasty, stenting and atherectomy 
angiographic studies revealed a linear relationship between relative gain and relative 
loss, although the coefficient of correlation is low. More importantly, not only the 
strength of the correlation varied between devices, the slope of the regression line 
was steeper in the atherectomy group than in the stent and angioplasty group 
implying that the reactive response (ie relative loss) was more pronounced after 
atherectomy than following angioplasty. The slope of the regression line between 
relative gain and relative loss, which reflects the inherent relationship between the 
degree of wall injnry and the degree of repair represent an index of luminal 
renarrowing specific for each treatment modality (atherectomy, balloon angioplasty). 
II) Matchil1!i. In chapters Ill-VII, we have employed and described the 
technique of "matching" which is based on three principles: a) the angiographic 
dimensions of matched lesions are assumed to be lIidentical", b) the observed 
difference between the two "identical" lesions must be within the range of the CAAS 
analysis reproducibility of 0.1 mm (= I s.d.), and c) the reference diameter of the 
potentially "matched" vessels are selected within a range of ± 0.3 mm (=3 s.d.; ie. 
99% confidence limits). The appropriate lesions are selected by an independent 
observer who is unaware of the 6 month angiographic outcome. Subsequent 
refinement of this technique allowed also the incorporation of clinical variables 
thereby creating similar patient groups with identical lesion and clinical 
characteristics. Eventually, matching may be used as a surrogate for randomized 
trials and may serve as a predictor of the outcome of sllch trials. 
III) A multivariate analysis of the J'ellarrowin~ process am/ {ate outcome. 
While examining the long-term results of intracoronary interventions, two aspects 
should be considered: (I) the clinical approach in which the determinant of the long-
term angiographic outcome (minimal luminal diameter at follow-up) is characterized 
and (2) the biological approach which describes the determinants of the dynamic 
process (late luminal loss) which is initiated by the injury inflicted to the vessel wall 
during intervention. Initially. these two viewpoints appear contradictory but on deeper 
examination it Illay be possible to reconcile the assessment of outcome and process 
and find that each view, in its way, may be correct, although not addressing the 
entire picture. In chapter XI, we sought to reconcile the clinical and biological views 
(i.e. long-term angiographic outcome as welJ as the dynamic process of renarrowing 
which occurs during follow-up) in a consecutive series of patients treated by 
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atherectomy. We concluded that while analyzing the long-term results of 
interventional techniques, the biological process (luminal loss during follow-up) -
which characterizes the traumatizing nature of the intervention - should be dissociated 
from the clinical all/come (minimal luminal diameter at follow-up). It is clear that 
while improved clinical outcome is associated with larger vessel size and post-
procedural luminal diameter, greater relative gain at intervention is strongly 
predictive of more extensive luminal renarrowing. 
The observations made by Kuntz et al [6-9] that achieving greater luminal gain with 
newer devices may reduce angiographic restenosis seem not completely in parallel 
with the linding that a greater luminal gain results in greater luminal loss. While our 
group are focusing in clinical studies mainly on the degree of renarrowing as a 
measure of the extent of the biological process i.e. the development of intimal 
hyperplasia, others have focused on the angiographic outcome i.e. final minimal 
luminal diameter. This is the difference, as has been expressed by Schwartz et aI [5] 
between the "doughnut and the doughnut hole". There is little doubt that a larger 
lumen at follow-up may be clinically "better" for the patient and this parameter is of 
great importance in assessing the long-term outcome of therapy. However, in large 
clinical trials directed at the prevention of renarrowing, the effect of therapy must be 
measured by its restricting effect on the thickness of the "doughnutH, which we 
believe is best encapsulated angiographically by the relative luminal loss during 
follow-up. As recently described, we believe that application of both approaches 
(clinical outcome and biological process) to the same population yield similar findings 
and the apparently diverse conclusions arise not from differences in therapeutic 
results but from differences in focus and approach [5]. 
Matchinf: to predict the aU/come (?f randomized device tdals: 
With the introduction of various new intracoronary devices, it is critical to assess the 
relative merits of each system. Matching a study population with a reference patient 
group of similar characteristics can be lIsed to compensate for some of the limitations 
of nonrandomized studies [10]. Furthermore, it may serve as a surrogate for 
randomized trials [II] or at least provide a more accurate calculation of power for 
upcoming randomized trials. In fact this form of comparative analysis has been 
validated demonstrating its value in predicting the outcome of randomized trials 
comparing angioplasty with atherectomy [12,13] and angioplasty with stenting [II]. 
In the matching study described in chapter VI, matching for clinical and angiographic 
variables resulted in two comparable groups with quite similar baseline stenosis 
characteristics. Atherectomy resulted in a more pronounced increase in minimal 
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luminal diameter than balloon angioplasty (mean ± SD: 1.17 ± 0.29 mm to 2.44 ± 
0.42 nllll versus 1.21 ± 0.38 mm to 2.00 ± 0.36 mm;p<O.OOI), this favorable 
immediate resuit was subsequently lost during late angiographic follow-up so that the 
minimal luminal diameter at follow-up and the net gain index did not differ 
significantly between the two groups (1.76 ± 0.62 mm versus 1.77 ± 0.59 111m; 
p~0.93 and 0.18 ± 0.19 versus 0.17 ± 0.17;p~0. 70) (Figure I). Consequently, the 
relative gain and relative loss were higher in the atherectomy group. For both 
techniques, the relative gain is linearly related to the relative loss but, the slope of 
the regression line is steeper for atherectomy suggesting that the relative loss is 
proportionally even larger for a given relative gain when compared to the balloon 
angioplasty group. This study confirmed that the long-term beneficial effect of 
directional atherectomy were less than expected, and indeed that important 
information could be derived by the evaluation of matched lesions which might be 
useful for the design of future randomized trials. For example, it can be calculated 
from this study that in order to demonstrate til at a difference in minimal luminal 
diameter of 0.07 mm at follow-up between atherectomy and balloon angioplasty 
groups is statistically different (with a 90% confidence interval and an error of 5%) 
1295 patients in each arm would be required in a randomized trial. However this 
calculation should not preclude attempting a randomized trial which includes less 
patients (such as the CAVEAT trial) since subgroup analysis might nevertheless 
unravel a subset of patients (or lesions) who may especially benefit from the new 
intervention. 
Outcome of randomized tria/,\': 
The CAVEAT and CCAT trials were the first completed randomized device trials 
[l,2). In both trials, the potential long-term benefit of at he recto my was evaluated and 
compared with conventional balloon angioplasty in primary native coronary arteries 
(CA VEAT) and primary lesions in the left anterior descending artery (CCAT). The 
primary endpoint encompassed quantitative angiographic measurements of luminal 
changes after intervention. Quantitative coronary angiography was performed in core-
laboratories with different quantitative analysis systems (CAVEAT: ImageCom and 
CCAT: CMS). By protocol, the administration of intracoronary nitrates before and 
after intervention and at follow-up was obligatory. The quantitative coronary analysis 
was performed for multiple view but reported only for the view in which the lesion 
was judged to be most severe. At the outset of the trials, reslenosis was defined as 
a diameter stenosis at follow-up;" 50% at follow-up. Secondary analysis included the 
assessment of the minimal luminal diameter at follow-up and its cumulative 
distribution for the two groups. The cUlllulative frequency distributions of the 
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minimal luminal diameter at the three time intervals are provided in figures II 
(CA VEAT) and III (CCAT). As can be appreciated in both figures, atherectomy 
induced a larger acute gain and late loss than balloon angiopiasty. As a consequence, 
the minimal luminal diameter at follow-up were comparable in both groups although 
a trend favoring atherectomy was shown in the CA VEAT study. Consequently, the 
distribution cllrves of the minimal luminal diameter at follow-up run closely together. 
Opposed to the CCAT findings, CA VEAT patients who underwent atherectomy for 
lesion in the proximal segment of the left anterior descending coronary artery had a 
significant higher minimal luminal diameter at follow-up compared to those who were 
treated with balloon angioplasty. Figures I-III summarize the findings of the outcome 
of the matching study and the outcome of the two randomized trials. It may be 
concluded that our matching technique is a reliable method to predict the 
angiographic outcome of randomized trials comparing new interventional devices. 
Future Directions: 
Although atherectomy did not lead to an improved late clinical or angiographic 
outcome in the abovementioned trials, further analysis is needed to identify subgroups 
of patients who may benefit from this procedure (e.g. unstable angina patients). Some 
investigators stated that the conservative atherectomy strategy in the CAVEAT trial, 
which represents loday's atherectomy practise, is potentially responsible for the 
disappointing clinical and angiographic atherectomy results. The majority of the 
clinical events were related to the phenomenon of subacute occlusion which has been 
shown to be related with a high residual diameter stenosis [14] (post-DCA diameter 
stenosis of 29 % in CA VEA T) and a low anticoagulation status of the patieht. Another 
group of investigators stated that this atherectomy strategy is also responsible for the 
high restenosis rate in this group since they have identified that a residual post-
atherectomy lumen of ,,20% diameter stenosis yielded the best results after 
atherectomy although there series has not been evaluated by quantitative angiography. 
These findings may urge for new angiographic endpoint definitions for (i) defining 
atherectomy to be successful and (ii) for defining the angiographic outcome of 
interventions lIsing a continuous approach (minimal luminal diameter at follow-up) 
rather than a categorical approach (restenosis rates). 
In a preliminary analysis frolll the Thoraxcenter patient cohort, we identified that 
atherectomy induced more luminal loss when the acute gain was comparable with a 
matched PTCA population. This indicates that the operator should strive for a large 
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acute gain to ensure a long-term angiographic benefit after atherectomy. Recently, 
Kuntz et al [15] found that a luminal gain after atherectomy of less than 0.7 mm was 
associated with a lower minimal luminal diameter at follow-up compared to the 
optimally treated group. Similarly, by dichotomizing our atherectomy population by 
the post-DCA minimal luminal diameter it appeared that patients with a large post-
atherectomy minimal luminal diameter had the best late outcome. Subsequent analysis 
showed that optimal atherectomy as defined by a large net gain (mId at follow-up -
mId pre) in our population was associated with large vessels and a large luminal gain 
(Figure IV). These results may call for a new definition of atherectomy success 
which should then be considered as successful when a post-atherectomy diameter 
stenosis is less than 20%. Early analysis of the acute results of the Angiopeptin trial 
have indicated that such an optimal atherectomy (post-DCA diameter stenosis 18%) 
can be performed with a low acute complication rate [16]. Whether such an optimal 
atherectomy indeed yields a better long-term result should be tested in a new 
randomized trial. These new findings should be considered when interpreting the 
outcome of the CAVEAT and CCAT trials since in these trials only a modest 
atherectomy was performed. 
A second technical wind in the post-CAVEAT and post-CCAT era can be expected 
when atherectomy can be performed under real-time ultrasound guidance which will 
enable the operator to selectively remove the plaque. Such ultrasound guidance should 
also be able to identify subcategories of lesions ideally suited to atherectomy and will 
permit the achievement of maximal luminal gain with safety. The possibility to 
measure luminal area and the area inside the external elastic lamina before and after 
coronary intervention allows one to study the mechanisms of slich intervention. 
Intracoronary ultrasound imaging has shown that gain in luminal area is primarily 
achieved by plaque removal with directional coronary atherectomy [17]. 
Ultimately the restenosis process may only be controlled by the combination of a 
large luminal gain which will provide a large lumen at follow-up and pharmacologic 
intervention to reduce the increased luminal loss associated with such a large gain. 
Indeed one such trial (EUROCARE) is soon to be undertaken and will specifically 
address this issue. This trial is designed from the perspective tithe more you gain, the 
more you loseu and combines a large acute gain ill combination with an anti-oxidant 
and anti-proliferative pharmacological agent to reduce subsequent luminal loss. On 
the other hand, the BOAT trial will evaluate the effect of optimal atherectomy versus 
balloon angioplasty and is designed from the perspective "bigger is better" with 
emphasis on optimal performance. In other words, the BOAT trial will increase the 
"doughnut's hole" while EUROCARE will also try to reduce the "doughnut". 
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SAMENV ATTING 
Sedert de introdllctie van de percutane transluminale coronaire angioplastiek als 
behandeling van coronair lijden hebben voortschrijdende verbeteringen in de 
cathetertechnieken en in dilatatiestrategieen geleid tot een hoog initiee! 
succespercentage (±90%). Ondanks deze verbeteringen treden in 3% tot 5% 
acute complicaties op als gevolg van een beschadiging van de vaatwand waardoor 
een adequate myocardperfusie niet meer mogelijk is. Mede door deze factoren 
bestaat er behoefte aan nieuwe percutane technieken ais aIternatief voor de 
conventionele ballonangioplastiek. Directionele coronaire atherectomie is een van 
deze nieuwe behandelingstechnieken waarbij op een gecontroleerde wijze de 
atheromateuze plaque wordt verwijderd. Met het verwijderde materiaal krijgt men 
op deze wijze levend menselijk (re)stenose materiaal ter beschikking. 
He! doel van de in deze dissertatie beschreven studies was het evalueren van de 
klinische, angiografische en histologische aspecten van directionele atherectomie 
en de angiografische bevindingen te vergelijken met het resuitaat van 
conventionele ballondilatatie. 
In hoofdstuk I word! de toepassing van quantitatieve coronaire angiografie in de 
interventie cardiologie besproken. Daarnaast wordt de klinische toepasbaarheid 
hiervan bij directionele coronaire atherectomie samengevat. De resultaten laten 
zien dat niet aileen de directe en lange-tennijns resuiaten maar ook het 
werkingsmechanisme van atherectomie met behulp van quantitative coronaire 
angiografie ge-evalueerd kllnnen worden. 
Hoofdstuk 2 is een studie die de resultaten van contourdetectie en 
videodensitometrie voor en na atherectomie vergelijkt. Het blijkt dat na 
atherectomie vergelijkbare verschillen bestaan tussen conteurdetectie en 
videodensitometrie. Op grand van deze gegevens kan geconcludeerd worden dat 
beide analysetechnieken geschikt zijn om de angiografische resllitaten van 
atherectomie Ie qllantiticeren. 
In hoofdstuk 3 wordl het werkingsmechanisme van atherectomie bestudeerd aan 
de hand van angiografische en hislologische bevindingen. Met atherectomie werd 
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een significant groter lumen verkregen in vergeJijking met hallonangioplastiek. 
Verder blijkt dat 63% van de luminale verbetering toe te schrijven valt aan een 
'Dotter' effect ten gevolge van het inbrengen de grate atheratoom. Quantitatieve 
coronaire angiografie en een histologische observatie ton en aan dat atherectomie 
resulteerl in een bijna circulair lumen. 
In hoofdstuk 4 worden de resultaten van atherectomie vergeleken met die van 
andere interventietechnieken zoals bailonangioplastiek, stentimpiantatie en 
ratablator. Hiertoe werden 51 atherectomie patienten gepaard aan 51 stent en 51 
ballonangioplastiek patienten. In een dergelijke gepaarde analyse blijken 
atherectomie en stentimplantatie een beler inilieeI resuItaat te geven dan 
ballonangioplastiek. 
Hoofdstuk 5 beschrijft de lange-termijns resultaten van een gepaarde atherectomie 
en ballonangioplastiek populatie. Opnieuw blijkt dat atherectomie tot een beter 
actlut resuitaat leidt dan ballonangiopiastiek maar dat het ook tot een verhoogde 
activiteit van het restenose proces leidt waardoor bij nacontrole dit gunstige acute 
effect verdwenen is zodat de minimale luminale diameter bij nacontrole in beide 
groepen vergelijkbaar is. 
In hoofdstuk 6 wordt het angiografische resultaat van atherectomie en 
ballonangiopiastiek in een gepaarde patientenpopulalie beschreven. Drie nieuwe 
criteria om deze resultaten te kunnen vergelijken werden gedetinieerd. Met 
alherectomie wordt een gratere initieele winst van de minimale lumen diameter 
behaald dan met ballonangioplastiek. Enkele maanden later is deze winst echter 
veri oren gegaan. Yoor beide technieken werd een Iineaire relatie tussen "relatieve 
winst" en "relatief verlies" gevonden. De helling van de regressielijn is steiler in 
de atherectomie populatie daarmee aangevend dat het Il relatief verlies" in deze 
groep grater is voor dezelfde Itrelatieve winst" dan in de angioplastiek groep. 
Hoofdstuk 7 geeft de uitkomst weer van een analyse van patienten waarbij met 
atherectomie of angiopiastiek eenzelfde eind-resultaat bereikl werd. Deze studie 
laat zien dat bij nacontrole de angioplastiek groep een groter lumen had dan de 
athereclomie groep zodat bij alherectomie meer weggesneden moet worden om 
een gunstig eindresulaat Ie behalen. Dit is de eerste shldie die aantoond dat 
restenose afhankelijk is van de wijze van behandeling (snijden versus dilateren). 
Multivariate analyse laat inderdaad zien dat winst in lumen diameter een 
onafllankelijke voorspeller is voor het optreden van restenose. Die patienten 
waarbij het de, post-atherectomie diameter stenose minder dan 20% bedraeg 
hadden een significant beter lange-termijns resulaat. 
In hoofdstuk 8 wordt het werking'smechanisme van atherectomie bestudeerd door 
middel van kwantitatieve coranaire angiografie, intravasculaire echografie en 
intracoronaire angioscopie. De informatie verkregen door het gecombineerde 
gebruik van deze 3 beeldtechnieken geeft aan dat het angiografische resultaat na 
atherectomie (gladde vaalwand en hijna circulaire lumen configuratie) niet 
bevestigd wordt door echografie en angioscopie. De lumen toenall1e tijdens 
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directionele coronaire atherectolllie wordt grotendeels veroorzaakt door afname 
van de plaque area als gevolg van het wegsnijden van de vernauwing. 
In hoofdstuk 9 wordt de gezall~enIijke klinische en angiogratische ervaringen van 
(wee europese atherectomie centra beschreven. In totaal werd in 113 patienten een 
poging tot atherectomie verricht. Het procedurele succespercentage en primaire 
angioplasliek succespercenlage bedroeg respeclievelijk 85.7% en 95.2 %. Ernslige 
complicaties zoals overlijden, myocard infarct of coronaire bypass operatie 
kwamen in 5.7% van de patienten voor. 
In hoofdstuk 10 wordt een overzicht gegeven van de klinische en angiografische 
lange-termijn resllltaten van directionele coronaire atherectomie. Om inzicht Ie 
verkrijgen of het klinische syndroom ten tijde van de ingreep van invloed is op 
de resuitalen werd de palienlenpopulalie in Iwee groepen verdeeld: onslabiele 
versus stabiele angina pectoris. Onze ervaring is dat atherectomie een veilige 
behandelingsmethode is voor stabiele en onstabiele angina pectoris maar dat de 
iange-termijns resliltatcn in patienten met onstabiele angina pectoris slechter zijn. 
Deze hogere incidentie van complicaties ontstond ondanks het wegsnijden van de 
onstabiele plaque en Iijkt veroorzaakt te worden door de instabiliteit van dit 
syndroolll en niet zozeer door het feit dat Illet atherectomie geen adequaat Jange-
termijns resuitaat bereikt karl worden. 
In hoofdstuk II wordt de multivariate analyse gepresenteerd waarin de klinische, 
angiograflsche en histologische voorspellers van de 6-maands minimale lumina Ie 
diameter en van het luminale verlies ge'identificeerd worden. In di! hoofdstuk 
worden de twee geldende restenose concepten (" bigger is betterU versus Uthe more 
you gain, the more YOll losel!) verenigd. Wanneer de lange-tennijns resuitaten na 
een interventie worden hestudeerd mocten zowe! het luminale verlies 
(restenoseproces) - hetgeen gekarakteriseerd wordt door het genezingsproces van 
de vaatwand na cen interventie - als de 6-lllaands Ininimale JUlllillale diameter 
(klinische uilkolllsl) legelijkerlijd gekarakleriseerd worden. Hel is duidelijk dat 
een betere klinische lIitkomst verkregen wordt bij patienten met grote bloedvaten, 
een grate post-atherectomie minimale IUlllinale diameter en in niet-LAD lesies 
terwijl een grote relatieve luminale wins! voorspellend is voor een versterkte 
Iliminale vernauwing. 
In hoofdstuk 12 worden de vroege en late resuitaten beschreven van alherectomie 
van vernauwde coronaire stents bij 9 patientcn. De celidentificatie, proliferatie en 
celdichtheid van het verwijderde restenosemateriaal werd bestudeerd met behulp 
van cOllventionele en electronen miscroscopie en imlllunohistochemische 
technieken. De reslIitaten werden vergeleken met een controlegroep van patienten 
die een PTCA ondergaan hadden. De angiografische resuitaten toonden aan dat 
atherectomie een effectieve hehandelingsmethode is maar da! het lange-termijns 
resuiaat bepaald werd door het optreden van restenose. De weefsel studies 
loon den aan dBI de gladde spiercel hel belangrijksle ccitype is dal aangelroffcn 
werd in restenoseweefsel\ onatlmnkelijk van het type voorgaande interventie en 
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dat proliferatie van de myocyten een vroegtijdig fenomeen is en 2 maanden na de 
ingreep nauwelijks meer aantoonbaar is. 
In hoofdstuk 13 worden de histologische kenmerken van het verwijderde 
atherectomie materiaal van 93 procedures bij patienten met stabiele en onstabiele 
angina pectoris vergeleken. De aanwezigheid van neo-intimalehyperplasie, fibreus 
weefsel, cholesterol kristalspleten, necrotische weefsel, kalk, macrofagen, 
trombus, media of adventitia werden beschreven. De resuitaten van deze studie 
laten zien dat trombusvofming en verkalkingen vaker bij onstabiele dan stabiele 
angina pectoris gevonden werden. Verder bleek dat er geen relatie bestond tussen 
de dum van onstabiele angina pectoris en de mate van trombusorganisatie. Veeder 
was de aanwezigheid van intimale hyperplasie sterk gecorreieerd met het 
ondergaan van een eerdere interventie. De restenose lesies hadden een identieke 
histologische kenmerken onafhankelijk van de aard van de voorafgaande 
interventie. 
In hoofdstuk 14 worden de toepassingen van histologie, celkweektechnieken en 
immunologie beschreven. De kweek resu!taten van gladde spiercellen uit 
coronaire arterie fragmenten laten zien dat slechts uit de minderheid van de lesies 
serieie passage mogelijk was en dat gladde spierceilen van restenose lesies een 
versnelde groei vertoonde dan cellen van primaire lesies of cellen van de 
naveistrengarterie. Hoewel er werden geen klinische parameters gevonden die 
uitgroei konden voorspellen, was de aanwezigheid van trombus in het 
atherectomieweefsel gerelateerd aan uitgroei van gladde spiercellen. Verder 
vertoonde de cellen uit het atherectoillieweefsel een hogere graad van 
extracellulaire matrixcomponenten cholesterol en glycosaminoglycanen dan 
navelstreng gladde spiercellen. De celkweektechniek Iijkt een nuttig model te zijn 
bij de bestudering van atherosclerose en in het bijzonder restenose. 
In hoofdstuk 15 wordt een samenvatting gegeven van de in dit proefschrift 
beschreven studies. In het bijzonder worden de bevindingen van de gepaarde 
vergelijkingen (ballon angioplastiek versus atherectomie) gerelateerd aan de 
uitkoillst van de twee gerandomiseerde studies. Het blijkt dat anze gepaarde 
analyse zoals beschreven in hoofdstuk 9, de uitkoillst van de gerandomiseerde 
studies nauwkeurig voorspelde. Hoewel atherectomie op dit moment niet 
aantoonbaar beter is dan ballonangioplastiek zullen toekomstige inzichten en 
ontwikkelingen zoals i) een betere definitie van een geslaagde 
atherectoillieprocedure, ii) de ontwikkeling van een gecoillbineerd 
atherectomie/echo apparaat en iii) de combinatie atherectomie/medicamenteuze 
therapie de lange-termijns reslJitaten van atherectomie nog verder verbeteren. 
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